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Abstract 
 
Background  
Stroke mimic (SM) conditions produce stroke-like symptoms through diverse mechanisms. 
Up to 43% of pre-hospital suspected stroke patients are SM because identification tools 
prioritise sensitivity over specificity, leading to inefficient use of ambulances and stroke 
services. No existing pre-hospital SM identification tools could be identified. A pragmatic SM 
identification tool using easily available information from suspected stroke patients was 
developed. 
 
Methods  
A systematic literature review and a national paramedic survey generated possible tool 
content. Independent predictors were isolated by regression analysis of selected variables 
documented in ambulance records of suspected stroke patients linked to primary hospital 
diagnoses (derivation dataset, n=1,650, 40% SM). The tool was refined using an expanded 
dataset (n=3,797, 41% SM), usability testing and professional focus groups. The potential 
clinical impact was evaluated through basic service efficiency modelling and focus groups. 
 
Results  
The “STEAM tool” combines six variables:  
 1 point for Systolic blood pressure<90mmHg 
 1 point for Temperature>38.5oC with heart rate>90bpm  
 1 point for seizures or 2 points for seizures with known diagnosis of Epilepsy  
 1 point for Age<40 years or 2 points for age<30 years 
 1 point for headache with known diagnosis of Migraine  
 1 point for FAST-ve suspected stroke 
 
A score of ≥2 on STEAM predicted SM diagnosis in the refinement dataset with 5.5% 
sensitivity, 99.6% specificity and positive predictive value (PPV) of 91.4%. External validation 
(n=1,848, 33% SM) showed 5.6% sensitivity, 99.5% specificity and a PPV of 85.0%. 
 
Focus groups with paramedics and hospital clinicians identified benefits and risks to patients 
ii 
 
and clinical services from using STEAM.  
 
Conclusions  
A multi-method approach developed and validated a tool using common clinical 
characteristics to identify a small proportion of SM patients with a high degree of certainty. 
The tool appears feasible for pre-hospital use but its impact will depend upon local models 
of stroke care. 
  
iii 
 
  
iv 
 
Acknowledgements 
 
I need to thank a lot of people for their support and help over the last three years including: 
 
The Stroke Association for their support and funding. 
North East Ambulance Service and the North East Ambulance Service charity for their 
support and specifically Sonia Townend, Marc Birkett and Zarna Phipps for their individual 
support. 
Dr Helen Bosomworth for being a very understanding office mate. 
Dr Kim Pearce at Newcastle University for statistical support. 
Professor Phil White and Professor Richard Thomson for acting as my progression panel and 
their support, advice and insight. 
Judith Plank at Northumbria Healthcare NHS Foundation Trust for helping with data at the 
start of the project.  
Dr Anand Dixit, Guy Galpin and Lorraine Bell from Newcastle upon Tyne Hospitals NHS 
Foundation Trust for their help. 
Dr Ijaz Anwar, Susan Crawford and Andrew James at North Tees and Hartlepool Hospitals 
NHS Foundation Trust for their help. 
Dr Yogish Pai and Michael Nixon at County Durham and Darlington NHS Foundation Trust for 
their help. 
All the survey, focus group and usability testing participants. 
My supervisory team who successfully navigated me through an interesting three years. Dr 
Chris Price who encouraged me to apply for a PhD in the first place then guided and 
supported me through the whole journey. Dr Darren Flynn for providing a different point of 
view and reminding me about work life balance. Professor Helen Rodgers for her time, 
insight and for helping me consider the bigger picture. 
My parents for their inspiration, encouragement and support over many years. 
v 
 
A special thank you needs to go to my wife Fiona for putting up with me, motivating me, 
believing in me when I didn’t believe in myself and being my biggest supporter. A special 
thank you also needs to go to my daughters Jessica and Abigail for being more interested in 
dressing up as princesses and reminding me what is really important on a daily basis. 
 
  
vi 
 
Thesis author responsibilities / contribution 
 
This project was developed with guidance and support from Dr Christopher Price.  
A PhD postgraduate fellowship was secured from The Stroke Association to fund this project 
with Dr Christopher Price as the lead supervisor. Dr Darren Flynn and Professor Helen 
Rodgers completed the supervisory team. 
I competed all the work included within this thesis under the supervision of Dr Christopher 
Price, Dr Darren Flynn and Professor Helen Rodgers.    
vii 
 
Publications, posters and presentations 
 
Publications 
 
McClelland, G., Rodgers, H., Flynn, D., Price, C. (2018). The frequency, characteristics and 
aetiology of stroke mimic presentations: a narrative review. European Journal of Emergency 
Medicine. Published online 1st May 2018. doi: 10.1097/MEJ.0000000000000550 
 
McClelland, G., Rodgers, H., Flynn, D., Price, C. (2018). Development and validation of a 
pragmatic pre-hospital tool to identify stroke mimic patients (poster abstract). BMJ Open, 
8(Suppl 1).  
 
McClelland, G., Flynn, D., Rodgers, H., Price, C. (2017). Development of a pre-hospital stroke 
mimic identification tool: a focus group study with healthcare professionals (poster 
abstract). International Journal of Stroke, 12(5S), pp. 22. 
 
McClelland, G., Rodgers, H., Flynn, D., Price, C. (2017). Development of a pre-hospital 
assessment to identify stroke mimic conditions (poster abstract). EMJ, 34(10), pp. 14. 
 
McClelland, G., Flynn, D., Rodgers, H., Price, C. (2017). A survey of UK paramedics’ views 
about their stroke training, current practice and the identification of stroke mimics. British 
Paramedic Journal, 2(1), pp. 4–15. 
 
McClelland, G., Rodgers, H., Flynn, D., Price, C. (2016). The frequency and diagnosis of stroke 
mimics in pre-hospital and hospital studies: a systematic literature review (poster abstract). 
International Journal of Stroke, 11(4S), pp 30-31. 
 
McClelland, G., Flynn, D., Rodgers, H., Price, C. (2015). A systematic review of the clinical and 
demographic characteristics of adult patients with stroke mimics. PROSPERO: 
CRD42015026457. Available at  
http://www.crd.york.ac.uk/PROSPERO/display_record.asp?ID=CRD42015026457 [Accessed 
21/06/18]. 
viii 
 
 
Posters 
 
Title: When is a stroke not a stroke? Development and validation of a pragmatic pre-hospital  
tool to identify stroke mimic patients  
Conference: EMS2018  
Location: Copenhagen, Denmark 
Date: 16-18th April 2018 
 
Title: Development of a pre-hospital stroke mimic identification tool: a focus group study 
with healthcare professionals 
Conference: The UK Stroke Forum  
Location: Liverpool, UK 
Date: 28-30th November 2017 
 
Title: When is a stroke not a stroke? Development of the STEAM tool to identify pre-hospital 
stroke mimics (Best poster prize) 
Conference: North East and North Cumbria Clinical Research Network Building our Research 
Capacity and Capability 
Location: Newcastle-upon-Tyne, UK 
Date: 7th November 2017 
 
Title: When is a stroke not a stroke? Development of the STEAM tool to identify pre-hospital  
stroke mimics 
Conference: Newcastle University Cardiovascular Research Centre trainees conference 
Location: Newcastle-upon-Tyne, UK 
Date: 28th June 2017 
 
Title: When is a stroke not a stroke? Development of the STEAM tool to identify pre-hospital  
stroke mimics 
Conference: EMS999 Research Forum 
Location: Bristol, UK 
ix 
 
Date: 28-29th March 2017 
 
Title: The frequency and aetiology of stroke mimics: a systematic literature review 
Conference: The UK Stroke Forum 
Location: Liverpool, UK 
Date: 28-30th November 2016 
 
Title: The frequency and aetiology of stroke mimics: a systematic literature review 
Conference: North East Postgraduate Conference 
Location: Newcastle-upon Tyne, UK 
Date: 24-25th November 2016 
 
Title: The frequency and aetiology of stroke mimics: a systematic literature review 
Conference: Newcastle University Cardiovascular Research Centre trainees conference 
Location: Newcastle University, UK 
Date: 14th September 2016 
 
Presentations  
 
Title: Why pre-hospital stroke care need to change 
Conference: EMS2018  
Location: Copenhagen, Denmark 
Date: 16-18th April 2018 
 
Title: Can we improve stroke care by identifying stroke mimics? (Highest quality research  
prize) 
Conference: EMS999 Research Forum 
Location: Stirling, UK 
Date: 26-27th March 2018 
 
Title: Improving pre-hospital stroke identification by reducing mimics 
Conference: Northern Emergency Medicine Conference 
x 
 
Location: Durham, UK 
Date: 9th January 2018 
 
Title: But is it a mimic? (part of stroke identification workshop) 
Conference: The UK Stroke Forum 
Location: Liverpool, UK 
Date: 28-30th November 2017 
 
Title: When is a stroke not a stroke? Development of a pre-hospital stroke mimic  
identification tool 
Conference: Webinar for College of Paramedics Research and Development Committee 
Location: Webinar 
Date: 18th October 2017 
 
Title: When is a stroke not a stroke? 
Conference: North West Stroke CPD Event 
Location: Salford, UK 
Date: 3rd August 2017 
 
Title: Paramedic Stroke Mimic Project 
Conference: North East Stroke Patient and Carer panel 
Location: Washington, UK 
Date: 27th April 2017 
 
Title: When is a stroke not a stroke? 
Conference: Institute of Neuroscience 2nd year postgraduate symposium 
Location: Newcastle-upon-Tyne, UK 
Date: 26th April 2017 
 
Title: Paramedic Stroke Mimic Project 
Conference: Stroke Research Group presentation day 
Location: Newcastle-upon-Tyne, UK 
Date: 3rd March 2017 
xi 
 
 
Title: Pre-hospital research and the Paramedic Stroke Mimic Project 
Conference: Explore lifelong learning event 
Location: Newcastle-upon-Tyne 
Date:  1st March 2017 
 
Title: Paramedic Stroke Mimic Project 
Conference: Regional Stroke Advisory Group meeting 
Location: Durham, UK 
Date: 10th January 2017 
 
Title: Paramedic Stroke Mimic Project 
Conference: North East Ambulance Service Clinical Effectiveness Group 
Location: Newcastle-upon-Tyne, UK 
Date: 8th December 2016 
 
Title: Development of a pre-hospital assessment to identify stroke mimic conditions 
Conference: Council for Allied Health Professionals Research Best Practice in AHP Research  
event 
Location: Newcastle-upon-Tyne, UK 
Date: 5th December 2016 
 
Title: The frequency and diagnoses of stroke mimics 
Conference: North East Postgraduate Conference 
Location: Newcastle-upon-Tyne, UK 
Date: 24-25th November 2016 
 
Title: Identification of pre-hospital stroke mimics 
Conference: CRN Regional Stroke Specialty Research Update meeting 
Location: Durham, UK 
Date: 30th June 2016 
 
 
xii 
 
Title: Identification of pre-hospital stroke mimics 
Conference: Institute of Neuroscience PhD student presentations 
Location: Newcastle-upon-Tyne, UK 
Date: 6th April 2016 
 
  
xiii 
 
Table of contents 
 
Abstract ............................................................................................................................ i 
Acknowledgements ......................................................................................................... iv 
Thesis author responsibilities / contribution .................................................................... vi 
Publications, posters and presentations .......................................................................... vii 
Publications .................................................................................................................................... vii 
Posters ........................................................................................................................................... viii 
Presentations .................................................................................................................................. ix 
Table of contents ........................................................................................................... xiii 
List of figures ................................................................................................................ xxiv 
List of tables ................................................................................................................. xxvi 
List of charts ................................................................................................................. xxxi 
List of abbreviations .................................................................................................... xxxii 
Chapter 1.0 Overview ....................................................................................................... 1 
1.0.1 Overview .................................................................................................................................... 1 
1.0.2 Project aims ................................................................................................................................ 3 
1.0.3 Research design.......................................................................................................................... 3 
1.0.4 Structure of thesis ...................................................................................................................... 4 
1.0.5 Summary .................................................................................................................................... 5 
Chapter 1.1 Background and rationale .............................................................................. 6 
1.1.1 Introduction ............................................................................................................................... 6 
1.1.2 Chapter aims and objectives ...................................................................................................... 6 
1.1.3 Overview of stroke ..................................................................................................................... 6 
1.1.4 Emergency stroke treatment ..................................................................................................... 7 
1.1.5 Pre-hospital stroke care ............................................................................................................. 9 
1.1.6 Pre-hospital stroke identification tools ...................................................................................... 9 
1.1.7 Assessment of diagnostic tests ................................................................................................ 12 
1.1.8 Stroke mimic conditions ........................................................................................................... 15 
1.1.9 SM identification tools ............................................................................................................. 17 
1.1.10 Clinical prediction rules .......................................................................................................... 20 
1.1.11 Summary ................................................................................................................................ 20 
Chapter 1.2 The frequency, characteristics and aetiology of stroke mimic presentations: a 
narrative review ............................................................................................................. 22 
1.2.1 Introduction ............................................................................................................................. 22 
xiv 
 
1.2.2 Methods ................................................................................................................................... 22 
1.2.2.1 Inclusion criteria ................................................................................................................ 22 
1.2.2.2 Database search strategy .................................................................................................. 23 
1.2.2.3 Study selection process ..................................................................................................... 23 
1.2.2.4 Data extraction and analysis ............................................................................................. 23 
1.2.2.5 Quality assessment ............................................................................................................ 23 
1.2.3 Results ...................................................................................................................................... 24 
1.2.3.1 SM final diagnoses ............................................................................................................. 32 
1.2.3.2 Pre-hospital studies ........................................................................................................... 33 
1.2.3.3 Thrombolysis studies ......................................................................................................... 33 
1.2.3.4 General studies .................................................................................................................. 34 
1.2.3.5 Clinical characteristics ....................................................................................................... 34 
1.2.4 Discussion ................................................................................................................................. 36 
1.2.4.1 Frequency .......................................................................................................................... 36 
1.2.4.2 Characteristics ................................................................................................................... 37 
1.2.4.3 Aetiology ............................................................................................................................ 38 
1.2.4.4 Clinical implications ........................................................................................................... 38 
1.2.4.5 Limitations ......................................................................................................................... 39 
1.2.5 Conclusions ............................................................................................................................... 39 
1.2.6 Summary ................................................................................................................................... 40 
Chapter 1.3 Survey of UK Paramedics stroke training, practice and stroke mimic knowledge
 ...................................................................................................................................... 41 
1.3.1 Introduction .............................................................................................................................. 41 
1.3.2 Chapter aims and objectives .................................................................................................... 41 
1.3.3 Methods ................................................................................................................................... 42 
1.3.3.1 Sample and recruitment .................................................................................................... 42 
1.3.3.2 Data collection and analysis .............................................................................................. 42 
1.3.3.3 Ethics.................................................................................................................................. 42 
1.3.4 Results ...................................................................................................................................... 43 
1.3.4.1 Demographics .................................................................................................................... 43 
1.3.4.2 Stroke training and continuing professional development ............................................... 45 
1.3.4.3 Stroke assessment tools .................................................................................................... 46 
1.3.4.4 Stroke compared to other time critical conditions ........................................................... 47 
1.3.4.5 Stroke transport ................................................................................................................ 48 
1.3.4.6 Transient Ischaemic Attacks .............................................................................................. 49 
1.3.4.7 Stroke general questions ................................................................................................... 50 
1.3.4.8 Stroke mimics .................................................................................................................... 50 
xv 
 
1.3.5 Discussion ................................................................................................................................. 53 
1.3.5.1 Pre-hospital workforce ...................................................................................................... 53 
1.3.5.2 Stroke training and continuing professional development ............................................... 53 
1.3.5.3 Stroke assessment, treatment and transport ................................................................... 53 
1.3.5.4 Stroke compared to other time critical conditions ........................................................... 54 
1.3.5.5 Research and developing treatments ............................................................................... 54 
1.3.5.6 Stroke mimics .................................................................................................................... 55 
1.3.5.7 Limitations ......................................................................................................................... 56 
1.3.6 Conclusions .............................................................................................................................. 56 
1.3.7 Summary .................................................................................................................................. 56 
Chapter 1.4 Pre-hospital suspected stroke in North East England .................................... 57 
1.4.1 Introduction ............................................................................................................................. 57 
1.4.2 Chapter aims ............................................................................................................................ 57 
1.4.3 Methods ................................................................................................................................... 57 
1.4.3.1 Study setting ...................................................................................................................... 57 
1.4.3.2 Pre-hospital data collection .............................................................................................. 58 
1.4.3.3 Pre-hospital data format ................................................................................................... 59 
1.4.3.4 Identifying pre-hospital stroke patients ............................................................................ 60 
1.4.3.5 Timeframe ......................................................................................................................... 60 
1.4.3.6 Pre-hospital data inclusion/exclusion criteria ................................................................... 61 
1.4.3.7 Linking pre-hospital data with patient diagnoses ............................................................. 61 
1.4.3.8 Data linkage methods ....................................................................................................... 63 
1.4.3.9 Data linkage – stage 1 ....................................................................................................... 63 
1.4.3.10 Data linkage – stage 2 ..................................................................................................... 63 
1.4.3.11 Patient diagnoses definitions .......................................................................................... 64 
1.4.3.12 Data analysis .................................................................................................................... 65 
1.4.3.13 Missing data .................................................................................................................... 65 
1.4.3.14 Approvals and ethics ....................................................................................................... 65 
1.4.4 Results - Establishing the SM rate and describing SM conditions ........................................... 66 
1.4.4.1 NEAS and NHCT data ......................................................................................................... 66 
1.4.4.2 Patient diagnosis data collection – stage 1 ....................................................................... 67 
1.4.4.3 Inter-rater reliability check of stroke identification .......................................................... 67 
1.4.4.4 Patient diagnosis data collection – stage 2 ....................................................................... 67 
1.4.4.5 Final diagnoses .................................................................................................................. 67 
1.4.4.6 SM diagnoses..................................................................................................................... 68 
1.4.5 Results – describing the suspected stroke population ............................................................ 73 
1.4.5.1 Structured and free-text data ........................................................................................... 73 
xvi 
 
1.4.5.2 Reliability of free-text data extraction .............................................................................. 74 
1.4.5.3 Pertinent negative data ..................................................................................................... 74 
1.4.5.4 Missing data ....................................................................................................................... 74 
1.4.5.5 Physiological observations data cleaning .......................................................................... 75 
1.4.5.6 Stroke and SM population demographics ......................................................................... 76 
1.4.5.7 Paramedic documentation of clinical impression ............................................................. 77 
1.4.5.8 Physiological observations ................................................................................................ 78 
1.4.5.9 Past medical history........................................................................................................... 79 
1.4.5.10 Clinical signs and symptoms ............................................................................................ 79 
1.4.6 Discussion ................................................................................................................................. 81 
1.4.6.1 Establishing the sample data ............................................................................................. 82 
1.4.6.2 Free-text data reliability .................................................................................................... 84 
1.4.6.3 Missing data ....................................................................................................................... 84 
1.4.6.4 Suspected stroke population ............................................................................................. 85 
1.4.6.5 Physiological observations ................................................................................................ 86 
1.4.6.6 Past medical history........................................................................................................... 86 
1.4.6.7 Signs and symptoms/general observations ....................................................................... 87 
1.4.6.8 Reported rate of SM .......................................................................................................... 87 
1.4.6.9 SM diagnoses ..................................................................................................................... 90 
1.4.6.10 Key findings to inform SM identification tool development ........................................... 90 
1.4.6.11 Strengths and limitations ................................................................................................ 91 
1.4.7 Summary ................................................................................................................................... 91 
Chapter 1.5 Development of a multivariable prediction tool to identify stroke mimic 
patients ......................................................................................................................... 92 
1.5.1 Introduction .............................................................................................................................. 92 
1.5.1.1 Background ........................................................................................................................ 92 
1.5.1.2 Desired outcome of SM identification tool ....................................................................... 93 
1.5.1.3 Target population .............................................................................................................. 93 
1.5.2 Chapter aims and objectives .................................................................................................... 94 
1.5.3 Methods ................................................................................................................................... 94 
1.5.3.1 Source of data .................................................................................................................... 95 
1.5.3.2 Participants ........................................................................................................................ 95 
1.5.3.3 Outcome ............................................................................................................................ 96 
1.5.3.4 Predictors........................................................................................................................... 96 
1.5.3.5 Sample size ........................................................................................................................ 97 
1.5.3.6 Missing data ....................................................................................................................... 97 
1.5.3.7 Statistical analysis methods ............................................................................................... 97 
xvii 
 
1.5.3.8 Univariate analysis ............................................................................................................ 97 
1.5.3.9 Multivariable analysis ........................................................................................................ 98 
1.5.3.10 Receiver operating characteristic curves ........................................................................ 98 
1.5.4 Results ...................................................................................................................................... 98 
1.5.4.1 Univariate analysis of the development dataset .............................................................. 99 
1.5.4.2 Distribution of physiological variables ............................................................................ 101 
1.5.4.3 Multicollinearity .............................................................................................................. 101 
1.5.4.4 Inclusion of the FAST test ................................................................................................ 103 
1.5.4.5 Impression ....................................................................................................................... 103 
1.5.5 Model development stage 1 – the regression model ............................................................ 104 
1.5.6 Model development stage 2 – the focussed model ............................................................... 107 
1.5.7 Model development stage 3 – the combined model ............................................................. 111 
1.5.7.1 Individual predictor variables .......................................................................................... 112 
1.5.7.2 Combined predictor variables ......................................................................................... 114 
1.5.7.3 Combining predictor variables into a tool ....................................................................... 115 
1.5.8 The STEAM tool ...................................................................................................................... 118 
1.5.8.1 Model specification ......................................................................................................... 118 
1.5.8.2 Model performance ........................................................................................................ 118 
1.5.9 Discussion ............................................................................................................................... 119 
1.5.9.1 Systolic blood pressure ................................................................................................... 120 
1.5.9.2 Temperature and heart rate ........................................................................................... 120 
1.5.9.3 Epilepsy and seizures ...................................................................................................... 121 
1.5.9.4 Age ................................................................................................................................... 121 
1.5.9.5 Migraine and headache ................................................................................................... 121 
1.5.9.6 Interpretation .................................................................................................................. 122 
1.5.9.7 Implications ..................................................................................................................... 123 
1.5.9.8 Limitations ....................................................................................................................... 123 
1.5.10 Conclusions .......................................................................................................................... 125 
1.5.11 Summary .............................................................................................................................. 125 
Chapter 2.0 Summary of part 1 and overview of part 2 ................................................. 126 
Chapter 2.1 Professional stakeholder views on the STEAM tool .................................... 128 
2.1.1 Introduction ........................................................................................................................... 128 
2.1.2 Chapter aim ............................................................................................................................ 128 
2.1.3 Methods ................................................................................................................................. 128 
2.1.3.1 Design .............................................................................................................................. 128 
2.1.3.2 Participants...................................................................................................................... 129 
2.1.3.3 Data collection and analysis ............................................................................................ 129 
xviii 
 
2.1.3.4 Approvals ......................................................................................................................... 131 
2.1.4 Findings ................................................................................................................................... 131 
2.1.4.1 Actions based on STEAM ................................................................................................. 132 
2.1.4.2 Triggering and improving communication ...................................................................... 134 
2.1.4.3 Decision making process ................................................................................................. 135 
2.1.4.4 Differential diagnoses for stroke mimics ......................................................................... 137 
2.1.4.5 Implementation across trusts .......................................................................................... 138 
2.1.4.6 Risk vs benefit for patients .............................................................................................. 139 
2.1.4.7 Further developing STEAM .............................................................................................. 140 
2.1.5 Discussion ............................................................................................................................... 140 
2.1.5.1 Strengths and limitations ................................................................................................ 143 
2.1.6 Conclusions ............................................................................................................................. 143 
2.1.7 Summary ................................................................................................................................. 143 
Chapter 2.2 Refinement of the STEAM tool ....................................................................144 
2.2.1 Introduction ............................................................................................................................ 144 
2.2.2 Chapter aims and objectives .................................................................................................. 144 
2.2.3 Background ............................................................................................................................. 144 
2.2.4 Methods ................................................................................................................................. 145 
2.2.4.1 Setting .............................................................................................................................. 146 
2.2.4.2 Timeframe ....................................................................................................................... 146 
2.2.4.3 Data extraction, linkage and analysis .............................................................................. 146 
2.2.4.4 Approvals ......................................................................................................................... 146 
2.2.5 Results .................................................................................................................................... 147 
2.2.5.1 Patient demographics ...................................................................................................... 148 
2.2.5.2 Source of diagnoses of suspected stroke patients .......................................................... 149 
2.2.5.3 Assumed SM patients ...................................................................................................... 149 
2.2.5.4 SM diagnoses ................................................................................................................... 150 
2.2.5.5 Comparison of SM diagnoses across hospital trusts ....................................................... 154 
2.2.5.6 Physiological observations .............................................................................................. 155 
2.2.5.7 Past medical history......................................................................................................... 156 
2.2.5.8 Clinical signs and symptoms ............................................................................................ 157 
2.2.5.9 Paramedic documentation of clinical impression ........................................................... 159 
2.2.5.10 STEAM results in datasets ............................................................................................. 159 
2.2.5.11 Characteristics triggering STEAM .................................................................................. 160 
2.2.5.12 STEAM performance in datasets ................................................................................... 161 
2.2.6 Refinement of the STEAM tool ............................................................................................... 162 
2.2.6.1 Univariate analysis ........................................................................................................... 162 
xix 
 
2.2.7 STEAM refinement version 1.1............................................................................................... 165 
2.2.7.1 Systolic blood pressure ................................................................................................... 165 
2.2.7.2 Temperature and heart rate ........................................................................................... 166 
2.2.7.3 Epilepsy and seizures ...................................................................................................... 166 
2.2.7.4 Age ................................................................................................................................... 166 
2.2.7.5 Migraine and headache ................................................................................................... 167 
2.2.7.6 STEAMv1.1 ...................................................................................................................... 167 
2.2.8 STEAM refinement version 1.2............................................................................................... 167 
2.2.8.1 STEAMv1.2 ...................................................................................................................... 169 
2.2.9 STEAM refinement version 1.3............................................................................................... 170 
2.2.10 STEAM refinement version 2................................................................................................ 174 
2.2.10.1 Sensitivity analysis of assumed SM in STEAMv2 ........................................................... 176 
2.2.11 Discussion ............................................................................................................................. 176 
2.2.11.1 Strengths and limitations .............................................................................................. 179 
2.2.12 Conclusions .......................................................................................................................... 179 
2.2.13 Summary .............................................................................................................................. 179 
Chapter 2.3 Usability testing of the STEAM tool ............................................................ 181 
2.3.1 Introduction ........................................................................................................................... 181 
2.3.2 Chapter aims .......................................................................................................................... 181 
2.3.3 Methods ................................................................................................................................. 181 
2.3.3.1 Design .............................................................................................................................. 181 
2.3.3.2 Participants...................................................................................................................... 182 
2.3.3.3 Participant training .......................................................................................................... 182 
2.3.3.4 Study timeframe .............................................................................................................. 183 
2.3.3.5 Data collection and analysis ............................................................................................ 183 
2.3.3.6 Ethical approval ............................................................................................................... 184 
2.3.4 Findings .................................................................................................................................. 185 
2.3.4.1 Feedback forms ............................................................................................................... 185 
2.3.4.2 Evaluation of suspected stroke EPCRs ............................................................................ 187 
2.3.4.3 Summary of feedback and EPCR evaluation ................................................................... 188 
2.3.4.4 Semi-structured Interviews ............................................................................................. 189 
2.3.4.5 The STEAM tool ............................................................................................................... 190 
2.3.4.6 Thought processes .......................................................................................................... 191 
2.3.4.7 History taking .................................................................................................................. 191 
2.3.4.8 Awareness ....................................................................................................................... 192 
2.3.4.9 Training and implementation .......................................................................................... 192 
2.3.4.10 Reminder ....................................................................................................................... 193 
xx 
 
2.3.4.11 Application ..................................................................................................................... 194 
2.3.4.12 FAST ............................................................................................................................... 194 
2.3.4.13 Patients .......................................................................................................................... 194 
2.3.4.14 Appropriate treatment .................................................................................................. 195 
2.3.4.15 Outcomes ...................................................................................................................... 196 
2.3.4.16 Transfer of care ............................................................................................................. 196 
2.3.4.17 Feedback ........................................................................................................................ 197 
2.3.4.18 Documentation .............................................................................................................. 197 
2.3.5 Discussion ............................................................................................................................... 199 
2.3.5.1 Implications for overall project and future work ............................................................ 201 
2.3.5.2 Strengths and limitations ................................................................................................ 201 
2.3.6 Conclusions ............................................................................................................................. 202 
2.3.7 Summary ................................................................................................................................. 202 
Chapter 3.0 Summary of parts 1 and 2 and overview of part 3 .......................................203 
3.0.1 Introduction ............................................................................................................................ 203 
3.0.2 Summary of part 1 .................................................................................................................. 203 
3.0.3 Summary of part 2 .................................................................................................................. 204 
3.0.4 Overview of part 3 .................................................................................................................. 204 
Chapter 3.1 Validation of the STEAMv2 tool ..................................................................205 
3.1.1 Introduction ............................................................................................................................ 205 
3.1.2 Chapter aim and objectives .................................................................................................... 205 
3.1.3 Methods ................................................................................................................................. 205 
3.1.3.1 Setting .............................................................................................................................. 206 
3.1.3.2 Data analysis .................................................................................................................... 207 
3.1.3.3 Approvals ......................................................................................................................... 207 
3.1.4 Results .................................................................................................................................... 207 
3.1.4.1 The validation dataset ..................................................................................................... 207 
3.1.4.2 Patient Selection .............................................................................................................. 207 
3.1.4.3 Patient discharge diagnoses ............................................................................................ 208 
3.1.4.4 CDDFT assumed SM patients ........................................................................................... 208 
3.1.4.5 SM diagnoses ................................................................................................................... 209 
3.1.4.6 Patient characteristics ..................................................................................................... 213 
3.1.4.7 Physiological observations .............................................................................................. 213 
3.1.4.8 Past medical history......................................................................................................... 214 
3.1.4.9 Clinical signs and symptoms ............................................................................................ 215 
3.1.4.10 Paramedic documentation of impression ..................................................................... 217 
3.1.4.11 STEAMv2 performance in the validation dataset .......................................................... 218 
xxi 
 
3.1.4.12 Comparing the development, refinement and validation datasets .............................. 220 
3.1.4.13 Patient demographics ................................................................................................... 220 
3.1.4.14 Source of diagnoses of suspected stroke patients ........................................................ 221 
3.1.4.15 Assumed SM patients .................................................................................................... 221 
3.1.4.16 STEAMv2 results in datasets ......................................................................................... 222 
3.1.4.17 STEAMv2 performance in datasets ............................................................................... 223 
3.1.5 Discussion ............................................................................................................................... 224 
3.1.5.1 Strengths and limitations ................................................................................................ 226 
3.1.6 Conclusions ............................................................................................................................ 226 
3.1.7 Summary ................................................................................................................................ 226 
Chapter 3.2 Modelling of potential impact of STEAMv2 ................................................ 227 
3.2.1 Introduction ........................................................................................................................... 227 
3.2.2 Chapter aims and objectives .................................................................................................. 227 
3.2.3 Methods ................................................................................................................................. 227 
3.2.4 Conceptual model of pre-hospital stroke care....................................................................... 228 
3.2.4.1 Population ....................................................................................................................... 231 
3.2.4.2 Pre-hospital recognition .................................................................................................. 231 
3.2.4.3 Pre-hospital actions ......................................................................................................... 231 
3.2.4.4 Destination ...................................................................................................................... 231 
3.2.5 Decision tree model of pre-hospital stroke recognition ........................................................ 231 
3.2.6 Scenario 1: Applying STEAMv2 to a theoretical population .................................................. 233 
3.2.7 Scenario 2: Applying STEAMv2 in the North East .................................................................. 234 
3.2.7.1 The North East ................................................................................................................. 235 
3.2.7.2 STEAMv2 impact on the North East ................................................................................ 237 
3.2.8 Scenario 3: Applying STEAMv2 to the UK population ........................................................ 238 
3.2.9 Discussion ............................................................................................................................... 239 
3.2.9.1 Treatment rates and speeds ........................................................................................... 239 
3.2.9.2 Missed stroke .................................................................................................................. 239 
3.2.9.3 Pre-hospital treatment times .......................................................................................... 240 
3.2.9.4 Pre-alerting by paramedics ............................................................................................. 241 
3.2.9.5 Summary of treatment rates and speeds ....................................................................... 241 
3.2.9.6 Population disability impact ............................................................................................ 242 
3.2.9.7 Resource implications ..................................................................................................... 242 
3.2.9.8 Markers of health economic outcomes .......................................................................... 243 
3.2.9.9 The impact of pre-hospital SM identification on hyper-acute stroke outcomes ............ 245 
3.2.9.10 Strengths and weaknesses ............................................................................................ 245 
3.2.10 Conclusions .......................................................................................................................... 246 
xxii 
 
3.2.11 Summary ............................................................................................................................... 246 
Chapter 3.3 Professional stakeholder views on STEAMv2 ...............................................248 
3.3.1 Introduction ............................................................................................................................ 248 
3.3.2 Chapter aims ........................................................................................................................... 248 
3.3.3 Methods ................................................................................................................................. 248 
3.3.3.1 Design .............................................................................................................................. 248 
3.3.3.2 Participants ...................................................................................................................... 248 
3.3.3.3 Data collection and analysis ............................................................................................ 249 
3.3.3.4 Approvals ......................................................................................................................... 250 
3.3.4 Findings ................................................................................................................................... 251 
3.3.4.1 Strengths and limitations of the STEAM tool .................................................................. 252 
3.3.4.2 The stroke mimic population ........................................................................................... 255 
3.3.4.3 Pre-hospital stroke identification .................................................................................... 257 
3.3.4.4 Implementing SM tools within care pathways ................................................................ 258 
3.3.4.5 Decision making ............................................................................................................... 260 
3.3.5 Discussion ............................................................................................................................... 262 
3.3.5.1 Comparing STEAMv2 with the NWAS exclusions ............................................................ 264 
3.3.5.2 Strengths and limitations ................................................................................................ 265 
3.3.5.3 Future research ............................................................................................................... 266 
3.3.6 Conclusions ............................................................................................................................. 267 
3.3.7 Summary ................................................................................................................................. 267 
Chapter 4.0 Discussion and conclusions .........................................................................268 
4.0.1 The development of STEAMv2 ............................................................................................... 268 
4.0.2 Other SM tools........................................................................................................................ 269 
4.0.3 Strengths and weaknesses ..................................................................................................... 270 
4.0.4 UK Pre-hospital stroke care .................................................................................................... 271 
4.0.5 Implementation of STEAMv2.................................................................................................. 271 
4.0.6 Future implications of SM identification ................................................................................ 276 
4.0.7 Diagnostics .............................................................................................................................. 277 
4.0.8 Future research ...................................................................................................................... 277 
4.0.9 Conclusions ............................................................................................................................. 279 
Appendices ...................................................................................................................280 
Appendix A. Literature search strategy from systematic review of stroke mimics ..................... 280 
Appendix B. QATSDD Scoring ...................................................................................................... 281 
Appendix C. Survey questions ..................................................................................................... 285 
Appendix D. Example EPRF .......................................................................................................... 289 
Appendix E. Free-text data collection protocol ........................................................................... 292 
xxiii 
 
Appendix F. NEAS and NHCT data linking protocol ..................................................................... 293 
Appendix G. Frequency distribution plots................................................................................... 296 
Appendix H. Focus group 1 topic guide ....................................................................................... 301 
Appendix I. Focus group 1 stimulus material .............................................................................. 303 
Appendix J. Approvals for qualitative work ................................................................................ 305 
Appendix K. Suspected stroke patients transported to Newcastle Hospitals ............................. 311 
Appendix L. Suspected stroke patients transported to North Tees Hospitals ............................ 322 
Appendix M. Usability testing feedback form ............................................................................. 332 
Appendix N. Usability testing training material .......................................................................... 334 
Appendix O. Usability testing interview topic guide ................................................................... 337 
Appendix P. Usability testing interview stimulus material ......................................................... 339 
Appendix Q. Focus group 3 topic guide ...................................................................................... 341 
Appendix R. Focus group 3 stimulus material ............................................................................. 343 
Appendix S. UK pre-hospital stroke pathways ............................................................................ 345 
References ................................................................................................................... 347 
 
  
xxiv 
 
List of figures 
 
Figure 1.0.1 Simple model of SM tool added to current stroke care pathway ………………… 2 
Figure 1.0.2 Flowchart with overview of pre-hospital SM project ………………………………….. 5 
Figure 1.1.2 ROC curves analysis of VI value, Graded-LASEC (G-LASEC), CHA2DS2-Vasc, 
qualitative LASEC (Q-LASEC), LAT and CHADS2 in predicting the risk of stroke in patients with 
NVAF ……………………………………………………………………………………………………………………………… 14 
Figure 1.2.1 Flowchart summarising study selection process …………………………………………. 24 
Figure 1.2.3 Taxonomy of SM using CCS codes ………………………………………………………………. 33 
Figure 1.4.1 Map of the North East showing NHCT approximate catchment area ………….. 62 
Figure 1.4.2 Data linking process for determining final diagnosis of suspected stroke patients 
admitted by NEAS ………………………………………………………………………………………………………….. 64 
Figure 1.4.3 NEAS suspected stroke patients filtered from raw data to NHCT dataset …… 66 
Figure 1.4.4 Data linking process showing final diagnoses of suspected stroke patients 
admitted by NEAS ………………………………………………………………………………………………………….. 68 
Figure 1.4.5 NHCT SM diagnoses summarised using CCS codes ……………………………………… 72 
Figure 1.4.6 Venn diagram showing source of data extracted from NEAS EPRF ……………… 73 
Figure 1.5.1 Model of decision tree SM identification tool …………………………………………….. 111 
Figure 2.1.1. Themes from phase 1 focus groups ……………………………………………………………. 132 
Figure 2.2.1 Map of the North East with NHCT, NUTH and NTEES approximate catchment 
areas ………………………………………………………………………………………………………………..………..…… 147 
Figure 2.2.2 Combined SM diagnoses summarised using CCS codes ………………………….…... 154 
Figure 2.2.3 STEAMv1.3 with added absence of limb weakness characteristic …………….…. 172 
Figure 2.3.1 Overall structure of usability testing project …………………………………….…………. 182 
Figure 2.3.2 Map of themes emerging from interviews with paramedics with application, 
outcomes and thought processes categories …………………………………….……………….…………… 189 
xxv 
 
Figure 3.1.1 Map of the North East showing approximate catchment areas of all included 
hospital trusts ……………………………………………………………………………………………….……………….. 206 
Figure 3.1.2 Identification of NEAS suspected stroke patients transported to CDDFT …..... 207 
Figure 3.1.3 CDDFT SM diagnoses summarised using CCS codes ………………………….…….…… 212 
Figure 3.2.1 Stroke patient pathway from pre-hospital stroke care to system outcomes .. 228 
Figure 3.2.2 Simple conceptual model of pre-hospital stroke pathway 1 …………………..…… 229 
Figure 3.2.3 Simple conceptual model of pre-hospital stroke pathway 2 ………………..……… 230 
Figure 3.2.4 Simple conceptual model of pre-hospital stroke pathway 3 …………….…….…… 230 
Figure 3.2.5 Decision tree representation of pre-hospital stroke recognition …….……...….. 232 
Figure 3.2.6 Map of the North East ………………………………………………………………….…………….. 236 
Figure 3.3.1 Themes from the four professional focus groups in phase 3 discussing STEAMv2 
……………………………………………………………………………………………………………………………………….. 252 
Figure 4.0.1. Potential pre-hospital stroke algorithm integrating STEAMv2 ……………………. 273 
  
xxvi 
 
List of tables 
 
Table 1.1.1 Summary of common pre-hospital stroke identification instruments …………… 11 
Table 1.1.2 2x2 table showing diagnostic test performance ……………………………………………. 12 
Table 1.1.3 Area under the ROC curve (AUC) of five stroke predictor variables ………………. 14 
Table 1.1.4 The 20 most common differential diagnoses of suspected stroke ……………….… 15 
Table 1.1.5 Stroke mimic tools …………………………………………………………………………….………….. 19 
Table 1.2.1 Studies included in the systematic review ……………………………………………….……. 25 
Table 1.2.2 Characteristics associated with SM diagnosis reported by number of papers .. 34 
Table 1.3.1 Characteristics of survey respondents included in the study ………………………… 44 
Table 1.4.1 Comparison of patients with confirmed SM diagnosis versus assumed SM 
diagnosis …………………………………………………………………………………………………………………………. 68 
Table 1.4.2. Most frequent ICD-10 diagnoses recorded for SM patients …………………………. 69 
Table 1.4.3 NHCT SM diagnoses displayed using level 2 CCS codes ……………………………….… 70 
Table 1.4.4 NHCT SM diagnoses displayed using level 1 CCS codes …………………………………. 71 
Table 1.4.5 Reference range for physiological observations and number of amended and 
deleted values ………………………………………………………………………………………………………………… 76 
Table 1.4.6 Demographics of NEAS suspected stroke patients admitted to NHCT reported by 
discharge diagnosis …………………………………………………………………………………………………………. 76 
Table 1.4.7 Paramedic impression and final diagnoses ……………………………………………………. 77 
Table 1.4.8 Physiological observations in NEAS data on suspected stroke patients admitted to 
NHCT reported by final diagnosis ……………………………………………………………………………………. 78 
Table 1.4.9 Past medical history of NEAS suspected stroke patients admitted to NHCT 
reported by final diagnosis ……………………………………………………………………………………………... 79 
Table 1.4.10 NEAS observations on suspected stroke patients transported to NHCT reported 
by final diagnosis …………………………………………………………………………………………………………….. 80 
xxvii 
 
Table 1.5.1 Characteristics of SM identification tool development cohort ………………………. 99 
Table 1.5.2 Correlation matrix of continuous physiological variables ……………………………… 102 
Table 1.5.3 Cohort described by composite FAST variables ………………………………………….…. 103 
Table 1.5.4 Variables in the regression modelv1 …………………………………………………………….. 105 
Table 1.5.5 Variables in the regression modelv2 ………………………………………………………….…. 106 
Table 1.5.6 ROC analysis of continuous physiological variables ………………………………….…… 108 
Table 1.5.7 Odds ratios of predictor variables for SM diagnosis …………………………………….… 108 
Table 1.5.8 Individual age values with number of stroke and SM patients identified by each 
value ………………………………………………………………………………………………………………………………. 112 
Table 1.5.9 SBP values considered for inclusion in SM tool ……………………………………………… 113 
Table 1.5.10 Characteristics considered for SM identification tool ………………………………..… 117 
Table 1.5.11 Characteristics included in the STEAM SM identification tool ……………………… 118 
Table 1.5.12 STEAM positive patients displayed by number of positive characteristics …… 119 
Table 1.5.13 STEAM positive patients in FAST+ve and FAST-ve populations ……………………. 119 
Table 2.2.1 Demographics of NEAS suspected stroke patients reported by discharge diagnosis 
………………………………………………………………………………………………………………………………………... 148 
Table 2.2.2 Source of diagnoses for suspected stroke patients in the refinement dataset        
………………………………………………………………………………………………………………………………………... 149 
Table 2.2.3 Comparison of patients with confirmed SM diagnoses versus assumed SM 
diagnoses ……………………………………………………………………………………………………………………….. 150 
Table 2.2.4 Most frequent ICD-10 diagnoses recorded for combined SM patients ………..… 151 
Table 2.2.5 Combined SM diagnoses displayed using level 2 CCS codes ………………………….. 152 
Table 2.2.6 Combined SM diagnoses displayed using level 1 CCS codes ………………………….. 153 
Table 2.2.7 Contributing trusts SM diagnoses % displayed using level 1 CCS codes …………. 155 
xxviii 
 
Table 2.2.8 Physiological observations in NEAS data on suspected stroke patients in the 
refinement dataset reported by discharge diagnosis ………………………………………………………. 156 
Table 2.2.9 Past medical history of suspected stroke patients in the refinement dataset 
reported by discharge diagnosis ……………………………………………………………………………………… 156 
Table 2.2.10 NEAS observations on suspected stroke patients in the refinement dataset 
reported by discharge diagnosis ……………………………………………………………………………………… 157 
Table 2.2.11 Paramedic impression and discharge diagnoses in the refinement dataset … 159 
Table 2.2.12 Suspected stroke patients displayed by number of STEAM characteristics …. 160 
Table 2.2.13 STEAM output when applied to refinement dataset …………………………………... 160 
Table 2.2.14 Characteristics triggering STEAM ………………………………………………………………… 161 
Table 2.2.15 STEAM performance in NUTH, NTEES and refinement datasets compared with 
development (NHCT) dataset ………………………………………………………………………………………….. 161 
Table 2.2.16 ROC analysis of continuous variables in refinement dataset ……………………….. 162 
Table 2.2.17 Odds ratios of predictor variables for SM diagnosis in refinement dataset ….. 163 
Table 2.2.18 SBP characteristics comparison in the refinement dataset …………………………. 165 
Table 2.2.19 STEAMv1.1 criteria and discharge diagnoses …………………………………………….… 167 
Table 2.2.20 STEAMv1.1 output when applied to refinement dataset …………………………….. 167 
Table 2.2.21 STEAMv1.2 criteria and discharge diagnoses ………………………………………………. 169 
Table 2.2.22 STEAMv1.2 output when applied to refinement dataset ………………………..…… 170 
Table 2.2.23 Absence of FAST characteristics in patients scoring 1 on STEAMv1.2 ……….…. 171 
Table 2.2.24 STEAMv1.3 + FAST-ve criteria and discharge diagnoses ………………………………. 173 
Table 2.2.25 STEAMv1.3 + FAST-ve output when applied to refinement dataset ………….…. 173 
Table 2.2.26 Summary of STEAM models from refinement process ……………………………..…. 174 
Table 2.3.1. STEAM characteristics recorded on the NEAS EPCR for suspected stroke patients 
during prospective testing ………………………………………………………………………………………….…… 187 
xxix 
 
Table 3.1.1 Comparison of CDDFT patients with confirmed SM diagnoses versus assumed SM 
diagnoses …………………………………………………………………………………………………………………….…. 208 
Table 3.1.2 Most frequent ICD-10 diagnoses recorded for CDDFT SM patients …………….... 209 
Table 3.1.3 CDDFT SM diagnoses displayed using level 2 CCS codes ……………………………….. 210 
Table 3.1.4 CDDFT SM diagnoses displayed using level 1 CCS codes ……………………………..… 211 
Table 3.1.5 Demographics of NEAS suspected stroke patients transported to CDDFT reported 
by discharge diagnosis ……………………………………………………………………………………………………. 213 
Table 3.1.6 Physiological observations in NEAS data on suspected stroke patients 
transported to CDDFT reported by discharge diagnosis ………………………………………………….. 214 
Table 3.1.7 Past medical history of NEAS suspected stroke patients transported to CDDFT 
reported by discharge diagnosis ……………………………………………………………………………………… 214 
Table 3.1.8 NEAS observation on suspected stroke patients transported to CDDFT reported 
by discharge diagnosis ……………………………………………………………………………………………………. 215 
Table 3.1.9 Paramedic impression and discharge diagnoses – CDDFT …………………………….. 217 
Table 3.1.10 STEAMv2 output when applied to the validation dataset …………………………… 218 
Table 3.1.11 Demographics of NEAS suspected stroke patients reported by discharge 
diagnosis …………………………………………………………………………………………………………………………. 220 
Table 3.1.12 Sources of diagnoses for suspected stroke patients ……………………………………. 221 
Table 3.1.13 Comparison of patients with confirmed SM diagnoses versus assumed SM 
diagnoses ……………………………………………………………………………………………………………………….. 222 
Table 3.1.14 Suspected stroke patients displayed by number of STEAM characteristics …. 223 
Table 3.1.15 STEAM tool performance in the validation and refinement datasets ………….. 223 
Table 3.2.1 Values used in scenario 1 ……………………………………………………………………………… 233 
Table 3.2.2 Outputs from scenario 1 ………………………………………………………………………………. 234 
Table 3.2.3 Costs for SM stay on HASU, stroke unit and general ward ……………………………. 244 
xxx 
 
Table 3.3.1 NWAS stroke pathway exclusion criteria tested in complete North East dataset 
………………………………………………………………………………………………………………………………………… 264 
Table 3.3.2 Comparison of NWAS exclusion criteria and STEAMv2 in complete North East 
dataset ……………………………………………………………………………………………………………………….…… 265 
  
xxxi 
 
List of charts 
 
Chart 1.2.1 Box plot showing median, IQR and range of stroke mimic rates ……………………. 32 
Chart 1.3.1 Paramedics’ stroke CPD source …………………………………………………………………….. 46 
Chart 1.3.2 Stroke assessment tools used by paramedics ……………………………………………..… 47 
Chart 1.3.3 How respondents rated their confidence dealing with time critical conditions 
………………………………………………………………………………………………………………………………………… 47 
Chart 1.3.4 To what extent do you think pre-hospital actions influence patients’ outcome 
….…………………………………………………………………………………………………………………………………….. 48 
Chart 1.3.5 How do you think pre-hospital care has changed over the course of your career 
………………………………………………………………………………………………………………………………………… 48 
Chart 1.3.6 Stroke patient destinations …………………………………………………………………………… 49 
Chart 1.3.7 Paramedics' estimates of the proportion of pre-hospital suspected stroke 
patients with a stroke mimic diagnosis …………………………………………………………………………… 51 
Chart 1.3.8 Conditions paramedics thought were the three most common pre-hospital stroke 
mimics ……………………………………………………………………………………………………………….…………… 51 
Chart 1.3.9 Certainty in stroke mimic diagnosis needed by paramedics to deviate from 
normal stroke protocol …………………………………………………………………………………………………… 52 
Chart 1.4.1 Impressions documented in addition to stroke ………………………………………….…. 78 
Chart 2.2.1 Number of stroke and SM patients age<40 years ………………………………….……… 168 
Chart 3.2.1 Percentage bypass model and number of stroke and SM patients identified by 
STEAMv2 ………………………………………………………………………………………………………………………... 238 
 
  
xxxii 
 
List of abbreviations 
 
AF  Atrial Fibrillation 
BM  Boehringer Mannheim (blood sugar) 
CCS  Clinical Classifications Software 
CHF  Congestive Heart Failure 
COP  College of Paramedics 
CT  Computerised Tomography 
DTN  Door to Needle time 
ECCM   Emergency Care Clinical Manager 
ED  Emergency Department 
EMS  Emergency Medical Services 
EPCR  Electronic Patient Care Record 
EPRF  Electronic Patient Report Form 
FAST  Face, Arms, Speech Test 
GCS  Glasgow Coma Scale 
HASU  Hyper-Acute Stroke Unit 
HES  Hospital Episode Statistics 
HR  Heart Rate 
ICD  International Classification of Diseases 
LOS  Length of Stay 
MI  Myocardial Infarction 
NEAS  North East Ambulance Service NHS Foundation Trust 
NHCT  Northumbria Healthcare NHS Foundation Trust 
NHS  National Health Service 
NIHSS  National Institutes of Health Stroke Scale 
NWAS  North West Ambulance Service NHS Trust 
PMH  Past Medical History 
PPV  Positive Predictive Value 
RCP  Royal College of Physicians 
RCT  Randomised Controlled Trial 
ROC  Receiver Operating Characteristic 
xxxiii 
 
RR  Respiratory Rate 
SaO2  Peripheral Oxygen Saturation 
SBP  Systolic Blood Pressure 
SM  Stroke Mimic 
SRFT  Salford Royal NHS Foundation Trust 
SSNAP  Sentinel Stroke National Audit Programme 
STEMI  ST segment Elevation Myocardial Infarction 
TIA  Transient Ischaemic Attack 
 
  
 1 
 
Chapter 1.0 Overview 
 
1.0.1 Overview  
Stroke is a serious medical emergency caused by disruption in the blood flow to brain tissue 
by either a blockage (ischaemic stroke) or a bleed (haemorrhagic stroke). Over 80,000 
people each year are hospitalised with stroke and it is the fourth commonest cause of death 
in the UK (RCP, 2016; The Stroke Association, 2018). Despite falling incidence of stroke in the 
developed world the global incidence of stroke is increasing (Feigin et al., 2009). Stroke is 
one of a small number of time critical conditions dealt with by pre-hospital emergency 
medical services (EMS) due to the short treatment window and accounts for around 2% of 
emergency calls (Seymour et al., 2012). 
Stroke mimics (SM) are conditions which produce the same symptoms as stroke but do not 
have a cerebrovascular aetiology. SM are common in all clinical settings due to the wide 
variety of clinical stroke presentations and alternative aetiologies but are particularly 
common in pre-hospital care, partly driven by the operational performance of stroke 
recognition instruments (Rudd et al., 2016a). This thesis focusses on pre-hospital stroke care 
which is mainly provided by paramedics working within ambulance services in the UK. 
Paramedic will be used throughout this thesis as a term to encompass all pre-hospital care 
providers unless otherwise stated.  
This project aimed to develop a novel SM identification tool and demonstrate whether it is 
feasible and acceptable to integrate this into the pre-hospital assessment of patients 
following initial recognition of suspected stroke. Early identification of a patient as a SM 
rather than a stroke may change the initial hospital that the patient is transported to and the 
focus of their immediate assessment and care. 
Sequential diagnosis is a recognised approach in healthcare where a simple initial test is 
used which is sensitive to the condition under examination, and then the diagnosis is refined 
with a second test (Denny et al., 2000; Iwasaki et al., 2003; Abdul-Ghani et al., 2011). The 
concept is that the two tests performed sequentially have a better combined performance 
than either test in isolation. In UK practice the SM tool would be primarily used in sequence 
with the Face Arms Speech Tool (FAST) (Harbison et al., 2003). 
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The purpose of developing the SM tool was to improve the overall accuracy of pre-hospital 
stroke diagnosis by reducing the number of SM incorrectly labelled as possible stroke. 
Application of the SM identification tool was not explored outside of pre-hospital care and 
there was no attempt to improve the initial identification of stroke.  
Previous research in pre-hospital stroke care has reported a range of SM rates from 4-62% 
(Saver et al., 2015; Andsberg et al., 2017). Increasing the precision of stroke identification by 
paramedics could improve future pre-hospital stroke research through more efficient 
delivery, more realistic sample size calculations and analysis which more accurately reflects 
clinical service activity (Libman et al., 1995; Restrepo et al., 2010).  
If identification of SM in the pre-hospital setting is possible, using data easily available to 
paramedics, then it may be possible to direct SM patients along more appropriate care 
pathways. A simple example of how a SM tool could modify the current pathway of care is 
shown in figure 1.0.1. 
Figure 1.0.1 Simple model of SM tool added to current stroke care pathway 
SM identification could be beneficial for the patient, the ambulance service and stroke 
services depending on how well the SM identification tool performs. Patients would be 
taken to the most appropriate location for their condition, the ambulance service would 
avoid unnecessary bypass of local hospitals and secondary repatriation journeys and stroke 
services would reduce the number of SM patients admitted which reduces demand on their 
services. 
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1.0.2 Project aims 
The aim of the work contained within this thesis was to develop and evaluate a pre-hospital 
SM identification tool based on information commonly collected during paramedic 
assessment in order to enable easy implementation. This consisted of four more specific 
aims:  
 A1. A systematic review to summarise the frequency, underlying aetiology and 
common characteristics of SM. 
 A2. Analysis of pre-hospital data to develop, refine and validate a SM identification 
tool for use in the pre-hospital setting. 
 A3. Qualitative exploration of the acceptability and implications of pre-hospital SM 
identification with clinicians. 
 A4. Basic modelling of the service level impact resulting from the introduction of a 
SM identification tool. 
1.0.3 Research design 
Multiple methods were used during the SM identification tool development, refinement and 
validation. Multiple, or mixed, methods are often used in pre-hospital research as a 
pragmatic way to address the complex environment (McManamny et al., 2014). 
The tool development was underpinned by the creation of a pre-hospital dataset linked to 
hospital based patient diagnoses. This was analysed to identify clinical characteristics 
documented by paramedics which differentiated statistically between stroke and SM. These 
characteristics were placed in the context of the findings of a systematic literature review, 
the results of a survey of UK paramedics and clinical input from the study team to develop 
the first iteration of the SM tool. 
Focus groups and semi-structured interviews collected views from healthcare professionals 
involved in stroke care including paramedics, doctors and nurses. Thematic analysis 
informed further development of the SM tool, described paramedic’s views about the 
usability of the initial tool in practice and reported healthcare professional’s opinions about 
the overall service impact. 
Prospective application of the tool by National Health Service (NHS) paramedics in pre-
hospital practice provided further data on acceptability, barriers and facilitators to clinical 
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deployment. Basic modelling explored the potential impact of introduction of a SM tool into 
clinical practice. 
The overall research process fits within the ‘development’ section of the Medical Research 
Council’s (MRC) framework for complex intervention development (Craig et al., 2008). 
1.0.4 Structure of thesis 
This thesis is presented in four parts. Part one describes the background to the study, the 
literature describing SM and the development of the initial SM tool. Part two describes the 
usability testing and refinement of the initial SM tool. The third part includes validation of 
the SM tool, basic modelling work exploring the potential impact of introducing a SM tool 
and clinicians’ views on the final SM tool. The fourth part of the thesis discusses the findings 
of the whole project. The chapters of the thesis are summarised below and the overall 
structure is displayed in figure 1.0.2. 
• Part 1 
o Chapter 1.1 presents the clinical context for this thesis and explores how 
diagnostic tools are described. 
o Key literature about SM are synthesised and discussed in chapter 1.2. This 
describes the variation in SM definitions, the reported rates of SM and how 
the rates of SM differ across healthcare settings.  
o Views about SM from a sample of paramedics across the UK, and other 
aspects of their practice related to stroke, are reported in chapter 1.3.  
o Data and methods involved in the development of the initial SM tool are 
described in chapters 1.4 and 1.5.  
• Part 2 
o Thematic analysis of views from focus groups with paramedics and hospital 
clinicians about the initial SM tool is reported in chapter 2.1.  
o Chapter 2.2 reports the refinement of the initial SM tool using additional 
linked clinical datasets.  
o Experiences of paramedics involved in prospective usability testing of the 
initial SM tool are described in chapter 2.3. 
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• Part 3 
o Validation of the refined SM tool in a separate clinical dataset is described in 
chapter 3.1. 
o Basic modelling of the service level impact of a SM tool is reported in chapter 
3.2. 
o Chapter 3.3 describes thematic analysis of focus groups with pre-hospital and 
hospital clinicians exploring the refined and validated SM tool. 
• Part 4 
o Chapter 4.0 discusses and summarises the whole project. 
 
 
Figure 1.0.2 Flowchart with overview of pre-hospital SM project 
1.0.5 Summary  
This chapter has given a brief overview of the thesis content. The next chapter expands upon 
pre-hospital stroke identification, defines the terminology that will be used to discuss stroke 
diagnosis and shows how this work differs from existing SM identification tools.  
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Chapter 1.1 Background and rationale 
 
1.1.1 Introduction  
This chapter will briefly describe the clinical context of emergency stroke care and how the 
pre-hospital and hospital phases combine to identify patients for administration of 
emergency treatments. Most pre-hospital stroke identification tools, such as FAST, are 
designed to identify the maximum number of stroke patients using symptoms alone, as 
opposed to hospital practice where symptoms are considered in conjunction with 
neuroimaging. Consequently most pre-hospital tools have poor specificity and identify a 
large number of “false positive” SM patients.  
1.1.2 Chapter aims and objectives  
The aim of this chapter is to provide the background, clinical context and methodological 
rationale for the development of a SM identification tool. 
The objectives of this chapter are: 
 Summarise stroke as a condition. 
 Describe the current UK model of pre-hospital and acute hospital stroke care. 
 Describe how the performance of diagnostic tests are assessed and compared. 
 Describe existing SM identification tools and justify the need for a pre-hospital SM 
tool. 
1.1.3 Overview of stroke 
The World Health Organisation (WHO) described stroke as “a clinical syndrome consisting of 
rapidly developing clinical signs of focal (or global in case of coma) disturbance of cerebral 
function lasting more than 24 hours or leading to death with no apparent cause other than a 
vascular origin” (Hatano, 1976).  
There are two types of stroke aetiology: haemorrhagic and ischaemic. In simple terms, 
haemorrhagic stroke is caused by a bleed within the brain whereas ischaemic stroke is 
caused by a clot, or thrombus, occluding a blood vessel within the brain. Ischaemic stroke is 
more common accounting for around 85% of stroke. Clinical presentations from stroke 
produce symptoms according to the location, size and duration of the cerebral insult. Short 
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episodes result in Transient Ischaemic Attacks (TIAs) which by definition must completely 
resolve within 24 hours with no lasting effect. TIAs can be precursors to stroke (Amarenco et 
al., 2016).  
For many years acute stroke was considered to be untreatable. The development of brain 
imaging in the form of Computed Tomography (CT) in the 1970s and the trials of drugs which 
could dissolve the occluding thrombus (thrombolytics) causing ischaemic stroke in the 1990s 
radically changed stroke care provision and outcomes (Snow, 2013). 
1.1.4 Emergency stroke treatment 
The current model of acute stroke care in the UK focusses on rapid identification of 
suspected stroke patients, access to specialist stroke units and delivery of reperfusion 
treatment (thrombolysis and/or thrombectomy) for eligible ischaemic stroke patients. Rapid 
identification of stroke is vital as the effectiveness of thrombolysis is time dependent. A 
Cochrane review of thrombolysis for acute ischaemic stroke (Wardlaw et al., 2014) reported 
that thrombolysis with alteplase had a net benefit in terms of reducing death and disability 
up to 3 hours from symptom onset (OR 0.7, 95% CI 0.5 to 0.8, P<0.0001; 6 trials, 1,779 
participants) and was potentially beneficial up to 6 hours from onset (OR 0.8, 95% CI 0.8 to 
0.9, P=0.0006; 8 trials, 6,729 participants). The current time window for thrombolysis is 4.5 
hours from stroke onset as past this point the risks outweigh the benefits (Emberson et al., 
2014). Very recent studies are exploring whether this treatment window can be extended 
for carefully selected patients (Ma et al., 2018; Thomalla et al., 2018). 
Mechanical thrombectomy (Evans et al., 2017) is a newer treatment for ischaemic stroke 
which involves physically removing the occluding thrombus if it is within the larger cerebral 
blood vessels. The HERMES collaboration reported a meta-analysis of five recent 
thrombectomy trials (Goyal et al., 2016a) which demonstrated benefit based on modern 
techniques, devices and highly specialised services. Mechanical thrombectomy has a slightly 
longer treatment window than thrombolysis, around 6 hours although recent trials show it 
may be longer (Nogueira et al., 2018), and is effective (number needed to treat (NNT) of 2.6 
to reduce disability) for patients with large vessel occlusions (LVO) which can be severely 
disabling. Thrombectomy was provisionally commissioned by the NHS in early 2017 but in 
2018 was not widely available (NHS England, 2017). The need to identify patients for this 
treatment at the earliest opportunity has led to the development of pre-hospital stroke tools 
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focused on identifying patients with symptoms associated with LVO (Perez de la Ossa et al., 
2014; Purrucker et al., 2017). These are not in current use in the UK due to the limited 
availability of thrombectomy and uncertainty over the best model for accessing these 
services (Evans et al., 2017; Milne et al., 2017).  
The Keogh Urgent and Emergency Care Review (UEC Review Team and ECIST, 2015) (p11) 
highlighted acute stroke as a key condition which would benefit from service centralisation. 
Delivering stroke care at specialist multi-disciplinary units has been shown to reduce both 
death and dependency (Stroke Unit Trialists Collaboration, 2013). Specialist stroke units 
covering large geographical areas with high numbers of patients, known as Hyper-Acute 
Stroke Units (HASUs), have been shown to be an effective method of delivering high quality, 
evidence based interventions and care in the first 48-72 hours (McMeekin et al., 2013; 
Morris et al., 2014; Ramsay et al., 2015).  
Stroke care is moving in a similar direction to other conditions that have been centralised 
e.g. trauma and cardiac emergencies. However, stroke care differs from trauma and cardiac 
care as initiation of the stroke care pathway is more challenging due to the lack of an 
objective diagnostic test and the frequency and number of SM conditions. 
The centralisation of stroke care at a small number of hospitals has required ambulance 
services to adapt and develop pathways for stroke patients to access these specialist 
centres. These pathways rely on pre-hospital identification, using tools like FAST, of patients 
who may be eligible for thrombolysis or who would benefit from HASU care. Further 
centralisation of specialist stroke services is likely to be seen in the future as thrombectomy 
services are developed. 
The short treatment window for reperfusion therapies, combined with the benefits of early 
access to specialist stroke services, means that early stroke recognition is very important for 
improving patient outcomes and reducing economic impact. Paramedics are often the first 
healthcare professionals to assess an acute stroke patient. The accuracy of paramedic’s 
recognition of stroke is important as their decision about which is the most appropriate 
hospital for the patient influences the timeliness of the patient’s access to specialist stroke 
care and potential treatments. 
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1.1.5 Pre-hospital stroke care 
For the purpose of this work, pre-hospital care is used to refer to emergency or unscheduled 
pre-hospital care. In the UK pre-hospital care is mainly provided by NHS ambulance 
paramedics on a regional basis. This definition excludes physician led primary care (General 
Practice (GP)) or nurse led routine out of hospital care (district nurses etc.) although the 
results of this work could be of interest to these groups as well. 
Pre-hospital care is evolving rapidly but pre-hospital stroke care has remained largely 
unchanged for many years. Improving pre-hospital clinical care pathways for stroke patients 
has been identified as a national priority by the National Ambulance Service Medical 
Directors (National Ambulance Service Medical Directors, 2014).  
Paramedics provide the first direct healthcare contact for around two thirds of stroke 
patients admitted to hospital (Bayer et al., 2013). Pre-hospital care of stroke patients 
focusses upon identification of the patient as a suspected stroke and rapid transport to an 
appropriate destination with a pre-notification which allows the receiving unit to prepare for 
the patients’ arrival. Pre-notification by paramedics has been shown to be associated with 
improvements in time to treatment for stroke patients (McKinney et al., 2013; Oostema et 
al., 2014; Sheppard et al., 2015b). 
National guidelines recommend pre-hospital stroke identification using a standardised 
assessment process, such as FAST, but due to the possibility of missed cases, paramedics are 
also encouraged to make a provisional diagnosis based upon their own clinical judgement 
(Intercollegiate Stroke Working Party, 2016). 
1.1.6 Pre-hospital stroke identification tools 
There are a range of tools designed to help with pre-hospital stroke identification. The 
majority of UK paramedics use the FAST (Harbison et al., 2003). This was developed within 
the North East of England as a rapid and simple stroke identification tool for use by 
paramedics based upon a review of North American stroke identification tools. This followed 
research into paramedic triage of stroke patients within Newcastle upon Tyne and the 
establishment of a rapid ambulance protocol allowing transport of suspected stroke patients 
directly to stroke services. This was originally necessary as the stroke services were in a 
different hospital to the emergency department (ED) (Harbison et al., 1999).  
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In order to be sensitive to different possible combinations of symptoms across a broad range 
of patients, all identification instruments overestimate stroke incidence and result in SM 
being identified as stroke (Rudd et al., 2016a). A summary of common pre-hospital stroke 
identification tools is shown in table 1.1.1 (Adapted from Rudd et al., 2016a). Sensitivity, 
specificity and positive predictive value (PPV) are explained in the next section. 
Pre-hospital stroke identification instruments with greater precision than FAST are 
described, but these were designed to focus on stroke patients potentially suitable for 
thrombolysis by excluding patients based on age or disability criteria (e.g. LAPSS and MASS). 
Other tools have been developed in hospital but have not shown additional value when 
applied in the pre-hospital setting (e.g. Recognition Of Stroke In the Emergency Room 
(ROSIER) (Fothergill et al., 2013)).  
The low specificity of pre-hospital stroke identification tools results in patients being taken 
to specialist stroke services despite 25-50% of pre-hospital suspected strokes receiving a SM 
final diagnosis.  
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1.1.7 Assessment of diagnostic tests  
This project focusses on the diagnosis of SM conditions, so it is important to define the terms 
that are used to describe and compare diagnostic tests. 
Measures of diagnostic performance are normally calculated by using a 2x2 table comparing 
the test in question against a gold standard or reference test. An example of this is shown in 
table 1.1.2. The definitions below are taken from chapter 38, Diagnostic tools, (Petrie and 
Sabin, 2009). 
Table 1.1.2 2x2 table showing diagnostic test performance 
 Gold standard test  
Disease present Disease absent Total 
Test under 
investigation 
Positive test A B A+B 
Negative test C D C+D 
 Total A+C B+D A+B+C+D 
 
The outputs from this 2x2 table allow the performance of the diagnostic test to be 
calculated. The commonly used terms are described below: 
 Sensitivity – proportion of individuals with a disease who are correctly identified by a 
test = A/(A+C) 
 Specificity – proportion of individuals without a disease who are correctly identified 
by a test = D/(B+D) 
 Positive predictive value (PPV) – proportion of individuals with a positive test result 
who have the disease = A/(A+B) 
 Negative predictive value (NPV) – proportion of individuals with a negative test result 
who do not have the disease = D/(C+D) 
The results of a diagnostic test are also referred to as: 
 True positive – the test correctly identifies the presence of the disease = A 
 True negative – the test correctly identifies the absence of the disease = D  
 False positive – the test incorrectly identifies the presence of the disease = B 
 False negative – the test incorrectly identifies the absence of the disease = C 
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In terms of stroke diagnosis a true positive is a stroke; a false positive is a SM; a false 
negative is known as a stroke chameleon (i.e. a stroke misdiagnosed as another condition) 
and a true negative is where stroke was correctly not one of the diagnoses under 
consideration. True negatives are not reported as they constitute all other activity within an 
ambulance service context. 
The positive and negative likelihood ratios for a diagnostic test can also be reported (Grimes 
and Schulz, 2005). The positive likelihood ratio (LR+) is the ratio of true positives to false 
positives. If in a population of 50 patients with the condition and 50 patients without the 
conditions, 40 patients with the condition would have a true positive results and 10 patients 
without would have a false positive result then the LR+ is (40/50)/(10/50) = 0.8/0.2 = 4. This 
can be interpreted as patients with the condition are 4 times more likely to get a positive 
test result than patients without. The negative likelihood ratio (LR-) is the opposite of this 
and is the ratio of false negatives to true negatives. This can be interpreted as how likely a 
negative result is in a patient without the condition which in the same population would be 
0.25. Likelihood ratios measure from 0 to infinity. A likelihood ratio of 1 means the test does 
not differentiate between patients with or without the condition, whereas the further the 
likelihood ratio is from 1 the greater the value of the test. 
Receiver Operating Characteristic (ROC) curves are a graphical format for displaying the 
performance of a test by plotting sensitivity against one minus specificity for various test 
values. This produces a curve on a chart that can be used to determine the value of the test 
and the optimum cut-off point for the test. Example ROC curves are shown in figure 1.1.2. 
A ROC curve can be examined to determine the Area Under the Curve (AUC). AUC is a 
method of measuring the tests value at discriminating the condition of interest. AUC is 
measured from 0 to 1. AUC of 0 represents the test being completely wrong, AUC of 0.5 
means the test performs no better than chance and AUC of 1 represents perfect 
discrimination (Hajian-Tilaki, 2013; Hoo et al., 2017). In practice the further the ROC curve is 
towards the upper left of the graph the better the test performs. The AUC for the tests 
shown in figure 1.1.2 are shown in table 1.1.3. Figure 1.1.2 and table 1.1.3 taken from (Zhao 
et al., 2016).  
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Table 1.1.3 Area under the ROC curve (AUC) of five stroke predictor variables 
Predictor variables AUC (mean ± SE) p 95% CI 
VI value 0.844 ± 0.041 0.000 0.764–0.924 
Graded LASEC 0.754 ± 0.065* 0.000 0.627–0.881 
CHA2DS2–Vasc 0.720 ± 0.065# 0.001 0.592–0.848 
Qualitative LASEC 0.692 ± 0.060* 0.005 0.574–0.810 
CHADS2 0.668 ± 0.073# 0.014 0.525–0.811 
Left Atrial Thrombus 0.648 ± 0.074* 0.030 0.502–0.794 
*p < 0.01 vs. VI value, #p < 0.05 vs. VI value.    
 
 
Figure 1.1.2 ROC curves analysis of VI value, Graded-LASEC (G-LASEC), CHA2DS2-Vasc, 
qualitative LASEC (Q-LASEC), LAT and CHADS2 in predicting the risk of stroke in patients 
with NVAF 
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The value of any diagnostic test is also reliant upon the reference standard or current gold 
standard for diagnosis against which it is judged. Any uncertainty in the reference standard 
will influence the performance of the diagnostic test under consideration. In stroke the gold 
standard diagnostic test has evolved over recent years and comprises a combination of 
expert clinical judgement and neuroimaging (Birenbaum et al., 2011; Musuka et al., 2015).  
1.1.8 Stroke mimic conditions  
Stroke is a complex condition which can present with a wide range of symptoms, the 
commonest of which are identified by the FAST. Other conditions also present with 
symptoms commonly associated with stroke and when mistaken for stroke are known as 
SM. Gibson and Whiteley’s systematic review of SM included 29 studies describing SM 
identified in ambulances, ED, stroke units, primary care and other settings and concluded 
that 26% of all suspected stroke were SM, although this figure was based on highly 
heterogeneous studies (Gibson and Whiteley, 2013). They reported the 20 most common 
differential diagnoses of suspected stroke patients which shows the wide range of conditions 
mistaken for stroke, their table is replicated below: 
Table 1.1.4 The 20 most common differential diagnoses of suspected stroke 
Differential diagnosis Percentage of patients (n=813) 
Seizure 19.6 
Syncope 12.2 
Sepsis 9.6 
Benign headache disorder 9.0 
Brain tumour 8.2 
Functional 7.4 
Metabolic 6.2 
Not specified 5.0 
Neuropathy 4.6 
Vertigo 3.2 
Dementia 2.3 
Extra- or subdural haemorrhage 1.8 
Drugs and alcohol 1.6 
Transient global amnesia 1.4 
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Table 1.1.4 The 20 most common differential diagnoses of suspected stroke 
cont. 
Differential diagnosis Percentage of patients (n=813) 
Myelopathy 1.0 
Hypertension related 0.9 
Parkinson’s disease 0.7 
Encephalopathy 0.5 
Trauma 0.5 
Invasive procedure 0.4 
 
Gibson and Whiteley’s work summarised the range of SM conditions using pre-determined 
diagnostic categories, but it included only 3 pre-hospital cohorts out of 29 so it has limited 
utility for this group of patients. Also, they did not describe characteristics that would help 
identify SM patients, although they did refer to the performance of the FAST and how FAST 
negative suspected stroke patients were less likely to have a stroke diagnosis (OR 0.4, 95% CI 
0.3-0.6).  
Long and Koyfman (Long and Koyfman, 2017) described the presentation and management 
of common SM for the emergency medicine physician which highlights that many stroke and 
SM patients will be seen by other healthcare professionals before they get to specialist 
stroke services.  
Whilst focussing upon stroke care, it is also important to remember that SM patients have an 
underlying condition that needs to be assessed and treated appropriately. Good pre-hospital 
care is about getting the right patient, to the right place at the right time. The misdiagnosis 
of SM impacts on patients, ambulance services and stroke services. Patients may bypass 
local hospitals to access distant stroke services which places them away from local re-
enablement services and supportive friends and family. Transporting a SM to a distant stroke 
centre means that ambulance crews are unavailable for an unnecessarily extended time. It 
may also necessitate a second ambulance to be called if the patient needs repatriation to 
their local hospital. There are also risks involved with transporting patients under emergency 
conditions (Lutman et al., 2008; Sanddal et al., 2010) which could potentially be avoided if 
the patient was diagnosed with a SM rather than a stroke.  
 17 
 
The impact of SM in different models of care has been considered and becomes particularly 
relevant when stroke care centralisation is considered. Bypassing local hospitals to access 
specialist stroke services with SM patients, impacts on the patient, the ambulance service 
and the stroke services. Recent data on patients admitted to UK HASUs revealed that a 
sizable proportion (24-64%) of patients admitted to HASUs were SM (Alonge et al., 2013; 
Shribman et al., 2013; Siddiqui et al., 2013; Aravind et al., 2015; Dawson et al., 2016; 
Sharobeem et al., 2016). 
Dawson et al (Dawson et al., 2016) examined the bed use and length of stay of SM in a 
London HASU. They reported that SM accounted for 8-17% of HASU beds despite relatively 
short lengths of stay. They also recognised that advanced imaging like Magnetic Resonance 
Imaging (MRI) could be used to rapidly identify these patients as SM although this does have 
resource implications. They concluded that SM need to be accounted for when designing 
stroke pathways and systems. This work was referred to when the feasibility of 
implementing a regional HASU model of care across the UK was considered (Allen et al., 
2017). They reported that if stroke units were centralised into large regional HASUs the 
number of SM would need to be considered in terms of workforce and infrastructure impact.   
Stroke services are a specialist and limited resource. Care on a HASU is more expensive than 
care on a general ward due to the specialist nature of the HASU. Bed days on a HASU are 
approximately three times more expensive than beds days on a general ward (£583 versus 
£181 based on 2010 costs (The Comptroller and Auditor General, 2010)). Therefore reducing 
the use of stroke services by SM should allow limited, specialist resources to be targeted at 
the intended recipients.  
1.1.9 SM identification tools 
SM identification has been explored by multiple authors and tools have been developed to 
identify SM. The tools described (summarised in table 1.1.5) were identified during the 
development of this project and supplemented by papers identified during the systematic 
review described in the next chapter. All of the studies were based on cohorts of 
hospitalised suspected stroke patients. The tools developed consistently included predictive 
variables from an epidemiological perspective such as age, seizures and the absence of 
vascular risk factors. Since the early work by Libman et al multivariate logistic regression has 
been the method used by all the studies apart from the Siddiqui et al paper. The focus of 
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some of the tools (Chang et al, Goyal et al and Hand et al) is described as informing and 
streamlining the acute assessment process and supporting the decision making around 
performing advanced imaging which makes sense in the context of the short time window 
for thrombolysis. 
The performance characteristics of the tools were reported using multiple measures but 
Libman et al, Siddiqui et al and Tobin et al all reported high specificity with low sensitivity. Ali 
et al, Chang et al and Hand et al report good overall tool performance based on AUC. Goyal 
et al described very good performance in terms of sensitivity, specificity and PPV but this is 
in a population selected following negative CT imaging. 
Tobin et al developed a tool on a small (n=206) sample of thrombolysis patients and only 
included three predictive variables. This paper was unusual in that it stated the tool 
developed was not clinically useful. They highlighted the neurological basis of many of the 
SM and recommended specialist stroke/neurology input for these patients. Merino et al also 
recommended specialist input despite describing predictive variables in a large dataset. 
Obviously, easy access to specialist input is impractical in pre-hospital assessment. 
Although the work by Merino et al, Newey et al and Nor et al was not intended to specifically 
define a SM identification tool, it is included due to the similar intention and methods used 
and the similarities in the predictive factors reported. The work by Nor et al on the ROSIER 
tool showed that SM identification can be incorporated into a tool intended to improve 
stroke identification. None of the tools described were intended for the pre-hospital setting. 
The Chang et al and Siddiqui et al papers were based on populations of thrombolysed 
patients which does not translate easily to pre-hospital care. Ali et al, Chang et al, Hand et al 
and Newey et al included variables that are not commonly collected or available in pre-
hospital care such as NIHSS and CT results, however the potential to develop a SM 
identification tool, based on readily available data, is clearly demonstrated by these studies. 
The majority of the variables considered by the studies described above are collected and 
available in the pre-hospital setting, although the reliability during standard patient 
assessment is unclear. SM identification has not been previously considered in the pre-
hospital setting but, based on the precedent set by these studies and with sufficient 
awareness of the information available to paramedics and their views on feasibility, it could 
be.   
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1.1.10 Clinical prediction rules 
Stroke identification tools and SM identification tools are both examples of clinical 
prediction rules. “Clinical prediction rules are mathematical tools that are intended to guide 
clinicians in their everyday decision making.” (Adams and Leveson, 2012). 
Clinical prediction rules come under many different names: prognostic tools; decision 
support aids; prediction models and other variations. In summary these are tools that aid in 
decision making, usually by predicting a patient’s outcome state. These tools are useful as 
they can inform decision making based on previous research with access to large datasets, 
help standardise decision making and allow the probabilities of various outcomes to be 
quantified. The clinical prediction rule developed in this work shall be referred to as a tool.  
There are numerous methods for developing clinical prediction tools (Adams and Leveson, 
2012) but the basic process involves four steps: 
1. Development of a tool that identifies the condition of interest. 
2. Validation that the tool performs as expected in a new population.  
3. Impact analysis of what difference the tool would make in practice. 
4. Implementation of the tool into regular healthcare. 
Steps one to three were described in greater depth in a series of prognostic research papers 
(Altman et al., 2009; Moons et al., 2009a; Moons et al., 2009b; Royston et al., 2009) which 
were summarised by Steyerberg et al (Steyerberg et al., 2013). These three steps guided the 
methods chosen for this project, fit within the development section of the MRC complex 
interventions framework (Craig et al., 2008) and are expanded upon in later chapters. Step 
four in the above process will not be completed within the scope of this project, but factors 
that would aid or hinder future implementation will be explored with professional 
stakeholders in chapters 2.1, 2.3 and 3.3.  
1.1.11 Summary  
This chapter has described advances in stroke care which require stroke patients to be 
accurately identified and directed to stroke services, often within limited time windows, but 
with the drawback that SM conditions are also caught up in the emergency assessment 
pathway. Misdiagnosis of SM causes problems for patients, ambulance services and stroke 
services but identification of SM has been shown to be possible in hospital cohorts using 
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simple clinical characteristics. Based on this there is an opportunity to improve pre-hospital 
stroke care through the development of a pre-hospital SM identification tool. 
The next chapter contains a systematic review of the literature describing SM including the 
frequency with which SM are documented, the conditions causing SM and clinical 
characteristics that may be associated with SM. This systematic review was used to inform 
the development of the initial SM tool and the remainder of this thesis.  
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Chapter 1.2 The frequency, characteristics and aetiology of stroke mimic 
presentations: a narrative review 
 
1.2.1 Introduction 
This chapter reports the findings of a systematic review of the literature investigating the 
frequency, characteristics and aetiology of SM. Due to the scarcity of pre-hospital specific 
literature this review describes SM across a broad range of settings. 
As described in the previous chapter, a number of studies have developed tools to identify 
SM (Merino et al., 2013; Ali et al., 2014; Goyal et al., 2016b) using characteristics associated 
with SM diagnosis, such as patient age or presence of seizures, along with the absence of 
factors associated with stroke diagnosis, such as Atrial Fibrillation (AF) or hypertension. 
However these tools are not in widespread use and have not been studied in pre-hospital 
settings where they may perform differently due to the different population, the limited 
information available to paramedics and their clinical interpretation. This review will report 
on literature describing the frequency and characteristics of SM in order to inform the 
development of a similar SM identification tool but with a pre-hospital focus. 
This chapter was published in the European Journal of Emergency Medicine in May 2018 as a 
stand-alone review (McClelland et al., 2018). 
1.2.2 Methods 
A systematic search was performed with the results reported using narrative synthesis. The 
review protocol was prospectively registered on PROSPERO (registration number 
42015026457) (McClelland et al., 2015). This review is reported following the PRISMA 
statement (Moher et al., 2009).  
1.2.2.1 Inclusion criteria 
To be eligible for inclusion studies had to fulfil the following criteria: 
 Primary studies describing adult (18 years and above) patients with initial diagnosis 
of stroke and final non-stroke diagnosis. 
 Reported a number and/or rate of SM. 
 Reported the clinical and/or demographic characteristics of a SM population. 
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 Published in the English language. 
Case reports were excluded from the review. 
1.2.2.2 Database search strategy 
A simple but structured search strategy (appendix A) was developed with input from an 
information specialist. This was applied to the following databases up to February 2017: 
MEDLINE; EMBASE; PsycInfo; CINAHL; Cochrane Database of Systematic Reviews and 
Database Of Research In Stroke. Grey literature was identified using the first 30 pages of 
Google and Google Scholar (Haddaway et al., 2015).  
1.2.2.3 Study selection process 
Studies were screened based upon title and abstract by one reviewer (GM) with 
uncertainties discussed with another member of the review team. Abstracts which appeared 
relevant were assessed for eligibility in full text format by the same reviewer (GM). The 
reference lists of all studies included were hand searched. Citation searching of included 
studies was undertaken using ISI Web of Science.  
1.2.2.4 Data extraction and analysis 
Data were extracted using a structured form to capture the following: title; authors(s); 
journal; year; country; setting; proportion of SM; stroke assessment tool; method of stroke 
diagnosis; method of SM diagnosis; presence of SM final diagnosis; demographics and/or 
clinical characteristics.  
Clinical Classification Software (CCS) codes were used to combine SM diagnoses reported 
within studies using variable terminology into clinically relevant groups (Healthcare Cost and 
Utilization Project, 2017).  
Due to the descriptive aims of the review, variability in the definition of stroke and SM and 
the anticipated heterogeneity of studies with variable quality there was no pre-specified 
meta-analysis.  
1.2.2.5 Quality assessment 
Due to anticipated heterogeneity within the literature the Quality Assessment Tool for 
Studies with Diverse Designs (QATSDD) was preselected for assessing study quality (Sirriyeh 
et al., 2012). This tool was not applied to abstracts.  
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1.2.3 Results 
The search strategy yielded 9,972 references. After initial screening 336 full text articles 
were reviewed. The screening process is summarised in figure 1.2.1.  
 
Figure 1.2.1 Flowchart summarising study selection process 
Seventy-nine studies (table 1.2.1) were included in the review. The median year of 
publication was 2013 (range 1982-2017). The majority of studies originated from North 
America (n=34, 43%) or Europe (n=29, 37%). The majority (n=78, 99%) of studies were 
cohort studies with 41 (53%) collecting data prospectively, 36 (46%) retrospectively and in 1 
(1%) study the direction of data collection was unclear. 
The overall population included 147,779 patients. SM patients were younger than stroke 
patients (pooled mean age 61.7 vs 69.6 years) with a higher percentage of females (pooled 
female gender 53.3% vs 47.7%). Included studies were described as three groups. Those with 
populations confined to pre-hospital settings (n=7) reflect the early identification of 
suspected stroke patients, usually through application of specific tools and protocols. 
Thrombolysis studies (n=21) are separately described as these have a clearly defined sub-
population based upon the criteria for administration of a specific treatment. All other 
studies (n=51) were not uniquely pre-hospital or thrombolysis focussed.  
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Table 1.2.1 Studies included in the systematic review 
Authors Year Country Design Setting 
Sampl
e size 
SM 
(%) 
Stroke 
identific
ation 
tool 
used 
QATSDD 
score 
(%) 
General settings 
Aiyesimoju et al 
(Aiyesimoju et al., 1983) 
1983 Nigeria 
Retrospective 
cohort 
Hospital 152 9 
NR 
43 
Ali et al (Ali et al., 
2014) 
2014 USA 
Retrospective 
cohort 
Tele 1387 23 
NR 
U 
Ali et al (Ali et al., 
2016) 
2016 
USA, 
Germany 
Cohort Tele 1985 35 
NR 
55 
Alonso et al 
(Alonso et al., 2014) 
2014 Spain 
Prospective 
cohort 
ED 140 26 
NR 
U 
Alves et al (Alves et 
al., 2016) 
2016 Portugal 
Retrospective 
cohort 
Stroke 
unit 
367 12 
NR 
36 
An et al (An et al., 
2013) 
2013 Korea 
Prospective 
cohort 
Hospital 278 32 
NR 
64 
Ay et al (Ay et al., 
1999) 
1999 USA 
Retrospective 
cohort 
Hospital 27 37 
NR 
48 
Barker et al 
(Barker et al., 1984) 
1984 USA 
Prospective 
cohort 
Hospital 1604 44 
NR 
55 
Brunser et al 
(Brunser et al., 2013) 
2013 Chile 
Prospective 
cohort 
ED 842 13 
NR 
57 
Clarey et al (Clarey 
et al., 2014) 
2014 Australia 
Prospective 
cohort 
GP 179 51 
NR 
76 
Dassan et al 
(Dassan et al., 2012) 
2012 UK 
Prospective 
cohort 
Stroke 
unit 
44 34 
NR 
52 
Dawson et al 
(Dawson et al., 2016) 
2016 UK 
Retrospective 
cohort 
HASU 2305 24 
NR 
62 
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Table 1.2.1 Studies included in the systematic review cont. 
Authors Year Country Design Setting 
Sampl
e size 
SM 
(%) 
Stroke 
identific
ation 
tool 
used 
QATSDD 
score 
(%) 
Delva et al (Delva 
et al., 2015) 
2015 Ukraine 
Retrospective 
cohort 
Hospital 2219 8 
NR 
U 
Eichel et al (Eichel 
et al., 2013) 
2013 Israel 
Retrospective 
cohort 
Hospital 124 63 
NR 
67 
El Husseini and 
Goldstein (El 
Husseini and Goldstein, 
2013) 
2013 USA 
Retrospective 
cohort 
Hospital 297 56 
NR 
45 
Ferro et al (Ferro 
et al., 1998) 
1998 Portugal 
Prospective 
cohort 
Hospital 237 9 
NR 
50 
Foerch et al 
(Foerch et al., 2012) 
2012 
Germany 
/Switzerlan
d 
Prospective 
cohort 
Hospital 205 3 
NR 
57 
Gargalas et al 
(Gargalas et al., 2017) 
2017 UK 
Retrospective 
cohort 
HASU 1165 22 
NR 
76 
Gonzalez-
Garcia et al 
(Gonzalez-Garcia et al., 
2012) 
2012 Cuba 
Prospective 
cohort 
Stroke 
unit 
72 15 
NR 
43 
Goyal et al (Goyal 
et al., 2016b) 
2016 
USA, 
Greece 
Prospective 
cohort 
ED 784 41 
NR 
67 
Hammermeiste
r et al 
(Hammermeister et al., 
2013) 
2013 USA 
Retrospective 
cohort 
ED 1002 47 
NR 
U 
Hand et al (Hand et 
al., 2006) 
2006 
Australia/U
K 
Prospective 
cohort 
Hospital 350 31 
NR 
79 
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Table 1.2.1 Studies included in the systematic review cont. 
Authors Year Country Design Setting 
Sampl
e size 
SM 
(%) 
Stroke 
identific
ation 
tool 
used 
QATSDD 
score 
(%) 
Hatzitolios et al 
(Hatzitolios et al., 2008) 
2008 Greece 
Retrospective 
cohort 
Stroke 
unit 
362 5 
NR 
38 
Hemmen et al 
(Hemmen et al., 2008) 
2008 USA 
Retrospective 
cohort 
ED 411 25 
NR 
60 
Jiang et al (Jiang et 
al., 2014) 
2014 China 
Prospective 
cohort 
ED 715 48 
NR 
79 
Knauer et al 
(Knauer et al., 2012) 
2012 Germany 
Prospective 
cohort 
Stroke 
unit 
174 28 
NR 
69 
Kose et al (Kose et 
al., 2013) 
2013 Turkey 
Retrospective 
cohort 
ED 671 13 
NR 
52 
Kothari et al 
(Kothari et al., 1995) 
1995 USA 
Retrospective 
cohort 
ED 441 4 
NR 
62 
Laskowitz et al 
(Laskowitz et al., 2009) 
2009 USA 
Prospective 
cohort 
Hospital 1289 40 
NR 
79 
Libman et al 
(Libman et al., 1995) 
1995 USA 
Prospective 
cohort 
ED 411 19 
NR 
40 
Luger et al (Luger 
et al., 2017) 
2017 Germany 
Prospective 
cohort 
Hospital 202 5 
NR 
71 
Mao et al (Mao et 
al., 2016) 
2016 China 
Prospective 
cohort 
ED 416 14 
NR 
48 
Martin et al 
(Martin et al., 1997) 
1997 UK 
Prospective 
cohort 
Hospital 508 27 
NR 
64 
Merino et al 
(Merino et al., 2013) 
 
2013 USA 
Prospective 
cohort 
Hospital 8187 30 
NR 
67 
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Table 1.2.1 Studies included in the systematic review cont. 
Authors Year Country Design Setting 
Sampl
e size 
SM 
(%) 
Stroke 
identific
ation 
tool 
used 
QATSDD 
score 
(%) 
Montaner et al 
(Montaner et al., 2011) 
2011 Spain 
Prospective 
cohort 
ED 1005 9 
NR 
76 
Natteru et al 
(Natteru et al., 2016) 
2016 USA 
Retrospective 
cohort 
Hospital 93 39 
NR 
55 
Nor et al (Nor et al., 
2005) 
2005 UK 
Prospective 
cohort 
ED 516 44 
NR 
69 
Norris and 
Hachinski (Norris 
and Hachinski, 1982) 
1982 Canada 
Retrospective 
cohort 
Stroke 
unit 
821 13 
NR 
33 
O'Brien et al 
(O'Brien et al., 1987) 
1987 Ireland 
Prospective 
cohort 
Hospital 100 1 
NR 
57 
O'Connell et al 
(O'Connell et al., 2016) 
2016 USA 
Prospective 
cohort 
Hospital 89 NR 
NR 
64 
Pearson et 
al(Pearson et al., 2017) 
2017 USA 
Prospective 
cohort 
ED 114 43 
NR 
U 
Penn et al (Penn et 
al., 2016) 
2016 Canada 
Prospective 
cohort 
ED 40 NR 
NR 
U 
Quenardelle et 
al (Quenardelle et al., 
2016) 
2016 France 
Prospective 
cohort 
Hospital 1361 38 
NR 
69 
Ramadan et al 
(Ramadan et al., 2015) 
2015 UK 
Prospective 
cohort 
Hospital 916 28 
NR 
U 
Reid et al (Reid et 
al., 2012) 
2012 UK 
Retrospective 
cohort 
Stroke 
unit 
375 31 
NR 
48 
Sharma et al 
(Sharma et al., 2014) 
2014 USA 
Prospective 
cohort 
Hospital 167 22 
NR 
76 
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Table 1.2.1 Studies included in the systematic review cont. 
Authors Year Country Design Setting 
Sampl
e size 
SM 
(%) 
Stroke 
identific
ation 
tool 
used 
QATSDD 
score 
(%) 
Taguchi et al 
(Taguchi et al., 2016) 
2016 Japan 
Prospective 
cohort 
Hospital 353 28 
NR 
45 
Tobin et al (Tobin 
et al., 2009) 
2009 USA 
Retrospective 
cohort 
ED 206 22 
NR 
60 
Tuntiyatorn et 
al (Tuntiyatorn et al., 
2013) 
2013 Thailand 
Retrospective 
cohort 
ED 704 26 
NR 
62 
Whiteley et al 
(Whiteley et al., 2011) 
2011 UK 
Prospective 
cohort 
ED 356 31 
NR 
74 
Wolf et al (Wolf et 
al., 2016) 
2016 Germany 
Prospective 
cohort 
ED 410 64 
NR 
45 
Prehospital 
Brandler et al 
(Brandler et al., 2015) 
2015 USA 
Retrospective 
cohort 
PH 736 36 CPSS 
74 
Bray et al (Bray et 
al., 2005) 
2005 Australia 
Prospective 
cohort 
PH 100 27 MASS 
69 
Gioia et al (Gioia et 
al., 2016) 
2016 Canada 
Retrospective 
cohort 
PH 960 43 CPSS 
60 
Karlinski et al 
(Karlinski et al., 2015) 
2015 Poland 
Prospective 
cohort 
PH 570 37 
Physician 
judgeme
nt 
57 
Restrepo et al 
(Restrepo et al., 2010)r 
2010 USA RCT PH 567 4 LAPSS 
U 
Sequeira et al 
(Sequeira et al., 2016) 
2016 USA 
Retrospective 
cohort 
PH 3376 19 CPSS 
57 
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Table 1.2.1 Studies included in the systematic review cont. 
Authors Year Country Design Setting 
Sampl
e size 
SM 
(%) 
Stroke 
identific
ation 
tool 
used 
QATSDD 
score 
(%) 
Wendt et al 
(Wendt et al., 2015) 
2015 Germany 
Prospective 
cohort 
PH 561 16 Unclear 
69 
Thrombolysis 
Artto et al (Artto et 
al., 2012) 
2012 Finland 
Retrospective 
cohort 
Stroke 
unit 
985 1 
NR 
69 
Asaithambi et al 
(Asaithambi et al., 2017) 
2017 USA 
Retrospective 
cohort Tele 
131 10 
NR 
45 
Chang et al (Chang 
et al., 2012) 
2012 USA 
Retrospective 
cohort Hospital 
193 16 
NR 
50 
Chen et al (Chen et 
al., 2011) 
2011 
France/Ser
bia 
Retrospective 
cohort 
Stroke 
unit 
488 1 
NR 
50 
Chernyshev et 
al (Chernyshev et al., 
2010) 
2010 USA 
Retrospective 
cohort 
ED 
512 14 
NR 
52 
Forster et al 
(Forster et al., 2012) 
2012 Germany 
Prospective 
cohort Hospital 
648 7 
NR 
69 
Goyal et al (Goyal 
et al., 2015) 
2015 USA 
Retrospective 
cohort Hospital 
535 14 
NR 
69 
Guillan et al 
(Guillan et al., 2012) 
2012 Spain 
Prospective 
cohort Hospital 
621 2 
NR 
55 
Lewandowski et 
al (Lewandowski et al., 
2015) 
2015 USA 
Retrospective 
cohort 
ED 
323 12 
NR 
52 
Liberman et al 
(Liberman et al., 2015) 
2015 USA 
Prospective 
cohort 
Hospital 
121 14 
NR 
55 
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Table 1.2.1 Studies included in the systematic review cont. 
Authors Year Country Design Setting 
Sampl
e size 
SM 
(%) 
Stroke 
identific
ation 
tool 
used 
QATSDD 
score 
(%) 
Mehta et al 
(Mehta et al., 2014) 
2014 USA 
Retrospective 
cohort 
Stroke 
unit 
120 17 
NR 
52 
Rostanski et al 
(Rostanski et al., 2016) 
2016 USA 
Retrospective 
cohort ED 
350 14 
NR 
55 
Sarikaya et al 
(Sarikaya et al., 2012) 
2012 
Switzerlan
d 
Prospective 
cohort Hospital 
326 7 
NR 
60 
Scott and 
Silbergleit (Scott 
and Silbergleit, 2003) 
2003 USA 
Retrospective 
cohort 
Hospital 
151 4 
NR 
62 
Siddiqui et al 
(Siddiqui et al., 2016) 
2016 USA 
Retrospective 
cohort Hospital 
106 25 
NR 
U 
Sivakumaran et 
al (Sivakumaran et al., 
2016) 
2016 UK 
Retrospective 
cohort 
HASU 
489 10 
NR 
50 
Tsivgoulis et al 
(Tsivgoulis et al., 2015) 
2015 USA 
Prospective 
cohort Hospital 
516 15 
NR 
83 
Tsivgoulis et al 
(Tsivgoulis et al., 2011) 
2011 USA 
Retrospective 
cohort Hospital 
539 10 
NR 
64 
Winkler et al 
(Winkler et al., 2009) 
2009 
Switzerlan
d 
Prospective 
cohort 
Stroke 
unit 
250 3 
NR 
60 
Xian et al (Xian et 
al., 2016) 
2016 USA 
Retrospective 
cohort Hospital 
90746 1 
NR 
U 
Zinkstok et al 
(Zinkstok et al., 2013) 
2013 Europe 
Prospective 
cohort Hospital 
5581 2 
NR 
62 
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The pooled mean and median SM rates were 22% (SD 16%) and 19% (IQR 9.5-33%) 
respectively. The median SM rates were 27% (IQR 13-38.5%) in the general group, 27% (IQR 
16-37%) in the pre-hospital group and 10% (IQR 2.5-14%) in the thrombolysis group. These 
SM rates are summarised in chart 1.2.1. 
 
QATSDD scoring was converted into an overall percentage for each study to simplify 
comparison. Included studies scored a median 60% (IQR 52-69) on the QATSDD (see 
appendix B). The three subgroups had similar pooled mean scores on the QATSDD: pre-
hospital 64%; mixed 59% and thrombolysis 59%. As a sensitivity analysis the studies scoring 
below the lower QATSDD quartile were compared with studies scoring above the upper 
quartile. The lowest quartile studies (n=17) reported a pooled mean SM rate of 21% (SD 
17.5) based on 5,601 patients and the highest quartile studies (n=11) reported a pooled 
mean SM rate of 28% (SD 15.1) based on 6,680 patients.  
1.2.3.1 SM final diagnoses 
Sixty-three studies (80%) reported the SM underlying diagnoses. Methods of identifying the 
diagnosis of SM included: discharge/final diagnosis (40%); neurologist or stroke specialist 
assessment (17%); expert panel (14%); registry (6%); and other/unclear (22%). There was 
insufficient information presented to make objective assumptions that any one approach 
0
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70
All General Prehospital Thrombolysis
Chart 1.2.1 Box plot showing median, IQR and range of 
stroke mimic rates
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was superior or inferior, and the investigator choice of reference standard did not exclude 
studies. 
SM diagnoses were summarised using CCS codes (Healthcare Cost and Utilization Project, 
2017). This resulted in 103 initial CCS codes, which were reported using level 1 CCS (broad 
disease categories) and level 2 CCS (more specific disease areas) codes (figure 1.2.3).  
 
Figure 1.2.3 Taxonomy of SM using CCS codes 
1.2.3.2 Pre-hospital studies 
Seven (9%) studies clearly described pre-hospital settings: 6,870 patients, mean SM rate 26% 
(SD 14%). SM patients were younger than stroke patients (67 vs 73 years pooled mean age) 
with a higher proportion of females (SM 58% female vs stroke 49% female).  
The most frequent level 1 CCS diagnostic groups in the pre-hospital setting were: diseases of 
the nervous system and sense organs (29%); symptoms, signs and ill-defined conditions and 
factors influencing health status (9%) and unknown (43%). The most frequent level 2 CCS 
diagnostic groups were: epilepsy and convulsions (19%); symptoms, signs and ill-defined 
conditions (9%) and ear conditions (5%). 
1.2.3.3 Thrombolysis studies 
Twenty-one (26%) studies described SM in patients treated with thrombolysis: 103,731 
patients, mean SM rate 9% (SD 7%). SM patients were younger than stroke patients (57 vs 68 
years mean age). More SM patients were female (SM pooled mean 57% vs stroke 46%). 
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The most frequent level 1 CCS diagnostic groups in the thrombolysis cohorts were: diseases 
of the nervous system and sense organs (37%); mental illness (18%) and unknown (42%). The 
most frequent level 2 CCS diagnostic groups were: miscellaneous mental disorders (17%); 
headache including migraine (17%); and epilepsy and convulsions (16%). 
1.2.3.4 General studies 
Fifty-one (65%) studies described cohorts that were not specifically identified as pre-hospital 
or receiving thrombolysis: 37,178 patients, mean SM rate 27% (SD 16%). These settings 
included: hospital (41%); ED (35%); stroke unit/HASU (18%); telemedicine (4%); and general 
practice (2%). The total population was 50% male with a pooled mean age of 68 years. SM 
patients were younger than stroke (63 vs 70 years pooled mean age) with a higher 
proportion of females (SM 51% female vs stroke 48% female). 
The most frequent level 1 CCS diagnostic groups were: diseases of the nervous system and 
sense organs (34%); diseases of the circulatory system (15%); mental illness (10%) and 
unknown (17%). The most frequent level 2 CCS diagnostic groups were: epilepsy and 
convulsions (10%); cerebrovascular disease e.g. TIA; subdural haemorrhage (9%); and 
headache including migraine (9%). 
1.2.3.5 Clinical characteristics 
Studies reporting clinical characteristics associated with SM are described in table 1.2.2. 
Associations between clinical characteristics and diagnosis were reported as positive for SM 
or stroke (p<0.05 or stated within text as significant) or non-significant.  
Table 1.2.2 Characteristics associated with SM diagnosis reported by number of papers 
  Characteristics  
Associated 
with SM 
No 
association 
Associated 
with stroke 
Past medical 
history 
Diabetes 2 23  9 
Hypercholesterolemia 3 6 2 
Migraine 5 1 0 
Seizure 9 2 0 
Smoker 1 21 4 
Stroke 7 11 5 
TIA 1 2 1 
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Table 1.2.2 Characteristics associated with SM diagnosis reported by number of papers cont. 
 
Characteristics  
Associated 
with SM 
No 
association 
Associated 
with stroke 
Symptoms 
(negative) 
Abnormal admission 
neurological examination 1 0 0 
Altered level of consciousness 
/ mental status 9 5 1 
Aphasia 1 0 1 
Cognitive impairment 3 1 0 
Confusion 3 1 0 
Dysphagia 1 0 0 
General weakness 1 0 0 
Sensory deficit 4 0 0 
Symptoms 
(positive) 
Diabetic symptoms 1  0 0 
Dizziness / vertigo 5 3 0 
Headache 1 5 1 
Pain 1 0 0 
Psychiatric / somatic disorder 6 1 0 
Seizure 6 0 0 
Other 
Can walk now 1 0 0 
Neuro symptoms inconsistent 
with vascular territory 1 0 0 
No lateralising symptoms 1 0 0 
No motor or speech deficit 1 0 0 
No neurological signs 1 0 0 
Normal extraocular 
movements 1 0 0 
Normal Glasgow Coma Scale 
(GCS) 1 0 0 
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1.2.4 Discussion 
This review identified SM studies with heterogeneous aims, settings, reference standards 
and reporting methods. The studies included had a wide range of QATSDD scores, however 
the subgroup mean scores were similar. As there were no pre-specified exclusion criteria 
based on quality assessment, all identified studies were included. The QATSDD identified 
that very few studies discussed sample size or considered the accuracy of the final diagnoses 
therefore an element of selection bias must be acknowledged.  
These findings build on earlier work (Gibson and Whiteley, 2013) by showing that despite 
advancing technology and better availability of specialist assessment, SM continue to be a 
diagnostic challenge. To inform the development of screening processes with improved 
specificity, this review has described typical characteristics that may aid with SM diagnosis. 
1.2.4.1 Frequency 
The reported rate of SM was influenced by the clinical definition of stroke used at the time 
of the study and therefore varied across the literature (Staubach et al., 2016). SM accounted 
for 22% of all suspected stroke cases, which is lower than the 26% previously reported 
(Gibson and Whiteley, 2013). This discrepancy may be the result of recent large thrombolysis 
cohorts being included (Zinkstok et al., 2013; Xian et al., 2016). Thrombolysis studies have a 
lower SM frequency because of the specialist assessment, treatment criteria and 
neuroimaging required to make treatment decisions. However, the pooled SM rates for the 
pre-hospital and general populations were similar at 27%. Studies in the upper quartile 
based on QATSDD scoring reported a higher SM rate (28%) than studies in the lower quartile 
(21%) so the combined figure may be an under-estimate. 
The high frequency of SM in pre-hospital care may be due to a number of factors: most pre-
hospital services are paramedic led; application of high sensitivity stroke identification 
instruments; insufficient time to assess in more detail to identify SM; availability of 
information about past medical history; and the lack of imaging or point of care diagnostics 
for stroke. Nevertheless, SM rates were similar in the pre-hospital and general groups. This 
may reflect that a significant portion of the general group were also unfiltered pre-hospital 
patients, and that apart from very obvious SM identified during initial ED assessment the 
initial diagnoses made in the pre-hospital setting were not over-ruled until later stroke 
specialist assessment with brain imaging.   
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The presence of SM in thrombolysis populations reflects the challenging nature of acute 
stroke treatment. The drive to reduce door-to-needle (DTN) time may be linked with 
increased SM thrombolysis (Liberman et al., 2015). Thrombolysing SM has relatively low risks 
(Zinkstok et al., 2013; Liberman et al., 2015) but should not become an acceptable 
consequence of optimising stroke treatment, and it does have financial implications (Goyal 
et al., 2015). Using current diagnostic processes this is a challenging area to address because 
of the lack of clear clinical characteristics differentiating stroke from SM, and the need to 
treat patients early to get the most benefit. Developments and investment in rapid advanced 
imaging to reveal positive evidence of acute ischaemia or the development of rapid 
biomarker tests would help avoid thrombolysis for some patients in this group (Bivard et al., 
2015).    
1.2.4.2 Characteristics 
SM patients tended to be younger than stroke patients and were more likely to be female. 
The mean age falls as patients move from pre-hospital care, to non-specialist care (general 
group) and on to specialist care (thrombolysis group). This may reflect the increasing rigour 
of the assessment process. 
Clinical characteristics (table 1.2.2) were reported under a variety of overlapping terms. Due 
to methodological concerns a weighted average or meta-analysis was not conducted. The 
distribution of clinical characteristics across studies was used as a crude measure of 
association. Seizures, history of migraine and psychiatric disorders were the characteristics 
with the clearest association with SM diagnosis. There was disagreement between studies as 
to the direction of association for some characteristics e.g. history of stroke is associated 
with stroke (5 studies), SM (7 studies) and non-significant (12 studies). This reflects that 
although vascular risk factors are more likely to be present amongst stroke patients, their 
presence was also a reason for clinicians to wrongly suspect stroke as a cause for new 
symptoms. However as a stronger risk factor AF had a clearer relationship with stroke (26 
studies positive association; 7 non-significant association).  
Focal neurological deficits used by most identification scores maintained their relationship 
with stroke e.g. facial palsy/weakness (1 non-significant, 13 associated with stroke) (Loomis 
and Mullen, 2014; Lip and Lane, 2015). The absence of these characteristics could be an 
indicator of SM, and has been used in SM identification tools (chapter 1, table 1.1.5).  
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1.2.4.3 Aetiology 
Many conditions present as SM and diagnostic methods, including the use of brain imaging, 
were highly variable in the literature. The definition of stroke, and therefore SM, varied and 
conditions such as TIA and sub-arachnoid haemorrhage were variably classified as stroke or 
SM. It is important that investigators transparently present data so that services can decide 
upon the relevance of the results.  
The use of CCS codes allowed the findings of this heterogeneous dataset to be summarised. 
Disorders of the nervous system and sense organs were the most common cause of SM, 
particularly seizures which mirrors previous findings (Gibson and Whiteley, 2013). Some pre-
hospital stroke tools used seizures to indicate a reduced likelihood of stroke (Kidwell et al., 
2000; Nor et al., 2005) and some SM identification tools also included seizures (Ali et al., 
2014; Goyal et al., 2016b). Accurate history taking is crucial, but seizures can be unwitnessed 
and it is only the gradual recovery, lack of acute changes on imaging, clarification of past 
medical history and further investigations which confirm the diagnosis. As 2% of acute stroke 
patients experience a seizure (Huang et al., 2014), this is an area where development of 
rapid diagnostics may be helpful.   
1.2.4.4 Clinical implications 
Pre-hospital identification of SM may help to ensure that patients access appropriate 
pathways of care, especially in centralised service configurations which require a pre-
hospital redirection decision. Application of a SM identification tool, such as those described 
in chapter 1.1, would support creation and evaluation of a two stage process. The initial 
stage is suspicion of stroke based on triggering a high sensitivity tool during clinical 
assessment such as FAST, the second stage is refinement of this initial diagnosis based upon 
a SM assessment with high specificity. This two stage assessment does not include the initial 
suspicion of stroke by the ambulance dispatch centre where high sensitivity to potential 
stroke is paramount. A recent study using CPSS guided dispatch of ambulances was able to 
identify 2/3rds of patients suitable for thrombolysis simply through structured telephone 
description of symptoms (Dami et al., 2017), but there is currently no formalised pre-
hospital equivalent score at dispatch to then identify patients who could be a SM. 
Due to the lack of clinical characteristics that clearly differentiate strokes and SM, this 
second stage provides an opportunity to apply novel point of care diagnostic technologies 
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(Gonzalez et al., 2013; Luger et al., 2017) to improve the overall assessment performance. A 
SM assessment could also be used to help target specialist resources such as mobile stroke 
units (Fassbender et al., 2017). These may also assist in early decision making about whether 
patients being assessed for thrombolysis should have additional imaging, other than CT, in 
order to minimize inappropriate treatment.  
In the meantime, clinician knowledge of common SM characteristics could inform the 
differential diagnoses considered when assessing suspected stroke patients. Training 
programmes should encourage clinicians to seek additional information which might 
broaden the diagnosis for key demographic groups, rather than just stop their clinical 
assessment once stroke is suspected.  
1.2.4.5 Limitations 
Meta-analysis was not attempted due to the narrative nature of this review and study 
heterogeneity. A quality assessment tool tailored for cohort studies may have been more 
appropriate than the QATSDD tool which was chosen prior to study identification. The initial 
screening and identification was performed by a single reviewer so relevant studies could 
have been missed. Non-English studies were not included. CCS coding simplified cases to a 
single diagnostic category to aid reporting, but this does not represent the multiple 
problems some patients possess. The pre-hospital population was small reflecting the lack of 
clearly described pre-hospital research. The representation of clinical characteristics is crude 
but could be used to inform the focus of future studies. 
1.2.5 Conclusions 
Twenty-two percent of all suspected stroke patients had a SM condition. SM patients 
included a higher proportion of females and tended to be younger than stroke patients, but 
these are unsuitable criteria to use in isolation to make a clinical judgement. Many 
conditions present as SM but seizures and migraines are the most frequent aetiologies. It is 
challenging to identify clinically useful characteristics that differentiate SM from stroke, 
however a combination of stroke and SM assessment tools during the acute phase of 
emergency stroke care might reduce the number of false positive identifications created by 
commonly used symptom checklists.  
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1.2.6 Summary 
This chapter has shown that pre-hospital care providers encounter and transport a large 
number of SM which will contribute to the high numbers seen in other settings. Although 
there was very little literature specific to pre-hospital care there were some consistent 
findings in terms of SM aetiology and characteristics of SM which will be used to inform the 
development of a pre-hospital SM tool. The next chapter reports a survey of paramedics’ 
views about stroke care and their views on pre-hospital SM identification.  
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Chapter 1.3 Survey of UK Paramedics stroke training, practice and stroke mimic 
knowledge 
 
1.3.1 Introduction 
This chapter reports the results of a survey of UK paramedics seeking their views on stroke 
training, practice, knowledge about SM conditions and their views about pre-hospital 
identification of SM. A previous survey reported on EMS providers basic pre-hospital stroke 
knowledge and treatment in America (Crocco et al., 2009) but this is not directly relevant to 
current UK practice due to healthcare system and temporal differences. This survey was 
conducted in order to inform the development of the SM tool. 
This survey was necessary because the development, and deployment, of any initiative is 
more likely to succeed if the context in which it will be applied is understood (Craig et al., 
2008). This understanding was sought through stakeholder engagement throughout the 
development process. The views of paramedics about priorities for practice and their 
general background understanding of the topic would influence whether a SM identification 
tool could make a difference during patient care. If they were unwilling to act upon a SM 
tool output, or only under certain circumstances (e.g. if it indicated that there was a high 
probability of a SM diagnosis) then these views would influence the development, the 
training and the implementation within the standard care pathway.  
This survey was supported by a small research grant from the College of Paramedics (CoP). 
The results of this survey were published in the British Paramedic Journal (McClelland et al., 
2017).  
1.3.2 Chapter aims and objectives 
The aim of this chapter is to describe paramedics’ views about pre-hospital stroke care. 
The objectives of this chapter are: 
 Report paramedics’ views about their stroke training. 
 Describe current practice in UK pre-hospital stroke care. 
 Assess how acceptable the idea of SM identification is to UK paramedics. 
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1.3.3 Methods 
An online survey was used to generate descriptive data from an opportunistic sample of UK 
paramedics. The content reflected contemporary literature regarding identification and 
treatment of patients with suspected stroke in the pre-hospital setting. To ensure clarity and 
relevance, the survey was piloted within the North East region of England with paramedics 
from North East Ambulance Service NHS Foundation Trust (NEAS). The survey questions can 
be found in appendix C. 
1.3.3.1 Sample and recruitment 
A web link to the survey was sent by email to members of the CoP, along with promotion of 
the survey in the CoP newsletter (28/09/16 and 17/10/16). The survey was open for six 
weeks between 08/09/16 and 23/10/16. CoP members were targeted as they work in pre-
hospital care across a range of settings and geographical locations in the UK. CoP and non-
CoP paramedics were also invited by advertising the survey on social media (Twitter and 
Facebook). Two NHS ambulance trusts (East of England Ambulance Service NHS Trust 
(EEAST) and NEAS) also promoted the survey through internal communications. 
In order to maximise the survey response rate, incentives (£50 gift vouchers), were offered 
to a random selection of 10 CoP members who participated.  
1.3.3.2 Data collection and analysis 
The data were collected via the web based service SurveyMonkey and reported descriptively 
(frequencies and percentage frequencies). Free-text comments were subjected to a 
functional content analysis to generate mutually exclusive categories. 
1.3.3.3 Ethics 
This survey was completed voluntarily by CoP members and did not include any sensitive 
topics. Ethics committee approval for the survey was not required based on the NHS Health 
Research Authority criteria.  
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1.3.4 Results 
Two hundred and seventy-one people started the survey. Thirty-nine responses were 
removed as they were blank and one was removed as the respondent was not a paramedic. 
The 231 respondents included are described below (table 1.3.1). The 12 respondents in non-
paramedic roles included 10 qualified paramedics and two student paramedics. All 
participants included from this point will be referred to as paramedics. Two hundred and 
thirty-one paramedics equated to 2% of CoP members (College of Paramedics, 2016) and 1% 
of paramedics registered with the Health and Care Professions Council (HCPC) (Health and 
Care Professions Council, 2016). 
1.3.4.1 Demographics 
The characteristics of respondents included in the study are shown in table 1.3.1. 
Thirty-six respondents (16%) indicated that their main role did not involve working for an 
NHS ambulance trust. These respondents were distributed across the UK and worked in roles 
including Helicopter Emergency Medical Services (HEMS), private ambulance services and 
universities. 
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Table 1.3.1 Characteristics of survey respondents included in the study 
Gender n (%) 
 Male 
 Female 
165 (71%) 
66 (29%) 
Age  
 18-20 
 21-29 
 30-39 
 40-49 
 50-59 
 60+  
2 (1%) 
61 (27%) 
76 (33%) 
65 (28%) 
26 (11%) 
1 (<1%) 
Length of service in pre-hospital care  
 <2 years 
 3-5 years 
 6-10 years 
 11-20 years 
 >20 years 
27 (12%) 
40 (17%) 
55 (24%) 
76 (33%) 
33 (14%) 
Current role  
 Paramedic 
 Specialist Paramedic 
 Advanced Paramedic 
 Consultant Paramedic 
 Other Paramedic 
 Non-Paramedic 
134 (58%) 
30 (13%) 
15 (6%) 
6 (3%) 
34 (15%) 
12 (5%) 
Highest level of education relevant to role  
 IHCD Paramedic (Certificate of Higher Education) 
 FdSc 
 BSc 
 Postgraduate (PGCert, PGDip, Masters) 
 Doctorate 
53 (23%) 
56 (24%) 
63 (27%) 
57 (25%) 
2 (1%) 
NHS Ambulance Employer  
 East Midlands Ambulance Service NHS Trust (EMAS) 18 (9%) 
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 East of England Ambulance Service NHS Trust (EEAST) 
 London Ambulance Service NHS Trust (LAS) 
 National Ambulance Service (Ireland) 
 North East Ambulance Service NHS Foundation Trust (NEAS) 
 North West Ambulance Service NHS Trust (NWAS) 
 Northern Ireland Ambulance Service Health & Social Care Trust (NIAS) 
 Scottish Ambulance Service (SAS) 
 South Central Ambulance Service NHS Foundation Trust (SCAS) 
 South East Coast Ambulance Service NHS Foundation Trust (SECAMB) 
 South West Ambulance Service NHS Foundation Trust (SWAST) 
 Welsh Ambulance Service NHS Trust (WAST) 
 West Midlands Ambulance Service NHS Foundation Trust (WMAS) 
 Yorkshire Ambulance Service NHS Trust (YAS)  
38 (19%) 
8 (4%) 
1 (<1%) 
32 (16%) 
10 (5%) 
6 (3%) 
13 (7%) 
7 (4%) 
18 (9%) 
15 (8%) 
4 (2%) 
13 (7%) 
12 (6%) 
 
1.3.4.2 Stroke training and continuing professional development 
Eighty-three respondents (36%) rated their initial pre-registration stroke training as 
inadequate, 144 (62%) as adequate and 4 (2%) rated it as excessive. 
One hundred and eighty-two (82% from 223 answers) respondents indicated they would like 
more training on pre-hospital stroke care, 26 (12%) thought they did not need more training 
and 15 (7%) were unsure. When asked whether paramedics as a group needed more stroke 
training, 174/223 (78%) replied yes, 26 (12%) replied no and 23 (10%) were unsure. 
One hundred and twenty-eight (55%) respondents supplied comments when asked about 
what type of stroke training they would like to receive in the future. The main themes within 
the responses were improved assessment of suspected stroke patients; delivery of training 
by experts who can expand on later stages of acute stroke care; updates on pre-hospital 
stroke research and recognition of patients with atypical strokes such as FAST-ve and 
posterior circulation stroke. 
One hundred and forty-three (64% from 223 answers) respondents indicated they had 
completed some stroke Continuing Professional Development (CPD) since qualifying (chart 
1.3.1). The majority of the ‘other’ CPD related to research study based training. The median 
stroke-related CPD completed in the previous 12 months was 3 hours (IQR 1-7).  
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1.3.4.3 Stroke assessment tools 
The tools used to assess patients with suspected stroke are displayed in chart 1.3.2. Most 
(n=209/216, 97%) respondents indicated they used FAST. Other stroke assessment tools 
were used infrequently (Cincinnati Pre-hospital Stroke Scale (CPSS) (Kothari et al., 1999), Los 
Angeles Pre-hospital Stroke Screen (LAPSS) (Kidwell et al., 2000), Melbourne Ambulance 
Stroke Screen (MASS) (Bray et al., 2005), Miami Emergency Neurological Deficit (MEND) 
(Brotons et al., 2012), National Institutes of Health Stroke Scale (NIHSS) (Brott et al., 1989), 
Recognition of Stroke in the Emergency Room (ROSIER) (Fothergill et al., 2013)) or not at all 
(Los Angeles Motor Scale (LAMS) (Llanes et al., 2004), Rapid Arterial oCclusion Evaluation 
(RACE) (Perez de la Ossa et al., 2014)). 
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1.3.4.4 Stroke compared to other time critical conditions 
Three questions compared stroke with other time critical conditions (sepsis, ST segment 
elevation myocardial infarction (STEMI) and major trauma) with answers in the form of 5 
point Likert scales. Answers were scored with 1 being the least confident/influence/change 
and 5 being the most. Responses to these three questions have been ordered using 
weighted averages. 
Respondents were asked to rate how confident they felt dealing with patients with the time 
critical conditions. In ascending order of confidence the average responses were major 
trauma (3.74); stroke (4.14); sepsis (4.25); STEMI (4.30). See chart 1.3.3 for more detail. 
 
Chart 1.3.3 How respondents rated their confidence dealing with time critical conditions 
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Respondents were asked to what extent they thought pre-hospital actions influenced 
patient outcomes. In ascending order of influence the average responses were stroke (4.37); 
sepsis (4.49); major trauma (4.69); STEMI (4.81). See chart 1.3.4 for more detail. 
 
Chart 1.3.4 To what extent do you think pre-hospital actions influence patients’ outcome 
Respondents were asked how they thought pre-hospital care for the conditions had changed 
over their careers. In ascending order of improvement the average responses were stroke 
(3.97); STEMI (4.43); major trauma (4.47); sepsis (4.60). See chart 1.3.5 for more detail. 
 
 
Chart 1.3.5 How do you think pre-hospital care has changed over the course of your career 
1.3.4.5 Stroke transport 
The responses to where most stroke patients were conveyed in their region are shown in 
chart 1.3.6. The most common destination for suspected stroke patients was the ED.  
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Fifty-nine (29% of 213 answers) respondents reported their destination could change 
depending on the time or day of the week.  
Sixteen (8%) respondents reported access to telemedicine for stroke patients. Those who 
expanded upon this answer defined their access as being able to telephone either stroke 
teams at hospital or senior paramedics for advice.  
 
The majority (n=197, 92%) of respondents thought that feedback on suspected stroke 
patients would be useful, but most (n=158, 74%) reported that they did not receive any. 
Forty-nine (23%) respondents indicated they received informal feedback, only 3% (n=6) 
reported they received feedback in a formal manner.  
One hundred and forty-four (68%) respondents routinely performed an electrocardiogram 
(ECG) on suspected stroke patients, 16 (8%) reported only if the patient had chest pain and 
53 (25%) reported that they would not routinely perform an ECG. 
1.3.4.6 Transient Ischaemic Attacks 
When asked whether they had TIA referral pathways in their region 94 (45% from 208 
respondents) said yes. Fifty-two (25%) had access to TIA clinics in their region. Fifty-eight 
(28%) reported administering aspirin and 6 (3%) used other antiplatelet agents to treat 
patients with suspected TIA. Ninety-eight (47%) respondents reported using the ABCD2 
(Johnston et al., 2007) score for TIA risk stratification. ABCD2 was the only TIA risk tool used. 
 
0%
10%
20%
30%
40%
50%
60%
Direct to scan Emergency
department
Hyper acute stroke
unit
Stroke ward Other
Chart 1.3.6 Stroke patient destinations
 50 
 
1.3.4.7 Stroke general questions 
Respondents were asked about the current timeframe for thrombolysis in stroke patients 
which is a maximum of 4.5 hours. Twelve (6%) thought <2.5 hours, 28 (13%) <3.5 hours, 126 
(61%) <4.5 hours and 42 (20%) <5.5 hours. One hundred and six (51%) respondents indicated 
they had heard of intra-arterial thrombectomy. Respondents thought stroke accounted for 
5% (IQR 3-10) of their workload.  
Forty-three individuals (20%) reported being involved in the following pre-hospital stroke 
studies: Rapid Intervention with Glyceryl trinitrate in Hypertensive stroke Trial 2 (RIGHT2) 
(Bath et al., 2016) (n=30, 70%); Paramedic Acute Stroke Treatment Assessment (PASTA) 
(Shaw et al., 2016) (n=11, 26%); Transient Ischaemic Attack 999 Emergency Referral (TIER) 
(Rees et al., 2018) (n=3, 7%) and others (n=5, 12%). 
At the end of the survey respondents were given the chance to comment on any aspect of 
pre-hospital stroke care. The main themes that emerged from 46 respondents’ comments 
were a desire to improve the care they provided, concern over geographical variability and 
recognition of the time critical nature of pre-hospital stroke care. 
1.3.4.8 Stroke mimics 
The majority (n=138, 65%) had heard of the term ‘stroke mimics’. Overall 183 (86%) 
identified the correct definition which was stated as “Where a patient appears to be having 
a stroke but their symptoms are due to a different condition”. 
Respondents tended to give a conservative estimate of the proportion of suspected stroke 
patients transported to hospital by ambulance that were later given a SM diagnosis (chart 
1.3.7). 
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Respondents were asked which three conditions, out of ten suggestions were the most 
common pre-hospital SM (chart 1.3.8). The most common responses were migraine and 
metabolic disorders. 
Respondents were asked if they thought a score to calculate the probability of a SM causing 
suspected stroke symptoms would be useful in pre-hospital care. One hundred and thirty-
seven (65% from 211 answers) respondents thought that this would be useful, 30 (14%) 
thought it would not be useful and 44 (21%) were unsure. If a score was developed, the 
majority (n=154, 73%) preferred an electronic tool, which could be built into an existing 
electronic patient record system as opposed to a stand-alone application.  
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The survey asked how acceptable it would be for paramedics to treat a suspected stroke 
(FAST+ve) patient differently, based on a test indicating a high probability that the patient’s 
symptoms were due to a SM condition e.g. transport to the ED as opposed to HASU: 24% 
thought that this was unacceptable; 27% were neutral; 49% thought this was acceptable. 
Chart 1.3.9 shows that most respondents would need to be 90-99% certain that a patient 
was a SM, in order to deviate from their normal stroke protocol. 
 
Respondents were asked for comments about pre-hospital identification and treatment of 
SM. The main themes were the potential risks for both patients and the staff making the SM 
diagnosis, and the need for organisational support if this type of decision was to be made. 
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1.3.5 Discussion 
The results of this survey are a snapshot of paramedics’ views about pre-hospital stroke care 
and SM. This is the first time a UK national survey of this type has been reported.  
1.3.5.1 Pre-hospital workforce 
Data were collected from paramedics with a range of roles, lengths of service, training and 
geographical locations in the UK. The respondents’ demographics were similar to the HCPC 
register data, although the current sample was slightly younger. There were large numbers 
of respondents from two NHS ambulance trusts (EEAST and NEAS) which may have 
influenced the results based on their local practices. Half of respondents had qualified 
through a university. Based on these findings, and the low response rate, it is impossible to 
claim these results are representative of all paramedics and findings and conclusions should 
be interpreted accordingly. 
1.3.5.2 Stroke training and continuing professional development 
Although a small percentage (11%) had completed no stroke related CPD in the past year, 
the majority of respondents were in favour of more stroke related training. Stroke could be 
added to mandatory paramedic refresher training but would be in competition with multiple 
other training needs within limited time. Online learning was frequently used and has 
benefits for a geographically dispersed workforce such as paramedics. Providing 
opportunities for paramedics to undertake CPD which focuses on identified areas of interest 
such as assessment of suspected stroke patients and atypical strokes, or uses multi-
disciplinary teams to deliver training, could encourage people to complete more stroke 
related training. Courses delivering this type of content report positive feedback (Haran et 
al., 2016).  
1.3.5.3 Stroke assessment, treatment and transport 
FAST was the most commonly used stroke assessment tool and continues to be supported 
by national recommendations (Intercollegiate Stroke Working Party, 2016) (p34). A recent 
review (Rudd et al., 2016a) reported that the FAST is supported by the most clinical evidence 
and has the best balance of characteristics, in terms of sensitivity and simplicity, for NHS 
stroke services. Despite being developed for ED use, and a clinical trial showing no additional 
value (Fothergill et al., 2013), ROSIER was the second most frequently used stroke 
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assessment tool. MEND (Brotons et al., 2012) was the third most frequently used 
assessment, largely due to use in one ambulance trust (SWAST). 
For suspected stroke patients transported to hospital there were differences in pathways 
across the UK which are further complicated by variations based upon day and/or time. In 
addition there were variations in the destinations within the hospital. 
There is little evidence that any standard pre-hospital interventions, beyond identification 
and rapid transport with pre-alert, positively affect stroke patient outcomes (Fassbender et 
al., 2013; Puolakka et al., 2016). Even standard observations such as ECGs, which 68% of 
respondents reported routinely performing on all stroke patients, have been questioned as 
they may delay transport (Munro et al., 2018).  
Most respondents received no feedback on stroke patients, but the majority would like 
feedback. Feedback on diagnosis would aid paramedics in reflecting on their decision making 
and actions. Feedback to paramedics about stroke patients has been shown to be beneficial 
(Choi et al., 2014; Pollard and Black, 2015) in terms of promoting reflection and improving 
practice. 
1.3.5.4 Stroke compared to other time critical conditions 
When stroke was compared with other time critical conditions, paramedics felt more 
confident dealing with sepsis or STEMI than stroke, and less confident dealing with major 
trauma. This may be due to the low exposure to major trauma compared to the other 
conditions.  
Respondents thought that pre-hospital stroke care had the least influence on outcome, and 
had improved the least over their career, out of the four conditions included in the study. 
The recent interest in sepsis, developments in regional trauma and STEMI care and the 
ability of paramedics to provide interventions perceived as beneficial in trauma, sepsis and 
STEMI may all contribute to the lack of perceived pre-hospital development of, and influence 
on patient outcomes in stroke care. 
1.3.5.5 Research and developing treatments 
Stroke consistently appears in priority setting exercises for pre-hospital research (National 
Ambulance Service Medical Directors, 2014) (p3) (Evans et al., 2009). Previous research has 
shown that paramedics are keen to be involved in stroke related studies (Ankolekar et al., 
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2014). Despite the fact that there were two large pre-hospital stroke studies recruiting 
(PASTA, RIGHT2), only 20% of respondents reported involvement in pre-hospital stroke 
research. This could be due to lack of opportunity, lack of desire to participate, lack of 
incentives, perceptions of research being an additional responsibility and other factors 
(Burges Watson et al., 2012). This means that there should be enthusiasm from ambulance 
services and from paramedics to engage with research into pre-hospital SM identification 
however the low rate of participation in current studies and the many barriers to paramedic 
participation need to be considered.  
Just over half (51%) of respondents were aware of intra-arterial thrombectomy. This is an 
emerging treatment for LVO strokes (McMeekin et al., 2017). Pre-hospital input will be 
important, in terms of patient identification and bypass to specialist centres, for this 
treatment (Perez de la Ossa et al., 2016).   
1.3.5.6 Stroke mimics 
As stroke services centralise, similar to STEMI care and regional trauma centres, awareness 
of, and potential paramedic identification of SM becomes more relevant due to the 
importance of pre-hospital redirection. A third of respondents had not heard of SM, which 
highlights a potential need for further education.  
The literature review in chapter 1.2 showed that around a quarter of patients with suspected 
stroke were SM and that the most frequently reported SM diagnoses were seizure, syncope, 
sepsis, migraine and brain tumours. Data from the survey showed that most paramedics’ 
perception of the frequency of SM was correct and that respondents were aware of the 
common SM.  
Two thirds of respondents thought a SM prediction tool could be useful but when asked 
about how acceptable this would be in practice respondents were less sure. If a tool was to 
be used in practice then it would need to instil a high degree of confidence in the results i.e. 
have high specificity. Narrative data around SM identification showed concern over the risks 
to patients and the possible consequences for staff making clinical decisions based upon a 
SM tool. These concerns were identified as a point for discussion within the focus groups. 
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1.3.5.7 Limitations 
Despite communications from the CoP, regular promotion through social media and the 
incentive of a prize draw, the number of completed surveys was low. Due to the diverse 
paramedic population it is impossible to calculate an exact response rate which is a potential 
source of bias in this study. It is difficult to judge the representativeness of the sample due 
to the lack of national paramedic demographic data, but the survey does include responses 
from the majority of trusts, roles and locations where paramedics work. Two trusts were 
disproportionately represented which may have biased the results based on their local 
practices. The proportion of respondents with postgraduate qualifications was high and may 
not be representative of the wider population of paramedics. This study relied on voluntary 
participation, self-reported data and respondents’ perceptions which have inherent 
limitations. 
1.3.6 Conclusions 
This study reports a survey of UK paramedics’ views about the stroke care that they provide. 
Conclusions are limited by the low number of responses. Assessment of suspected stroke 
patients is recognised as an important skill by paramedics and an area where many would 
like further training. Respondents’ current practice varied in terms of the stroke assessment 
tools used and where suspected stroke patients were admitted. Many were aware of SM, 
but underestimated their frequency. A SM identification tool would be useful if it allowed 
SM patients to be directed to appropriate care, but it would need to have a high level of 
specificity and not adversely impact on time to treatment for true stroke patients. 
1.3.7 Summary 
This chapter demonstrated that most paramedics were aware of SM, had some 
comprehension of what proportion of suspected stroke cases they comprised and what the 
common SM were. Paramedics appear to be open to the idea of a SM identification tool. The 
data reported here, particularly the need for high levels of certainty, will influence the 
development of the SM identification tool. The next chapter describes the creation of a 
dataset describing suspected stroke patients attended by a UK regional ambulance service 
linked with the final diagnoses of these patients. This dataset will be used, in conjunction 
with the findings of the systematic review described in chapter 1.2 and the survey of 
paramedics reported in this chapter, to develop the initial SM identification tool.  
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Chapter 1.4 Pre-hospital suspected stroke in North East England 
 
1.4.1 Introduction 
The systematic review (chapter 1.2) showed that 27% of pre-hospital suspected strokes were 
SM. However, it reported a combination of pre-hospital studies, none of which were based 
in the UK or used FAST. The survey of paramedics in chapter 1.3 found that FAST was the 
most commonly used stroke identification tool in the UK. As the aim of this project was to 
develop a SM identification tool in the UK, data were sought from a UK ambulance service 
using FAST. This chapter describes suspected stroke patients identified by a regional UK 
ambulance service using FAST, linked to the final hospital diagnosis in order to establish the 
SM rate and describe the characteristics of the SM population. 
1.4.2 Chapter aims  
This chapter has three aims: 
1. To describe the pre-hospital suspected stroke population. 
2. To establish the SM rate in a UK ambulance service. 
3. To describe the causes of SM conditions. 
1.4.3 Methods 
A retrospective cohort study used individual pre-hospital patient data to establish the 
suspected stroke population. This was then linked with hospital based patient diagnoses to 
report the number of stroke patients who were correctly identified in the pre-hospital 
setting, this allowed the SM rate to be calculated and the characteristics of SM patients to be 
reported. 
1.4.3.1 Study setting 
NEAS is the regional ambulance service provider for ~2 million people in North East England. 
The stroke identification tool used in NEAS is the FAST, which was developed in the North 
East as described in chapter 1.1. Research involving NEAS has previously reported SM rates 
of 22-23% (Harbison et al., 2003; Nor et al., 2004). These figures are over 10 years old and 
based upon a newly established redirection service. In order to inform this thesis, more 
recent data were needed. 
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1.4.3.2 Pre-hospital data collection  
Retrospective data were obtained from NEAS using a clinical database query created by the 
NEAS Informatics team. This report included data on NEAS patients with a recorded 
suspicion of stroke defined as any recording of stroke or TIA in the chief complaint or clinical 
impression sections of the NEAS patient care record. The report included demographic data; 
physiological observations; presenting signs and symptoms; Past Medical History (PMH) and 
free-text comments.  
Forty-eight variables (listed below) were extracted from the pre-hospital data based on the 
findings of the systematic review (chapter 1.2) and availability within the NEAS records. 
 Impression 
 Age 
 Gender 
 Blood sugar (BM) 
 Glasgow Coma 
Scale (GCS) 
 Heart Rate  
 Pain (0-10) 
 Peripheral Oxygen 
Saturation (SaO2) 
 Respiratory Rate  
 Systolic Blood 
Pressure (SBP) 
 Diastolic Blood 
Pressure (DBP) 
 Temperature 
 Pulse regularity 
 PMH Angina 
 PMH Heart failure  
 PMH High 
Cholesterol 
 PMH 
Hypertension 
 PMH MI 
 PMH Diabetes 
 PMH Smoking 
 PMH Epilepsy 
 PMH Stroke 
 PMH TIA 
 PMH Migraine 
 PMH Alcohol 
misuse 
 Dizziness 
 General weakness 
 Nausea or 
vomiting 
 Syncope 
 Chest pain 
 Abnormal Gait 
 Arm weakness 
 Confusion 
 Facial droop or 
weakness 
 Floppy 
 Headache 
 Leg weakness 
 Neck Stiffness 
 Seizures 
 Speech symptoms 
 Tremors 
 Unconscious 
 FAST+ve 
 Alcohol/Drug use 
reported 
 AF 
 Eye issues 
 Visual 
disturbances 
 Altered Sensation 
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1.4.3.3 Pre-hospital data format 
Information on patients seen by NEAS was recorded using an Electronic Patient Record Form 
(EPRF). An example EPRF is included in appendix D. The EPRF contained information 
recorded in two formats.  
The first was structured data. Structured data included frequently used fields, usually with 
pre-set answers, such as gender, FAST and the ABC based primary survey. Structured data 
also included commonly recorded identifiers recorded using free-text including name, date 
of birth or address.  
Structured data were normally recorded in a positive fashion, i.e. if a patient had chest pain 
then the chest pain box was ticked. Data could also be recorded in a negative fashion. If a 
paramedic wished to document the absence of a sign or symptom the box could be ticked 
twice which recorded a pertinent negative, i.e. if a patient with chest pain reported that they 
have not vomited then this would be recorded as a pertinent negative to show that it has 
been considered. Pertinent negative data were included in the data requested. 
The second data format was free-text or narrative. This was recorded through a free-text 
comments field in the EPRF. This was used to expand on the structured data, provide a 
narrative history of events and decisions taken and to include data that did not fit in the 
structured data sections. These data were typically not used for audit or reporting purposes 
due to the wide variability in what, and how, data were recorded.  
Some factors relevant to differentiating strokes and SM identified in the systematic review 
were not part of the EPRF structured data, therefore in order to report a complete 
description of the pre-hospital observations, free-text data were included in the database 
query.  
A protocol was written for collecting the free-text data to reduce the variability inherent in 
reporting the narrative information (appendix E). These data were extracted using a 
standardised checklist with the 48 variables taken from the list above. Data collection was 
performed by a single researcher (GM).  
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Due to awareness of the problems inherent in narrative data extraction and interpretation, 
and the use of a single researcher to extract all the data, the reliability of the free-text data 
extraction was examined. In order to examine the intra-rater reliability of the data extraction 
process the process was repeated on a randomly chosen sample of 60 cases 14 months after 
the initial data extraction. The inter-rater reliability of the free-text data extraction was also 
tested by a second researcher extracting data from a randomly chosen sample of 60 cases 
using the data collection protocol and data extraction sheet. The second researcher was a 
senior paramedic within NEAS with a similar level of experience to the author. Data were 
analysed for agreement using Cohen’s kappa. 
1.4.3.4 Identifying pre-hospital stroke patients 
There were two fields in the EPRF where paramedics record their suspicion of stroke: ‘Chief 
complaint’ and ‘Impression’.   
Chief complaint was documented early in the EPRF as a single choice from a pre-specified 
list. Chief complaint included very broad common categories such as chest pain, falls, 
stroke/TIA and traumatic injuries and summarised the patient’s stated primary problem.  
Impression was documented at the end of the EPRF and represented the paramedic’s 
provisional conclusions and the conditions identified. Impression could include multiple 
conditions and was also selected from pre-specified options. 
Impression including stroke was selected for the cohort inclusion criteria as it represented 
the paramedic’s suspicion of stroke as the main problem as opposed to the much broader, 
patient based chief complaint. 
1.4.3.5 Timeframe 
The final dataset included 36 months of data covering 01/06/2013 to 31/05/2016. This 
timeframe was chosen based on the availability of a complete retrospective dataset with all 
the NEAS data available in an electronic format. 
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1.4.3.6 Pre-hospital data inclusion/exclusion criteria 
Inclusion 
- NEAS contact between 01/06/2013 and 31/05/2016 
- Adult (18+) patients with a recorded impression including ‘stroke’ 
- Patient transported to hospital 
Exclusion 
- Inter-hospital transfers 
- Admission other than by NEAS emergency ambulance (e.g. helicopter, self-
presentation)  
1.4.3.7 Linking pre-hospital data with patient diagnoses 
Pre-hospital data cannot be used in isolation when seeking to establish any measure of 
diagnostic accuracy, including the SM rate, as it does not include a final diagnosis. In order to 
report on the accuracy of pre-hospital stroke identification, and identify factors 
differentiating stroke and SM, the pre-hospital dataset was linked to hospital sourced 
diagnostic data.  
An application was made to the Sentinel Stroke National Audit Programme (SSNAP) to obtain 
data on suspected stroke patients attended by NEAS across the North East in order to create 
a regional dataset. SSNAP audits stroke care in England, Wales and Northern Ireland through 
the collection of individual stroke patient data and reports on care from the acute phase 
through to six month outcomes. SSNAP is entered by the local specialist stroke teams and 
then cross referenced with the Office for National Statistics (ONS), therefore all patients in 
SSNAP are confirmed stroke. The application to SSNAP was eventually withdrawn due to the 
extended timeframe involved and concerns with the completeness of the SSNAP data 
pertinent to this thesis. However, with suitable information governance processes in place 
individual services were able to share their SSNAP data with other NHS organisations (i.e. 
NEAS). Consequently, acute NHS trusts with stroke services in the North East were 
approached directly for access to their data.  
The first acute trust approached was Northumbria Healthcare NHS Foundation Trust (NHCT). 
NHCT is an NHS acute trust covering Northumbria and North Tyneside which is the northern 
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part of the area covered by NEAS. NHCT provides care for over 500,000 people across the 
region. NHCT stroke care was provided at three hospitals which then centralised into one 
site, the Northumbria Specialist Emergency Care Hospital (NSECH) at Cramlington. NSECH 
admitted 1,008 confirmed stroke patients in 2016/17. NHCT consistently performs well in 
the SSNAP audit in criteria relevant to this work such as case ascertainment where it scored 
90%+ (North of England SCN, Apr16-Mar17, (RCP, 2017b)).  
 
Figure 1.4.1 Map of the North East showing NHCT approximate catchment area 
Linkage of NEAS suspected stroke patients with NHCT diagnoses provided robust data for 
developing a SM identification tool which is described in the next chapter. Other acute trusts 
in the North East were also approached about sharing their stroke data in order to expand 
the dataset and allow further development of the SM tool which is described in parts 2 and 3 
of this thesis.   
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1.4.3.8 Data linkage methods 
Patient diagnoses data were collected from NHCT to determine the stroke or SM status of 
patients admitted as suspected stroke by NEAS. These data were collected in two stages: 
1. NHCT SSNAP data was used to identify patients recorded as stroke. 
2. All patients not matched with SSNAP were sought in NHCT patient administration 
system records to determine their final diagnoses.  
1.4.3.9 Data linkage – stage 1 
NEAS and NHCT data were linked using a protocol (appendix F). Patient identifiers such as 
name and date of birth were removed from the NHCT SSNAP data for information 
governance reasons, so data were linked with NEAS data using ambulance call number. If 
ambulance call number was not recorded in the NHCT SSNAP data, probabilistic matching 
was performed using admission timestamp, gender and age.  
Patients with a positive match between NEAS records and NHCT SSNAP were recorded as 
stroke (see figure 1.4.2 below). Patients with a potential match (admission time >20 minutes 
difference, missing age, etc.) were re-examined with access to the original NEAS EPRF to look 
for additional data.  
The reliability of the data linkage process was checked by an independent researcher 
repeating the process on a sample of 60 randomly selected records. The independent 
researcher was based within NEAS with a similar knowledge of clinical record systems and 
access to the same resources. Inter-rater reliability is reported using Cohen’s kappa as a 
measure of agreement. 
1.4.3.10 Data linkage – stage 2 
NEAS suspected stroke patients who could not be linked with the NHCT SSNAP data were 
then sought in other NHCT records. This process involved using identifiers within the NEAS 
data (name, age, date of admission) to identify the patient in the NHCT Hospital Episode 
Statistics (HES) records and establish their discharge diagnoses. HES is the central standard 
data warehouse that has collected data on all hospital attendances in England since 1989. 
HES is used to guide NHS and governmental decisions on healthcare in England and is a 
reliable source of standardised information. 
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Discharge diagnoses were categorised using International Statistical Classification of 
Diseases and Related Health Problems 10th revision (ICD-10) codes. ICD-10 codes are 
standard codes used to record diagnoses.  
NEAS suspected stroke patients who were unable to be linked with SSNAP or confidently 
linked with NHCT HES records were assumed to be SM. Confidently linked SM patients and 
the assumed SM patients were compared for any demographic differences. 
Figure 1.4.2 summarises the data linking and adjudication process. 
 
Figure 1.4.2 Data linking process for determining final diagnosis of suspected stroke 
patients admitted by NEAS 
1.4.3.11 Patient diagnoses definitions 
For this study stroke was defined as inclusion in the SSNAP dataset or as hospital recorded 
diagnosis including ICD-10 codes I61 (nontraumatic intracerebral haemorrhage), I63 
(cerebral infarction) and I64 (stroke, not specified as haemorrhage or infarction). This is 
based on the definition of stroke used by SSNAP, which also provides a high degree of 
confidence about complete data capture within SSNAP because of cross-referencing with 
Hospital Episode Statistics (HES).  
Patients with a diagnosis of TIA are not included in SSNAP. TIA is defined as “stroke 
symptoms and signs that resolve within 24 hours” (National Institute for Health and Care 
Excellence, 2017) which means differentiating stroke and TIA can be challenging in the pre-
hospital setting where total patient contact time is often short. The decision was taken to 
group TIA with stroke due to the similar presentation and pre-hospital response. TIA has 
been grouped with stroke in other pre-hospital studies (Fothergill et al., 2013; Brandler et 
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al., 2015). This grouping also allowed suspected stroke patients to be reported using a 
dichotomous outcome measure (stroke/TIA versus SM). TIA patients were identified by ICD-
10 codes G458 (other transient cerebral ischaemic attacks and related syndromes) and G459 
(transient cerebral ischaemic attack, unspecified). All other ICD-10 codes were reported as 
SM. 
1.4.3.12 Data analysis 
All data were collated in Microsoft Excel and analysed in IBM SPSS Statistics v23.  
Continuous variables, such as means for physiological variables, were compared using the 
independent samples t-tests. Independent categorical variables, such as the presence of 
FAST symptoms, were compared using the chi-squared test. Inter and intra-rater reliability 
of the data matching and extraction processes were examined using Cohen’s kappa. 
1.4.3.13 Missing data 
Listwise deletion, or complete-case analysis, was used to explore the impact of missing data 
(Haukoos and Newgard, 2007). Listwise deletion involves removing all cases with any missing 
data.  
1.4.3.14 Approvals and ethics 
This case identification and data collection study was conducted as a service evaluation 
based upon the HRA definition (Health Research Authority, 2017). NEAS provided R&D 
project registration, and Caldicott approvals were secured from NEAS and NHCT to share the 
necessary data.  
  
 66 
 
1.4.4 Results - Establishing the SM rate and describing SM conditions 
1.4.4.1 NEAS and NHCT data 
Across NEAS there were 24,764 suspected stroke cases between 01/06/2013 and 
31/05/2016.  
1,552 cases (6%) had a null value for destination. These cases were excluded from any 
further analysis due to the small numbers and the difficulty in establishing the final diagnosis 
in the absence of a destination. These missing location cases may have been: data entry 
errors; patients with reports completed by rapid response vehicles who handed the patient 
on to a second crew to transport; or the patient may not have travelled to hospital. 
The NEAS suspected stroke patients were filtered to identify patients admitted to NHCT. The 
remaining patients were filtered based on paramedic impression then duplicates and inter-
hospital transfers were removed. There were no patients <18 years old. This resulted in 
1,742 suspected stroke cases being included. The filtering process is shown in figure 1.4.3. 
 
Figure 1.4.3 NEAS suspected stroke patients filtered from raw data to NHCT dataset 
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1.4.4.2 Patient diagnosis data collection – stage 1  
Initial matching with NHCT SSNAP data positively identified 875 (50%) NEAS suspected 
stroke patients as strokes.  
1.4.4.3 Inter-rater reliability check of stroke identification 
The agreement for the data linkage process was 58/60 (97%). Cohen’s kappa = 0.933 (95% CI 
0.843-1) which is very good agreement (Landis and Koch, 1977). The cases where 
disagreement was reported were discussed to arrive at a consensus. One disagreement was 
due to an error in the recording of patient gender in the NEAS data. The second 
disagreement was due to incorrect data matching by the independent checker.  
1.4.4.4 Patient diagnosis data collection – stage 2  
From the total cohort of 1,742 suspected stroke patients 875 (50%) were identified as stroke 
patients using SSNAP. The remaining 867 suspected stroke patients who were not positively 
matched in the SSNAP data were searched for within the NHCT HES records.  
 84 patients were identified as TIA (ICD-10 codes G458 and G459) based on NHCT HES 
records. 
 74 patients were identified as stroke based on NHCT HES records including diagnostic 
codes I61, I63 and I64.  
 560 patients had a SM ICD-10 diagnosis. 
 149 patients were unable to be linked with either SSNAP or HES. These patients were 
all assumed to be SM.  
Combining these figures results in 1,033 (59%) stroke patients and 709 (41%) SM patients. 
1.4.4.5 Final diagnoses 
The final diagnoses of NEAS suspected stroke patients (n=1,742) was 59% stroke (n=1,033, 
949 strokes plus 84 TIAs) and 41% SM (n=709). This achieves the second aim of this chapter 
which was to report the SM rate in a UK ambulance service. The process of establishing the 
final diagnoses for NEAS suspected stroke patients is summarised in figure 1.4.4. 
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Figure 1.4.4 Data linking process showing final diagnoses of suspected stroke patients 
admitted by NEAS 
1.4.4.6 SM diagnoses 
SM patients were identified (n=709) by either confirmed non-stroke diagnoses (n=560, 79%, 
including any ICD-10 code other than I61, I63, I64 or TIA codes G458 and 459) in NHCT HES 
system or assumed (n=149, 21%) based on inability to match with either SSNAP or HES.  
The patients assumed to be SM (n=149) were compared with the patients with a confirmed 
SM diagnosis as shown in table 1.4.1. 
Table 1.4.1 Comparison of patients with confirmed SM diagnosis versus assumed SM 
diagnosis 
Diagnosis Age (mean, SD) Gender (% Male) 
Confirmed (n=560) 74.2 (14.5) 39 
Assumed (n=149) 68.6 (16.4) 41 
 
The two groups of SM patients were significantly different in age (independent samples t-
test, p<0.001) but not significantly different in gender (chi square test, p=0.608). 
One hundred and seventy-two different ICD-10 diagnostic codes were recorded for the 560 
patients with a confirmed SM diagnosis. The ICD-10 based SM diagnoses are displayed in 
table 1.4.2. 
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Table 1.4.2 Most frequent ICD-10 diagnoses recorded for SM patients 
ICD-10 
Code 
ICD-10 description Number (%) 
of patients 
N390 Urinary tract infection, site not specified 38 (7%) 
R568 Convulsions, not elsewhere classified 37 (7%) 
R55X Syncope and collapse 30 (5%) 
R298 Other symptoms and signs involving the nervous and 
musculoskeletal systems 
25 (4%) 
G409 Epilepsy, unspecified 24 (4%) 
J181 Lobar pneumonia, unspecified organism 22 (4%) 
G439 Migraine, unspecified 14 (3%) 
G510 Bell's palsy 14 (3%) 
R296 Repeated falls 11 (2%) 
R478 Other speech disturbances 11 (2%) 
E162 Hypoglycemia, unspecified 10 (2%) 
F059 Delirium due to known physiological condition 10 (2%) 
I620 Nontraumatic subdural hemorrhage 10 (2%) 
J22X Unspecified acute lower respiratory infection 10 (2%) 
G819 Hemiplegia, unspecified 9 (2%) 
I609 Nontraumatic subarachnoid hemorrhage, unspecified 9 (2%) 
C793 Secondary malignant neoplasm of brain and cerebral meninges 8 (1%) 
N179 Acute kidney failure, unspecified 8 (1%) 
A419 Sepsis, unspecified organism 7 (1%) 
G442 Tension-type headache 7 (1%) 
I629 Nontraumatic intracranial hemorrhage, unspecified 6 (1%) 
I951 Orthostatic hypotension 6 (1%) 
R410 Disorientation, unspecified 6 (1%) 
R471 Dysarthria and anarthria 6 (1%) 
Other Other conditions with less than 1% (n=6) prevalence 222 (40%) 
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The ICD-10 codes were summarised using CCS codes (as used earlier in chapter 1.2). The 
most frequent SM diagnoses represented using level 2 CCS codes are shown in table 1.4.3.  
Table 1.4.3 NHCT SM diagnoses displayed using level 2 CCS codes 
CCS level 2 
code 
CCS description Number 
(%) of 
patients 
6.4 Epilepsy; convulsions 70 (13%) 
6.9 Other nervous system disorders 50 (9%) 
10.1 Diseases of the urinary system 48 (9%) 
13.8 Other connective tissue disease 38 (7%) 
17.1 Symptoms; signs; and ill-defined conditions 36 (6%) 
8.1 Respiratory infections 32 (6%) 
7.3 Cerebrovascular disease 31 (6%) 
6.5 Headache; including migraine 26 (5%) 
5.4 Delirium dementia and amnestic and other cognitive 
disorders 
18 (3%) 
7.2 Diseases of the heart 15 (3%) 
3.4 Other endocrine disorders 11 (2%) 
6.3 Paralysis 10 (2%) 
7.4 Diseases of arteries; arterioles; and capillaries 10 (2%) 
8.8 Other lower respiratory disease 10 (2%) 
1.1 Bacterial infection 9 (2%) 
2.12 Secondary malignancies 8 (1%) 
6.8 Ear conditions 8 (1%) 
3.8 Fluid and electrolyte disorders 7 (1%) 
Unknown Unknown 7 (1%) 
2.11 Cancer; other primary 6 (1%) 
2.3 Cancer of bronchus; lung 6 (1%) 
16.4 Intracranial injury 6 (1%) 
16.8 Superficial injury; contusion 6 (1%) 
Other Other conditions with less than 1% (n=6) prevalence 92 (16%) 
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The CCS codes were combined into level 1 CCS codes to show broader clinical groupings as 
shown in table 1.4.4.   
Table 1.4.4 NHCT SM diagnoses displayed using level 1 CCS codes 
CCS1 
code 
CCS description Number (%) 
of patients 
1 Infectious and parasitic diseases 11 (2%) 
2 Neoplasms 34 (6%) 
3 Endocrine; nutritional; and metabolic diseases and immunity 
disorders 
22 (4%) 
4 Diseases of the blood and blood-forming organs 2 (<1%) 
5 Mental Illness 26 (5%) 
6 Diseases of the nervous system and sense organs 175 (31%) 
7 Diseases of the circulatory system 59 (11%) 
8 Diseases of the respiratory system 53 (9%) 
9 Diseases of the digestive system 11 (2%) 
10 Diseases of the genitourinary system 48 (9%) 
11 Complications of pregnancy; childbirth; and the puerperium 1 (<1%) 
12 Diseases of the skin and subcutaneous tissue 3 (1%) 
13 Diseases of the musculoskeletal system and connective tissue 44 (8%) 
16 Injury and poisoning 26 (5%) 
17 Symptoms; signs; and ill-defined conditions and factors 
influencing health status 
38 (7%) 
18 Residual codes; unclassified; all E codes [259. and 260.] 7 (1%) 
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The NHCT SM diagnoses are graphically displayed in figure 1.4.5 with figure 1.2.3 from the 
systematic review repeated below for comparison. 
 
Figure 1.4.5 NHCT SM diagnoses summarised using CCS codes 
 
Figure 1.2.3 Taxonomy of SM using CCS codes (repeated from chapter 1.2) 
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1.4.5 Results – describing the suspected stroke population 
The suspected stroke population is described based on NEAS data combined with the stroke 
or SM diagnoses supplied by NHCT.  
1.4.5.1 Structured and free-text data 
The data presented includes 11,435 data points extracted from the NEAS EPRFs (n=1,742 
patients). This includes a combination of structured and free-text data to present a complete 
picture of the information documented on suspected stroke patients. Figure 1.4.6 shows 
that 50% of the data were only recorded in a structured format, 30% of the data were 
duplicated (recorded in both structured and free-text format) and 19% of the data were only 
recorded in a free-text format. Two characteristics were only found in the free-text data (eye 
issues and altered sensation) and one characteristic (visual disturbances) was a combination 
of a free-text and a structured characteristic. If these three characteristics were removed, 
then the free-text data would account for 15% additional data as opposed to 19%. All data 
reported in the thesis are based on combined structured and free-text data. 
 
Figure 1.4.6 Venn diagram showing source of data extracted from NEAS EPRF 
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1.4.5.2 Reliability of free-text data extraction 
The results of the intra-rater testing was a Cohen’s kappa intra-rater reliability coefficient of 
0.936 (95% CI 0.911-0.961, p<0.001) which indicates near perfect agreement (Landis and 
Koch, 1977). The results of the inter-rater testing was a Cohen’s kappa reliability coefficient 
of 0.752 (95% CI 0.707-0.797, p<0.001) which indicates substantial agreement.  
A sample of 20 data points where there was disagreement were examined in detail. In 14 
(70%) it was obvious on re-examination why there was disagreement as the data was 
recorded in the EPRF but one of the data extractors had failed to record it. In 4 cases (20%) 
there was vagueness in the free-text data which had been interpreted in different ways. In 2 
cases (10%) a data point had been recorded by the data extractor with no obvious 
justification or source within the EPRF.   
1.4.5.3 Pertinent negative data 
The medical history and observational data extracted from NEAS included pertinent negative 
data (observations marked as not present, i.e. patient did not have chest pain).  
Pertinent negative data was not included in the analysis for three reasons: 
 The frequency with which negative data was recorded. Positive characteristics were 
recorded twice as frequently as negative characteristics. 
 Positive and negative features were sometimes recorded due to a changes in a 
patient’s condition. Inclusion of both would have introduced a cancelling effect and 
created unusual associations during the regression analysis. 
 The absence of positive documentation of a characteristic in clinical practice does 
usually reflect an assumption that the patient did not have the characteristic.  
Based on these reasons the decision was made to focus on positively recorded 
characteristics. 
1.4.5.4 Missing data 
Listwise deletion was used to explore the impact of removing patients with missing data (all 
patients without a full set of demographic and physiological observations were excluded). If 
this was applied the remaining dataset would include 882 (51% of total) patients. This 
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reduced dataset would include 541 (58%) stroke patients and 341 (42%) SM, the mean age 
would be 74.7 (SD 13.3) and 50% of patients would be male so the overall demographics and 
SM rate would be similar to the complete dataset. As the aim was to describe the suspected 
stroke population, which includes which data is present or missing, and listwise deletion 
would have severely reduced the sample size and the power of the study, all the data were 
included. 
Examination of the missing data led to the assumption that the missing data were randomly 
distributed apart from SBP and DBP which are linked. Pain and temperature were the main 
observations that were not documented. If patients with missing pain and/or temperature 
values were excluded then the remaining dataset included 958 (55%) patients. The 
remaining patients had all the other physiological observations documented in >95% of 
cases.  
A small number (n=3, 0.2%) of patients had no physiological data recorded at all. One of 
these patients had no other data apart from age and gender recorded. All three of these 
patients were classed as SM. A slightly larger group (n=10, 0.6%) of patients had no 
physiological observations apart from pulse regularity recorded. Three of these patients 
were classed as SM and seven had a stroke diagnosis. The only missing demographic data 
was age in eight (0.5%) patients all of whom were recorded as adults. All of these patients 
had physiological and other observations documented and two were classed as SM and six 
received a stroke diagnosis. 
1.4.5.5 Physiological observations data cleaning 
The physiological data were checked for anomalous values before any analysis was 
conducted. GCS and pain were checked for values outside of the defined limits (GCS 3-15; 
pain 0-10). Other observations were checked for values outside of the reference ranges 
shown in table 1.4.5. If anomalous values were identified these were checked against the 
source data (NEAS EPRF). Values which were physiologically implausible (respiratory rate of 
1, temperature of 18oC) were removed. Entries which appeared to be data input errors 
(respiratory rates of 12, 12, 92, 12) were amended.  
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Table 1.4.5 Reference range for physiological observations and number of amended and 
deleted values 
Variable Range counted as plausible Outcome 
BM 3-30 1 amendment 
Heart rate 40-170 2 deleted, 2 amended 
SAO2 75+ 1 deleted, 3 amended 
Respiratory rate 10-40 2 deleted, 4 amended 
SBP 80-240 1 amended 
DBP 40-150 1 amended 
Temperature 34+ 3 deleted, 4 amended 
 
Where multiple observations were recorded on a single patient the mean of the values was 
calculated. The mean was used based on the assumption that patients’ observations would 
not change dramatically in the short period of time that they were in the care of paramedics. 
1.4.5.6 Stroke and SM population demographics 
The demographics of the NHCT cohort are displayed below. 100% of patients had a gender 
recorded. Eight (0.5%) patients had no age documented but were recorded as adults so were 
included. 
Table 1.4.6 Demographics of NEAS suspected stroke patients admitted to NHCT 
reported by discharge diagnosis 
 Total 
sample 
Stroke SM P value 
Number patients 1,742 1,033 709 - 
Mean age (SD) 75.4 (13.3) 77.1 (11.6) 73.0 (15.1) <0.001 
Gender (% male) 46% 50% 41% <0.001 
 
The mean age for males in the NHCT cohort was 73.2 (stroke 74.2, SM 71.4). The mean age 
for females in the NHCT cohort was 77.3 (stroke 79.9, SM 74.1). 
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1.4.5.7 Paramedic documentation of clinical impression 
Paramedic impression was examined to establish whether it related to final diagnosis. 
Impression was grouped into three distinct categories: 
1. Stroke only = stroke as only suspected diagnosis. 
2. Stroke and TIA = stroke and TIA documented as only diagnoses. 
3. Stroke plus other = stroke included amongst multiple differential diagnoses. 
These three categories of impression were then compared with final hospital diagnoses to 
see if there was any pattern. 
Table 1.4.7 Paramedic impression and final diagnoses 
Impression Total patients Stroke  SM 
Stroke only 1353 881 (65%) 472 (35%) 
Stroke and TIA 132 74 (56%) 58 (44%) 
Stroke plus others 257 78 (30%) 179 (70%) 
 
The stroke plus other impression category included stroke plus a median of 1 additional 
impression (range 1-7, IQR 1-2). Stroke patients with impression of ‘stroke plus other’ had 26 
different impressions documented in addition to stroke. SM patients with impression ‘stroke 
plus other’ had 41 different impressions documented in addition to stroke. The 5 most 
common additional impressions are shown in chart 1.4.1. TIA reported below denotes stroke 
plus TIA plus at least one other impression being recorded. 
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1.4.5.8 Physiological observations 
The physiological observations are displayed below.  
Table 1.4.8 Physiological observations in NEAS data on suspected stroke patients 
admitted to NHCT reported by final diagnosis 
Physiological 
observation 
% of patients 
with 
observation 
documented 
Stroke  
(mean, SD) 
SM 
(mean, SD) 
P value 
BM (mmol/l) 95% 7.7 (2.7) 7.3 (2.4) 0.003 
GCS 99% 13 (2.5) 13 (2.8) 0.038 
Heart rate 99% 82 (18.8) 85 (20.3) 0.002 
Irregular pulse 97% 25% 19% 0.001 
Pain (0-10) 62% 0.3 (1.2) 0.5 (1.5) 0.023 
SaO2 99% 96 (2.9) 95 (3.8) 0.102 
Respiratory rate 99% 17 (3.1) 17 (3.4) 0.248 
SBP (mmHg) 98% 160 (28.5) 153 (30.3) <0.001 
DBP (mmHg) 98% 89 (17.4) 87 (19.0) 0.013 
Temperature (Celsius) 86% 36.4 (0.7) 36.6 (0.9) 0.001 
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1.4.5.9 Past medical history  
The recording of relevant items of PMH are displayed below. These items were selected 
based on the systematic review (chapter 1.2), clinical input from the supervisory team and 
availability within the NEAS dataset. 
Table 1.4.9 Past medical history of NEAS suspected stroke patients admitted to NHCT 
reported by final diagnosis 
Medical History  Patients with 
condition (% of 
total patients) 
Stroke (% of 
stroke 
patients with 
condition) 
SM (% of SM 
patients with 
condition) 
P value 
Alcohol misuse 24 (1%) 8 (1%) 16 (2%) 0.009 
Angina 148 (8%) 88 (9%) 60 (8%) 0.967 
Diabetes 284 (16%) 178 (17%) 106 (15%) 0.206 
Epilepsy 59 (3%) 17 (2%) 42 (6%) <0.001 
Heart failure 43 (2%) 35 (3%) 8 (1%) 0.003 
High cholesterol 238 (14%) 146 (14%) 92 (13%) 0.490 
Hypertension 518 (30%) 341 (33%) 177 (25%) <0.001 
MI 148 (8%) 96 (9%) 52 (7%) 0.150 
Migraine 25 (1%) 8 (1%) 17 (2%) 0.005 
Smoking 38 (2%) 24 (2%) 14 (2%) 0.624 
Stroke 466 (27%) 247 (24%) 219 (31%) 0.001 
TIA 270 (15%) 160 (15%) 110 (16%) 0.988 
 
1.4.5.10 Clinical signs and symptoms 
The signs and symptoms recorded by the paramedics are displayed below. 
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Table 1.4.10 NEAS observations on suspected stroke patients transported to NHCT 
reported by final diagnosis 
Observation  Patients with 
observation 
(% of total) 
Stroke (% of 
stroke 
patients with 
observation) 
SM (% of SM 
patients with 
observation) 
P value 
Abnormal gait 167 (10%) 110 (11%) 57 (8%) 0.069 
AF 210 (12%) 153 (15%) 57 (8%) <0.001 
Alcohol/Drug use 
reported 
38 (2%) 20 (2%) 18 (3%) 0.398 
Altered Sensation 
(FT)* 
132 (8%) 84 (8%) 48 (7%) 0.291 
Arm weakness** 1074 (62%) 746 (72%) 328 (46%) <0.001 
Chest pain 16 (1%) 6 (1%) 10 (1%) 0.075 
Confusion 497 (29%) 282 (27%) 215 (30%) 0.17 
Dizziness 135 (8%) 81 (7%) 54 (8%) 0.863 
Eye issues (FT)* 97 (6%) 72 (7%) 25 (4%) 0.002 
Facial droop or 
weakness 
922 (53%) 612 (59%) 310 (44%) <0.001 
FAST+ve*** 900 (52%) 582 (56%) 318 (45%) <0.001 
Floppy 107 (6%) 71 (7%) 36 (5%) 0.125 
General weakness 425 (24%) 234 (23%) 191 (27%) 0.041 
Headache 354 (20%) 189 (18%) 165 (23%) 0.011 
Leg weakness** 777 (45%) 564 (55%) 213 (30%) >0.001 
Nausea and 
vomiting**** 
205 (12%) 112 (11%) 93 (13%) 0.148 
Neck Stiffness 23 (1%) 12 (1%) 11 (2%) 0.484 
Seizures 71 (4%) 19 (2%) 52 (7%) <0.001 
Speech symptoms 1077 (62%) 700 (68%) 377 (53%) <0.001 
Syncope 16 (1%) 7 (1%) 9 (1%) 0.203 
Tremors 50 (3%) 19 (2%) 31 (4%) 0.002 
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Table 1.4.10 NEAS observations on suspected stroke patients transported to NHCT 
reported by final diagnosis cont. 
Observation  Patients with 
observation 
(% of total) 
Stroke (% of 
stroke 
patients with 
observation) 
SM (% of SM 
patients with 
observation) 
P value 
Unconscious***** 129 (7%) 47 (5%) 82 (12%) <0.001 
Visual 
disturbances****** 
127 (7%) 73 (7%) 54 (8%) 0.665 
*Altered sensation and eye issues are not documented in a structured fashion in the EPRF so 
these have been taken from the free-text data (indicated by FT). Altered sensation included 
descriptions such as tingling, pins and needles and strange sensations. Eye issues were 
recorded when signs related to eye movement or function were documented such as 
dysconjugate gaze or fixed stare. 
**Limb weakness includes documented left, right or bilateral limb weakness.  
***FAST+ve is reported when the FAST test is documented or completed in a structured 
format, not when individual FAST components are documented in isolation.  
****Nausea and vomiting were documented separately but have been combined together 
in this analysis.  
*****Unconscious includes any documented or reported episode. 
******Visual disturbances were recorded when symptoms such as blurred or double vision 
were documented. 
1.4.6 Discussion 
This study describes linkage of clinical data between suspected stroke patients transported 
by a UK regional ambulance service and hospital records to establish the patients’ final 
diagnoses. This allowed the true positive and false positive rates to be calculated for the pre-
hospital diagnoses and the stroke and SM populations to be described. Based on this data 
the false positive (SM) rate in suspected stroke patients transported by NEAS to NHCT was 
41%.  
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1.4.6.1 Establishing the sample data 
The choice of NEAS as the location for this study was pragmatic but also informed by the 
history of pre-hospital stroke research within the area. This study builds on earlier work on 
pre-hospital stroke identification and redirection (Harbison et al., 2003; Nor et al., 2004), as 
well as more recent work exploring pre-hospital documentation of stroke symptoms (Rudd 
et al., 2016a) and ongoing work on streamlining pre-hospital stroke pathways (Shaw et al., 
2016). 
The local partnership with NHCT allowed confident reporting of patients’ final diagnoses 
based upon hospital records which may not have been possible using either a regional or 
national data source. This method will serve as a template for expanding the dataset and 
involving additional hospital trusts to refine and validate a SM identification tool as 
described in chapter 1.0.   
Linking pre-hospital data to hospital outcomes is of interest to ambulance services across the 
UK (Clark et al., 2016; Duncan et al., 2017). However, there are challenges with this process 
due to inconsistencies such as misspelling of names, missing data and differences in 
admission times recorded between ambulance and hospital datasets. The data linkage 
method was developed based on identifiers available within the pre-hospital and hospital 
datasets. The process for linking NEAS data to NHCT SSNAP was tested and showed a high 
level of agreement which demonstrated the reliability of the process. Similar methods have 
been used in other pre-hospital studies (Downing et al., 2005; Mumma et al., 2015) despite 
the acknowledged difficulties (Sanddal et al., 2017). The stepwise process of using NHCT 
SSNAP data and then tracing unmatched patients in HES appears to have been largely 
successful as the number of additional stroke patients found in the HES data was small 
(n=74, 7% of total stroke patients). These patients may have been missed during the initial 
matching due to inconsistencies between NEAS and NHCT data, missing data within the 
NEAS EPRF or the patient having been missed off SSNAP (although the latter is unlikely due 
to the high case ascertainment rate within NHCT).  
SSNAP and NHCT HES data were used as the reference standards for patient diagnoses. The 
choice of these reference standards was very important as they defined the diagnoses of the 
suspected stroke patients, and by extension the performance of any tests developed on 
 83 
 
these data. The combination of SSNAP and HES patient diagnoses should be highly reliable 
and provide as close to a gold standard reference test as is practical for this type of study 
(Knottnerus et al., 2002).  
All diagnoses that are reported were based on retrospective analysis and therefore local 
clinical judgement as opposed to pre-defined diagnostic criteria. In an ideal world all 
patients included in this study would have undergone identical assessments and 
investigations and therefore all diagnoses would have been established using the same 
methods. As this work is based on clinical service data, this is acknowledged not to be the 
case. Patients that appeared to be SM, or with non-typical stroke symptoms, may have been 
assessed in a different manner to patients with more obvious stroke symptoms, in turn this 
may have influenced the final diagnosis. The impact of a standardised protocol for 
assessment of all suspected stroke patients would make an interesting area for further 
research. 
Whilst the reference standard for stroke has been discussed above, the reference standard 
for TIA is less clearly defined. TIA is a hospital based diagnosis based on clinical information 
similar to stroke but often without neuroimaging evidence, so there may be more variability. 
In this thesis TIA is grouped with stroke based on the difficulties distinguishing the two 
conditions in the pre-hospital setting and due to the time related nature of TIA diagnosis. TIA 
has been defined in other studies as both stroke (Fothergill et al., 2013; Brandler et al., 
2015) and SM (Barker et al., 1984; Eichel et al., 2013). If TIAs were completely excluded, 
then the SM rate increased to 43% whereas if TIA was classed as a SM then the SM rate 
increased to 46%. It would be very difficult to exclude TIA from pre-hospital records as it can 
be indistinguishable from stroke in the pre-hospital setting. Considering the data on 
paramedic impression presented in table 1.4.7, when paramedics included TIA in their 
impression the SM rate increased from 35% to 44%, therefore excluding TIA patients would 
exclude a large number of SM patients. 
Data reported in this study were guided by the systematic review (chapter 1.2) and 
availability within the NEAS systems. The choice of impression as the inclusion criteria 
excluded some patients with a chief complaint of stroke/TIA, but as the study focussed on 
pre-hospital identification impression was more relevant as it represented the pre-hospital 
clinicians’ provisional diagnosis.  
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1.4.6.2 Free-text data reliability 
The inclusion of free-text data within this study was labour intensive, but was necessary 
when the limitations of the structured data were realised. Inclusion of the free-text data 
added 2,224 data points which would have been missed if the structured data were used in 
isolation. Extracting and interpreting free-text data raises issues around reliability due to the 
variability in how patient observations are documented by individual clinicians (John et al., 
2016). 
Intra-rater reliability of the free-text data extraction showed near perfect agreement which 
demonstrates that the data extraction was performed consistently. Inter-rater reliability of 
the free-text data extraction revealed some differences in how the narrative data could be 
interpreted and that the free-text data were extracted in slightly different ways by the two 
data extractors. This would need to be accounted for in future work in this area with more 
than one researcher extracting data through a standard data extraction process and 
development of agreed definitions for potentially ambiguous data.  
In order to achieve reliable free-text data extraction in future work a clear protocol would 
need to account for issues including the timing of documented observations (i.e. did the 
reporters witness the symptoms or were they reported by others) and the numerous ways in 
which similar observations can be documented, i.e. arm weakness; right/left sided 
weakness; limb weakness; lack of arm strength.  
1.4.6.3 Missing data 
There were varying amounts of missing data within the NEAS dataset. Demographic data 
were consistently documented. Physiological observations were largely (>95%) recorded 
apart from pain (62%) and temperature (86%). Other observations, including PMH and signs 
and symptoms, were assumed to be present if recorded and absent if not recorded 
therefore it was assumed there were no missing data in these fields. Patients with missing 
data were not excluded and missing data were not imputed as one of the aims of this study 
was to describe the suspected stroke population and this includes the completeness of the 
dataset. As it stands, the current data reflect the real-world documentation made by 
paramedics. 
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1.4.6.4 Suspected stroke population 
Demographics in the form of mean age (suspected stroke 75.4, stroke 77.1, SM 73.0) and 
gender (suspected stroke 46% male, stroke 50% male, SM 41% male) were reported for 
patients in this study. Males had a lower mean age than females in all three categories.  
These demographics are consistent with the chapter 1.2 which reported the demographics 
of pre-hospital stroke patients as 51% male with a mean age of 73 and SM patients as 42% 
male with a mean age of 67. The national stroke audit showed that the median age for 
stroke patients admitted to hospital was 77 years and 51% were male (RCP, 2017a)(pg 36).  
The SM population are older than would be expected from the literature which may be due 
to the exclusion of patients under 18 years. The overall pattern in the data presented here is 
of SM patients being younger and more likely to be female than stroke patients, which is 
consistent with the literature review. 
The population reported in this chapter was drawn from the catchment area of a single 
hospital trust (NHCT) so the demographics of the population covered by NHCT need to be 
considered. The area covered by NHCT includes eight medium sized towns and suburbs, but 
does not include central Newcastle, or another major city, therefore the population included 
in this study may not be generalizable to populations outside the NHCT catchment area. 
NHCT also covers a large amount of sparsely populated rural areas which again may limit 
generalisability.  
Comparing the demographics of stroke patients reported here against recent figures from 
Manchester, London and similar areas across the UK (Ramsay et al., 2015) the age of the 
NHCT patients was higher (NHCT 77.1 years vs 72.7-74.6 years), whereas the data on gender 
were similar (NHCT 50% male vs 48-51% male). Consequently, the demographics reported in 
this chapter are reasonably representative of the national stroke population. 
The suspected stroke population was defined by paramedic impression including stroke. 
Impression could be interpreted as a measure of certainty of diagnosis, with impression of 
stroke in isolation representing the highest level of certainty and impression including stroke 
in combination with multiple other diagnoses representing the lowest level of certainty. 
Impression is a subjective finding and how it is documented will vary between users. 
Paramedic impression of stroke is a logical inclusion criteria for this study, however the 
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subjective nature of the observation would make it a difficult characteristic to prospectively 
test or to include in a SM identification tool. 
1.4.6.5 Physiological observations 
Physiological observations were consistently recorded, apart from pain and temperature as 
mentioned earlier. Stroke and SM patients had very similar mean values for all physiological 
observations (table 1.4.8). There was a statistically significant difference (p<0.05) between 
all physiological observation mean values, with the exception of SaO2 and respiratory rate. 
The reported differences are statistically significant but the magnitude of the differences 
were too small to be considered clinically significant.    
1.4.6.6 Past medical history 
Twelve pertinent factors from patients’ PMH relevant to the stroke or SM diagnosis were 
selected from the systematic review (see table 1.4.9) and extracted from the NEAS records. 
Hypertension, a recognised risk factor for stroke (Sacco, 1997), was the most frequently 
recorded finding and was significantly associated with stroke diagnosis. Previous stroke was 
the second most commonly recorded factor, but this was significantly associated with SM 
diagnosis. This may represent decompensation of existing symptoms or knowledge of the 
previous stroke unduly influencing the paramedic’s suspected diagnosis. Diabetes was the 
third most commonly recorded PMH factor. 
The three most commonly recorded items of PMH in patients in this study were also 
commonly recorded in national data (RCP, 2017a)(pg 36). The SSNAP report showed that 
hypertension (53%), stroke/TIA (26%) and diabetes (21%) were frequently recorded in stroke 
patients. 
A statistically significant (p<0.05) difference between the frequency of recording in the 
stroke and SM populations was identified in 50% of the recorded factors (heart failure; 
hypertension; epilepsy; stroke; migraine; alcohol). Out of these six factors four were 
recorded on small (<4%) numbers of patients: alcohol, migraine, heart failure and epilepsy. 
In contrast a large percentage of the suspected stroke population had hypertension (30%) or 
previous stroke (27%) recorded. It is noteworthy that no statistically significant difference 
between stroke and SM patients was found in a number of common risk factors for 
cardiovascular disease such as alcohol misuse, smoking, diabetes and high cholesterol. These 
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factors were recorded on small numbers of patients and the presence of these risk factors 
may have been influential in the suspected diagnosis of stroke. 
1.4.6.7 Signs and symptoms/general observations 
Twenty-three observations or combinations of observations are reported in table 1.4.10. In 
52% (n=12) there was a statistically significant difference in the rate of reporting between 
the stroke and SM populations. 
The individual aspects of the FAST were the most commonly recorded items (Face 56%, arms 
64%, speech 68%). The FAST itself was recorded for just over half (52%) of suspected stroke 
patients. The rate of recording of FAST appears low in this suspected stroke population and 
reasons for this are explored further in the next section. All of the elements of FAST were 
statistically associated with stroke diagnosis. 
Leg weakness was frequently recorded (45% of suspected stroke patients) but this may have 
been due to interpretation of the recording of right or left sided weakness on the EPRF. In 
patients with limb weakness leg weakness was recorded in isolation in only 6% of cases and 
in combination with arm weakness in 94% of cases. Arm weakness was recorded without leg 
weakness in 33% of cases.  
Confusion (29% of suspected stroke patients) and general weakness (23% of suspected 
stroke patients) were the next most frequently recorded observations. These are both non-
specific observations that may be subject to reporter interpretation. It is not surprising that 
neither showed a statistically significant difference between the stroke and SM populations. 
Headache was the only other observation recorded in >10% of the populations. Headache 
was statistically different in the stroke and SM populations.  
Apart from the factors associated with FAST, including leg weakness, the observations 
showing the greatest statistically significant difference between stroke and SM were seizures 
and unconscious (both p<0.001). Neither were recorded for large numbers of patients, but 
both were significantly associated with a final SM diagnosis. 
1.4.6.8 Reported rate of SM 
The rate of SM (41%) reported in this study is based on confident linkage of NEAS suspected 
stroke patients with hospital diagnoses. This rate is higher than the mean pre-hospital SM 
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rate reported in chapter 1.2 of 27% and higher than previous pre-hospital stroke research in 
the North East which reported 22-23% SM (Harbison et al., 2003; Nor et al., 2004). This study 
did include patients with reduced GCS which were excluded from the previous local studies. 
The SM rate in this study is exceeded by only one pre-hospital paper in the literature review 
which reported a SM rate of 43% (Gioia et al., 2016). The paper by Gioia et al described a 
Canadian EMS service using CPSS, which is functionally identical to FAST. These authors also 
classified TIA with stroke so used similar definitions to those used in this chapter. 
The SM rate is influenced by the tool used to initially identify stroke. The stroke 
identification tools used in pre-hospital care have a range of PPVs from 40-98 (Rudd et al., 
2016a). The range of PPV values implies a range of SM rates from 2-60%. The PPV reported 
for FAST was 62-89% which implies a SM rate of 11-38%.  The SM rate reported in this 
chapter (41%) sits outside of this range. One reason for this could be the inclusion of FAST-ve 
patients in the sample described in this chapter. UK stroke guidelines specify the use of a 
recognised screening tool, such as FAST, but also leave clinicians an option to suspect stroke 
in patients with a negative screen (Intercollegiate Stroke Working Party, 2016) (pg 35) in 
recognition of the range of presentations that stroke can have and the limitations inherent 
in the tools.  
Only 52% (n=900) of patients in this study were FAST+ve. If the FAST+ve patients are 
explored further, then 65% (n=582) had a stroke diagnosis which results in a 35% SM rate 
which is within the range of figures described by Rudd et al. When this was examined further 
a large number of patients had either facial weakness, arm weakness or slurred speech 
documented but not the FAST test. Other pre-hospital studies have identified similar issues 
with the way stroke is recorded in ambulance records (Williams et al., 2017). 
This led to the creation of a composite variable called ‘any FAST’ which included FAST+ve or 
any documentation of facial droop, arm weakness or slurred speech. Any FAST included 
1,573 (90%) patients, 967 (61%) of whom had a stroke diagnosis which equates to a 39% SM 
rate. The inverse of ‘any FAST’ represents patients with no documented FAST test or FAST 
symptoms and these patients were classed as ‘true FAST-ve’. This study included 169 (10%) 
‘true FAST-ve’ patients, 67 (40%) received a stroke diagnosis therefore 102 (60%) were SM. 
Williams et al (Williams et al., 2017) found 34% of FAST negative suspected stroke patients 
admitted in an Australian pre-hospital study received a stroke diagnosis. 
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In addition to the influence of the screening tool, there are multiple reasons why the SM 
rate reported here is higher than would be expected from the literature. None of the pre-
hospital papers in the literature review described a UK population so there may be national 
differences in SM rates. The literature described stroke, and SM, patients identified using a 
variety of stroke identification methods which will result in differing populations being 
identified. This study reports a larger sample than previous pre-hospital papers with one 
exception. Sequeira et al (Sequeira et al., 2016) reported on SM in a sample of 3,376 
patients who were screened as stroke, but this was in an American HEMS service so 
represents a specific population. The geographical area served by NHCT covers a mixed rural 
and urban area with an elderly demographic which may have influenced the SM rate. 
Personal communications with stroke researchers around the UK reveal that many stroke 
services assume that 50% of ambulance stroke admissions will be SM. Consequently, the 
figure of 41% SM may be closer to representing UK practice than the figure of 27% reported 
in the literature review. 
The assumption that patients without a confirmed diagnosis from either SSNAP or NHCT HES 
were patients with SM conditions also influenced the reported SM rate. Performing a 
sensitivity analysis by excluding all patients with an assumed SM diagnoses (n=149) reduced 
the sample to 1,593 patients. The reduced sample included 1,033 patients with a stroke 
diagnosis and 560 patients with a SM diagnosis, this leads to a 35% SM rate.  
Patients with an assumed SM diagnosis were significantly younger than patients with a 
confirmed SM diagnosis. Younger age is associated with increased likelihood of SM diagnosis 
which supports the assumption that the assumed SM patients were SM.  
Explanations for the assumed SM population include patients unable to be linked with either 
SSNAP or HES due to a lack of identifying information recorded in the EPRF, as well as 
patients not admitted to NHCT who would not appear in HES or SSNAP. This would include 
patients who self-discharged from ED, patients who died in ED or during transfer and 
patients transferred to a different care provider e.g. specialist neurosurgery which is based 
at a different trust. 
Understanding the reported SM rate is vital to the development of this overall project as this 
population will be used to inform the development of a pre-hospital SM identification tool. 
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Recognising the variation in documentation of FAST was addressed by the creation of the 
‘any FAST’ and ‘true FAST-ve’ characteristics. 
1.4.6.9 SM diagnoses 
SM had a wide range of underlying diagnoses which was expected given the range of SM 
conditions identified in chapter 1.2. When SM diagnoses were examined using ICD-10 codes 
the large number of diagnoses (n=172) made it difficult to identify patterns. Converting the 
diagnoses into CCS codes allowed clinically similar conditions to be combined and patterns 
to be examined. The most common conditions, based on ICD-10 or CCS codes, are similar to 
the most common SM diagnoses identified in the literature review. The literature review 
combined pre-hospital SM diagnoses with other settings whereas the data are derived from 
a single pre-hospital setting. 
Comparing the SM diagnoses summaries from NEAS/NHCT against the literature review 
using figures 1.4.5 and 1.2.3, the overall pattern of SM diagnoses were very similar. Nervous 
system was the most common level 1 CCS code followed by circulatory. Epilepsy and 
headache were the leading level 2 CCS groups within the level 1 nervous system category. 
There were some differences between the pattern of SM diagnoses in the NEAS/NHCT data 
and the data reported in the literature review. The literature review included 27% patients 
with an unknown/other diagnosis whereas the NEAS/NHCT data included 149 (21%) patients 
with an assumed SM diagnosis which may be the closest equivalent to the unknown/other 
diagnosis group. One other noticeable difference is that the NEAS/NHCT data includes 5% 
mental illness cases whereas these accounted for 10% of diagnoses in the literature review. 
1.4.6.10 Key findings to inform SM identification tool development 
The data described in this phase of the study will inform the development of the SM 
identification tool. The stroke and SM populations will be further analysed to identify 
predictive factors for SM diagnoses. The key findings from this study that will inform the 
development of the SM identification tool are: 
 Younger age and female gender are associated with SM diagnosis. 
 Mean physiological observations are very similar between stroke and SM patients. 
 Previous stroke or the absence of hypertension may help discriminate between stroke 
and SM.  
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 Clinical information such as headache and seizure appear to differentiate stroke and SM 
patients. 
1.4.6.11 Strengths and limitations 
Strengths 
 Pre-hospital data were confidently linked with hospital diagnoses. 
 1,742 patients is a large sample for pre-hospital stroke identification research. 
 Data on a large number of characteristics that potentially differentiate stroke and SM 
patients were collected. 
 Recognition that FAST can be recorded in different ways and requires interpretation. 
Limitations 
 Some NEAS suspected stroke admissions did not have a location. 
 Some NEAS suspected stroke admissions to NHCT could not be linked. 
 A small number of patients have an assumed diagnosis. 
 Extraction of free-text data was subject to interpretation. 
 These data were based on a single hospital catchment area. 
1.4.7 Summary 
The data presented in this chapter describes suspected stroke patients identified by NEAS 
linked with patient’s final diagnoses from NHCT. This allowed the SM rate to be calculated 
(41%) and the cohort described in terms of stroke and SM patients. This chapter includes a 
large amount of data on the pre-hospital suspected stroke population. The data presented 
will be further analysed in the next chapter and used in the development of a SM 
identification tool.  
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Chapter 1.5 Development of a multivariable prediction tool to identify stroke mimic 
patients 
 
1.5.1 Introduction 
This chapter describes the primary research aim of this thesis i.e. development of a tool to 
identify SM patients amongst pre-hospital suspected stroke patients. The focus on SM in the 
pre-hospital setting distinguishes this tool from other stroke assessment and identification 
tools.  
The data on suspected stroke patients transported to NHCT hospitals reported in chapter 
1.4, supported by the findings of the systematic review (chapter 1.2) and the paramedic 
survey (chapter 1.3) were used to derive the content of a SM tool that was likely to be 
feasible and have clinical utility in the pre-hospital setting. 
This chapter is structured following the TRIPOD guidelines for prediction model 
development (Collins et al., 2015). 
1.5.1.1 Background  
This chapter describes the development of a clinical prediction tool. Clinical prediction tools 
inform clinical decisions by combining discrete observations to provide evidence based 
guidance as to the optimal decision, diagnosis or prognosis for the patient. Large datasets 
can be analysed, summarised and converted into tools which are then used to inform clinical 
practice. Clinical prediction tools were introduced in chapter 1.1. 
It is important to consider the wider context of clinical prediction tools when selecting one 
for use in clinical practice, such as: the number available to choose from; concerns about 
usability; application to populations other than the original intended target; availability of 
the key information variables; the potential for bias in the development and human reliance 
on intuition and factors outside of the scope of the tool (Liao and Mark, 2003; Cook, 2008; 
Moons et al., 2009a). 
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1.5.1.2 Desired outcome of SM identification tool 
Diagnostic tools balance sensitivity and specificity according to the desired clinical 
application (Adams and Leveson, 2012). The intention of the SM tool was application after 
the initial suspicion of stroke had been established, using a sensitive assessment like FAST, 
but before a decision was made about the appropriate patient pathway. Due to the range of 
conditions that present as SM, and the desire for a very specific tool expressed by the 
surveyed paramedics in chapter 1.3, the decision was made to focus on high specificity and 
PPV and accept that this would result in low sensitivity. 
As the tool had to be usable by a pre-hospital clinician with access to variable clinical 
information and the diagnostic equipment that is currently carried on ambulances, it had to 
be intuitive and quick to apply. Consideration of these factors led to the principle of ‘simple 
and specific’ which guided the development of the SM tool. 
1.5.1.3 Target population 
The pre-hospital suspected stroke population consists of two groups: the larger FAST+ve 
group, and a second group where the paramedic suspects that stroke is the most likely 
diagnosis because of other characteristics that are not included in FAST.  
Applying the SM tool to all suspected strokes would increase the potential target population 
and would simplify application in clinical practice. Although the National Clinical Guideline 
(Intercollegiate Stroke Working Party, 2016) recommend the use of a suitable screening tool, 
such as FAST, to identify stroke, it also states that clinicians must use their own clinical 
judgement because some stroke symptoms are excluded by the commonly used tools. This 
approach also had the benefit of not linking the SM tool directly to an existing identification 
tool which might not be universally used and which may change in the future. 
The second option considered was applying the tool only to FAST+ve suspected stroke 
patients. This had the benefit of targeting a more clearly defined suspected stroke 
population recognised by a commonly used, and validated, tool. Some pre-hospital services 
already exclude FAST-ve patients from their stroke pathways (UK pre-hospital stroke 
pathways are discussed further in chapter 4.0). This option would reduce the target 
population and exclude a group of patients that may include a high proportion of SM. 
Therefore, the target population for SM tool application was all suspected stroke patients. 
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This meant that the SM tool would need to be used sequentially after an initial screening 
test which identified the patient as a suspected stroke. 
It is a recognised approach in health screening to use a simple initial test which is sensitive to 
the condition under examination in order to be inclusive, and then to refine the judgement 
with a second test which has greater precision i.e. lower rate of false positive cases (Doubilet 
and Cain, 1985; Macaskill et al., 2002). This is known as sequential testing. This approach 
underpins the practice of population screening for conditions such as breast cancer followed 
by specific diagnostic testing to confirm or exclude the diagnosis (Public Health England, 
2013). 
In relation to pre-hospital stroke identification, the advantage of a sequential testing 
approach is that it would not change the initial provisional diagnosis of stroke, based upon 
FAST, another stroke identification tool or paramedic judgement, but would inform the 
subsequent response according to the results of the SM tool. 
1.5.2 Chapter aims and objectives 
The aim of this chapter is to describe the development of a SM identification tool. 
The objectives are: 
 To describe the decisions and criteria that were applied during the tool development 
process. 
 To describe the multiple methods used to develop the tool. 
 To describe the SM identification tool content. 
 Describe the performance of the SM identification tool when retrospectively applied 
to a clinical ambulance dataset.  
1.5.3 Methods 
Clinical prediction tools are developed using one or more of the following five methods: 
univariate analysis; multivariate analysis; neural networks; nomograms; and classification 
and regression trees (Grobman and Stamilio, 2006). 
The multivariable analysis method was chosen for this project, as the literature review 
revealed a range of common SM conditions which may be possible to identify using different 
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specific characteristics. Univariate analysis was used to inform the development of the 
multivariable model. Nomograms are graphical representations of clinical prediction tools, 
which can be challenging to interpret if several variables are involved and are not widely 
used in pre-hospital care. Neural networks require complex computational techniques and 
familiarity with machine learning so are beyond the scope of this work. Classification and 
regression tree analysis would produce a decision tree similar to many algorithms used in 
pre-hospital care but could oversimplify the outcomes where there are likely to be multiple 
predictive factors.  
For a clinical prediction tool with a binary outcome, such as stroke or SM, multivariable 
logistic regression is a frequently adopted multivariate statistical analytical technique. This is 
due to its flexibility, ability to include categorical and continuous predictors, consideration of 
the weight of predictor variables and its overall reflection of the multivariable nature of 
clinical decision making.  
Clinical prediction tools for SM were described in chapter 1.1. All of the SM tools, apart from 
one (Siddiqui et al., 2016), were developed using multivariable analysis informed by initial 
univariate analysis. Multivariable models do have some weaknesses as they rely upon 
statistical assumptions about data distribution that need to be appropriately interpreted, 
furthermore the models produced may be influenced by interactions between predictor 
variables that can be difficult to identify (Grobman and Stamilio, 2006; Adams and Leveson, 
2012).  
1.5.3.1 Source of data 
The SM tool was developed using retrospective pre-hospital clinical data collected from 
NEAS, linked with hospital diagnoses supplied by NHCT. The dataset included patients seen 
by NEAS paramedics during a three year period between 01/06/2013 and 31/05/2016. The 
creation of the dataset was described in chapter 1.4. The SM tool development was 
informed by the systematic review (chapter 1.2) and the survey of UK paramedics (chapter 
1.3). 
1.5.3.2 Participants 
A development cohort was established using the 1,742 patients identified by NEAS as 
suspected stroke described in chapter 1.4. 
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The following inclusion and exclusion criteria were applied: 
Inclusion 
Suspected stroke patient conveyed by NEAS to NHCT with an impression including 
stroke between 01/06/2013 and 31/05/2016 
Exclusion 
GCS<8 
Reduced consciousness level (GCS<8) was chosen as an exclusion criterion based upon 
standard pre-hospital practice. These patients are difficult to assess due to their lowered 
consciousness level and are normally rapidly transported to the nearest ED for assessment 
and stabilisation irrespective of their underlying condition. This decision was also informed 
by the original work on FAST (Harbison et al., 2003) which specified that patients with GCS<8 
were transported to ED as opposed to direct to a stroke unit.  
1.5.3.3 Outcome 
The outcome predicted by the SM identification tool is final discharge diagnosis of a non-
stroke condition i.e. a binary state of stroke or SM. As discharge diagnoses were not 
available in the NEAS clinical records, it was necessary to obtain these from the receiving 
hospital trust i.e. NHCT. 
1.5.3.4 Predictors 
The predictors used in developing the SM identification tool were those variables described 
in chapter 1.4. The variables were selected based on the literature review (chapter 1.2), 
availability within the NEAS data and the clinical input of the supervisory team. Forty-nine 
variables (listed below), plus the patients’ final diagnoses, were included in the development 
dataset. 
Variables included in dataset: 
Hospital discharge diagnosis; Impression; Age; Gender; BM; GCS; Heart Rate; Pain: Numeric; 
SaO2; Respiratory Rate; SBP; DBP; Temperature; Pulse regularity; PMH Angina; PMH Heart 
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Failure; PMH High Cholesterol; PMH Hypertension; PMH MI; PMH Diabetes; PMH Smoking; 
PMH Epilepsy; PMH Stroke; PMH TIA; PMH Migraine; PMH Alcohol misuse; Dizziness; 
General weakness; Nausea or vomiting; Syncope; Chest pain; Abnormal gait; Arm weakness; 
Confusion; Facial droop or weakness; Floppy; Headache; Leg weakness; Neck Stiffness; 
Seizures; Speech symptoms; Tremors; Unconscious; FAST+ve; True FAST-ve; Alcohol/Drug 
use reported; AF; Eye issues; Visual disturbances; Altered Sensation 
1.5.3.5 Sample size 
No formal sample size calculation was performed for the development dataset. All available 
data were used. Based on the rule of >10 cases per predictor variable being necessary for a 
regression model (Vittinghoff and McCulloch, 2007; Austin and Steyerberg, 2015) the sample 
needed to include >980 patients (>490 stroke patients and >490 SM patients) to fulfil this 
criterion. 
1.5.3.6 Missing data  
Patients with missing data were included within the dataset. Missing data were assumed to 
be randomly distributed apart from SBP and DBP. SBP and DBP are observed, collected and 
documented as a pair and so they were considered to be linked. The linkage between SBP 
and DBP is relevant when considering multicollinearity which is discussed later in this 
chapter. Missing data were identified using the code ‘999’ for analysis within SPSS. There 
was no imputation or adjustment in variable weighting used in the analysis. 
1.5.3.7 Statistical analysis methods 
All data were collected in Microsoft Excel and imported into SPSS 23 or SigmaPlot 12.5 for 
analysis. Statistical advice was taken on the regression analysis and the use of SPSS from the 
Newcastle University statistical support team. 
1.5.3.8 Univariate analysis 
Univariate analysis was performed on all 49 candidate variables. This was done to identify 
suitable variables, defined as those with p<0.2, for inclusion in the multivariable logistic 
analysis.  
Continuous variables, primarily physiological measurements, were tested for differences in 
the outcome using the independent samples t-test. Categorical variables, including presence 
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of relevant items of medical history or presenting signs and symptoms, were tested using 
the chi squared test. 
1.5.3.9 Multivariable analysis 
Binary logistic regression (BLR) was the multivariable method chosen to analyse the data. 
BLR is a form of regression analysis where the variable of interest (dependent variable) is 
binary in nature and there are multiple explanatory (predictor) variables. BLR was a suitable 
method as the outcome was binary, stroke or SM, and there were a large number (n=49) of 
candidate variables. BLR allowed identification of statistically significant predictor variables 
and the magnitude of their association with the outcome.  
BLR was an appropriate technique because:  
 Few distributional assumptions are made. 
 The dependent variable is dichotomous (stroke or SM). 
 Due to the size of the sample (>30) the central limit theorem allows a normal 
distribution to be assumed (Field, 2013) (p54). 
 Multicollinearity amongst predictor variables can be identified. 
 Combinations of continuous and discrete variables can be used. 
 Extra data can be easily added once the initial dataset is established.  
BLR has been used in a number of studies with similar aims and datasets (Chang et al., 2012; 
Ali et al., 2014; Goyal et al., 2016b) so there was a precedent for using BLR in this thesis.  
1.5.3.10 Receiver operating characteristic curves 
Receiver Operating Characteristic (ROC) curves (introduced in chapter 1.1) were generated 
for the continuous variables using Sigmaplot 12.5 software.  
1.5.4 Results 
The development dataset is described using characteristics selected as clinically plausible 
predictors where the relevant information would be available to paramedics. Associations 
between the characteristics are reported in terms of collinearity and correlation. Additional 
information on the recording of FAST and paramedic impression are also reported. 
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1.5.4.1 Univariate analysis of the development dataset 
Applying the inclusion and exclusion criteria to the dataset described in chapter 1.4 resulted 
in 1,650 suspected stroke patients in the development dataset. The dataset is described in 
table 1.5.1 along with the results of the univariate analysis to identify initial associations 
with stroke/SM diagnosis. 
Table 1.5.1 Characteristics of SM identification tool development cohort 
  Patients with 
observation 
documented (% 
total) 
Stroke SM p value 
Patients   989 (60%) 661 (40%)   
Mean age (SD) 100% 77 (12) 73 (15) <0.001 
Gender (% male) 100% 50% 41% <0.001 
Physiological 
observation 
 
Stroke  
(mean, SD) 
SM  
(mean, SD) 
 
BM (mmol/l) 96% 7.6 (2.7) 7.2 (2.3) 0.002 
GCS 100% 14 (2) 14 (2) 0.510 
Heart rate 100% 82 (19) 85 (20) 0.004 
Irregular pulse 97% 25% 18% 0.003 
Pain (0-10) 65% 0.3 (1.2) 0.5 (1.6) 0.020 
SaO2 99% 96 (3) 96 (3) 0.299 
Respiratory rate 100% 17 (3) 17 (3) 0.171 
SBP (mmHg) 99% 160 (28) 153 (30) <0.001 
DBP (mmHg) 99% 89 (17) 87 (19) 0.024 
Temperature (Celsius) 87% 36.4 (0.7) 36.6 (1.0) 0.001 
Past Medical History  
 
% stroke patients % SM patients 
 
Alcohol misuse 1% 1% 2% 0.013 
Angina 8% 8% 9% 0.812 
Diabetes 16% 17% 15% 0.268 
Epilepsy 3% 2% 6% <0.001 
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Table 1.5.1 Characteristics of SM identification tool development cohort cont. 
  Patients with 
observation 
documented (% 
total) 
Stroke SM p value 
Heart failure 2% 3% 1% 0.007 
High cholesterol 14% 14% 13% 0.491 
Hypertension 30% 33% 25% <0.001 
MI 9% 9% 7% 0.179 
Migraine 2% <1% 3% 0.004 
Smoking 2% 2% 2% 0.682 
Stroke 27% 24% 31% 0.001 
TIA 16% 16% 16% 0.983 
Signs and symptoms 
 
% stroke patients % SM patients 
 
Abnormal gait 10% 11% 8% 0.072 
AF  12% 15% 8% <0.001 
Alcohol/Drug use 
reported 
2% 2% 3% 0.460 
Altered Sensation 8% 9% 7% 0.309 
Arm weakness 63% 73% 48% <0.001 
Chest pain 1% 1% 2% 0.066 
Confusion 30% 28% 32% 0.149 
Dizziness 8% 8% 8% 0.900 
Eye issues 6% 7% 4% 0.004 
Facial droop or 
weakness 
54% 60% 45% <0.001 
FAST+ve 53% 58% 47% <0.001 
Floppy 6% 7% 5% 0.109 
General weakness 25% 23% 28% 0.028 
Headache 21% 19% 25% 0.006 
Leg weakness 46% 55% 31% <0.001 
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Table 1.5.1 Characteristics of SM identification tool development cohort cont. 
 Patients with 
observation 
documented (% 
total) 
Stroke SM p value 
Nausea or vomiting 11% 10% 13% 0.110 
Neck Stiffness 1% 1% 2% 0.338 
Seizures 4% 2% 7% <0.001 
Speech symptoms 64% 70% 56% <0.001 
Syncope 1% 1% 1% 0.113 
Tremor 3% 2% 4% 0.001 
True FAST-ve 8% 6% 11% <0.001 
Unconscious 5% 3% 8% <0.001 
Visual disturbances 8% 7% 8% 0.633 
 
1.5.4.2 Distribution of physiological variables 
The physiological variables were reported as means but this may have hidden differences in 
stroke and SM patient distributions. In order to address this and explore if subgroups within 
these observations were relevant to differentiating stroke and SM, frequency distribution 
plots were constructed. The frequency distribution plots can be found in appendix G. 
The frequency distribution plots of the physiological variables revealed broadly similar 
distribution patterns between stroke and SM patients although there were some differences 
at the extremes of some variables such as age.  
1.5.4.3 Multicollinearity 
Multicollinearity describes the presence of correlation between predictor variables that 
unduly influences the output of a regression analysis. 
All variables were tested for multicollinearity by examining the Variance Inflation Factor (VIF) 
and tolerance statistics. Individual VIF>10 or average VIF<1 are causes for concern that 
multicollinearity may be present (Field, 2013) (p 325). The mean VIF was 1.275. The only 
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variables with VIF>2 were SBP (2.458) and DBP (2.600). Tolerance <0.2 indicates there may 
be a problem with multicollinearity. The mean tolerance was 0.812. The only variables with 
tolerance<0.5 were SBP (0.407) and DBP (0.385).  
The physiological observations were predominantly reported as continuous variables. Due to 
the interdependent relationships between these variables, they were thought to be more at 
risk of correlation than the other measurements. The physiological continuous variables 
were examined for correlation using a correlation matrix (table 1.5.2).  
 
Table 1.5.2 Correlation matrix of continuous physiological variables 
A number of statistically significant (p<0.05) correlations were identified. When the relative 
strengths of the correlations were examined (represented by the Pearson correlation) then 
the only variables which were more than ‘weakly’ correlated (Pearson correlation 
coefficients 0.20-0.39) were SBP and DBP which displayed a ‘strong’ (0.60-0.79) correlation 
(Mukaka, 2012).  
Due to the link between SBP and DBP in both the multicollinearity testing and the 
correlation matrix, DBP was removed from the tool development, as it is less predictive of an 
abnormal physiological state than the broader range of SBP.  
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1.5.4.4 Inclusion of the FAST test 
FAST was considered as a predictor variable for the SM tool. Reliance on the FAST+ve 
variable was problematic due to the issues identified in chapter 1.4. Therefore the ‘Any 
FAST’ and ‘True FAST-ve’ variables were created. ‘Any FAST’ includes FAST+ve or any 
combination of FAST elements. ‘True FAST-ve’ is where ‘AnyFAST’=0. The dataset is 
described by ‘Any FAST’ and ‘True FAST-ve’ in table 1.5.3. 
Table 1.5.3 Cohort described by composite FAST variables 
  Patients with observation 
documented (% total) 
Stroke SM p value 
Any FAST 92% 94% 89% <0.001 
True FAST-ve 8% 6% 11% <0.001 
 
1.5.4.5 Impression 
Ambulance clinician impression was also considered as a variable that could be included in 
the SM identification tool. Data on impression were reported in chapter 1.4, table 1.4.7 from 
chapter 1.4 is repeated below, and showed a trend where impression ‘stroke’ > impression 
‘stroke and TIA’ > impression ‘stroke plus others’ in terms of accuracy of stroke diagnosis. 
Table 1.4.7 Paramedic impression and final diagnoses 
Impression Total patients Stroke  SM 
Stroke only 1353 881 (65%) 472 (35%) 
Stroke and TIA 132 74 (56%) 58 (44%) 
Stroke plus others 257 78 (30%) 179 (70%) 
 
However, impression was not included as a variable in the SM identification tool 
development due to its subjective nature. 
  
 104 
 
1.5.5 Model development stage 1 – the regression model 
The first attempt at developing a SM tool used BLR to generate a model which would detect 
SM with the best balance of sensitivity and specificity. This represented an inclusive attempt 
to detect the maximum number of SM based on all the available data.  
The following variables (n=34) were selected for inclusion in the BLR based upon results of 
univariate analyses at p<0.2 (Labopin and Iacobelli, 2003): 
Age; gender; BM; heart rate; irregular pulse; pain; respiratory rate; SBP; temperature; PMH 
alcohol; PMH epilepsy; PMH heart failure; PMH hypertension; PMH MI; PMH migraine; PMH 
stroke; abnormal gait; AF; arm weakness; chest pain; confusion; eye issues; facial droop; true 
FAST-; floppy; general weakness; headache; leg weakness; nausea or vomiting; seizures; 
speech symptoms; syncope; tremors; unconscious. 
Although there were a large number of potential predictor variables at this stage, based on 
the rule of thumb that for each explanatory variable >10 patients are needed, the sample 
was above the minimum number acceptable. 
Using the ‘Forward likelihood ratio’ method in SPSS (which was chosen due to the large 
number of variables and the exploratory nature of the first analysis) all 34 variables were 
entered into a BLR. The model included 875 (53.0%) of cases. The model produced included 
12 predictor variables (shown below in table 1.5.4), was statistically significant (X2 (12) = 
175.891, p<0.001) and explained 24.7% of the variance in stroke/SM diagnosis (Nagelkerke 
R2). The model had a sensitivity of 51.2%, specificity 84.9% and a PPV of 68.1% for SM.   
The regression model excluded a large number of cases due to missing data. Pain (recorded 
in 65% of all patients) and temperature (recorded in 87% of all patients) accounted for the 
majority of the missing data. A second BLR was run with these two variables removed. 
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Table 1.5.4 Variables in the regression modelv1 
 B S.E. Wald df Sig. Exp(B) 
Step 12l Age -.027 .006 19.850 1 .000 .974 
Gender(1) -.523 .157 11.127 1 .001 .593 
BM -.112 .035 9.916 1 .002 .894 
Systolic Blood 
Pressure 
-.010 .003 13.567 1 .000 .990 
PMH Epilepsy(1) -1.408 .499 7.950 1 .005 .245 
PMH Stroke(1) -.372 .175 4.513 1 .034 .689 
Arm weakness(1) .857 .192 19.835 1 .000 2.356 
Leg weakness(1) .546 .191 8.164 1 .004 1.726 
Speech symptoms(1) .671 .165 16.490 1 .000 1.956 
Tremors(1) -1.246 .430 8.393 1 .004 .288 
Unconsciousness(1) -.973 .394 6.085 1 .014 .378 
FT Eye issues(1) 1.366 .643 4.507 1 .034 3.920 
Constant 5.780 1.198 23.290 1 .000 323.722 
 
Using the ‘Forward likelihood ratio’ method in SPSS 32 variables were entered into a BLR. 
The model included 1,524 (92.4%) of cases. The model produced included 19 predictor 
variables (shown below in table 1.5.5), was statistically significant, (X2 (19) = 338.483, 
p<0.001) and explained 27.0% of the variance in stroke/SM diagnosis (Nagelkerke R2). The 
model had a sensitivity of 53.2%, specificity 81.6% and a PPV of 65.2% for SM.  
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Table 1.5.5 Variables in the regression modelv2 
 B S.E. Wald df Sig. Exp(B) 
Step 19s Age -.021 .005 19.920 1 .000 .979 
Gender(1) -.519 .121 18.486 1 .000 .595 
BM -.058 .024 5.753 1 .016 .943 
Systolic Blood Pressure -.011 .002 25.857 1 .000 .989 
PMH CHF(1) 1.020 .448 5.171 1 .023 2.772 
PMH Hypertension(1) .283 .133 4.546 1 .033 1.327 
PMH Epilepsy(1) -1.017 .345 8.716 1 .003 .362 
PMH Stroke(1) -.451 .132 11.753 1 .001 .637 
Arm weakness(1) .839 .153 30.054 1 .000 2.314 
Confusion(1) -.348 .131 7.098 1 .008 .706 
Facial droop or 
weakness(1) 
.366 .127 8.331 1 .004 1.442 
Headache(1) -.401 .147 7.401 1 .007 .670 
Leg weakness(1) .666 .145 21.005 1 .000 1.947 
Seizures(1) -1.079 .350 9.498 1 .002 .340 
Speech symptoms(1) .597 .137 18.945 1 .000 1.816 
Tremors(1) -1.139 .372 9.363 1 .002 .320 
Unconsciousness(1) -.687 .285 5.825 1 .016 .503 
AF(1) .394 .192 4.236 1 .040 1.483 
TrueFASTneg(1) .653 .261 6.284 1 .012 1.922 
Constant 4.935 1.016 23.600 1 .000 139.076 
 
The results of these BLR models were informative, however the aim was to produce a tool 
with a higher specificity and PPV than either of these models achieved, and the large 
number of factors with variable weightings would be a barrier to clinical application. The 
models generated by the BLR sought the best balance of sensitivity and specificity, but these 
did not attain the high specificity which was necessary based on the national paramedic 
survey reported in chapter 1.3. Based on the analyses it became obvious that a generic SM 
tool would not meet the aims of this project as it was neither simple nor specific. This led to 
reconsidering the adopted approach and a move away from a comprehensive predictive 
approach focussed on high sensitivity and high specificity. What was needed was a tool 
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focused on specificity and PPV with the acceptance that this could only be achieved at the 
expense of sensitivity and with a different approach. 
1.5.6 Model development stage 2 – the focussed model 
Developing a SM identification tool focused on high specificity and PPV was the preferred 
option for a number of reasons: 
 Due to the wide range of SM aetiologies and variable associations with clinical 
characteristics developing a generic tool seemed impractical. 
 The intention of the SM tool was that it would be applied after the initial suspicion of 
stroke was established so sensitivity was not the most important measure of 
performance. 
 The relative consequences of failure to recognise stroke were considered to be 
greater than failure to recognise SM due to the time-critical nature of treatment.  
 This was reinforced by the survey reported in chapter 1.3 which indicated that 
paramedics wanted a SM tool to be very highly specific. 
Odds ratios (OR) were used to inform the development of a more focussed tool.  
“An odds ratio (OR) is a measure of association between an exposure and an outcome. The 
OR represents the odds that an outcome will occur given a particular exposure, compared to 
the odds of the outcome occurring in the absence of that exposure.” (Szumilas, 2010). 
Odds ratios (OR) were calculated to quantify the strength of each predictor’s association 
with SM diagnosis. These were then used to select the predictor variables with the strongest 
association with SM diagnosis for inclusion in a focussed SM tool.  
The continuous variables (age; BM; GCS; heart rate; pain; SaO2; respiratory rate; SBP; 
temperature) were converted into binary predictors as the wide range of possible values for 
each created complex weighting coefficients which reduced the clinical utility. The optimum 
cut-off points were calculated using AUC generated by ROC analysis as shown in table 1.5.6.  
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Table 1.5.6 ROC analysis of continuous physiological variables 
Variable Cut-off % SM 
based on 
cut-off 
P value Sensitivity Specificity 
Age <52 71 <0.0001 0.10 0.97 
BM <4.6 68 0.01 0.04 0.99 
GCS <8 0 0.17 0.00 1 
Heart rate >179 0 0.003 0.00 1 
Pain >7 71 0.16 0.01 1 
SaO2 >99.8 42 0.91 0.00 1 
Respiratory 
rate 
>31 67 0.10 0.01 1 
SBP <95 80 <0.0001 0.02 1 
Temperature >37.7 70 <0.0001 0.08 0.98 
 
The cut-off values calculated in the ROC analysis were used to dichotomise the continuous 
variables and calculate OR. OR were not calculated for GCS, pain, SaO2 or respiratory rate 
based on statistical non-significance (p>0.05) in the ROC analysis. Heart rate was also 
excluded as there was only one patient with HR>179. The OR for all variables are shown in 
table 1.5.7. As the outcome of interest was SM diagnosis an OR>1 was associated with SM 
diagnosis and OR<1 was associated with stroke diagnosis.   
Table 1.5.7 Odds ratios of predictor variables for SM diagnosis 
  Odds ratio Lower 95% CI Upper 95% CI 
Age<52 4.0 2.5 6.3 
Gender (female) 1.5 1.2 1.8 
Physiological observation    
BM<4.6mmol/l 3.3 1.6 6.6 
Irregular pulse 0.7 0.5 0.9 
SBP<95mmHg 6.7 1.9 23.6 
Temperature>37.7oC 3.8 2.1 6.7 
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Table 1.5.7 Odds ratios of predictor variables for SM diagnosis cont. 
  Odds ratio Lower 95% CI Upper 95% CI 
Past Medical History     
Alcohol misuse 2.8 1.2 6.8 
Angina 1.0 0.7 1.5 
Diabetes 0.9 0.7 1.1 
Epilepsy 4.0 2.2 7.2 
Heart failure 0.4 0.2 0.8 
High cholesterol 0.9 0.7 1.2 
Hypertension 0.7 0.5 0.8 
MI 0.8 0.5 1.1 
Migraine 3.2 1.4 7.6 
Smoking 0.9 0.4 1.7 
Stroke 1.5 1.2 1.8 
TIA 1.0 0.8 1.3 
Signs and symptoms    
Abnormal gait 0.7 0.5 1.0 
AF  0.5 0.4 0.7 
Alcohol/Drug use reported 1.3 0.7 2.5 
Altered Sensation 0.8 0.6 1.2 
Arm weakness 0.3 0.3 0.4 
Chest pain 2.5 0.9 7.0 
Confusion 1.2 0.9 1.5 
Dizziness 1.0 0.7 1.4 
Eye issues 0.5 0.3 0.8 
Facial droop or weakness 0.6 0.5 0.7 
FAST+ve 0.7 0.5 0.8 
Floppy 0.7 0.5 1.1 
General weakness 1.3 1.0 1.6 
Headache 1.4 1.1 1.8 
Leg weakness 0.6 0.3 0.4 
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Table 1.5.7 Odds ratios of predictor variables for SM diagnosis cont. 
  Odds ratio Lower 95% CI Upper 95% CI 
Nausea or vomiting 1.3 0.9 1.7 
Neck Stiffness 1.5 0.6 3.5 
Seizures 4.3 2.4 7.8 
Speech symptoms 0.6 0.4 0.7 
Syncope 2.2 0.8 6.4 
Tremor 2.6 1.4 4.8 
True FAST-ve 2.2 1.5 3.1 
Unconscious 3.3 2.0 5.3 
Visual disturbances 1.1 0.8 1.6 
 
Using the information from the initial regression models, the frequency distribution graphs 
and the OR, variables such as younger age, gender, PMH epilepsy, seizures and hypotension 
(low blood pressure) were identified that were consistently associated with SM diagnosis 
which was supported by the literature review (chapter 1.2).  
This information was used to identify smaller groups of patients who were more likely to be 
SM. The smaller groups were selected based on clinical presentations associated with SM 
diagnoses such as seizures or sepsis and the presence of predictor variables. These groups 
were further explored using univariate and BLR analyses to identify predictive variables 
within these reduced populations. Through this process a small number of predictive 
variables started to emerge. Younger age, history of epilepsy and high temperature were all 
strongly associated with SM diagnosis in the literature and in the analyses.  
Using these target populations with common SM presentations and the emerging predictive 
variables, a decision tree was constructed to identify each population by focussing on its 
unique predictive variables. Figure 1.5.1 illustrates the combinations of populations and 
predictor variables that were considered, and how a model focussed on these target 
populations was envisaged. Different populations were identified and predictive variables in 
these smaller populations were sought and are documented at the end of each pathway. 
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Figure 1.5.1 Model of decision tree SM identification tool 
The aim of this thesis was to develop a simple tool whereas what emerged was a 
complicated and unwieldy tool based on differing combinations of individual variables which 
were predictive in small, distinct sub-populations.  
1.5.7 Model development stage 3 – the combined model 
The final stage in the tool development process involved organising, weighting and exploring 
the variables according to their strength of association and known clinical value. Rather than 
treating all the variables as independent predictors, clinically meaningful combinations were 
sought. Variables were regarded as clinically meaningful if they pointed towards a common 
SM diagnosis, or were characteristics strongly associated with SM diagnosis, which had been 
identified in the literature review (chapter 1.2). Individual variables were ranked according 
to OR and the strongest individual predictors (OR>3 or <0.3) were considered for inclusion 
either individually, or in combination with other variables.    
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1.5.7.1 Individual predictor variables 
Age, SBP and BM were included in the BLR models and had good individual OR for predicting 
SM, but for inclusion in the SM tool it was necessary to explore their threshold values to 
convert them into binary predictors. 
The optimum cut-off for age that was indicated by the ROC analysis was <52 years. This age 
cut-off identified 28 stroke patients and 69 SM patients, which was not acceptable due to 
the high number of stroke patients identified. Individual age values were considered, as 
shown in table 1.5.8, to identify a more suitable cut-off point for inclusion in the SM tool. 
Age<40 years gave an acceptable balance of stroke and SM patients, was lower than the age 
(50 years) used in other SM tools (Ali et al., 2014; Goyal et al., 2016b; Siddiqui et al., 2016), 
and reflected specialist views about the age below which a vascular cause for stroke 
symptoms was less likely (Nacu et al., 2016), so was included in the SM identification tool. 
Table 1.5.8 Individual age values with number of stroke and SM patients 
identified by each value  
Age 
(years) 
Stroke Stroke 
running 
total 
SM SM 
running 
total 
Grand 
total 
% SM 
22 
 
0 2 2 2 100% 
24 
 
0 2 4 4 100% 
25 
 
0 2 6 6 100% 
30 1 1 1 7 8 88% 
32 
 
1 1 8 9 89% 
33 
 
1 3 11 12 92% 
34 
 
1 2 13 14 93% 
35 1 2 1 14 16 88% 
36 
 
2 1 15 17 88% 
37 2 4 3 18 22 82% 
38 
 
4 1 19 23 83% 
39 1 5 4 23 28 82% 
40 2 7 6 29 36 81% 
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Table 1.5.8 Individual age values with number of stroke and SM patients 
identified by each value cont. 
Age 
(years) 
Stroke Stroke 
running 
total 
SM SM 
running 
total 
Grand 
total 
% SM 
41 2 9 1 30 39 77% 
42 2 11 1 31 42 74% 
43 1 12 3 34 46 74% 
44 3 15 1 35 50 70% 
45 1 16 4 39 55 71% 
46 1 17 3 42 59 71% 
47 2 19 2 44 63 70% 
48 2 21 4 48 69 70% 
49 4 25 10 58 83 70% 
50 3 28 6 64 92 70% 
51 
 
28 5 69 97 71% 
 
SBP was included in both BLR models and when split according to the ROC analysis at 
SBP<95mmHg was the strongest individual predictor based on OR (6.7). SBP<95mmHg 
identified 3 stroke patients and 12 SM patients. Increasing or decreasing the SBP value was 
considered to see what impact this would have on the predictive power of the variable, the 
results of this are shown in table 1.5.9. As there was no improvement in discrimination 
between states, SBP<95mmHg was retained and included in the SM identification tool. 
Table 1.5.9 SBP values considered for inclusion in SM tool 
SBP (mmHg) Stroke SM 
100 8 16 
95 3 12 
90 3 8 
85 2 5 
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BM was considered for inclusion as a predictor variable as it was included in both BLR 
models and when split using ROC analysis at BM<4.6mmol/l it was strongly predictive (OR 
3.3) of SM diagnosis. BM<4.6mmol/l identified 12 stroke patients and 25 SM patients. 
Lowering the BM value to 4.0mmol/l identified 4 stroke patients and 7 SM patients. 
Lowering it again to 3.5mmol/l, as per the NEAS guidelines for suspected stroke assessment, 
identified 1 stroke patient and 3 SM patients.  
Based on the high proportion of stroke patients identified, unless BM<3.5mmol/l was used, 
and the fact that hypoglycaemia was already included as an exclusion criteria in the NEAS 
pre-hospital stroke pathway, the decision was made not to include BM in the SM 
identification tool at this point. As BM was already part of the stroke identification process, 
patients with stroke like symptoms due to hypoglycaemia may not have been included in the 
data as they were treated by the paramedics and documented as diabetic emergencies 
rather than stroke. This would mean that there would be very little data on this group within 
our population so showing predictive utility would be challenging. 
1.5.7.2 Combined predictor variables 
In addition to the individual variables, combinations of variables predictive of SM diagnoses 
were considered for inclusion. Seizures were identified by the literature review (chapter 1.2) 
as a common SM. PMH epilepsy and seizures were individually strong predictors of SM 
diagnoses (OR 4.0 and 4.3). Clinically it made sense to combine these two predictor variables 
to identify patients who had a PMH of epilepsy and a seizure to increase confidence in this 
possible SM diagnosis. This combined variable identified 1 stroke patient and 15 SM patients 
and had an OR of 22.9. 
Migraine was also recognised as a common SM diagnosis. The variables clinically indicative 
of migraine in this dataset were PMH migraine and headache. PMH migraine had a strongly 
predictive OR (3.2) but headache was less predictive (OR 1.4). The combination of PMH 
migraine and headache identified 4 stroke patients and 12 SM patients with an OR of 4.6. 
Raised temperature (>37.7oC) had a high OR (3.8), but in isolation did not point towards a 
specific SM diagnosis, plus it identified a large number of stroke patients (n=17) compared to 
the number of SM patients (n=40). Considering sepsis as a common SM, and the sepsis 
indicators within the Systemic Inflammatory Response Syndrome (SIRS) criteria developed 
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by the Surviving Sepsis Campaign (Bone et al., 1992), other predictor variables which could 
link temperature to sepsis diagnosis were identified. Tachycardia (raised heart rate) of >90 
was another SIRS indicator of sepsis which was considered in combination with raised 
temperature. When heart rate>90 was combined with temperature>37.7oC the combination 
identified 6 stroke patients and 28 SM patients. Due to the high number of stroke patients, 
refinements to this variable were considered. 
The National Early Warning Score (NEWS) (RCP, 2012) is a physiological scoring system which 
includes temperature and heart rate which was in common use in hospital and growing use 
in pre-hospital care. The temperature predictor variable was raised to >38.0oC to bring it into 
line with NEWS. Heart rate>90 was an existing NEWS variable. This combination of 
temperature>38.0oC and heart rate>90 identified 2 stroke patients and 18 SM patients and 
had an OR of 14.3. 
The dataset was examined for other variables that in combination had better predictive 
power if added to the SM tool. As unconscious was a strong predictor based on OR (3.3) and 
was included in both BLR models, other variables were reviewed that could in combination 
increase its predictive power. Combining unconscious with headache, another predictor of 
SM diagnosis, plus absence of facial weakness, the presence of which is a strong predictor of 
stroke diagnosis, generated a strong predictive combination. Unconscious plus headache 
without facial weakness identified 0 stroke patients and 9 SM patients. 
1.5.7.3 Combining predictor variables into a tool 
With a selection of individual and combined clinically meaningful predictor variables, 
targeting common SM conditions or characteristics, a scoring system was devised based on 
the aim of developing a simple and specific tool for pre-hospital use. Variables that were 
predictive of SM diagnoses were allocated a single point so that they could be combined to 
form a pragmatic scoring system. Variables were not weighted at this stage. This led to an 
iterative process where predictive factors were incrementally combined to create an initial 
SM tool.  
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Step 1. Age<40 years = 1 point (n=28) 
 Patients scoring 1 point = 28 comprising 23 (82%) SM and 5 (18%) strokes 
Step 2. Include seizures AND PMH epilepsy = 1 point (n=16) 
 Patients scoring 1 point = 40 comprising 34 (85%) SM and 6 (15%) strokes 
 Patients scoring 2 points = 2 comprising 2 (100%) SM 
 Patients scoring 1 or 2 points = 42 comprising 36 (86%) SM and 6 (14%) stroke 
Step 3. Include headache AND PMH migraine = 1 point (n=16) 
 Patients scoring 1 point = 50 comprising 42 (84%) SM and 8 (16%) strokes 
 Patients scoring 2 points = 5 comprising 4 (80%) SM and 1 (20%) stroke 
 Patients scoring 1 or 2 points = 55 comprising 46 (84%) SM and 9 (16%) stroke 
Step 4. Include Unconscious AND headache WITHOUT facial weakness = 1 point (n=9) 
 Patients scoring 1 point = 53 comprising 45 (85%) SM and 8 (15%) strokes 
 Patients scoring 2 points = 8 comprising 7 (88%) SM and 1 (12%) stroke 
 Patients scoring 1 or 2 points = 61 comprising 52 (85%) SM and 9 (15%) stroke 
Step 5. Include SBP<95mmHg = 1 point (n=15) 
 Patients scoring 1 point = 68 comprising 57 (84%) SM and 11 (16%) strokes 
 Patients scoring 2 points = 8 comprising 7 (88%) SM and 1 (12%) stroke 
 Patients scoring 1 or 2 points = 76 comprising 64 (84%) SM and 12 (16%) stroke 
Step 6. Include temperature>38.0oC AND heart rate>90 = 1 point (n=20) 
 Patients scoring 1 point = 88 comprising 75 (85%) SM and 13 (15%) strokes 
 Patients scoring 2 points = 8 comprising 7 (88%) SM and 1 (12%) stroke 
 Patients scoring 1 or 2 points = 96 comprising 82 (85%) SM and 14 (15%) stroke 
This generated a collection of characteristics for inclusion in a SM identification tool which 
are summarised in table 1.5.10. 
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Table 1.5.10 Characteristics considered for SM identification tool 
Characteristic Stroke SM OR (95% CI) 
Age<40 years 5 23 7.1 (2.7-18.7) 
PMH epilepsy AND seizures  1 15 22.9 (3.0-174.1) 
PMH migraine AND headache  4 12 4.6 (1.5-14.2) 
Unconscious AND headache 
WITHOUT facial weakness 
0 9 15.1 (1.9-118.8)* 
SBP<95mmHg 3 12 6.7 (1.9-23.6) 
Temperature>38.0oC AND heart 
rate>90bpm 
2 18 14.3 (3.3-61.7) 
*Approximated by adding 1 to each variable 
 
Despite ‘Unconscious and headache without facial weakness’ being a good predictor of SM 
diagnosis, this combination of characteristics did not have the same clinical meaningfulness 
or biological plausibility as the other characteristics i.e. it did not point towards an obvious 
SM diagnosis. This combination of variables also included headache which was already 
present in the migraine and headache combination. Therefore this combination was 
excluded from the final version. 
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1.5.8 The STEAM tool 
1.5.8.1 Model specification 
The final iteration of the initial SM tool is described below in table 1.5.11, with STEAM 
chosen as the acronym. If a suspected stroke patient possessed any of these five 
characteristics then the tool was judged positive and the patient had a high chance of being 
a SM. The tool was simple, based on five characteristics that are commonly available in the 
pre-hospital setting, and critically it identified SM with a high level of specificity.  
Table 1.5.11 Characteristics included in the STEAM SM identification tool 
Characteristic Stroke SM OR (95% CI) 
SBP<95mmHg 3 12 6.7 (1.9-23.6) 
Temperature>38.0oC AND heart rate>90bpm 2 18 14.3 (3.3-61.7) 
Epilepsy AND seizures at onset 1 15 22.9 (3.0-174.1) 
Age<40 years 5 23 7.1 (2.7-18.7) 
Migraine AND headache at onset 4 12 4.6 (1.5-14.2) 
 
1.5.8.2 Model performance 
Based upon the 1,650 suspected stroke patients transported by NEAS to NHCT over three 
years, including 989 (60%) stroke and 661 (40%) SM, the STEAM tool retrospectively 
identified 90 patients: 76 (84%) SM and 14 (16%) strokes. The diagnostic performance of the 
STEAM tool was calculated as follows: 
 Sensitivity 11.5% (9.2-14.2) 
 Specificity 98.6% (97.6-99.2) 
 Positive predictive value (PPV) 84.4% (75.6-90.5) 
 Negative predictive value (NPV) 62.5% (61.8-63.2) 
 Positive likelihood ratio (PLR) 8.1 (4.6-14.2) 
 Negative likelihood ratio (NLR) 0.9 (0.9-0.9) 
 Odds ratio (OR) 9.3 (5.2-16.7) 
The STEAM positive patients are reported in table 1.5.12 based on the number of STEAM 
characteristics they triggered. 
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Table 1.5.12 STEAM positive patients displayed by number of positive characteristics 
STEAM positive characteristics Stroke SM Total 
1 13 72 85 
2 1 4 5 
 
The five patients who triggered two STEAM characteristics were all positive for age, three 
were positive on migraine plus headache and two were positive on epilepsy plus seizures. 
The STEAM false positive (stroke patient) triggered on age and migraine plus headache.  
The patients who were STEAM false positives (i.e. true stroke patients identified as SM by 
the STEAM tool, n=14) were traced back to the original SSNAP data to establish the rate of 
reperfusion treatment. Thrombolysis had been administered to three (21%, 1 x 
SBP<95mmHg, 1 x age<40, 1 x migraine and headache) of these patients.  
STEAM performance was also reported based on FAST status. The relationship between 
FAST and the STEAM tool is explored further in chapter 2.2 where the initial STEAM tool is 
refined. 
Table 1.5.13 STEAM positive patients in FAST+ve and FAST-ve populations 
FAST status Stroke SM Total 
Positive (n=1,520) 14 65 79 
Negative (n=130) 0 11 11 
 
1.5.9 Discussion 
The STEAM tool achieved simple and specific SM identification. It was developed using 
unfiltered pre-hospital data to ensure applicability in the pre-hospital setting. The concept of 
clinically meaningful combinations and ‘simple and specific’ guided the choice of predictor 
variables for inclusion in the final tool. STEAM identified a small proportion of the SM 
population with a high level of certainty. 
STEAM includes similar variables to other SM identification tools as reported in table 1.1.5 in 
chapter 1.1. The five variables included in STEAM identify different populations of SM 
 120 
 
patients, although a small number (n=5) of patients trigger multiple STEAM characteristics. 
The individual STEAM characteristics are discussed below. 
1.5.9.1 Systolic blood pressure 
SBP is a common measurement in pre-hospital care and is easily monitored either manually 
or using an automatic non-invasive blood pressure cuff, which most ambulances carry. 
SBP<95mmHg is a relative hypotension especially in the context of stroke which is commonly 
associated with hypertension (Appleton et al., 2016).  
Hypotension is rare in stroke patients (~5%, (Leonardi-Bee et al., 2002)) but hypotension can 
lead to syncope which is a recognised SM (Gibson and Whiteley, 2013). The mechanisms 
underlying syncope are usually either orthostatic hypotension or vasovagal, either of which 
can lead to reduced cerebral perfusion (Shukla and Zimetbaum, 2006). Reduced cerebral 
perfusion caused by hypotension can produce stroke-like symptoms such as: 
 dizziness / vertigo 
 slurred speech 
 visual disturbances 
 motor weakness  
 cognitive impairment    
Hypotension, or the absence of hypertension, is included as a predictive factor for SM in 
three existing SM tools (Hand et al., 2006; Ali et al., 2014; Goyal et al., 2016b). 
1.5.9.2 Temperature and heart rate 
These two variables are easily measured in the pre-hospital setting and commonly recorded 
as part of the basic observations completed on all patients. Individually, a raised 
temperature nor a raised heart rate discriminate between stroke and SM, but in 
combination they point towards an underlying infection or sepsis. Sepsis or the presence of 
infection can present with stroke like symptoms or lead to decompensation in patients with 
a previous stroke. Sepsis was the third most frequently reported SM by Gibson and Whiteley 
(Gibson and Whiteley, 2013). 
A raised temperature and heart rate are included in the NEWS as physiological markers of 
illness and the SIRS criteria for identifying patients with an infection or sepsis (Comstedt et 
 121 
 
al., 2009). Matching the NEWS and SIRS criteria should facilitate use of STEAM as the trigger 
points are consistent across the assessment tools. 
1.5.9.3 Epilepsy and seizures 
A seizure or seizures can lead to stroke like symptoms and a condition known as Todd’s 
paresis. This is a recognised phenomenon where patients present with symptoms such as 
weakness, slurred speech or a focal neurological deficit in the postictal phase following a 
seizure (Werhahn, 2010). Many pre-hospital stroke pathways have seizures as an indication 
for transporting the patient directly to the nearest ED as opposed to a stroke unit. The 
ROSIER stroke identification tool (Nor et al., 2005) included seizures, as well as loss of 
consciousness, as factors that reduced the probability of final stroke diagnosis.  
Seizures were the most common SM identified by Gibson and Whiteley and the most 
common level 2 CCS diagnostic group in the literature review (chapter 1.2). Seizures in 
isolation were associated with SM diagnosis and seizures when combined with PMH epilepsy 
were the strongest predictor (based on OR) in STEAM. Seizures are included in three existing 
SM tools (Chang et al., 2012; Ali et al., 2014; Goyal et al., 2016b). 
1.5.9.4 Age 
Age is included in four of the SM identification tools described in chapter 1.1 (Merino et al., 
2013; Ali et al., 2014; Goyal et al., 2016b; Siddiqui et al., 2016). The association between 
increasing age and increased risk of stroke is well documented (Asplund et al., 2009). 
Although young age is a strong epidemiological predictor of SM diagnosis in the data and 
identifies a large number of SM there is a risk associated with dismissing stroke symptoms in 
individual patients purely based on age. The inclusion of age is discussed further in the focus 
groups described in chapters 2.1 and 3.3. Recent campaigns have sought to increase the 
awareness of stroke in the younger population, which could change the balance between 
stroke and SM presentations.  
1.5.9.5 Migraine and headache 
Headache was the fourth most common SM documented by Gibson and Whiteley and the 
second most common level 2 CCS diagnostic group described in chapter 1.2. In the data 
presented headache in isolation was not a strong predictor of SM diagnoses. PMH migraine 
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was more predictive than headache, but in a similar fashion to temperature and heart rate 
the two factors combined were strongly predictive and had a biologically plausible 
explanation for stroke like symptoms due to a SM condition. 
Headache is not an unusual symptom during stroke (Tentschert et al., 2005) but it is also the 
main symptom of migraine and is present in many other SM conditions (Devenney et al., 
2014). Hemiplegic migraine is a rare condition which presents with single sided weakness 
which is a classic stroke symptom. This condition could be misdiagnosed as a stroke and 
potentially thrombolysed. 
1.5.9.6 Interpretation 
STEAM was developed from pre-hospital data with the principles of simplicity and specificity 
guiding the development process. These factors should increase the probability that STEAM 
is applicable in the pre-hospital setting. The dataset used to create STEAM was large 
(n=1,650) compared to other SM tool cohorts (chapter 1.1) but with a higher SM rate (40%) 
than would have been expected based on the literature (chapter 1.2).  
The process of creating STEAM moved through three stages, from an all-encompassing 
regression model, through a more focussed model and concluded with a simple but specific 
combined model. This represented an iterative development process as insight was gained 
into the range of SM conditions and the limitations of the pre-hospital data. In developing a 
clinical prediction tool the aim is to maximise both sensitivity and specificity, which was 
attempted by the initial regression model. In many cases sensitivity and specificity have an 
inverse relationship at the level of maximum test performance, i.e. one is gained at the 
expense of the other. Specificity was more important in the development of the SM tool so a 
low sensitivity was accepted. In other settings, such as during telephone triage or in-hospital, 
a different balance of priorities will be present. Telephone triage prioritises high sensitivity in 
order to detect the maximum number of potential stroke cases, whereas in-hospital decision 
making, supported by advanced neuro-imaging, can strive for maximum sensitivity and 
specificity. 
STEAM is the only SM tool designed for pre-hospital use and derived from pre-hospital data 
so comparisons to other SM tools need to take this into account. STEAM has a lower 
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sensitivity but a similar specificity to other tools reporting these performance characteristics 
(Libman et al., 1995; Goyal et al., 2016b).  
1.5.9.7 Implications 
STEAM achieved the stated aim which was to develop a simple but specific tool that could be 
used in the pre-hospital setting to identify SM patients. STEAM now needs to be refined and 
validated in new datasets as this is only the first stage of the development process. The 
potential clinical uses, such as diversion away from a stroke unit, and acceptability to 
stakeholders need to be explored.  
The implications of introducing STEAM on a large scale can be considered based on the 
performance characteristics described. If the following basic assumptions are made: 
 100,000 strokes in the UK in a single year.  
 75% of stroke patients are identified and admitted by ambulance.  
 40% SM rate in ambulance admissions. 
Then there would be 75,000 stroke admissions and 50,000 SM admissions per year by 
ambulance. If STEAM detects 12% of SM patients with 84% PPV then it will identify 7,142 
patients, 6,000 will be SM and 1,142 will be false positive (true stroke) patients. This basic 
modelling of the impact of STEAM will be developed and expanded upon in chapter 3.2. 
STEAM has demonstrated one possible outcome of linking pre-hospital stroke data with in-
hospital diagnoses. There are many other potential uses for this type of linked dataset. 
Further research in this area could examine how STEAM could be applied in practice, the 
high SM rate in this cohort, how paramedics are identifying stroke patients with reference to 
the FAST+ve and FAST-ve populations and what are the implications of using it in 
combination with the increased sensitivity gained by expanding the criteria for stroke 
identification such as the FAST-AVVV (ataxia, vomiting, vertigo, visual deficit) tool being 
using by one UK ambulance service (Roberts-Andreou, 2016). 
1.5.9.8 Limitations 
The methods used to develop the STEAM tool were based on an iterative and intuitive 
process that combined regression analysis with information gained from multiple sources 
and the clinical insight of the author and supervisory team. The method might be difficult to 
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replicate as STEAM was not derived purely from the regression analysis and the process 
included a number of assumptions based upon clinical experience, but these will be explored 
during the professional focus groups described in chapter 2.1. The focus on simplicity limited 
the amount of variables that were considered for combination in this work whereas a more 
sophisticated electronic tool, or use in a less time pressured setting, would enable more 
variables and a more complex tool to be constructed. 
The retrospective nature of the data introduced limitations in terms of data quality from a 
lack of complete recording of items of interest. Information that may have been of interest, 
such as psychiatric history, was not easily available within the dataset. Gargalas et al  
identified two groups of SM patients; medical and functional/psychiatric (Gargalas et al., 
2017). STEAM focussed on the medical group of SM patients due to the lack of psychiatric 
data in the pre-hospital records and the lack of expertise paramedics have in psychiatric 
assessment.  
It is important to recognise that this dataset reflected spontaneous assessment and clinical 
record keeping by ambulance clinicians who were not routinely required to document 
STEAM clinical characteristics. Therefore, STEAM might perform differently if completion 
was mandatory. The hospital diagnoses were also based on retrospective records so the 
outcome of interest, stroke or SM, may not have been considered at the time therefore 
patients will have undergone differing assessment processes. A prospective study of STEAM 
would need to ensure complete recording of relevant variables on all patients and consistent 
assessment in hospital to allow more robust analysis and evaluation. 
There were varying amounts of missing data in the physiological variables. An imputation 
method could have been used to replace the missing data items but most methods would 
have imputed values close to the mean which would not have affected the development of 
STEAM as only abnormal values are discriminatory.  
Pain was the characteristic with the most missing data, but it was not included in the final 
tool due to low specificity and little biological plausibility. Temperature was the only other 
characteristic with less than 95% completeness (87%) and it was included in STEAM. When 
the patients with missing temperature values (n=216) were examined only 64 (4% of total) 
had a heart rate>90. Only 2% of all patients had a temperature>38.0oC so it appears unlikely 
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that any imputation method would have caused many of this group of patients to trigger 
STEAM. 
Some predictor variables identified by the analysis and chosen for inclusion were only 
recorded in a small number of patients. This may be due to the variables only being present 
in the small number or they may not have been considered as relevant at the time.  
STEAM was derived from data from a single hospital so the sample may not be 
representative of all pre-hospital stroke patients. Expanding the dataset to include other 
sites would address this limitation. 
1.5.10 Conclusions 
This chapter described the development of the initial SM identification tool. The final version 
was the STEAM tool which includes five characteristics that identify a small number of SM 
with a high level of certainty. STEAM meets the aim of developing a simple but specific SM 
identification tool. The iterative development process was guided by analysis of pre-hospital 
data linked with patient diagnoses. The survey of paramedics and a systematic review of the 
literature also contributed to the development process. 
1.5.11 Summary 
Development of the STEAM tool concludes part 1 of this thesis. The next stages are reported 
in part 2 of the thesis and include focus groups with professional stakeholders (paramedics 
and hospital clinicians) to explore their views about the STEAM tool, refinement of the 
STEAM tool using an expanded dataset, and prospective testing of the STEAM tool by NEAS 
paramedics to generate data on its usability.  
 126 
 
Chapter 2.0 Summary of part 1 and overview of part 2 
 
Part 1 of this thesis described the initial idea, literature review, survey and development 
dataset that led to the creation of the SM tool v1 (STEAM). Figure 1.0.2 from chapter 1.0 is 
reproduced below to illustrate the overall research process.  
 
Figure 1.0.2 Flowchart with overview of pre-hospital SM project 
Part 2 builds on the STEAM tool that was developed in part 1. Chapter 2.1 describes the 
findings from focus groups with paramedics and hospital clinicians exploring their views on 
the acceptability of STEAM, how it could be improved and the implications of using STEAM in 
practice. 
STEAM is refined in chapter 2.2 based on the findings of the focus groups and expansion of 
the patient dataset with the addition of data from two additional acute trusts. This 
expanded the dataset from 1,650 to 3,797 suspected stroke patients which allowed more 
precise estimation of predictive variables. 
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Chapter 2.3 reports on the prospective use of STEAM by NEAS paramedics, in order to 
explore its usability and how it could be incorporated into current practice. This prospective 
testing was conducted using mixed methods. The culmination of the results reported in part 
2 of the thesis is a refined STEAM tool with qualitative data in support of its usability and 
acceptability in practice.   
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Chapter 2.1 Professional stakeholder views on the STEAM tool 
 
2.1.1 Introduction 
Following the development of STEAM, described in part 1, views from relevant professional 
stakeholders about its perceived acceptability in the clinical setting were sought. This 
chapter describes the design, data collection and findings of a qualitative study exploring 
professional stakeholder views on the development of STEAM. 
This is the first of three phases of qualitative work that were conducted to inform the 
development of STEAM and explore healthcare professional views about applying the tool in 
practice. The second and third qualitative phases are described in chapters 2.3 and 3.3. 
2.1.2 Chapter aim 
The aim of this chapter is to report the views of healthcare professionals, who have 
experience and interest in pre-hospital and acute stroke care, regarding the development, 
structure and content of STEAM.  
2.1.3 Methods 
2.1.3.1 Design 
A generic qualitative approach (Cooper and Endacott, 2007; Griffiths and Mooney, 2011) 
was selected due to the inexperience of the researcher and the multi-methods nature of the 
wider project. 
Focus groups were chosen as an appropriate method for data collection. Barbour (Barbour, 
2008) (p8) described how focus groups are useful in health services research as the 
perspectives of relevant parties can assist with the development of effective interventions. A 
focus group allows participants with varying roles and responsibilities to discuss the issue of 
interest and the interaction between the participants provides insights that would be 
difficult to gain using other methods. Focus groups were appropriate as they allowed 
participants, selected for their experience in acute stroke care, to express and discuss their 
views on SM and the STEAM tool. This data would then be used to inform the development 
and refinement of STEAM. 
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2.1.3.2 Participants 
Participants were sought from relevant professional stakeholders including paramedics, 
stroke physicians, ED physicians and stroke nurse practitioners in one acute trust (NHCT) and 
one ambulance trust (NEAS). These groups were targeted as representative of professionals 
with clinical responsibilities where a SM tool might impact upon practice. The aim of the 
focus groups was to gain insight into the development and future deployment of STEAM so a 
convenience sample was used. Participants were considered representative of their 
professions. No specific eligibility criteria were applied other than participants had to be 
employed by NEAS or NHCT and involved in providing acute stroke care. Participants were 
recruited by advertising for volunteers within the respective organisations and attendance at 
existing meetings where relevant professionals were present. All participants were supplied 
with information sheets regarding the study prior to the focus groups. Informed written 
consent was gained at the start of each focus group after participants had a chance to ask 
questions.  
The aim was to recruit 4-6 participants per focus group based on the recommendations of 
Barbour (Barbour, 2008) (p60) and Pope and Mays (Pope and Mays, 2006) (p26). These 
numbers would ensure a variety of views were represented, there were enough participants 
to promote discussion and the group was manageable by the single facilitator. 
2.1.3.3 Data collection and analysis 
Separate focus groups were organised for the paramedics and the hospital staff. This was 
done in order to focus on the views of each professional group, as opposed to the 
interaction between the groups, and to avoid any perceived authority of one group over the 
other. As the aim was to seek clinical insight for the development and future deployment of 
the SM tool there was no expectation of reaching data saturation with only two focus 
groups.  
A topic guide was used for both focus groups (see appendix H). The topic guide was 
developed by the researcher and the supervisory team, informed by relevant literature and 
covered broad areas such as the development of STEAM, application and barriers or 
facilitators to use. The guide was intended to help keep the groups focussed on the issues of 
interest whilst allowing unexpected areas of discussion to arise.  
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Stimulus material (see appendix I) was used in the form of a short summary of the findings 
from the literature review, the background to the study along with the STEAM tool and 
descriptors of its performance in terms of sensitivity, specificity, positive and negative 
predictive values. This was given to all participants to stimulate views and to act as reference 
material during the discussion. 
Brief field notes were taken during the focus group and used by the researcher to ensure key 
points were covered and interesting points that arose were investigated without 
interrupting the flow of conversation. 
Digital audio recordings were made of the focus groups. The audio recordings were 
transcribed verbatim by the researcher and anonymised for the purpose of analysis. 
Thematic analysis was conducted using a five stage framework as described by Pope and 
Mays (Pope and Mays, 2006) (p72-74). This approach is described as suitable for applied 
research with predetermined topics and outcomes, in this case views about STEAM and its 
structure/content. The five stages of thematic analysis applied to the data are summarised 
below: 
 Familiarisation. Immersion in the data by transcription, reading and listening to 
recordings. 
 Identification of thematic framework. Key issues, themes and concepts identified. 
 Indexing. Coding of data. 
 Charting. Grouping of data according to themes. 
 Mapping and interpretation. Explanation of findings based on original question. 
In practice this involved repeatedly reading through the original transcripts and listening 
through the original recordings to ensure a good overview of the discussions was gained. 
After this the transcripts were examined line by line to identify any themes of interest. 
Themes were identified based on the a priori topics documented in the topic guide along 
with other issues that appeared relevant to the development of the STEAM tool. Once these 
initial themes were identified then they were combined and grouped based on similar 
content, issue or meaning. This involved a measure of interpretation and going back to the 
original transcripts to examine the context for some themes to ensure they were being 
interpreted and grouped appropriately. The charting and mapping stages involved testing for 
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patterns and overlap between data in various combinations and establishing whether there 
were links between identified themes, and groups of themes, in a way which reflected the 
original views of the participants. 
2.1.3.4 Approvals 
Approvals for all three phases of qualitative work were secured at the same time as this was 
considered one extended project running throughout the SM tool development study. 
Ethical approval for the qualitative phases of the study was gained from Newcastle 
University Faculty of Medical Sciences Ethics Committee (ref 01203/2016). Health Research 
Authority (HRA) approval was gained as this project included staff selected due to their 
positions in the NHS across multiple trusts (ref 207285). This project was adopted onto the 
National Institute for Health Research (NIHR) Clinical Research Network (CRN) portfolio (ref 
CPMS 32323). All approvals related to the qualitative work can be found in appendix J. 
2.1.4 Findings 
Focus group 1a (FG1a) was conducted at NHCT and lasted 31 minutes. There were nine 
participants comprising five stroke consultants; one ED consultant; two stroke nurse 
practitioners and one medical student. Focus group 1b (FG1b) was conducted at NEAS and 
lasted 57 minutes. There were three participants comprising three senior paramedics.  
The two focus groups were conducted on consecutive days. This meant that structured 
analysis of the first focus group was not completed prior to the second focus group. Topics 
raised during the first focus group were noted by the researcher and influenced the second 
focus group. 
Data from the two focus groups is presented in a combined fashion due to the common 
themes that emerged. Seven interconnected themes were identified which are displayed in 
figure 2.1.1. The themes are described in more detail below with illustrative anonymised 
quotes to enhance credibility. NHCT participants are indicated by N1-9 and FG1a. NEAS 
participants are indicated by P1-3 and FG1b. 
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Figure 2.1.1 Themes from phase 1 focus groups 
2.1.4.1 Actions based on STEAM 
Actions that could be triggered by STEAM were discussed within both focus groups. This key 
theme highlighted the importance of developing clear guidance for ambulance staff in 
response to the STEAM result:  
“So I suppose it’s what do you do with that patient when you’ve come to the end of 
this process, so you identify you think it’s a mimic, what are we going to do with that 
patient?” P1, FG1b 
This was closely linked to how STEAM would interact with the stroke identification tools, 
primarily FAST, currently used by the ambulance service: 
 “If you’re negative FAST would you do STEAM anyway?” P1, FG1b 
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There was discussion around what would be considered to be the most appropriate 
destination and who should make the stroke or SM decision. Current practice in most North 
East hospitals is for suspected stroke patients to be transported to specialist stroke services, 
whereas other conditions are primarily admitted via ED. The NEAS focus group could see the 
benefits from using STEAM to allow ambulances to deviate from this pathway for SM in 
terms of reduced journey times, reduced use of secondary ambulances for repatriation and 
an increased accuracy for initial diagnosis:  
“I think from a paramedic point of view it’s a good idea, I think it’s a good idea from 
the patients point of view because you know right care right treatment and they’re 
getting treated for something that potentially isn’t a stroke anyway so I think there’s 
an issue there but I think as we move more to centralised hyper acute strokes then 
we’re taking people significant distance further for potentially for something that 
they don’t need to be taken for and I think we’re missing therefore what is wrong 
with them” P1, FG1b 
The difference between paramedic and non-paramedic crews was discussed within the NEAS 
focus group. There was a general view that STEAM could be used by non-paramedic crews. 
This led on to a discussion about whether suspected stroke patients needed paramedic 
input, as ambulance services utilise a variety of staff with varying levels of clinical 
responsibility in order to provide all emergencies with rapid assessment. There is a move 
towards a more targeted approach in order to make more efficient use of limited or 
specialist resources for specific patient groups i.e. critical care teams with pre-hospital 
physicians are targeted at life threatening conditions where they can provide time critical 
interventions.  
This was a point of interest from a service provision perspective as ambulance clinicians 
currently deliver no treatment specifically for stroke. The primary function of the ambulance 
clinician is to identify the patient as a suspected stroke and transport them safely to the 
most appropriate receiving unit which is achievable by paramedics and non-paramedics. 
There were conflicting views about this shared role within the ambulance service focus 
group. One participant highlighted the enhanced assessment skills and greater underpinning 
knowledge of paramedics as well as the potential for patients to deteriorate and need 
paramedic interventions: 
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“I think one of the problems with strokes is that they’re often looked at as being low 
risk, but I’ve seen stroke patients deteriorate and arrest” P2, FG1b 
One key insight which came from the ambulance service focus group was that the idea of 
STEAM was unusual in pre-hospital care in that it is a ‘rule out’ as opposed to a ‘rule in’ tool. 
Pre-hospital care tends to be conservative and err on the side of caution, it is unusual to rule 
something out once it is initially suspected: 
“There may be some challenges because we’ve always worked on a ruling in system” 
P2, FG1b 
The hospital response to the introduction of STEAM was discussed at greater length in the 
hospital focus group. The discussion focussed upon the potential for STEAM to help prioritise 
resources and organise the appropriate response to a SM, which was supported by stroke 
services and ED staff:  
 “So then the question becomes prioritisation within the ED service itself” N1, FG1a 
It was also recognised that STEAM could be used by non-stroke service staff in hospital such 
as junior doctors or ED triage nurses: 
“I have to say from our junior point of view I would say anyone who comes in who is 
FAST positive it’s like oh my god it’s a stroke and sometimes there’s not really the 
thought process about what else” N4, FG1a 
There was a feeling that STEAM was more useful in the pre-hospital setting where it would 
be more likely to affect the actions taken. However, pre-hospital services need to 
communicate with hospital services using common terminology so actions based on STEAM 
need to be considered across services:  
“A conversation is a two person thing so the other person on the end of the 
conversation has to understand,” N4, FG1a 
2.1.4.2 Triggering and improving communication 
A SM tool has the potential to trigger or improve communications. This was discussed at 
greater length in the hospital focus group than the ambulance focus group. The potential to 
use STEAM to trigger a conversation between the ambulance crew on scene and the 
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receiving stroke team was considered a more acceptable use of STEAM than it being used to 
determine the patient’s destination without input from the receiving clinicians: 
“It just needs to be coupled with a discussion somewhere along the lines, isn’t it, 
especially in that situation where you’re going to potentially go somewhere 
different.” N4, FG1a 
The potential for STEAM to provide structured content within the information passed to the 
hospital via a pre-alert was discussed. Pre-alerts trigger a hospital response according to the 
information contained, whether this is a single message passed via ambulance control to the 
hospital or whether this is a direct clinician to clinician discussion: 
“It may have impact from an A&E point of view as stroke get pre-alerted, if you say 
I’m happy this is a stroke mimic that would maybe mean less pre-alerts” N4, FG1a 
A tool like STEAM would allow a direct conversation to be structured. A structured 
conversation encourages collection of the relevant data and eases the communication of 
information in a scenario where efficiency is beneficial. This would be an indirect benefit of 
introducing a tool like STEAM. 
2.1.4.3 Decision making process 
Decision making was a key theme that linked closely with the actions, risk and the 
differential diagnosis themes (see below). Decision making incorporates multiple facets such 
as how the SM decision is made, how decision making could be supported and who is 
responsible for the decision. Both focus groups were concerned by who should be making 
the decision about probable SM and considered whether stroke physician input was 
required.   
However, there was an argument put forward, primarily in the NEAS discussion, that STEAM 
could support and empower ambulance crew decision making, and that the best person to 
make the decision was the person face to face with the patient at the scene. The discussion 
about who should make the decision was very closely linked to who had responsibility for 
the patient:  
“Have a conversation with the stroke unit and get the stroke unit to make the 
decision” P1, FG1b 
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“But I think it would be difficult to put the responsibility of calling it a stroke mimic 
onto the paramedics if it then turns out to be something else” N2, FG1a 
The topic of support for making these decisions, both at the time and afterwards, if they 
proved to be mistaken was discussed: 
“It’s about making sure that that’s (acceptance of risk) communicated out to staff so 
that they feel supported and they don’t feel isolated in their decision making” P3, 
FG1b 
There was discussion within the hospital focus group about whether there should be some 
consideration of time since onset of symptoms and therefore potential eligibility for 
thrombolysis in the application and decision making based upon STEAM. 
“You have to consider thrombolysing them if they come in within the time limit” N2, 
FG1a 
There was recognition that time elapsed affects the way that stroke patients are treated and 
also that mechanical thrombectomy was on the horizon which may have a longer treatment 
window than thrombolysis although there will still be the need to get suspected stroke 
patients assessed as soon as possible. 
The decision making process for patients who are clearly unwell was discussed and the 
opinion within the NEAS focus group was that individual clinicians have to make the best 
decision for the patient at that time. The exclusion of patients with GCS<8 from STEAM 
removed one group of unwell patients, and if there were other reasons to be concerned 
about immediate risks then it is hoped that paramedics would always act in the best 
interests of the patient.  
FAST was discussed, particularly within the ambulance service focus group, and how this 
guides pre-hospital decision making. It was recognised that FAST is established in ambulance 
service practice, which is supported by the survey results in chapter 1.3, and has been for a 
number of years:  
“FAST is very ingrained into practice and is seen as being, you know, sacred” P2, FG1b 
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The introduction of any assessment which alters the decision making resulting from the 
FAST, which STEAM may do, is likely to be challenged or ignored, and deployment will have 
to overcome cultural hurdles: 
“You’re not going to change people’s perception of FAST are you, so, sorry P3, so 
you’re not going to then, the cultural bit’s really important as they’ve always done 
FAST.” P1, FG1b 
However, there was recognition that ambulance crews sometimes suspect a patient is a SM, 
but treat the patient as a stroke due to organisational protocols and a lack of other options:  
“I mean this may support people as well because it’s often that you will get FAST 
positive patients who you don’t think are having a stroke, but they are FAST positive 
and you’re using sort of clinical intuition that you don’t think it’s a stroke, you’ve 
taken that history but they’re still FAST positive and currently you are then going to 
treat them as a potential stroke patient when you don’t believe they are.” P2, FG1b 
STEAM would support the clinical intuition, assessment or experience of these paramedics 
and support their decision making with a recognised tool if introduced. 
2.1.4.4 Differential diagnoses for stroke mimics 
Both focus groups recognised that the patients in question were not going to be referred on 
to another care provider or left at home. These patients were going to be transported to 
hospital, but which hospital, which ward and with what level of urgency depends on the 
assessment and the initial diagnosis made by the ambulance crew. It was recognised that 
there are a number of differential diagnoses for these patients, including stroke, and that 
the underlying condition may not be immediately obvious.  
The ambulance service focus group strongly supported the idea of adding in some measure 
of blood sugars, as an indicator of a hypoglycaemic episode, into STEAM. The absence of this 
was also noted in the hospital focus group: 
 “Why’s blood glucose not in there?” N2, FG1a 
 “I’m surprised BM isn’t in there” P3, FG1b 
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BM is a common abbreviation used to refer to a blood sugar reading (Bannister, 2013). 
Measuring BM is part of the existing NEAS stroke pathway, and is included in most pre-
hospital stroke pathways. Low BM, hypoglycaemia, is a recognised SM that paramedics can 
identify and address, however it is not always completed in practice. 
Mental health issues are a common SM and there was discussion about whether STEAM 
could include some way of identifying this group of SM. It was recognised that these can be 
a difficult group to rapidly diagnose and that mental health assessment is something that 
ambulance crews may struggle with in the setting of a suspected acute stroke: 
“Our history taking about psychiatric and mental health conditions isn’t necessarily 
as strong as it is when we’re looking at physical health conditions” P3, FG1b 
One common item of discussion in both focus groups was the importance of taking a good 
history as this is the only way that factors indicative of a patient being a SM would be 
identified. The inclusion of items of past medical history in two of the STEAM criteria made 
this a very relevant issue: 
“It relies on them being fairly compos mentis or somebody else telling you the 
information” P2, FG1b 
2.1.4.5 Implementation across trusts 
How STEAM could be implemented was a theme that both focus groups touched on. There 
was concern from the ambulance focus group about the potential for hospital stroke 
services to want differing actions based upon the SM tool. Organisations could have 
different risk thresholds and this would need to be addressed. There was a strong feeling 
that a tool with consistent actions would be easier to implement. Ambulance crews are a 
mobile workforce and anything which requires a different response based on either time or 
geography would be more challenging to implement: 
“So if you’re doing a stroke patient in Gateshead at 11 o clock then a stroke patient in 
South Tyneside at 3 o clock I’d like you to be able to use the same tools and to do the 
same with the patient” P1, FG1b 
There was recognition that any SM tool would need to be integrated into existing pathways 
of care and that this would work best if done at a regional level. The importance of involving 
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regional networks in the introduction and implementation of a SM tool was recognised by 
both focus groups. UK ambulance services cover large regions and interact with multiple 
acute trusts, therefore regional introduction would be the only logical way to implement a 
tool like this.  
The ambulance focus group raised a concern about performance metrics and how the 
introduction of a SM tool would impact on ambulance stroke related, and more general, 
targets:  
“At the moment the national measure is for FAST positive patients taken to hospital 
within the 60 minutes, we would need to take something forward that recognised 
that FAST positive patients could be stroke mimics and therefore should be excluded 
from that group of patients when we are considering ultimately what happens to 
them, otherwise potentially as an ambulance service your performance could 
potentially be woefully inadequate” P3, FG1b 
2.1.4.6 Risk vs benefit for patients 
The potential risks associated with introduction of STEAM were discussed at length in both 
focus groups. The potential benefits of introducing STEAM were mentioned but did not 
receive the same level of discussion. Risk stratification was brought up by the ED 
representation and how STEAM could aid the ED by prioritising patients:  
“It’s part of risk stratification isn’t it, it doesn’t make the final decision for you” N4, 
FG1a 
There was concern over the potential for STEAM to mean stroke patients potentially eligible 
for thrombolysis would miss the opportunity and a strong desire from the stroke physicians 
to see patients within the treatment window. The risk of younger patients having access to 
specialist treatment delayed was particularly concerning:  
“They’re the ones that hit, because, you know, they’ve still got 60 years left of their 
life or 80 years left of their life because they’re really young” P1, FG1b 
The inclusion of age as a factor in STEAM was of concern to both focus groups as patients 
could be identified as SM based solely on age as opposed to any clinical characteristics or 
observations: 
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“I mean you wouldn’t want people who had a stroke who just happened to be 39 not 
to be offered thrombolysis because they were inevitably STEAM positive” N5, FG1a 
2.1.4.7 Further developing STEAM 
The hospital focus group largely accepted STEAM in its current form whereas the ambulance 
service focus group were more interested in the development process. The suggestion of 
including some measure of blood sugar, mentioned earlier, came from both focus groups. 
There was the suggestion from the ambulance service focus group of combining STEAM with 
FAST, or another stroke identification tool, to create a single stroke tool rather than having 
two separate tools. This was suggested to reduce confusion but went against the opinion 
that FAST was so well established that any change to FAST would need to be done at a 
national level. There was acknowledgement that it was beyond the scope of this work to 
reinvent FAST, and it was more flexible for clinical adoption to have a SM tool that could 
follow different stroke identification instruments. 
Using an electronic platform to facilitate STEAM use was discussed and was felt to be a good 
way to overcome some of the challenges identified:  
“Electronically you could do that, we could build this all in so you get FAST positive 
then you could come up with a box saying what’s the BP, have you checked the BM” 
P1, FG1b 
The implication was that a tool like STEAM could be automated so that when relevant 
observations were documented in the electronic record it would automatically recognise 
that STEAM either needed completing or had been triggered. This would remove the need to 
remember STEAM or check values against printed tables and would potentially improve 
documentation. 
2.1.5 Discussion 
This first phase of qualitative work reports the views of paramedics, stroke and ED clinicians 
regarding STEAM. A number of interrelated issues have been described that emerged from 
the discussions including what should be done with a STEAM positive patient, who makes 
this decision, the implications, and how STEAM could be developed and implemented. The 
focus groups provided useful insight into how STEAM would be received by clinicians and 
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how it could be developed further to enhance its acceptability and integration into existing 
assessment processes. 
Other studies describing the development of SM tools have not reported any qualitative 
input into the process (Merino et al., 2013; Ali et al., 2014; Goyal et al., 2016b). However, 
stakeholder input during the development process is valuable for creating a usable and 
useful tool (Barbour, 2008) (p8) as was demonstrated during the creation of the COMPASS 
tool for decision making in stroke thrombolysis (Flynn et al., 2015). 
The development and content of STEAM generated few expressions of concern, apart from 
the age criteria. Age has long been recognised as an important risk factor for stroke. Sacco 
stated “Age is the single most important risk factor for stroke.” (Sacco, 1997). Age has been 
used as a criterion in other SM tools and also as an exclusion from stroke identification tools, 
most notably the LAPSS which excluded patients under 45 years (Kidwell et al., 2000). 
Although the age criterion in STEAM has a similar odds ratio to the migraine criterion, is a 
strong predictor in the development data and is well documented as a differential factor in 
the literature, as shown in chapter 1.2, concerns were raised during both focus groups about 
missing a young presentation of stroke.  
Age is distinct from the other STEAM criteria as it doesn’t point towards another diagnosis, 
and purely reflects demographic risk. Young patients (defined as age<50 years) account for 
10% of ischaemic stroke patients with the incidence rate rising steeply above 40 years 
(Putaala, 2016). Younger stroke presentations are also diagnosed late due to atypical 
presentations, lack of classical risk factors and the influence of age upon the wider 
differential diagnoses (Kuruvilla et al., 2011). Although there is a lower probability of stroke, 
the more challenging diagnosis and discomfort for clinicians believing that they might be 
denying a younger stroke patient the opportunity for expedited care meant that the 
continued inclusion of age was given careful consideration.  
The inclusion of blood sugars is a prudent suggestion for improving STEAM as hypoglycaemia 
is a recognised SM commonly seen in pre-hospital care (Walker, 2011). Measuring blood 
sugar is part of national ambulance stroke guidelines (Association of Ambulance Chief 
Executives and Joint Royal Colleges Ambulance Liaison Committee, 2016) but is not explicitly 
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included in either the FAST or STEAM tool. If an algorithm including FAST and STEAM was 
strictly followed, then measuring blood sugar could be forgotten. 
The risk of applying STEAM in practice was covered by both focus groups. The focus was on 
the risk of a stroke being incorrectly classified as a SM and the potential to delay treatment 
i.e. thrombolysis. The risks to SM patients treated with thrombolysis has been documented, 
and although very low, should be avoided if possible (Winkler et al., 2009; Zinkstok et al., 
2013; Tsivgoulis et al., 2015).  
The lack of evidence, at this stage of the project, as to the potential benefits of identifying 
SM made it difficult to discuss the wider advantages from deployment. The potential 
benefits were commented on in terms of better risk stratification, improved 
communications and more targeted use of resources. The impact on resources was 
discussed by the hospital clinicians in terms of providing an appropriate response to an 
ambulance pre-alert and how many staff and what grade of staff to allocate to these calls. 
The impact on ambulance resources was more focussed around getting the right patient to 
the right hospital, similar to the model used for major trauma and heart attacks, and 
avoiding secondary transfers. Clarification of the potential impact of introducing a tool like 
STEAM will be explored in greater depth in chapter 3.2. 
The actions that could be linked to STEAM were discussed at length in both groups and 
connected with the other themes that emerged. Who should make the final decision that a 
suspected stroke is actually a SM was a point of disagreement between the groups. The 
most appropriate action that should be taken with a suspected SM was discussed at length 
and raised the possibility of having different actions linked to different triggering criteria. 
The action agreed upon by both focus groups was to use STEAM to trigger communication 
between pre-hospital and stroke services.  
Overall the focus groups provided valuable contextual insight that informed the further 
development of STEAM. The two groups expressed some similar views such as: support for 
the concept; benefits of communication; concern over age; and also some diverging views 
such as who should make the SM decision. Due to the lack of literature describing 
professional’s views on SM tools these insights provide essential guidance for developing 
STEAM and identify challenges that may be encountered if STEAM was to be implemented.  
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2.1.5.1 Strengths and limitations 
The focus group participants were all relevant professionals with an interest in stroke care. 
The results of the focus groups provided useful insight into STEAM content and 
development, suggestions to potentially improve the acceptability and performance of the 
tool and opinions about barriers and facilitators to its use in practice. The findings are 
limited by the fact that both groups work in the same region, although participants in both 
groups had knowledge of pathways and practices outside of this region. 
The small numbers attending the ambulance service focus group were disappointing 
although it was never the aim to describe views representing the breadth of the service. In 
focus groups there is the risk of strong personalities or characters dominating the discussion 
and leading others towards their viewpoint. The ambulance service participants all 
contributed equally towards the discussion and were well known to each other despite their 
different roles. The paramedics may have been biased towards supporting STEAM as they 
were all volunteers. The physicians dominated the hospital based focus group. Due to the 
number of physicians within the group there was still a useful discussion, with some input 
from the other healthcare professionals involved in emergency stroke patient assessment. 
2.1.6 Conclusions 
The views collected during the focus groups were valuable for considering how STEAM could 
be developed and deployed to enhance acceptability.  
This phase of qualitative data collection has resulted in a number of key points that were 
considered during the further development of STEAM. 
 Inclusion of BM. 
 The acceptability of an age criterion. 
 The actions that STEAM will trigger.  
2.1.7 Summary 
The qualitative information described in this chapter provides valuable insight to 
complement the additional clinical information reported in the next chapter, and the 
usability testing, which is reported in chapter 2.3. Collectively these three stages informed 
the revised STEAM tool that was developed.  
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Chapter 2.2 Refinement of the STEAM tool 
 
2.2.1 Introduction 
STEAM was developed using data from 1,650 suspected stroke patients transported by NEAS 
to a single hospital (NHCT). This chapter describes the impact of adding data from 2,147 
additional suspected stroke patients collected at another two hospital trusts. This created a 
larger dataset which was used to refine the STEAM tool. The refinement process was also 
informed by the findings from the focus groups reported in the previous chapter.  
2.2.2 Chapter aims and objectives 
The aim of this chapter is to describe the refinement of the STEAM tool. 
The objectives are to: 
 Describe a refinement dataset combining suspected stroke patients transported by 
NEAS to three acute trusts in the North East.  
 Refine STEAM using the dataset and the focus group findings from chapter 2.1 with 
the intention of developing a simple and specific tool. 
2.2.3 Background 
The basic method for developing a clinical prediction tool, based on Adams & Leveson 
(Adams and Leveson, 2012) and Moons et al (Moons et al., 2009b), was outlined in chapter 
1.1 and included four basic steps: 
1. Development of a tool that identifies the condition of interest. 
2. Validation that the tool performs as expected in a new population.  
3. Impact analysis of what difference the tool would make in practice. 
4. Implementation of the tool into regular healthcare. 
Step 1 was completed with the development of the STEAM tool. Instead of moving straight 
to validation work (step 2) extra data was first collected in the form of a refinement dataset 
which enabled STEAM to be improved before validation work was undertaken.  
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Refinement was undertaken for the following reasons: 
 Although a regional pre-hospital dataset had been created, STEAM was developed on 
data from a single hospital trust. The refinement process used data from three 
hospital trusts which reduces any biases introduced by the standards, processes or 
practices in a single trust. 
 To account for demographic or population differences due to hospital catchment 
areas.  
 To utilise the increased dataset to consider the predictive value of individual 
variables with greater power. 
 To increase the generalisability of the STEAM tool. 
The development of STEAM, reported in chapters 1.4 and 1.5, was completed before access 
to the diagnoses data used to create the refinement dataset was available. The staggered 
access to hospital diagnoses data allowed methods and processes to be tested and refined 
on a single trust (NHCT) before they were applied in additional settings.  
2.2.4 Methods 
The refinement dataset was created using the same methods as the development dataset 
described in chapter 1.4 which are summarised below: 
 Suspected stroke patients transported by NEAS were identified. 
 Data on variables relevant to stroke or SM diagnoses were collected from NEAS. 
 NEAS suspected stroke patients were linked with hospital SSNAP and HES records to 
establish discharge diagnoses. 
Following advice from statisticians within Newcastle University, STEAM was refined using an 
iterative process based on the development methods reported in chapter 1.5: 
 The performance of STEAM was tested using the refinement dataset. 
 Univariate analysis of variables in the refinement dataset in order to increase the 
precision of previously established predictive variables and see if any new predictive 
variables emerged. 
 Clinically logical combinations of variables were explored for meaningful predictors 
of SM diagnoses. 
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 STEAM was refined based upon clinician feedback (reported in chapter 2.1) and 
analyses of the refinement dataset. 
This process was undertaken to refine and improve the previously developed STEAM tool. 
Major alterations were only considered if there was significant variation in the predictive 
value of individual variables.   
2.2.4.1 Setting 
Data were collected from two additional acute hospital trusts in the North East.  
The first was Newcastle upon Tyne Hospitals NHS Foundation Trust (NUTH), which serves 
Newcastle upon Tyne. NUTH admitted 748 confirmed stroke patients in 2016/17. NUTH 
consistently performs well in the SSNAP audit in criteria relevant to this work, such as case 
ascertainment where it scored 90%+ from 2014 onwards (RCP, 2017b).  
The second was North Tees and Hartlepool NHS Foundation Trust (NTEES) which admits 
stroke patients in the south of the region covered by NEAS. NTEES provides care to around 
400,000 people living in Hartlepool, Stockton and County Durham. NTEES admitted 576 
confirmed stroke patients in 2016/17. NTEES consistently performs well in the SSNAP audit 
in criteria relevant to this work, such as case ascertainment where it scored 90%+ from 2014 
onwards (RCP, 2017b).  
2.2.4.2 Timeframe 
Data were collected over the same three year timeframe as the development cohort i.e. 
01/06/2013 to 31/05/2016. 
2.2.4.3 Data extraction, linkage and analysis 
Extraction, linkage and analysis of all data followed the same processes described in chapter 
1.4. All data were extracted into Excel and imported into SPSS for analysis. 
2.2.4.4 Approvals 
Local approvals were secured from all participating trusts for data sharing. 
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Figure 2.2.1 Map of the North East with NHCT (top), NUTH (middle) and NTEES (bottom) 
approximate catchment areas 
2.2.5 Results 
The 1,650 suspected stroke patients transported to NHCT have already been described in 
chapters 1.4 and 1.5.  
NEAS transported 1,000 suspected stroke patients to NUTH, including 38% SM. Full details of 
the NUTH cohort can be found in appendix K. 
NEAS transported 1,147 suspected stroke patients to NTEES, including 45% SM. Full details 
of the NTEES cohort can be found in appendix L. 
The refinement dataset therefore included 3,797 suspected stroke patients of which 2,240 
(59%) were stroke and 1,557 (41%) were SM. 
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2.2.5.1 Patient demographics 
The demographics of the suspected stroke cohorts are displayed in table 2.2.1. All patients 
had gender recorded. Twenty-six patients had no age documented but were included as 
they were recorded as adults.  
Table 2.2.1 Demographics of NEAS suspected stroke patients reported by discharge 
diagnosis 
  Suspected 
stroke 
Stroke SM P value 
NHCT 
(development 
cohort) 
Patients  1,650 989 661 - 
Mean age (SD) 75.3 (13.4) 77.0 (11.7) 72.8 (15.3) <0.001 
Gender (% 
male) 
47% 50% 41% <0.001 
NUTH Patients  1,000 618 382 - 
Mean age (SD) 73.5 (14.6) 75.3 (12.8) 70.8 (16.9) <0.001 
Gender (% 
male) 
48% 50% 46% 0.060 
NTEES Patients 1,147 633 514 - 
Mean age (SD) 71.3 (14.9) 73.8 (13.0) 68.1 (16.5) <0.001 
Gender (% 
male) 
49% 49% 49% 0.982 
Refinement 
dataset 
Patients 3,797 2,240 1,557 - 
Mean age (SD) 73.6 (14.3) 75.6 (12.4) 70.8 (16.2) <0.001 
Gender (% 
male) 
48% 50% 44% 0.001 
 
Stroke patients were significantly older (independent samples t-test, p<0.001) than SM 
patients across all trusts. SM were significantly more likely to be female in the development 
and refinement datasets (chi squared test) but not in the NUTH and NTEES individual 
hospital cohorts. 
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2.2.5.2 Source of diagnoses of suspected stroke patients 
The source of the diagnoses for the NEAS suspected stroke patients transported to the three 
hospitals in the refinement dataset are reported in table 2.2.2. 
Table 2.2.2 Source of diagnoses for suspected stroke patients in the refinement dataset 
 NHCT NUTH NTEES Total 
Suspected stroke 
patients 
1,650 1,000 1,147 3,797 
Stroke based on 
SSNAP 
839 (85%) 527 (85%) 547 (86%) 1,913 (85%) 
Stroke based on 
HES 
66 (7%) 52 (8%) 45 (7%) 163 (7%) 
TIA based on HES 84 (8%) 39 (6%) 41 (6%) 164 (7%) 
Total Stroke  
(inc TIA) 
989 618 633 2,240 
SM based on HES 526 (80%) 306 (80%) 158 (31%) 990 (64%) 
Assumed SM 135 (20%) 76 (20%) 356 (69%) 567 (36%) 
Total SM 661 382 514 1,557 
Note. Percentages refer to the percentage of the relevant diagnostic group (stroke or SM) 
for each hospital i.e. 85% of stroke diagnoses in NHCT were based on SSNAP. 
2.2.5.3 Assumed SM patients 
SM patients were identified by either confirmed non-stroke diagnosis (any ICD-10 code 
other than I61, I63, I64 or TIA codes G458 and 459) in hospital HES systems or assumed 
based upon an inability to match with either SSNAP or HES. The assumed diagnoses group 
are likely to reflect patients that were assessed and treated in ED but were not admitted. 
Patients with an assumed SM diagnosis are compared with patients with a confirmed SM 
diagnosis in table 2.2.3 below.  
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Table 2.2.3 Comparison of patients with confirmed SM diagnoses versus assumed SM 
diagnoses 
 Diagnoses Age (mean, 
SD) 
Gender (% 
Male) 
NHCT (n=661) Confirmed 
(n=526) 
74.0 (14.7) 41 
Assumed (n=135) 67.5 (17.4) 41 
NUTH (n=382) Confirmed 
(n=306) 
71.1 (16.2) 44 
Assumed (n=76) 68.5 (21.1) 41 
NTEES (n=514) Confirmed 
(n=158) 
68.0 (16.4) 49 
Assumed (n=356) 68.2 (16.6) 49 
Refinement dataset (n=1,557) Confirmed 
(n=990) 
72.2 (15.6) 43 
Assumed (n=567) 68.3 (17.0) 46 
 
The NHCT confirmed and assumed SM patients were significantly different in age 
(independent samples t-test, p=<0.001) but not gender (chi square test, p=0.977). 
The NUTH confirmed and assumed SM patients were not significantly different in age 
(independent samples t-test, p=0.323) or gender (chi square test, p=0.565). 
The NTEES confirmed and assumed SM patients were not significantly different in age 
(independent samples t-test, p=0.917) or gender (chi square test, p=0.965). 
SM patients in the refinement dataset with confirmed and assumed SM diagnoses were 
significantly different in age (independent samples t-test, p=<0.001) but not significantly 
different in gender (chi square test, p=0.302). 
2.2.5.4 SM diagnoses 
Two hundred and fifty-seven different ICD-10 diagnostic codes were recorded for the 990 
patients with a confirmed SM diagnosis. 
 151 
 
The ICD-10 based SM diagnoses are displayed in table 2.2.4. 
Table 2.2.4 Most frequent ICD-10 diagnoses recorded for combined SM patients 
ICD-10 
Code 
ICD-10 description 
Number (%) of 
patients 
N390 Urinary tract infection, site not specified 66 (7%) 
R55X Syncope and collapse 55 (6%) 
R568 Convulsions, not elsewhere classified 55 (6%) 
R298 
Other symptoms and signs involving the nervous and 
musculoskeletal systems 46 (5%) 
G409 Epilepsy, unspecified 33 (3% 
J181 Lobar pneumonia, unspecified organism 30 (3%) 
G510 Bell's palsy 25 (3%) 
G439 Migraine, unspecified 24 (2%) 
G819 Hemiplegia, unspecified affecting unspecified side 18 (2%) 
J22X Unspecified acute lower respiratory infection 18 (2%) 
F059 Delirium, unspecified 17 (2%) 
R478 Other speech disturbances 17 (2%) 
R296 Repeated falls 16 (2%) 
C793 
Secondary malignant neoplasm of brain and cerebral 
meninges 15 (2%) 
R51X Headache 15 (2%) 
I620 Nontraumatic subdural hemorrhage 13 (1%) 
R410 Disorientation, unspecified 13 (1%) 
R208 Other disturbances of skin sensation 11 (1%) 
I951 Orthostatic hypotension 10 (1%) 
J189 Pneumonia, unspecified organism 10 (1%) 
N179 Acute kidney failure, unspecified 10 (1%) 
Other Other conditions with less than 1% (n=10) prevalence 473 (48%) 
 
The ICD-10 codes were summarised using Clinical Classification Software (CCS) codes. The 
most frequent SM diagnoses represented using level 2 CCS codes are shown in table 2.2.5.  
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Table 2.2.5 Combined SM diagnoses displayed using level 2 CCS codes 
CCS level 2 code CCS description 
Number 
(%) of 
patients 
6.4 Epilepsy; convulsions 106 (11%) 
6.9 Other nervous system disorders 100 (10%) 
10.1 Diseases of the urinary system 79 (8%) 
13.8 Other connective tissue disease 78 (8%) 
17.1 Symptoms; signs; and ill-defined conditions 62 (6%) 
6.5 Headache; including migraine 59 (6%) 
8.1 Respiratory infections 46 (5%) 
7.3 Cerebrovascular disease 44 (4%) 
5.4 Delirium dementia and amnestic and other cognitive disorders 27 (3%) 
7.2 Diseases of the heart 27 (3%) 
7.4 Diseases of arteries; arterioles; and capillaries 22 (2%) 
6.3 Paralysis 20 (2%) 
8.8 Other lower respiratory disease 20 (2%) 
2.12 Secondary malignancies 16 (2%) 
2.11 Cancer; other primary 14 (1%) 
NR Not recorded 14 (1%) 
3.8 Fluid and electrolyte disorders 13 (1%) 
5.11 Alcohol-related disorders 13 (1%) 
1.1 Bacterial infection 12 (1%) 
2.3 Cancer of bronchus; lung 12 (1%) 
6.8 Ear conditions 11 (1%) 
2.14 Neoplasms of unspecified nature or uncertain behaviour 10 (1%) 
9.1 Intestinal infection 10 (1%) 
16.4 Intracranial injury 10 (1%) 
Other Other conditions with less than 1% (n=10) prevalence 165 (17%) 
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The CCS codes were combined into level 1 CCS codes to show broader clinical groupings as 
shown in table 2.2.6.   
Table 2.2.6 Combined SM diagnoses displayed using level 1 CCS codes 
CCS1 
code 
CCS code description 
Number (%) of 
patients 
1 Infectious and parasitic diseases 16 (2%) 
2 Neoplasms 68 (7%) 
3 
Endocrine; nutritional; and metabolic diseases and 
immunity disorders 29 (3%) 
4 Diseases of the blood and blood-forming organs 4 (<1%) 
5 Mental Illness 50 (5%) 
6 Diseases of the nervous system and sense organs 320 (32%) 
7 Diseases of the circulatory system 96 (10%) 
8 Diseases of the respiratory system 83 (8%) 
9 Diseases of the digestive system 24 (2%) 
10 Diseases of the genitourinary system 79 (8%) 
11 Complications of pregnancy; childbirth; and the puerperium 1 (<1%) 
12 Diseases of the skin and subcutaneous tissue 6 (1%) 
13 
Diseases of the musculoskeletal system and connective 
tissue 89 (9%) 
16 Injury and poisoning 46 (5%) 
17 
Symptoms; signs; and ill-defined conditions and factors 
influencing health status 65 (7%) 
18 Residual codes; unclassified; all E codes 14 (1%) 
 
The combined SM diagnoses are graphically displayed in figure 2.2.2 with figure 1.2.3 from 
the systematic review repeated below for comparison. 
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Figure 2.2.2 Combined SM diagnoses summarised using CCS codes 
 
Figure 1.2.3 Taxonomy of SM using CCS codes (repeated from chapter 1.2) 
2.2.5.5 Comparison of SM diagnoses across hospital trusts 
The percentage of each level 1 CCS SM diagnoses are displayed by individual hospital trust 
included in the refinement dataset below. 
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Table 2.2.7 Contributing trusts SM diagnoses % displayed using level 1 CCS codes 
CCS1 
code 
CCS code description NHCT NUTH NTEES 
1 Infectious and parasitic diseases 2% 1% 2% 
2 Neoplasms 6% 10% 3% 
3 Endocrine; nutritional; and metabolic diseases and 
immunity disorders 
3% 3% 1% 
4 Diseases of the blood and blood-forming organs 0% 0% 1% 
5 Mental Illness 5% 6% 4% 
6 Diseases of the nervous system and sense organs 31% 29% 41% 
7 Diseases of the circulatory system 9% 11% 8% 
8 Diseases of the respiratory system 9% 8% 8% 
9 Diseases of the digestive system 2% 3% 3% 
10 Diseases of the genitourinary system 9% 6% 8% 
11 Complications of pregnancy; childbirth; and the 
puerperium 
0% 0% 0% 
12 Diseases of the skin and subcutaneous tissue 1% 0% 1% 
13 Diseases of the musculoskeletal system and 
connective tissue 
8% 9% 11% 
16 Injury and poisoning 5% 6% 2% 
17 Symptoms; signs; and ill-defined conditions and 
factors influencing health status 
7% 6% 8% 
18 Residual codes; unclassified; all E codes 1% 3% 0% 
 
2.2.5.6 Physiological observations 
The physiological observations recorded from suspected stroke patients in the refinement 
dataset are displayed in table 2.2.8 below.  
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Table 2.2.8 Physiological observations in NEAS data on suspected stroke patients in the 
refinement dataset reported by discharge diagnosis 
Physiological  
observations 
n (%) of 
patients with 
observation 
documented 
Stroke  
(mean, SD) 
SM (mean, SD) P value 
(stroke vs 
SM) 
BM (mmol/l) 3,639 (96) 7.6 (2.8) 7.4 (2.7) 0.032 
GCS 3,797 (100) 14 (1.9) 14 (1.9) 0.878 
Heart rate 3,791 (99) 82 (18.7) 84 (19.3) 0.003 
Irregular pulse 3,690 (97) 25% 17% <0.001 
Pain (0-10) 2,452 (65) 0.3 (1.1) 0.6 (1.7) <0.001 
SaO2 3,770 (99) 96 (2.6) 96 (3.2) 0.191 
Respiratory rate 3,793 (99) 17 (3.0) 17 (3.0) 0.142 
SBP (mmHg) 3,772 (99) 161 (28.6)  154 (29.0) <0.001 
DBP (mmHg) 3,763 (99) 89 (17.3) 87 (18.5) 0.015 
Temperature (Celsius) 3,300 (87) 36.5 (0.7) 36.6 (0.9) <0.001 
 
2.2.5.7 Past medical history 
The PMH of suspected stroke patients in the refinement dataset are shown in table 2.2.9 
below. 
Table 2.2.9 Past medical history of suspected stroke patients in the refinement dataset 
reported by discharge diagnosis 
 n (%) of total 
patients with 
condition  
Stroke (% of 
stroke 
patients with 
condition) 
SM (% of SM 
patients with 
condition) 
P value 
(stroke vs 
SM) 
PMH Alcohol 
misuse 
61 (2) 25 (1) 36 (2) 0.004 
PMH Angina 322 (9) 191 (9) 131 (8) 0.902 
PMH Diabetes 615 (16) 384 (17) 231 (15) 0.058 
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Table 2.2.9 Past medical history of suspected stroke patients in the refinement dataset 
reported by discharge diagnosis 
 n (%) of total 
patients with 
condition  
Stroke (% of 
stroke 
patients with 
condition) 
SM (% of SM 
patients with 
condition) 
P value 
(stroke vs 
SM) 
PMH Epilepsy 157 (4) 56 (3) 101 (6) <0.001 
PMH Heart failure 97 (3) 72 (3) 25 (2) 0.002 
PMH High 
cholesterol 
614 (16) 372 (17) 242 (16) 0.381 
PMH Hypertension 1172 (31) 757 (34) 415 (27) <0.001 
PMH MI 348 (9) 217 (10) 131 (8) 0.181 
PMH Migraine 51 (1) 17(1) 34 (2) <0.001 
PMH Smoking 78 (2) 48 (2) 30 (2) 0.644 
PMH Stroke 937 (25) 468 (21) 469 (30) <0.001 
PMH TIA 596 (16) 325 (15) 271 (17) 0.016 
 
2.2.5.8 Clinical signs and symptoms 
The signs and symptoms recorded by the paramedics are displayed below. 
Table 2.2.10 NEAS observations on suspected stroke patients in the refinement dataset 
reported by discharge diagnosis 
  
n (%) of total 
patients with 
condition 
Stroke (% of 
stroke 
patients with 
condition) 
SM (% of SM 
patients with 
condition) 
P value 
(stroke vs 
SM) 
Abnormal gait 355 (9) 238 (11) 117 (8) 0.001 
AF 362 (10) 258 (12) 104 (7) <0.001 
Alcohol/Drug use 
reported 
100 (3) 41 (2) 59 (4) <0.001 
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Table 2.2.10 NEAS observations on suspected stroke patients in the refinement dataset 
reported by discharge diagnosis 
 
n (%) of total 
patients with 
condition 
Stroke (% of 
stroke 
patients with 
condition) 
SM (% of SM 
patients with 
condition) 
P value 
(stroke vs 
SM) 
Altered Sensation 
(FT)* 
332 (9) 171 (8) 161 (10) 0.004 
Arm weakness* 2472 (65) 1637 (73) 835 (54) <0.001 
Chest pain 44 (1) 17 (1) 27 (2) 0.006 
Confusion 1109 (29) 613 (27) 496 (32) 0.003 
Dizziness 303 (8) 161 (7) 142 (9) 0.031 
Eye issues (FT)* 205 (5) 145 (7) 60 (4) <0.001 
Facial droop or 
weakness 
2139 (56) 1383 (62) 756 (49) <0.001 
FAST +ve* 1958 (52) 1242 (55) 716 (46) <0.001 
Floppy 200 (5) 125 (6) 75 (5) 0.3 
General weakness 858 (23) 457 (20) 401 (26) <0.001 
Headache 826 (22) 420 (19) 406 (26) <0.001 
Leg weakness* 1772 (47) 1223 (55) 549 (35) <0.001 
Nausea or 
vomiting* 
398 (11) 199 (9) 199 (13) <0.001 
Neck Stiffness 61 (2) 29 (1) 32 (2) 0.067 
Seizures 125 (3) 29 (1) 96 (6) <0.001 
Speech symptoms 2607 (69) 1653 (74) 954 (61) <0.001 
Syncope 33 (1) 12 (1) 21 (1) 0.008 
Tremors 102 (3) 45 (2) 57 (4) 0.002 
Unconscious 167 (4) 63 (3) 104 (7) <0.001 
Visual 
disturbances* 
311 (8) 163 (7) 148 (10) 0.014 
*The same criteria for these characteristics were used as described in chapter 1.4 
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2.2.5.9 Paramedic documentation of clinical impression 
“Paramedic impression” was examined to see if it related to discharge diagnosis. Impression 
was grouped into three distinct categories: 
1. Stroke only = stroke as only suspected diagnosis. 
2. Stroke and TIA = stroke and TIA documented as only diagnoses. 
3. Stroke plus other = stroke included amongst multiple differential diagnoses. 
These three categories of impression were then compared with hospital discharge 
diagnoses. 
Table 2.2.11 Paramedic impression and discharge diagnoses in the refinement dataset 
Impression Total patients Stroke  SM 
Stroke only 2,910 1,871 (64%) 1,039 (36%) 
Stroke and TIA 299 166 (56%) 133 (44%) 
Stroke plus other 588 203 (35%) 385 (65%) 
 
The “stroke plus other” impression category included stroke plus a median of 1 additional 
impression (range 1-7, IQR 1-2) out of 40 different conditions for stroke patients and 50 for 
SM.  
2.2.5.10 STEAM results in datasets 
The results of applying STEAM to the NHCT (development), NUTH, NTEES and refinement 
datasets are shown below.  
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Table 2.2.12 Suspected stroke patients displayed by number of STEAM characteristics 
Trust Number of 
positive STEAM 
characteristics 
Stroke SM Total patients 
NHCT 0 975 585 1560 
1 13 72 85 
2 1 4 5 
NUTH 0 606 337 943 
1 12 43 55 
2 0 2 2 
NTEES 0 620 463 1083 
1 13 51 64 
Note: STEAM positive rows are shaded. 
The results of applying STEAM to the combined refinement dataset are shown in table 
2.2.13. STEAM identified 172 SM patients and 39 stroke patients.  
Table 2.2.13 STEAM output when applied to refinement dataset 
STEAM score Stroke SM Total patients 
0 2,201 1,385 3,586 
1 38 166 204 
2 1 6 7 
Note: STEAM positive rows are shaded. 
2.2.5.11 Characteristics triggering STEAM  
The STEAM characteristics recorded as present are shown in table 2.2.14. 
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Table 2.2.14 Characteristics triggering STEAM  
Characteristic NHCT 
Development 
(n=90) 
NUTH (n=57) NTEES (n=64) Total Refinement 
(n=211) 
 Stroke SM Stroke SM Stroke SM Stroke SM 
SBP<95mmHg 3 12 3 5 3 1 9 18 
Temperature 
+ HR 
2 18 4 8 1 8 7 34 
Seizures + 
PMH Epilepsy 
1 15 0 8 1 9 2 32 
Age<40 5 23 3 21 6 26 14 70 
Headache + 
PMH 
Migraine 
4 12 2 5 2 7 8 24 
Totals* 14 76 12 45 13 51 39 172 
*Note: totals represent total number of patients and do not match the column totals as 
some patients triggered multiple characteristics. 
2.2.5.12 STEAM performance in datasets 
The performance characteristics of STEAM when applied to the NUTH, NTEES and 
refinement datasets using STEAM≥1 to indicate SM are shown in table 2.2.15 compared with 
STEAM performance in the development dataset. 
Table 2.2.15 STEAM performance in NUTH, NTEES and refinement datasets compared 
with development (NHCT) dataset 
 NHCT NUTH NTEES Refinement 
 Development 
dataset 
Performance Change Performance Change Performance Change 
Sensitivity 
(95% CI) 
11.5%  
(9.2-14.2) 
12.2%  
(9.1-15.9) 
+0.7% 9.9%  
(7.5-12.8) 
-1.6% 11.1%  
(9.5-12.7) 
-0.4% 
Specificity 
(95% CI) 
98.6%  
(97.6-99.2) 
98.1%  
(96.6-99.0) 
-0.5% 98.0%  
(96.5-98.9) 
-0.6% 98.3%  
(97.6-98.8) 
-0.3% 
PPV  
(95% CI) 
84.4  
(75.6-90.5) 
79.7%  
(67.8-87.9) 
-4.7% 79.7%  
(68.3-87.7) 
-4.7% 81.5%  
(75.8-86.1) 
-2.9% 
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STEAM performed in a consistent manner in terms of sensitivity and specificity in the 
refinement dataset. However, the PPV of STEAM went down from 84.4% to 81.5%. This 
reduction in accuracy, and the availability of the extra data in the refinement dataset, led to 
the components of STEAM being revised in order to improve the predictive performance of 
the tool. 
2.2.6 Refinement of the STEAM tool 
It was not surprising that the larger refinement cohort, combining multiple services and 
populations, resulted in a different predictive performance by STEAM. Further examination 
of characteristics associated with SM diagnosis was performed in order to consider whether 
STEAM could be improved. The methods of data analysis were based on those described in 
chapter 1.5 but the refinement process started with the existing STEAM tool which will be 
referred to as STEAMv1 from this point. 
2.2.6.1 Univariate analysis 
Individual variables in the refinement dataset were analysed. ROC analysis was applied to 
the continuous variables that were significant (p<0.05) in univariate analysis to calculate 
optimum cut-off values. DBP was excluded due to its close relationship with SBP. 
Table 2.2.16 ROC analysis of continuous variables in refinement dataset 
Variable Cut-off P value Sensitivity Specificity 
Age <40 <0.001 0.05 0.99 
BM <3.2 0.010 0.00 1 
Heart rate <37 0.002 0.00 1 
Pain >3 0.002 0.09 0.97 
SBP <92 <0.001 0.01 1 
Temperature <29.8 <0.001 0.00 1 
 
All the variables analysed using ROC were significant which may be due to the increased 
amount of data in the refinement dataset. The following decisions were made about 
including the following variables in the refinement process: 
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 Age, pain and SBP did not interact with each other and were included. 
 Low heart rate and low temperature were excluded as these extreme values only 
identified a single patient each. 
 The inclusion of BM within the refinement process, based upon feedback from the 
focus groups reported in chapter 2.1, triggered extensive discussions within the 
supervisory team. As BM testing exists as a discrete point of care test in most 
ambulance service clinical pathways, this was made an inclusion criteria for STEAM 
application. This is discussed further in the STEAMv2 refinement section later in this 
chapter. 
The cut-off values calculated in the ROC analysis were used to dichotomise the continuous 
variables and calculate OR. The OR for the included variables are shown in table 2.2.17. As 
the outcome of interest was SM diagnosis an OR>1 was associated with SM diagnosis and 
OR<1 was associated with stroke diagnosis.   
Table 2.2.17 Odds ratios of predictor variables for SM diagnosis in refinement dataset 
  Odds ratio Lower 95% CI Upper 95% CI 
Age<40 7.5 4.2 13.3 
Gender (female) 1.3 1.1 1.4 
Physiological observation    
Pain>3 2.8 1.9 4.0 
Irregular pulse 0.6 0.5 0.7 
SBP<92mmHg 4.1 1.5 11.4 
Past Medical History     
Alcohol misuse 2.1 1.3 3.5 
Angina 1.0 0.8 1.2 
Diabetes 0.8 0.7 1.0 
Epilepsy 2.7 1.9 3.8 
Heart failure 0.5 0.3 0.8 
High cholesterol 0.9 0.8 1.1 
Hypertension 0.7 0.6 0.8 
MI 0.9 0.7 1.1 
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Table 2.2.17 Odds ratios of predictor variables for SM diagnosis in refinement dataset cont. 
 Odds ratio Lower 95% CI Upper 95% CI 
Migraine 2.9 1.6 5.2 
Smoking 0.9 0.6 1.4 
Stroke 1.6 1.4 1.9 
TIA 1.2 1.0 1.5 
Signs and symptoms    
Abnormal gait 0.7 0.5 0.9 
AF  0.6 0.4 0.7 
Alcohol/Drug use reported 2.1 1.4 3.2 
Altered Sensation 1.4 1.1 1.7 
Arm weakness 0.4 0.4 0.5 
Chest pain 2.3 1.3 4.2 
Confusion 1.2 1.1 1.4 
Dizziness 1.3 1.0 1.6 
Eye issues 0.6 0.4 0.8 
Facial droop or weakness 0.6 0.5 0.7 
FAST+ve 0.7 0.6 0.8 
Floppy 0.9 0.6 1.1 
General weakness 1.4 1.2 1.6 
Headache 1.5 1.3 1.8 
Leg weakness 0.5 0.4 0.5 
Nausea or vomiting 1.5 1.2 1.9 
Neck Stiffness 1.6 1.0 2.7 
Seizures 5.0 3.3 7.6 
Speech symptoms 0.6 0.5 0.6 
Syncope 2.5 1.2 5.2 
Tremors 1.9 1.2 2.8 
True FAST-ve 2.0 1.6 2.6 
Unconscious 2.5 1.8 3.4 
Visual disturbances 1.3 1.1 1.7 
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The characteristics with the strongest association with SM diagnoses based on the OR were: 
age<40 (OR 7.5, 95% CI 4.2-13.3); seizures (OR 5.0. 95% CI 3.3-7.6); SBP<92mmHg (OR 4.1, 
95% CI 1.5-11.4); and migraine (OR 2.9, 95% CI 1.6-52). The characteristics with the strongest 
association with stroke diagnoses based on the OR were: arm weakness (OR 0.4, 95% CI 0.4-
0.5); leg weakness (OR 0.5, 95% CI 0.4-0.5); and a PMH heart failure (OR 0.5, 95% CI 0.3-0.8).  
2.2.7 STEAM refinement version 1.1 
The univariate analysis showed that four of the STEAMv1 criteria were still the strongest 
individual predictors of SM diagnoses based on OR. To maximise predictive value, these 
were further examined in the refinement dataset. 
2.2.7.1 Systolic blood pressure 
The magnitude of the association between SBP<95mmHg and SM diagnosis fell from an OR 
of 6.7 in the development dataset to 2.9 in the refinement dataset. The NTEES cohort was 
unusual as SBP<95mmHg was more strongly associated with stroke than SM. Analysis of SBP 
in the refinement dataset indicated that a lower value of 92mmHg was the optimum 
threshold for classification of stroke versus SM. Applying the principle of “simple and 
specific”, a value of 90mmHg was considered instead of 92mmHg. This would be easier to 
remember as it features in other areas of pre-hospital practice such as trauma and fluids 
administration. The threshold of 90mmHg was compared with the previous STEAM 
development value of 95mmHg, and 85mmHg as an equivalent difference below 90mmHg:  
Table 2.2.18 SBP characteristics comparison in the refinement dataset 
 Stroke patients SM patients OR 
SBP<95mmHg 9 18 2.9 
SBP<90mmHg 4 11 4.0 
SBP<85mmHg 3 7 3.4 
 
For clinical convenience and based on the OR shown in table 2.2.18, SBP<90mmHg was 
included in STEAMv1.1. 
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2.2.7.2 Temperature and heart rate 
Raised temperature and heart rate were included in STEAMv1 as indicators of infection and 
sepsis as the potential underlying SM aetiology. In the refinement dataset both of these 
variables were individually significant in the univariate analysis so the combination of 
temperature and heart rate was re-examined in the refinement dataset. 
In the development dataset temperature and heart rate had a combined OR of 14.3 but in 
the refinement dataset this fell to 7.2. The patients that were STEAM positive based upon 
raised heart rate and temperature were examined and it was observed that a large 
proportion of the STEAM false positives were due to temperature values close to 38.0oC. 
Raising the temperature criteria to 38.5oC identified 22 suspected stroke patients including 3 
stroke and 19 SM patients. This improved the predictive power of this combination of 
characteristics to an OR of 9.2. 
Based on this data and support for identifying patients with suspected sepsis expressed in 
the focus groups, the combination of raised temperature and heart rate was included in 
STEAMv1.1 with the heart rate maintained at 90 and the temperature increased to 38.5oC. 
2.2.7.3 Epilepsy and seizures 
Seizures and PMH epilepsy were each significantly associated with SM diagnoses in the 
univariate analysis and strong predictors based upon OR (seizures OR 5.0, PMH epilepsy OR 
2.7). As a combination this pair was a strong predictor of SM diagnoses in the refinement 
dataset (OR 23.5) and generated the lowest rate of false positives amongst the original 
STEAMv1 criteria. Based upon this PMH epilepsy and seizures were included in STEAMv1.1 
without alteration. 
2.2.7.4 Age 
The use of an age criterion in STEAM was challenged during the focus groups, particularly 
during the hospital focus group. However, in the refinement dataset age<40 was still 
strongly predictive of SM diagnoses with an OR of 7.5 and it identified nearly half of the SM 
that triggered STEAM. Based on this performance, age was included in STEAMv1.1 but with 
the intention to re-consider in the next iteration as described below.  
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2.2.7.5 Migraine and headache 
Headache and PMH migraine were each significantly associated with SM diagnoses in the 
univariate analysis and strong predictors based upon OR (headache OR 1.5, PMH migraine 
OR 3.2). As this combination was still a strong predictor of SM diagnoses in the refinement 
dataset (OR 4.4) and generated a low rate of false positives, it was included unchanged in 
STEAMv1.1. 
2.2.7.6 STEAMv1.1 
The first refinement of STEAM changed the SBP and temperature values. The STEAMv1.1 
criteria and performance characteristics are summarised below. 
Table 2.2.19 STEAMv1.1 criteria and discharge diagnoses 
Criteria Stroke SM OR 
SBP<90mmHg 4 11 4.0 
Temperature>38.5oC AND heart rate>90 3 19 9.2 
Seizures + PMH Epilepsy 2 32 23.5 
Age<40 14 70 7.5 
Headache + PMH Migraine 8 24 4.4 
 
Table 2.2.20 STEAMv1.1 output when applied to refinement dataset 
STEAMv1.1 score Total patients Stroke SM 
0 3616 2210 1406 
1 175 29 146 
2 6 1 5 
Note: STEAM positive rows are shaded. 
A STEAMv1.1 score≥1 identified 181 suspected stroke patients including 30 (17%) stroke 
patients and 151 (83%) SM patients, representing a 9.7% (95% CI 8.3-11.3%) sensitivity, 
98.7% (95% CI 98.1-99.1) specificity and 83.4% (95% CI 77.4-88.1%) PPV. 
2.2.8 STEAM refinement version 1.2 
When applied to the combined dataset, STEAMv1.1 had lower sensitivity than STEAMv1 with 
little gain in specificity or PPV. However, the increased dataset now allowed consideration of 
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score weighting within specific STEAM characteristics. In order to enhance the specificity and 
PPV, differential scoring within two characteristics of STEAMv1.1 were considered: age and 
seizures with PMH epilepsy. 
In STEAMv1 and STEAMv1.1 the age criterion generated the largest numbers of stroke and 
SM patients, but the implications for clinical decision making were questioned in the focus 
groups (chapter 2.1). Examples of young stroke patients were presented, and clinicians 
reported feeling uncomfortable with the idea of a patient being classified as a SM based 
solely on age.  
It was apparent that seizures and PMH epilepsy in combination were the strongest predictor 
by a substantial margin. However other SM tools (described in chapter 1.1) included seizures 
or history of seizures as individual predictors. 
Considering these two criteria, and comments in the focus group likening STEAMv1 to other 
scores with factor weighting, age and seizures with PMH epilepsy were explored to see if 
STEAM operational performance could be improved and at the same time address the 
concerns around the inclusion of age as a binary indicator of SM prediction.  
Age<40 years generated high numbers of STEAM+ve patients but also a high proportion of 
the overall false positives. Chart 2.2.1 displays the number of cumulative stroke and SM 
patients identified using each age value below 40. 
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Based on considering this, age as a predictive factor was split into two easy to remember 
groups reflecting the increasing number of stroke patients from age 30 upwards: age<30 
years and age 30-39 years. Age<30 years included 30 suspected stroke patients of which 29 
(97%) were SM. Age 30-39 years included 54 suspected stroke patients of which 41 (76%) 
were SM. With these two groupings identified the age criterion was split so suspected stroke 
patients received 1 point for age<30 and 1 point for age<40, in effect the patient receives 2 
points for age<30 as it triggers both criteria. Therefore a suspected stroke patient aged 28 
would receive 2 points whereas a suspected stroke patient aged 35 would only receive 1 
point, thus giving greater weight to younger age. 
Individually, seizures and PMH epilepsy were each predictive of SM diagnoses (seizures OR 
5.0, PMH epilepsy OR 2.7) but the OR for seizures was approximately twice that of PMH 
epilepsy. Therefore, suspected stroke patients were given 1 point for seizures and 1 point for 
seizures and PMH epilepsy. This meant that a patient with seizures and PMH epilepsy would 
receive 2 points. 
2.2.8.1 STEAMv1.2 
As a result of the analysis and refinement process described above, STEAMv1.2 was created 
with criteria and predictive performance characteristics summarised below. 
Table 2.2.21 STEAMv1.2 criteria and discharge diagnoses 
Criteria Stroke SM OR 
SBP<90mmHg 4 11 4.0 
Temperature>38.5oC + heart rate>90 3 19 9.2 
Seizures 29 96 5.0 
Seizures + PMH Epilepsy 2 32 23.5 
Age<30 1 29 42.5 
Age<40 14 70 7.5 
Headache + PMH Migraine 8 24 4.4 
 
For example, a 35 year old suspected stroke patient who presented with a seizure and had a 
known history of epilepsy would score 3 points (age<40, seizures, seizures + PMH epilepsy). 
A 28 year old suspected stroke patient with SBP of 85, heart rate 120 and temperature of 
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39.1oC would score 4 points (age<30, age<40, SBP<90mmHg, temperature>38.5 + heart 
rate>90). 
Table 2.2.22 STEAMv1.2 output when applied to refinement dataset 
STEAM score Total patients Stroke SM 
0 3528 2183 1345 
1 201 53 148 
2 63 4 59 
3 5 0 5 
Note: STEAM positive rows are shaded. 
A STEAMv1.2 score≥1 identified 269 suspected stroke patients including 57 (21%) stroke 
patients and 212 (79%) SM patients, resulting in 13.6% (95% CI 12.0-15.4%) sensitivity, 
97.5% (95% CI 96.7-98.1) specificity and 78.8% (95% CI 73.7-83.2%) PPV. 
2.2.9 STEAM refinement version 1.3 
It was apparent that STEAMv1.2 had increased the sensitivity of STEAMv1 and STEAMv1.1 
but with corresponding losses in both specificity and PPV. Sensitivity and specificity normally 
have an inverse relationship. In this case the performance losses were largely due to the 
patients scoring 1 on STEAMv1.2. Examining the performance of STEAMv1.2 and the 
distribution of patients scoring 1-3, the potential to improve the specificity by increasing the 
predictive threshold from 1 to 2 points was considered. 
Raising the threshold needed for STEAM positive status to 2 points identified 68 suspected 
stroke patients including 4 (6%) stroke patients and 64 (94%) SM patients. Therefore 
STEAMv1.3 (same criteria as STEAMv1.2 but now requiring 2 points) showed 4.1% (95% CI 
3.2-5.2%) sensitivity, 99.8% (95% CI 99.5-99.9%) specificity and 94.1% (95% CI 85.4-97.8%) 
PPV.  
As STEAMv1.3 had good specificity and PPV, but reduced sensitivity, patients that scored 1 
point on STEAMv1.2 were examined for any characteristics which could be added to the tool 
in order to increase the recognition of SM.  
Patients who scored 1 point on STEAMv1.2 (n=201) included a high proportion who scored 
points from seizures (n=88, 27 stroke and 61 SM) and age<40 (n=48, 12 stroke and 36 SM). 
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These two subgroups also accounted for the majority of the false positives (true strokes) 
that triggered STEAMv1.2 (n=39, 77%). These cases were examined for characteristics which 
differentiated the stroke and SM populations. It was apparent that the absence of common 
stroke symptoms (FAST and leg weakness), was associated with SM diagnoses. The absence 
of FAST characteristics, and leg weakness, in STEAMv1.2 positive patients who scored 1 point 
is shown in table 2.2.23. 
Table 2.2.23 Absence of FAST characteristics in patients scoring 1 on STEAMv1.2 
 Age<40 years (n=48) Seizures (n=88) 
Absent symptom Stroke (%) SM (%) Stroke (%) SM (%) 
Face 7 (58%) 21 (58%) 8 (30%) 34 (56%) 
Arms 1 (8%) 11 (31%) 8 (30%) 29 (48%) 
Speech 2 (17%) 18 (50%) 13 (48%) 36 (59%) 
Legs 1 (8%) 20 (56%) 10 (37%) 38 (62%) 
 
Patients without any limb weakness were the group with the fewest false positives and the 
highest number of SM patients. Leg weakness was closely associated with arm weakness in 
this group of patients. The 87 patients with arm weakness included 97% of the patients with 
leg weakness. 
If the absence of arm and leg weakness was combined into a new “absence of limb 
weakness” characteristic to predict SM, then amongst patients who scored 1 point on 
STEAMv1.2 for either age<40 or seizures this new variable identified 47 suspected stroke 
patients including 7 (15%) stroke patients and 40 (85%) SM patients. 
If this new variable was added into STEAMv1.3 then it produced a more complicated 
algorithm which is shown below in figure 2.2.3. 
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Figure 2.2.3 STEAMv1.3 with added absence of limb weakness characteristic 
This version of STEAMv1.3 identified 115 suspected stroke patients including 11 (10%) stroke 
patients and 104 (90%) SM patients. “STEAMv1.3 + limbs” had 6.7% (95% CI 5.5-8.0%) 
sensitivity, 99.5% (95% CI 99.1-99.8%) specificity and 90.4% (95% CI 83.6-94.6%) PPV. 
Although the performance of STEAMv1.3 + limbs achieved good specificity and PPV it was 
becoming a more complex process which went against the aim of maintaining simplicity and 
it was also blurring the intention between stroke and SM identification.  
However, limb weakness was based on exploration of the absence of FAST symptoms, and 
most leg weakness was associated with arm weakness. This led to consideration of 
incorporating FAST-ve status (reported earlier as True FAST-ve) as a predictor to add into the 
STEAM refinement process. 
FAST-ve (either documented FAST-ve or the absence of any positive FAST symptoms) was a 
moderate predictor of SM diagnosis in the univariate analysis (OR 2.0). To assist in the 
identification of SM amongst the subgroup only scoring 1 point on STEAM, but with little 
positive evidence of stroke symptoms to start with, FAST-ve was added in to STEAMv1.3 as 
an independent sixth predictor variable scoring 1 point.  
The “STEAMv1.3 + FAST-ve” criteria and performance characteristics are summarised below. 
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Table 2.2.24 STEAMv1.3 + FAST-ve criteria and discharge diagnoses 
Criteria Stroke SM OR 
SBP<90mmHg 4 11 4.0 
Temperature>38.5oC + heart rate>90 3 19 9.2 
Seizures 29 96 5.0 
Seizures + PMH Epilepsy 2 32 23.5 
Age<30 1 29 42.5 
Age<40 14 70 7.5 
Headache + PMH Migraine 8 24 4.4 
FAST-ve 117 158 2.0 
 
Table 2.2.25 STEAMv1.3 + FAST-ve output when applied to refinement dataset 
STEAM score Total patients Stroke Stroke mimics 
0 3283 2070 1213 
1 421 162 259 
2 84 8 76 
3 8 0 8 
4 1 0 1 
Note: STEAM positive rows are shaded. 
STEAMv1.3 + FAST-ve score≥2 identified 93 suspected stroke patients including 8 (9%) stroke 
patients and 85 (91%) SM patients. STEAMv1.3 + FAST-ve had 5.5% (95% CI 4.4-6.7%) 
sensitivity, 99.6% (95% CI 99.3-99.9%) specificity and 91.4% (95% CI 83.8-95.6%) PPV. 
The results of the refinement process are summarised in table 2.2.26 below. 
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Table 2.2.26 Summary of STEAM models from refinement process 
 Stroke SM Sensitivity 
(%) 
Specificity 
(%) 
PPV (%) 
STEAMv1 
(development) 
14 76 11.5 98.6 84.4 
STEAMv1 
(refinement) 
39 172 11.1 98.3 81.5 
STEAMv1.1 30 151 9.7 98.7 83.4 
STEAMv1.2  57 212 13.3 97.5 78.8 
STEAMv1.3  
2 points 
4 64 4.1 99.8 94.1 
STEAMv1.3  
2 points + 
limbs 
11 104 6.7 99.5 90.4 
STEAMv1.3 
2 points + 
FAST-ve 
8 85 5.5 99.6 91.4 
 
2.2.10 STEAM refinement version 2 
In order to retain simplicity of use whilst maximising specificity, STEAMv1.3 (2 points) + 
FAST-ve was selected as the most suitable version to evaluate as STEAMv2.  
Further refinements to STEAMv2 were explored including increasing the SBP to 100mmHg, 
raising the age<40 criterion to 45 or 49 and inclusion of other characteristics associated with 
stroke diagnoses such as hypertension, AF and eye symptoms. None of these were judged to 
improve the performance whilst maintaining the principle of being simple and specific. 
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The final STEAMv2 tool is:  
Target population = suspected stroke patients who are age≥18 with GCS≥8 and BM>3.5. 
 SBP<90mmHg = 1 point 
 Temperature>38.5oC AND heart rate>90 = 1 point 
 Seizures = 1 point 
 Seizures AND PMH epilepsy = 1 point 
 Age<40 years = 1 point 
 Age<30 years = 1 points 
 Headache AND PMH migraine = 1 point 
 FAST-ve = 1 point 
Patients scoring 2 or more points were considered likely SM. STEAMv2 positively identified 
93 suspected stroke patients including 8 (9%) stroke patients and 85 (91%) SM patients. 
The eight stroke patients incorrectly identified by STEAMv2 (false positives) were identified 
on the following combinations of characteristics: 
 Seizures and FAST-ve = 2 patients 
 Seizures AND PMH epilepsy = 2 patients 
 Age<40 years and Headache AND PMH migraine = 1 patient 
 Headache AND PMH migraine and FAST-ve = 1 patient 
 Temperature>38.5oC AND heart rate>90 and FAST-ve = 1 patient 
 Age<30 years = 1 patient 
The performance characteristics of STEAMv2 were: 
 Sensitivity 5.5% (4.4-6.7) 
 Specificity 99.6% (99.3-99.9) 
 Positive predictive value (PPV) 91.4% (83.8-95.6) 
 Negative predictive value (NPV) 60.3% (60.0-60.6) 
 Positive likelihood ratio (PLR) 15.3 (7.4-31.5) 
 Negative likelihood ratio (NLR) 1.0 (0.9-1.0) 
 Odds ratio (OR) 16.1 (7.8-33.4) 
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2.2.10.1 Sensitivity analysis of assumed SM in STEAMv2 
To consider STEAMv2 performance without the uncertainty of cases based on assumed SM 
diagnoses in the refinement dataset, a sensitivity analysis was performed excluding patients 
with an assumed SM diagnoses. This resulted in a population of 3,230 suspected stroke 
patients including 2,240 (69%) stroke patients and 990 (31%) SM patients.  
In the sensitivity analysis STEAMv2 score≥2 identified 62 suspected stroke patients including 
8 (13%) stroke patients and 54 (87%) SM patients. STEAMv2 had 5.5% (95% CI 4.1-7.1%) 
sensitivity, 99.6% (95% CI 99.3-99.9%) specificity and 87.1% (95% CI 69.2-72.3%) PPV. 
2.2.11 Discussion 
The aim of this chapter was to refine STEAMv1 based on the creation of an expanded 
dataset, informed by the findings of the focus groups reported in chapter 2.1. The iterative 
process to refine STEAM was guided by the principle of creating a tool that was both simple 
and specific. Different versions of STEAM were developed with varying combinations of 
characteristics and consequently operational performance measures. The final iteration 
(STEAMv2) added FAST-ve to the original five STEAM characteristics and increased the 
scoring threshold to 2 points. STEAMv2 has a lower sensitivity than STEAMv1 but increases 
the specificity and PPV. 
The creation of the expanded dataset with NUTH and NTEES data provided the opportunity 
to refine STEAM, which was necessary due to the reduced performance in the refinement 
dataset. This process allowed STEAM to be developed and refined prior to validation in a 
further dataset from a fourth hospital which is described in chapter 3.1.  
The data from NUTH was similar to the development data from NHCT in terms of 
demographics. NTEES suspected stroke, diagnosed stroke and SM were younger than the 
other two trusts and had a slightly different mix of genders. The combination of these 
different populations should increase the general applicability of STEAM across the NHS. 
The SM diagnoses reported using ICD-10 and CCS codes were consistent in the most 
frequently reported diagnostic groups, i.e. nervous system and sense organs followed by 
circulatory, and more specific diagnoses, i.e. epilepsy and convulsions followed by headache 
and migraine. The overall pattern of SM diagnoses was similar to that found in the 
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systematic review in chapter 1.2. Within the refinement dataset there were lower rates of 
mental illness, higher rates of musculoskeletal injuries, respiratory and genitourinary CCS 
codes and slightly different proportions in the most common nervous system CCS codes, i.e. 
headache and ear conditions. These differences are probably due to the refinement data 
being based on pre-hospital suspicion of stroke whereas the literature review included all 
settings. The patterns of SM diagnoses within each contributing trust were similar although 
NUTH had a higher rate of neoplasm SM and NTEES had a lower rate of injuries and 
poisonings. These may be due to the small numbers in each group, although in terms of the 
impact of hospital setting upon the reference standard it is interesting to note that NUTH 
houses the regional neurosurgical unit and that NTEES is adjacent to a larger NHS trust with 
a major trauma centre. 
Documentation of physiological observations, the FAST test and individual FAST elements 
were consistent across all three trusts. Pain and temperature were the only physiological 
characteristics not documented in over 95% of cases. The pattern of PMH presentations was 
similar across the three trusts with PMH hypertension and PMH stroke being the most 
commonly reported. These patterns of observations are unsurprising in this pre-hospital 
suspected stroke population and provide reassurance during the further development of 
STEAM that the populations from each trust were representative of the pre-hospital 
suspected stroke population. This is important because if there were unusual or unique 
features in these populations it could affect the development of the tool and limit the 
generalisability.  
FAST is the standard pre-hospital stroke identification tool in the North East which will have 
influenced the pre-hospital data and therefore the development, refinement and 
generalisability of STEAM. If a SM tool were developed in a setting where a different stroke 
identification tool was used, such as LAPSS, or where additional criteria, such as leg 
weakness or visual deficit, were already included this would change the tool that was 
developed. If STEAMv2 were to be applied in a setting where a different stroke identification 
tool was used it would perform differently. LAPSS excludes seizures and age<45 years so two 
of the STEAMv2 criteria would be redundant. 
The addition of FAST-ve as a criterion was the most obvious change between STEAMv1 and 
STEAMv2. National guidelines advocate the use of a standardised stroke identification tool 
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like FAST (Intercollegiate Stroke Working Party, 2016) due to its high sensitivity for stroke. 
Many ambulance trusts use FAST as the main, and sometimes only, inclusion criteria in their 
stroke pathways. FAST-ve was not individually strongly predictive enough in the 
development dataset to be included within STEAM nor was it considered in combination 
with other predictors as it did not point towards a specific non-stroke diagnosis. However, 
during STEAM refinement, FAST-ve was identified as being valuable for prediction of SM 
amongst patients that were being excluded from STEAM when the predictive threshold was 
raised from 1 to 2 points. This led to FAST-ve being included as an individual predictor 
variable as it worked well in conjunction with the other existing predictors. Being FAST-ve, 
especially in combination with other SM predictive characteristics, has face validity as FAST 
identifies the commonest stroke symptoms.  
Blood glucose measurement is a common feature of existing pre-hospital stroke pathways so 
featured in STEAMv2 as a reminder to consider this common SM rather than creating 
duplication. There were nine patients with BM<3.5mmol/l in the refinement dataset, 
probably due to hypoglycaemia being identified and treated during pre-hospital assessment, 
so including BM within the SM tool would have had a negligible impact.  
Consideration of whether to incorporate BM within STEAM and the alterations to the age 
criteria were examples of the how the focus group findings influenced the refinement 
process. STEAMv2 will be explored in a similar fashion in further focus groups which are 
reported in chapter 3.3.   
The refinement of STEAM sought to maximise specificity and PPV and accepted that this 
would in all likelihood come at the expense of sensitivity. The various versions of STEAM 
exhibited differing combinations of these three performance measures, but the operational 
characteristic that most strongly influenced selection was the PPV. High predictive value in a 
small group of patients was accepted and understood in the focus groups which informed 
the refinement process. STEAMv2, despite not having the highest achievable PPV was 
considered to have the best balance of characteristics whilst retaining simplicity. Simplicity 
was also regarded as valuable by the focus groups and would help with training paramedics 
for the usability testing described in the next chapter and any future implementation. 
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2.2.11.1 Strengths and limitations 
The refinement process followed clearly defined steps and utilised a larger dataset than the 
initial development of STEAM. The larger dataset generated more precise estimates, 
indicated by the narrower 95% confidence intervals, of the relative predictive strengths of 
the included variables.  
The inclusion of data from three different acute trusts strengthens the generalisability of the 
results, although all three were within the North East. The data supplied by NTEES differed 
from the NHCT and NUTH data in terms of demographics and the percentage of patients 
with an assumed SM diagnoses. There may have also been differences in how diagnoses, 
stroke and SM, were made in the three trusts despite standard codes (ICD-10) being used 
e.g. from differences in the use of MRI, although the data in table 2.2.7 suggests that 
diagnostic practices were broadly similar. 
There may be combinations of variables within the refinement dataset that were overlooked 
and there may be variables that would differentiate stroke and SM patients that were not 
collected in the dataset. Acknowledging these unknowns, STEAMv2 may be the best 
combination of variables that meets the aims of this thesis that is achievable with this 
imperfect dataset. 
2.2.12 Conclusions 
This chapter describes the refinement of the SM identification tool which resulted in 
STEAMv2. The iterative refinement process was based on a large pre-hospital dataset and 
informed by professional focus groups. STEAMv2 includes six characteristics which in 
combination identify a small number of SM patients with a high level of certainty. STEAMv2 
achieved the stated aim of performing better than the original STEAM tool whilst retaining 
user simplicity.  
2.2.13 Summary 
The usability of a SM tool in clinical practice is reported in the next chapter along with initial 
views from paramedics about STEAMv2. The next chapter concludes part 2 of this thesis 
which has focussed on improving the initial STEAMv1 tool and collecting feedback from 
professional stakeholders about the development process and clinical usability of the tool. In 
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part 3 of the thesis STEAMv2 will be validated in a separate dataset, modelled to explore 
potential impact and discussed in a final phase of focus groups. 
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Chapter 2.3 Usability testing of the STEAM tool 
 
2.3.1 Introduction 
This is the second of three qualitative phases of the study. The first phase of qualitative work 
explored paramedics and hospital clinicians’ views on the development of STEAM and was 
reported in chapter 2.1. The third phase reports paramedics and hospital clinicians’ views on 
STEAMv2 and is reported in chapter 3.3. 
2.3.2 Chapter aims 
The primary aim of this chapter was to report prospective data on the acceptability and 
usability of the STEAM tool from the perspective of paramedics who applied the STEAM tool 
in practice. The secondary aim was to collect, analyse and report on qualitative data 
pertaining to paramedics’ feedback on the mode, form and content of STEAM. 
2.3.3 Methods 
2.3.3.1 Design 
A mixed methods design was used to address the aims of this phase of the study, with a 
generic qualitative approach (Cooper and Endacott, 2007; Griffiths and Mooney, 2011) due 
to the relative inexperience of the researcher and the multi-method nature of the wider 
project.  
Volunteer paramedics were recruited and trained to use STEAM in their clinical practice over 
a period of up to 4 months as a service evaluation project. It was emphasised that this study 
was a data gathering exercise and STEAM was not to be used under any circumstances to 
change the clinical care of suspected stroke patients.  
At the end of the data collection period quantitative data on the acceptability and usability 
of STEAM were collected from paramedics using a structured feedback form with 12 
questions (appendix M). Semi-structured interviews with individual paramedics collected 
data on participants’ views and experiences around applying STEAM in clinical practice. 
Prospective data on STEAM use in the pre-hospital setting were collected by evaluating 
Electronic Patient Care Records (EPCR) completed by participants regarding suspected stroke 
patients to establish what information pertinent to the STEAM tool was documented.  
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The original plan was to recruit 30 paramedics to prospectively test the STEAM tool. It was 
assumed this would allow 8-12 participants to be recruited for two focus groups consisting 
of 4-6 participants as informed by the recommendations of Barbour (Barbour, 2008) (p 60) 
and Pope and Mays (Pope and Mays, 2006) (p26). Due to smaller than expected numbers of 
participants, and the participants being paramedics who worked across a large area with 
differing shift patterns, it was difficult to arrange focus groups. Therefore, the participants 
were instead invited to individual semi-structured interviews.  
The overall structure of the study is summarised in figure 2.3.1 below. 
 
Figure 2.3.1 Overall structure of usability testing project 
2.3.3.2 Participants 
A volunteer sample of paramedics were recruited by advertising within NEAS using: mass 
email, circulation of information to staff by Emergency Care Clinical Managers, internal 
weekly bulletins and posts on social media (Twitter and Facebook). Paramedics were 
targeted as they are the main clinical decision makers in the pre-hospital setting. Paramedics 
within NEAS that were based at intervention stations in the PASTA study (Shaw et al., 2016) 
were excluded to avoid contamination of either study. 
2.3.3.3 Participant training 
All volunteers were supplied with study information sheets and given the opportunity to ask 
any questions prior to participating. Once volunteers had provided their written consent to 
participate they were emailed the STEAM tool and an instruction sheet on how it should be 
applied, along with a STEAM aide memoire (see appendix N). All participants were offered 
face to face training if requested. Participants were asked to document STEAM 
characteristics and any use of STEAM on the EPCR so this could be evaluated. 
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2.3.3.4 Study timeframe 
The study ran for four months from when the first participating paramedic started to use 
STEAM i.e. from 17/02/17 to 22/06/17. This time interval was selected based on allowing 
the participants at least one month to use STEAM in practice and the parallel work packages. 
At the end of the four months participants were informed that the study was completed, 
sent the feedback form and invited to participate in a semi-structured interview.  
2.3.3.5 Data collection and analysis 
The questions included within the feedback form were developed, with input from the 
supervisory team, around the usability and development of the STEAM tool and also covered 
some of the issues that emerged in the first focus groups (chapter 2.1). The feedback form 
was deliberately kept short (2 pages) with only 12 questions to encourage completion. Two 
questions required answers using a 5 point Likert scale and are reported using descriptive 
statistics. The remaining ten questions on the feedback form asked for freetext feedback and 
are reported using simple thematic analysis. Findings from the feedback forms were used to 
inform the semi-structured interviews.  
The EPCR evaluation data was collected by NEAS informatics team executing a query using 
the participants NEAS ID number and searching for any cases during the study timeframe 
with a recorded impression of stroke. These cases were then examined for any 
documentation of STEAM characteristics or evidence of the application of STEAM. The data 
from the EPCR evaluation is presented using simple descriptive statistics. The evaluation 
results were used to inform the semi-structured interviews. 
Participants were invited to take part in a semi-structured interview and offered a small 
incentive, in the form of a £10 Amazon voucher, as thanks for their time. Interviews were 
arranged at a time and place convenient for the participants. Informed written consent was 
gained at the start of each interview after participants had a chance to ask questions.  
A topic guide was used for the interviews (see appendix O). The topic guide was developed 
with the support of the supervisory team after consideration of the survey data, and covered 
broad areas such as development of STEAM, application and barriers or facilitators to 
acceptability and usability. Due to the timing of the interviews, the revised version of the SM 
tool (STEAMv2) was added to the topic guide in order to gather some early opinions from 
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paramedics on the differences between STEAMv1 and STEAMv2. The topic guide was 
designed to help keep the interview focussed on issues of interest whilst allowing 
unexpected areas of discussion to arise.  
Stimulus material (see appendix P) was used within the interviews. This consisted of the 
STEAMv1 tool, the results of the EPCR evaluation with reference to the presence of 
STEAMv1 characteristics, and the refined STEAMv2 tool. This was given to participants to act 
as reference material at appropriate points during the interview. 
Digital audio recordings were made of the interviews and brief field notes were taken during 
the interviews and used by the researcher to ensure key points were covered and interesting 
points that arose were investigated without interrupting the flow of conversation. The audio 
recordings were transcribed verbatim by the researcher and anonymised for the purpose of 
analysis. The data analysis method for the semi-structured interviews was the same as used 
in chapter 2.1, thematic analysis using a five stage framework as described by Pope and 
Mays (Pope and Mays, 2006) (p72-74).  
The findings from the interviews and the themes that emerged were discussed with the 
supervisory team. This debriefing, along with the use of direct participant quotes to illustrate 
themes, enhances the trustworthiness of the analysis. 
2.3.3.6 Ethical approval 
The three phases of qualitative work were granted research governance approvals as one 
project as reported in chapter 2.1.  
An amendment was submitted to, and approved by, the HRA, NEAS and the Newcastle 
University Faculty of Medical Sciences ethics committee to include one-to-one semi-
structured interviews for data collection.   
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2.3.4 Findings 
Ten paramedics were trained and participated in this phase of the study. No paramedics 
requested face to face training. Participants used STEAM for a median of 89 days (IQR 55-
111, range 43-125). The findings are based on four feedback forms, evaluation of 13 EPCRs 
from nine paramedics and three semi-structured interviews. The findings from the three 
data collection methods are presented separately. The feedback forms and semi-structured 
interviews represent 60% (n=6) of the 10 participants (one participant completed both a 
feedback form and participated in an interview). Participants are indicated by F1-4, Int2 for 
the feedback forms and P1-3, Int2 for the semi-structured interviews.  
2.3.4.1 Feedback forms 
The data collected from the feedback forms is summarised below. Anonymised illustrative 
quotes are used for some of the free-text questions. 
Q1. What are your general thoughts on the mimic assessment tool? 
All four participants thought STEAM was easy to use. One participant remarked on the low 
number of patients it was applicable to in practice. 
Q2. How easy or difficult was it to include the mimic tool characteristics in your 
assessment? 
On a five point scale (Very difficult, Difficult, Neutral, Easy, Very easy) 100% (n=4) of 
participants rated STEAM as very easy. 
Q3. Did the mimic tool agree with your clinical decision making? 
On a five point scale (Never, Rarely, Sometimes, Mostly, Always) 75% (n=3) of participants 
said always and 25% (n=1) said mostly. 
Q4. What did you think about using the mimic tool in practice? 
All four participants reported that STEAM was easy to apply in normal practice. Two 
participants remarked on the lack of stroke patients with any STEAM criteria they had seen 
and therefore their lack of opportunities to consider its use in practice. One participant 
suggested “could the EPCR have a section for this like the sepsis recognition tool” F4, Int2. 
Q5. Are there any criteria within the tool that you think need changing? 
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Three participants said no to this question. The fourth participant questioned how patients 
with a history of migraine but who described a different headache to normal should be dealt 
with. 
Q6. What format do you think the tool would be most useful in? 
All four participants liked the aide memoires that were supplied. One participant suggested 
adding STEAM onto the EPCR. 
Q7. What would be the best way to train paramedics to use this tool if it became part of 
normal practice? 
All four participants felt STEAM was self-explanatory and little training beyond what was 
used in this study was actually needed, “little training required, email or info leaflet” F2, Int2.  
Q8. When the tool indicated a patient may be a stroke mimic how would you have felt 
about not following your standard stroke protocol? 
Three participants commented on the lack of opportunities to use STEAM. One participant 
said they would feel confident as long as STEAM fitted with national guidelines. A second 
participant said they would follow the normal stroke care protocol but with a “confident 
handover that stroke mimic was a differential diagnosis” F1, Int2. 
Q9. How could you see the mimic tool fitting in with your local protocols? 
Participants all felt STEAM could fit within local clinical protocols. One participant said “The 
only thing that would need to be made clear is when the stroke bypass would not be 
implemented” F3, Int2. 
Q10. What do you think of the simplicity of the tool? 
All four participants were positive about the simplicity of STEAM. 
Q11. How would you feel about a more complex tool with different scores for different 
factors? 
All four participants were happy with the idea of a more complex tool. One participant 
referenced the ABCD2 tool as an example of a more sophisticated tool already in use. One 
participant commented “however due to the serious clinical nature of CVAs I feel it would be 
more beneficial to be more in depth, if we are using this to not use the stroke bypass” F3, Int2 
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Q12. Is there anything else you think might be useful to the project going forward that we 
haven’t asked about? 
No further comments were made by the participants. 
2.3.4.2 Evaluation of suspected stroke EPCRs 
The NEAS informatics report identified 42 suspected stroke patients seen by nine 
participating paramedics within the study timeframe. During the usability testing NEAS 
changed its data collection system from the EPRF to the EPCR. Due to technical issues 
integrating the new EPCR system into practice there was no method of searching the EPCR 
database for a number of months. Using a manual process of searching calls attended by 
individual paramedics through the dispatch system the source data (EPCR) for 36% (n=15) of 
the suspected stroke patients were located. These EPCRs were examined for the presence, 
or documented absence, of STEAM characteristics recorded by participating paramedics.  
Two suspected stroke patients were excluded due to low GCS; therefore the evaluation data 
is based on 13 EPCRs completed by participating paramedics and is reported in table 2.3.1 
Table 2.3.1 STEAM characteristics recorded on the NEAS EPCR for suspected stroke 
patients during prospective testing 
STEAM characteristics Recorded on EPCR 
(total=13) 
% 
SBP 13 100 
Temperature 12 92 
HR 13 100 
Seizures* 10 77 
PMH Epilepsy 1 8 
Age 13 100 
Headache 8 62 
PMH Migraine 1 8 
STEAM or mimic tool 2 15 
*The EPCR includes a Stroke/TIA section under ‘Acute Medical Assessment’. Within this 
section convulsions are one or the characteristics that paramedics are requested to record. 
Therefore, this served as a prompt for paramedics to consider, and document, seizures. 
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2.3.4.3 Summary of feedback and EPCR evaluation 
The feedback demonstrated that paramedics felt comfortable using STEAM but did not apply 
it very often. Participants thought that their training was sufficient and that adding STEAM 
onto the EPCR would be a good method of promoting consistent use. Although participants 
reported that they liked the simplicity of STEAM they were not averse to a more complex 
tool. The EPCR audit revealed that commonly completed observations, e.g. SBP, 
temperature, HR, and easily obtained information like age were all documented 
consistently. However, the presence or absence of headaches was less well documented and 
the presence or absence of epilepsy or migraine was rarely documented. The reasons for 
these differences, and the other findings of these two data collection methods, were 
explored in the semi-structured interviews.  
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2.3.4.4 Semi-structured Interviews 
The findings from the three interviews are presented in a combined fashion due to the 
overlapping nature of the findings. Eleven themes emerged during data analysis. As STEAM 
had now been refined there was no attempt to combine this interview data with that 
obtained during the development phase. All the themes revolved around use of the STEAM. 
Three large categories: application, outcomes and thought processes emerged during the 
charting and mapping stage of analysis. These categories and themes are illustrated in figure 
2.3.2. The themes are described below in more detail with illustrative anonymised quotes. 
 
Figure 2.3.2 Map of themes emerging from interviews with paramedics with application 
(green), outcomes (red) and thought processes categories (orange) 
The use of STEAM was at the centre of the discussions, although STEAMv2 was discussed 
briefly at the end of each interview. The three categories are arranged around the inner 
circle representing STEAM as the central theme with the other ten themes arranged around 
the outer circle: 
 Thought processes (shown in orange in fig 2.3.2) which includes how the paramedic 
is trained on STEAM and how and with which patients they would decide to use it.  
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 Application (shown in green in fig 2.3.2) which includes when during patient 
assessment STEAM should be used and how it can interact with, and influence, the 
treatment of patients.  
 Outcomes (shown in red in fig 2.3.2) which includes the outcome of applying STEAM 
in terms of transferring care to the hospital, feedback from the hospital to the 
paramedics and documentation. 
2.3.4.5 The STEAM tool 
All three participating paramedics thought that STEAM was simple and straightforward to 
use: 
 “Very simple in how it’s set out and simple to use” P2, Int2 
In order to use the tool in practice, paramedics asserted that they would need to have 
confidence in the performance of the tool: 
“I think people would have to have confidence in the tool, that it was doing what it 
says it’s going to do” P1, Int2 
The age criterion in STEAM was discussed.  One participant linked this to their training where 
stroke was associated with older age, and another participant questioned the inclusion of 
age as a criterion: 
“Just because you’re under 40 I mean doesn’t rule you out does it, so, I’ve been to 
patients younger than 40 who have had a stroke.” P1, Int2  
This same participant did acknowledge why they remembered these patients: 
 “Cause they’re unusual” P1, Int2 
The question of putting the tool onto the EPCR to make it easier to access and record was 
raised by two of the paramedics: 
“Is the plan to have this as part of the EPRF (EPCR) so you can have like the sepsis, in 
the stroke element where you do all your checks” P3, Int2 
In summary participants reported that STEAM was acceptable for use in the pre-hospital 
setting. There were no suggestions of changes to the variables in STEAM, but suggestions 
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around the format and presentation of the tool such as making it part of an algorithm or 
flowchart for ease of understanding were made.  
Participants were introduced to STEAMv2 in order to gather their views on the revised tool. 
STEAMv2 was presented in isolation and participants commented that it would be better if it 
was presented in a more user friendly format such as an algorithm or flowchart: 
“You could lay it out differently so it’s a bit more, you know, what’s the word, just a 
bit more friendly I suppose” P1, Int2 
The refinements were accepted by the participants who understood the reasons for the 
changes. Participants thought the inclusion of BM improved the tool and that STEAMv2 was 
still simple and straightforward despite the addition of another variable and the need to 
score 2 points:  
“It’s very simplistic in the way it’s laid out so perfect, I think it’s very straightforward 
to use.” P2, Int2 
2.3.4.6 Thought processes  
The following four themes have been grouped together as they all involve the thought 
processes behind ‘how and when’ the paramedics would use STEAM. This includes 
participant’s views on when STEAM would be thought relevant, how SMs were something 
they had previously given very little attention, and their views on how paramedics could be 
trained on STEAM.  
2.3.4.7 History taking 
All three participants described the importance of a good patient history as part of deciding 
whether a patient was a stroke or a SM: 
 “It’s the history taking that’s got to be absolutely specific and accurate” P3, Int2 
The difficulties in establishing a clear history for some patients were also recognised and 
how third parties were sometimes the only source of pertinent information: 
“You’d be getting history from a third party, so you would still, you would treat a 
dementia patient with a bit more caution though wouldn’t you because they can’t, 
sort of interact with and confirm or deny something” P1, Int2 
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One participant described their assessment process in three stages: first rule out any 
immediate threats to life; second take observations and a good history; third make a 
decision on what to do with the patient. They saw the history taking as being key to 
informing the decisions that were made. They also thought underpinning knowledge and 
awareness of differential diagnoses was important in terms of guiding the history taking. 
Participants thought that STEAM would help ensure relevant questions were asked during 
the history taking and that the documentation of the history taking could be improved. 
2.3.4.8 Awareness 
Two participants reported a lack of awareness of SM prior to being involved in this research: 
“Till I started I don’t think I had been aware of such a condition or other causes” P2, 
Int2 
These same two participants both reported that their involvement in this research was due 
to personal interest in stroke as a condition: 
“It’s only been my personal interest in strokes, as you know, that has made me 
develop my sort of learning a lot more” P3, Int2 
Awareness of signs, symptoms and risk factors for stroke or SM is important as this can 
guide the history taking and patient assessment, which in turn determines the actions taken 
by the paramedic. Participants said they were unaware that seizures could lead to stroke-like 
symptoms in some patients: 
 “In all honesty before this I’ve never put a stroke in an epileptic” P3, Int2 
One participant reported that they mentored student paramedics who they felt had limited 
knowledge about stroke, TIA or SM. This links in to the training that paramedics receive 
around stroke and emphasises the potential value of STEAM in raising awareness of stroke in 
paramedics. 
2.3.4.9 Training and implementation 
There was a lot of discussion within all three interviews around how paramedics could be 
trained to use a tool like STEAM and how it could be integrated into their decision making 
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process. Explaining to people why they should use STEAM was felt to be vital to successful 
implementation: 
“I think a lot of people can be convinced to do something or can be more inclined to 
do something if they know why they’re doing it” P1, Int2 
There were numerous suggestions for how to best train staff to use STEAM including the use 
of social media, podcasts, introducing SM during pre-registration education, using 
Emergency Clinical Care Managers (paramedic team leaders in NEAS) to train other staff as 
well as using the annual mandatory training days that all NEAS staff must attend. One 
interesting observation that was made was about how STEAM would be presented to 
paramedics and whether it was seen as optional or not: 
 “If you give people the option to use it or not they won’t use it” P1, Int2 
This point was reflected in discussions around how organisational support would be vital to 
give paramedics the confidence to use a new tool like STEAM. One way that STEAM could be 
endorsed by the organisation would be to mandate its use by including it in the stroke care 
bundle (documentation of FAST status, blood pressure and blood sugar): 
“I think putting it into the care bundle would be, it’s almost mandating it, isn’t it” P1, 
Int2 
2.3.4.10 Reminder 
STEAM was seen as a good way for people to check they had asked relevant questions 
during their patient assessment, with the aide memoire considered to be a useful checklist. 
This represents paramedics using STEAM at the end of the decision making process as 
opposed to the history taking theme which referred to paramedics using STEAM earlier in 
the assessment process: 
 “I think I would use it as a checklist, after, I think, rather than as a prompt” P1, Int2 
All three participants said they carried the aide memoire around and referred to it when 
they had a patient who they thought may be suitable. Participants suggested using the EPCR 
to automatically trigger people to consider STEAM when stroke symptoms were 
documented. One participant explained how completing the various sections on the EPCR 
served to reassure them that they had documented a thorough assessment: 
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“I’ve ticked all these boxes and I kind of know that this is where I’m going and great, 
and it just gives you that little bit of security that you’ve seen it on black and white” 
P2, Int2 
This use of the EPCR links into the documentation theme in the outcomes section. 
2.3.4.11 Application  
The following themes were grouped together as they converged on how STEAM could be 
applied in practice. This includes how STEAM interacts with FAST, patients where 
participants thought STEAM would be useful and how STEAM could influence decision 
making about appropriate treatment for suspected stroke or SM patients.  
2.3.4.12 FAST 
One participant expressed how the FAST test was seen as “very basic” P3, Int2 and that 
STEAM gave paramedics an opportunity to develop their stroke recognition beyond FAST. 
Another participant expressed concern about how STEAM would interact with FAST:  
 “That might cloud the issue a little bit if someone’s FAST positive” P1, Int2 
Participants referred to practice at local hospitals where some EDs would not expect to see 
FAST positive patients. An example was given where the paramedic tried to admit a patient 
to a local stroke unit based on a positive FAST test, but the stroke unit thought the patient 
should be seen at ED and the ED thought the patient should be seen on the stroke unit. This 
shows the importance of the FAST test in pre-hospital stroke recognition and how pathways 
are organised around it. If STEAM were to be implemented, how the results of STEAM would 
interact with the results of FAST would need to be very clearly described. 
2.3.4.13 Patients 
All three participants reported being unable to use STEAM as often as they anticipated: 
“Within the length of the trial I don’t think I’ve had anybody who’s actually met any 
of the criteria that are on there” P2, Int2 
Whether this lack of opportunities was due to the short length of the usability study, the low 
number of suspected stroke patients encountered or whether paramedics automatically 
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decided that the majority of patients were not suitable for STEAM would be areas for future 
research. 
In contrast to the previous point, there was recognition that STEAM was applicable to most 
suspected stroke patients. However, it was acknowledged that in certain groups of patients, 
such as those with cognitive or communication difficulties, it would be more challenging to 
apply STEAM. There was also acknowledgment that geographical factors, in terms of 
distance to hospital for rural patients, and temporal factors, primarily whether the patient 
was in the thrombolysis treatment window, came into play when assessing stroke patients: 
“If it is going to be a stroke and you have caught it at a particular time then you want 
to be able to act on it in the same way that you want to be able to do the right thing 
by a stroke mimic” P3, Int2 
2.3.4.14 Appropriate treatment 
Participants recognised that appropriate treatment for SM patients may not be admission to 
a stroke unit and that diverting SM patients to other pathways could free up specialist stroke 
resources: 
“If we’re being given more informed information, that’s going to benefit those people 
and free up the stroke departments” P3, Int2 
There was recognition of the need for a high level of certainty in the SM diagnosis which 
linked to the history taking theme. Paramedics felt accountable for their treatment of 
suspected stroke patients and wanted to provide the best possible care. A thorough history 
would need to be taken to ensure that variables that could influence the decision making 
had all been considered: 
 “There’s potential dangers attached too, it’s being absolutely certain that you’re not 
going to miss out on something that’s quite crucial” P3, Int2 
Opinions differed as to what participants felt was appropriate treatment for a SM: 
“If the patient was showing classic stroke symptoms I would still err down that 
pathway, stroke pathway, but I would be mindful of the fact that it might be a mimic 
but I would still treat for the worst case scenario” P2, Int2 
 196 
 
“We can treat those patients (SM) appropriately which may not be transporting them 
to a stroke unit or to a major hospital if they need to be more appropriately treated 
locally” P1, Int2 
Participants agreed that transportation to hospital was still the appropriate treatment for 
SM patients, which links to the hospital theme, as these patients would have an underlying 
(potentially serious) issue that would need investigation and treatment: 
“You’re recognising a stroke mimic and you’re getting that seen to and whatever’s 
wrong with them treated” P3, Int2 
2.3.4.15 Outcomes  
The final grouping describes themes relating to the impact and outcome of applying STEAM. 
This includes: how STEAM would be received by hospital staff and departments; feedback 
that paramedics receive on stroke patients; and how suspected stroke patient encounters 
are documented. 
2.3.4.16 Transfer of care 
The interaction between paramedics and the hospital was a topic discussed by all three 
participants. The influence that the hospitals reception would have on paramedic use of 
STEAM was raised: 
“People would need to have confidence that hospitals were going to be accepting of 
this being a recognised method of filtering patients” P1, Int2 
“As long as the departments that are receiving are understanding why you’re coming 
in, even though the presenting complaint was possible stroke” P3, Int2 
This linked into the need for the pathways to hospital to be clear with both paramedics and 
hospital staff having a good understanding of the tool and the implications of its use. The 
differing departments that patients could be admitted to, which was highlighted in the FAST 
theme, was a prominent issue: 
“If you’re going to a different department but in the same hospital, it’s not so much of 
an issue, but if you’re going to a completely different site, then that’s a big issue” P1, 
Int2 
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This difference in potential destinations links closely to the appropriate treatment theme as 
paramedics recognised that not every hospital has a stroke unit and getting the right patient 
to the right hospital was a key part of their role. 
2.3.4.17 Feedback 
The lack of feedback paramedics receive on suspected stroke patients was raised in two 
interviews as a potential influence upon how well STEAM would be adopted in practice. 
When feedback was received it was informal and only because the paramedic actively 
sought it out from hospital staff. The benefits of feedback regarding the accuracy of the pre-
hospital diagnosis for suspected stroke patients (and other patients) were described by one 
participant: 
“You want to know that you’re making the right decisions about all your patients and 
yet unless you ask or you mess up majorly you don’t get to hear any of that feedback 
so how are you supposed to learn?” P2, Int2 
One participant reported receiving feedback on suspected stroke patients, but only if they 
took them directly to the CT scanner. This was an example of the differing practices of 
departments within a hospital and how feedback can be linked to, and influenced by, the 
practices of the individual hospital or department. As STEAM would be a new intervention 
then feedback would be important to reassure paramedics that the right decisions had been 
taken or to identify examples where the wrong decisions had been made so lessons could be 
learnt and care could be improved. 
2.3.4.18 Documentation 
The place of STEAM during completion of clinical record documentation by the paramedics 
was a theme that emerged during discussions of the EPCR evaluation. One issue raised with 
extracting data from the EPCR was assuming something hadn’t happened because it wasn’t 
written down: 
“If they haven’t filled it in, is it because they weren’t aware or is it because the patient 
didn’t show any of those things.” P2, Int2 
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This led into a discussion around how paramedics decide what needs to be documented and 
how some results and findings are recorded without explaining the decision making or 
process by which they were reached: 
“I think in terms of documenting it, that might be that people maybe thought like 
because I’m using it I don’t need to document it, almost as such like you would 
document a GCS but you wouldn’t document that you were using the GCS method of 
assessing someone’s consciousness level” P1, Int2 
This links into the awareness and training themes. Paramedics need to know which 
information is relevant in order to target questioning and patient assessment, and also in 
order to record appropriate information. 
Participants described how documenting the patient encounter could act as a trigger to 
consider use of STEAM: 
“It was probably only something that I thought about in depth once I was doing my 
write up” P2, Int2 
Discussing the write up of the patient encounter led to how documentation was needed to 
support and justify clinical decisions, which is especially important when a tool like STEAM 
may indicate alternatives to current standard practice: 
“Your documentation, well, it’s justifying your reasons as to why you’ve done that” 
P2, Int2 
This could be an example of defensive practice where a recognised tool or assessment would 
be used to defend the decision which may be later challenged.   
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2.3.5 Discussion 
This chapter reports the views and experiences of paramedics who were trained on STEAM 
and applied it in practice. The aim was to explore acceptability and usability and how STEAM 
could fit into clinical care when it was applied during the assessment of real patients. 
The interviews allowed the participating paramedics’ experiences to be recorded, as well as 
allowing the EPCR evaluation results and the findings from the feedback forms to be 
explored in more depth within a meaningful context.  
The EPCR evaluation showed that basic observations were consistently documented 
whereas aspects of the patient’s PMH, such as history of migraine or epilepsy, were rarely 
recorded. The lack of documentation of PMH is supported by previous work  which showed 
that paramedics documented PMH less frequently than hospitals (Rudd et al., 2016b). The 
reasons for this were explored during the interviews and included paramedic perceptions 
about what was relevant information to document during routine assessment of suspected 
stroke.  
The feedback forms and interviews showed that the participants were positive about STEAM 
and considered it to be usable in the pre-hospital setting. They understood why SM 
identification was important and the potential benefits from routine assessment for this 
purpose. The training, although short, was considered sufficient which overcomes the issue 
of arranging face to face training, as this is difficult with a geographically widespread 
workforce (Ankolekar et al., 2014).  
Participants thought STEAM was simple, easy to use, fitted into their normal clinical 
assessments and could improve the transfer of care to the hospital. Use of a standardised 
tool to transfer information from the pre-hospital to the hospital setting has been shown to 
improve efficiency of information handover (Iedema et al., 2012). Feedback from the 
hospitals about the paramedics’ stroke diagnosis was infrequent but perceived as beneficial 
which mirrors previous findings (Hodell et al., 2016). Participants were also aware of the 
risks inherent in missing a true stroke patient based on application of STEAM and wanted 
STEAM to be as specific as possible if it was to be used in practice. 
Previous qualitative analysis of paramedic’s views on pre-hospital stroke research (Ankolekar 
et al., 2014) revealed that simplicity was valued by paramedics and that individual 
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paramedics encountered few suitable stroke patients, both of these findings were replicated 
in this work. The low rate of use was not unexpected given the number of participants, the 
duration of the testing and the small number of SM cases where STEAM would be triggered. 
Individual paramedics see relatively few strokes and confidence with a study intervention 
can come from repeated use (Ankolekar et al., 2014). This would need to be considered if 
STEAM were to be introduced as paramedics may forget or not complete items 
appropriately if it is rarely used in practice. Building STEAM into a bundle of care, a pathway 
or using a reminder like the EPCR may help embed it within practice and overcome the 
barrier of infrequent use. Bundles of care have been developed for stroke, and other 
conditions, and shown to standardise the collection and reporting of data and lead to 
improvements in care (Siriwardena et al., 2014).  
Various aspects of paramedic’s interactions with receiving hospitals were raised in the 
interviews. The influence of local pathways including which units would take stroke patients 
was discussed, which gave some context for how STEAM could change current practice. 
Paramedics have placed high importance on clear patient benefit and reported seeing their 
role as enabling access to the best treatment (Burges Watson et al., 2012) especially through 
getting the right patient to the right hospital. When all suspected stroke patients go to a 
single location the paramedics’ opinion has lower risk attached, but if a SM tool and 
redirection pathway were introduced then the risk of making the wrong decision has greater 
consequences. 
Discussing the interaction with receiving hospitals revealed a desire for feedback regarding 
transported suspected stroke patients. The lack of feedback has previously been reported as 
a concern for paramedics as it is seen as necessary to improve services (Oostema et al., 
2016). The introduction of a new assessment like STEAM would benefit from an established 
feedback system to encourage consistent completion and ongoing learning about SM 
presentations. 
Paramedics appeared to be comfortable with the idea of taking SM patients to ED rather 
than a stroke unit. SM presentations include a wide range of conditions, some of which are 
potentially life threatening or life changing similar to a stroke and some of which are less 
immediately concerning. The comment in the appropriate treatment theme about erring on 
the side of caution gives an insight into the mind-set of some paramedics who will always 
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treat for the worst case scenario and take the patient to where they perceive they will get 
the highest level of care. This mind-set could be driven by historic practices of taking every 
patient to hospital and perceptions of which hospitals provide the best care for a patient, 
but there may also be issues around accountability and what is perceived as the least risky 
option for the paramedic and the patient. This comment also highlights the difficulties 
clinicians face when trying to apply a decision tool derived from a population level dataset to 
an individual patient. Whether STEAM is perceived as a checklist, part of an algorithm with 
pre-determined actions or whether it is perceived as supporting autonomous decision 
making will depend on the paramedic in question and their view on how the profession 
should practice. 
2.3.5.1 Implications for overall project and future work 
The themes described in this chapter build upon those described in the initial focus groups 
(chapter 2.1). There are areas of overlap between themes including the actions triggered by 
STEAM, the decision making by the paramedics and how STEAM could be implemented 
across pre-hospital and acute trusts. Despite the low usage of STEAM the findings from this 
phase are useful for informing the development of STEAM to enhance its acceptability and 
usability. Key points that emerged were:   
 The age criterion was an area of concern.  
 The omission of BM was addressed in the criteria for STEAMv2. 
 The actions triggered by STEAM would need to be made clear during 
implementation.  
2.3.5.2 Strengths and limitations 
The findings reported in this chapter were largely consistent with the views expressed by 
paramedics in the national survey (chapter 1.3) and in the previous focus groups (chapter 
2.1) which reinforces the credibility of the findings.  
The small number of participants, and the lack of data from 40% of the participants, are 
limitations of this study. Technical issues at NEAS led to an inability to access a large number 
of EPCRs which limited the data available for the documentation evaluation. The non-
responders to the interview invitation may have had different experiences and views to 
those reported which would be a source of responder bias. The participants who did 
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respond agreed on most major topics regarding the acceptability and usability of STEAM. 
The small number of interviews, and the particular interest in stroke reported by two of the 
interview participants, means that these findings may not be representative of the wider 
paramedic population. As the aim of this work was to inform the development and future 
application of the STEAM tool, this is probably a lesser concern than might be the case for 
other studies, such as a process evaluation of a new intervention. 
Reflecting on the interviews forced me to consider whether my position as the researcher 
conducting the interviews may have influenced the findings. I was known to the participants, 
which is largely unavoidable in a small service like NEAS. I had no managerial responsibilities 
over any of the participants and did not work directly with them. However, it is still possible 
that the participants chose to assist and provide specific views because of pre-existing 
associations.   
2.3.6 Conclusions 
Paramedics who applied STEAM during the assessment of real patients found it easy to use. 
Participants liked the simplicity of STEAM but were open to a more complex tool and 
considered that STEAMv2 was acceptable. Paramedics reported a general lack of awareness 
or knowledge of SM which highlights the need for effective training on STEAM to support 
implementation in practice. There were no suggestions on changes to STEAM although the 
inclusion of a young age cut-off was questioned again. Clarifying the actions that application 
of STEAM could lead to, and how this could affect paramedics’ interactions with receiving 
hospitals, were key issues raised by participants.  
2.3.7 Summary 
The findings reported here build upon the stakeholder work reported in chapters 1.3 and 2.1 
and support the development of STEAM and the refinements made with STEAMv2. There 
were useful suggestions around how to implement STEAM in practice. No major issues with 
STEAM or STEAMv2 were raised by participants, although a positive responder bias should 
be considered. 
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Chapter 3.0 Summary of parts 1 and 2 and overview of part 3  
 
3.0.1 Introduction 
This brief chapter will recap parts 1 and 2 of the thesis and give a short overview of part 3. 
Figure 1.0.2 from chapter 1.0 is repeated below to illustrate the overall research process.  
 
Figure 1.0.2 Flowchart with overview of pre-hospital SM project 
3.0.2 Summary of part 1 
Part 1 described the background to pre-hospital and emergency stroke care. The systematic 
review summarised the frequency, underlying aetiology and common characteristics of SM 
and identified that SM were commonly encountered in the pre-hospital setting. The 
systematic review, the stroke focussed survey of UK paramedics and the creation of a linked 
dataset describing suspected stroke patients transported to NHCT by NEAS led to the 
development of the STEAM tool. 
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3.0.3 Summary of part 2 
Part 2 reported focus groups and interviews with paramedics and hospital clinicians which 
allowed their views around SM and the development, strengths and weaknesses of STEAM 
to be included within the development process. Part 2 described the refinement of STEAM 
into STEAMv2 based on the findings of the focus groups and expansion of the dataset from 
1,650 to 3,797 suspected stroke patients which improved the generalisability and the power 
of the predictive variables.  
3.0.4 Overview of part 3  
Part 3 includes the validation of STEAMv2 using a new dataset (n=1,848 suspected stroke 
patients) from a fourth acute trust which is reported in chapter 3.1. Chapter 3.2 employs a 
basic modelling approach to consider what high level impact STEAMv2 could have if it was 
introduced into clinical practice. Part 3 concludes with paramedic and clinician focus groups 
across two regions, the North East and the North West, to report professional stakeholder 
views on STEAMv2. 
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Chapter 3.1 Validation of the STEAMv2 tool 
 
3.1.1 Introduction 
STEAMv2 was developed and refined using data on suspected stroke patients transported by 
NEAS to three acute hospital trusts (NHCT, NUTH, NTEES). This chapter describes the 
validation of STEAMv2 which is the next stage in the development process. Validation 
involves testing the tool on new patients i.e. a dataset from a different source to the one 
used during development. It is important to validate a new tool in order to demonstrate that 
it performs as expected across other settings before it can be considered for widespread 
clinical use (Stiell, 1996; Altman et al., 2009).  
Three methods of validating a tool have been identified: internal, temporal and external 
(Altman et al., 2009). Internal validation involves splitting a single dataset into two parts, a 
training set and a validation set. Temporal validation involves data from the same location 
but from a separate time period.  External validation requires data from a different location 
to the original development dataset. In order to externally validate STEAMv2 data were 
collected from a fourth hospital trust and STEAMv2 was tested in this new dataset. 
3.1.2 Chapter aim and objectives 
The aim of this chapter is to describe external validation of the STEAMv2 tool. 
This objectives are: 
 Describe an external validation dataset of suspected stroke patients.  
 Determine the performance of STEAMv2 in the validation dataset. 
3.1.3 Methods 
The validation dataset was created using the same methods as the development (chapter 
1.4) and refinement (chapter 2.2) datasets. The method is summarised below: 
 Suspected stroke patients transported by NEAS were identified. 
 Data on variables relevant to stroke or SM diagnoses were collected from NEAS records. 
 NEAS suspected stroke patients were linked with hospital SSNAP and HES records to 
establish discharge diagnoses. 
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3.1.3.1 Setting 
Data for the external validation were collected from County Durham and Darlington NHS 
Foundation Trust (CDDFT) which includes two acute hospitals in the North East. University 
Hospital of North Durham (UHND) has a stroke unit and receives all stroke patients from the 
CDDFT catchment area. Darlington Memorial Hospital (DMH) is the second CDDFT acute 
hospital but does not routinely accept stroke patients. CDDFT provides care to around 
650,000 people in County Durham and the surrounding area. CDDFT admitted 691 
confirmed stroke patients in 2016/17. CDDFT consistently performs well in the SSNAP audit 
in criteria relevant to this work such as case ascertainment where it scored 80-90%+ from 
2014 onwards (RCP, 2017b).  
 
Figure 3.1.1 Map of the North East showing approximate catchment areas of all included 
hospital trusts. CDDFT is the lower left trust 
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Data were collected over the same period as the development and refinement cohorts. 
3.1.3.2 Data analysis 
Extraction, linkage and analysis of all data followed the same processes described in chapter 
1.4. All data were extracted into Excel and imported into SPSS for analysis. 
3.1.3.3 Approvals 
Local approvals were secured from NEAS and CDDFT for data sharing. 
3.1.4 Results 
3.1.4.1 The validation dataset 
There were 1,848 suspected stroke patients, including 605 (33%) SM, transported by NEAS 
to CDDFT hospitals within the study timeframe. 
3.1.4.2 Patient Selection 
The process of identifying suspected stroke patients transported by NEAS to CDDFT hospitals 
is shown in figure 3.1.2. 
 
Figure 3.1.2 Identification of NEAS suspected stroke patients transported to CDDFT 
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3.1.4.3 Patient discharge diagnoses 
From the total cohort of 1,848 suspected stroke patients 915 (50%) were identified as stroke 
patients using SSNAP. The remaining 933 suspected stroke patients who were not positively 
matched with the SSNAP data were searched for using the CDDFT electronic record system 
(HES).  
 156 patients were identified as TIA (ICD-10 codes G458 and G459) based on CDDFT 
HES records. 
 172 patients were identified as stroke based on CDDFT HES records including 
diagnostic codes I61, I63 and I64. 
 414 patients had a SM ICD-10 diagnosis. 
 191 patients were unable to be linked with either SSNAP or HES. These patients were 
all assumed to be SM. 
Combining these figures results in 1,243 (67%) stroke patients and 605 (33%) SM patients. 
3.1.4.4 CDDFT assumed SM patients 
SM patients were identified (n=605) by either confirmed non-stroke diagnosis (n=414, 68%, 
including any ICD-10 code other than I61, I63, I64 or TIA codes G458 and 459) in CDDFT HES 
system or assumed (n=191, 32%) based on inability to match with either SSNAP or HES.  
The patients assumed to be SM were compared with the patients with a confirmed SM 
diagnosis. 
Table 3.1.1 Comparison of CDDFT patients with confirmed SM diagnoses versus 
assumed SM diagnoses 
Diagnosis Age (mean, SD) Gender (% Male) 
Confirmed (n=414) 67.8 (16.9) 45 
Assumed (n=191) 71.2 (17.1) 47 
 
The two groups of SM patients were significantly different in age (independent samples t-
test, p=0.022) but not significantly different in gender (chi square test, p=0.615). 
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3.1.4.5 SM diagnoses 
One hundred and forty different ICD-10 diagnostic codes were recorded for the 414 patients 
with a confirmed SM diagnosis. The ICD-10 based SM diagnoses are displayed in table 3.1.2. 
Table 3.1.2 Most frequent ICD-10 diagnoses recorded for CDDFT SM patients 
ICD-10 
Code 
ICD-10 description 
Number (%) of 
patients 
R568 Convulsions, not elsewhere classified 34 (8%) 
G819 Hemiplegia, unspecified 25 (6%) 
R298 
Other symptoms and signs involving the nervous and 
musculoskeletal systems 25 (6%) 
R55X Syncope and collapse 24 (6%) 
G510 Bell's palsy 20 (5%) 
N390 Urinary tract infection, site not specified 17 (4%) 
G439 Migraine, unspecified 15 (4%) 
R478 Other speech disturbances 12 (3%) 
R51X Headache 11 (3%)  
R410 Disorientation, unspecified 9 (2%) 
G409 Epilepsy, unspecified 8 (2%) 
J181 Lobar pneumonia, unspecified organism 8 (2%) 
R268 Other abnormalities of gait and mobility 7 (2%) 
R470 Dysphasia and aphasia 6 (1%) 
G431 Migraine with aura 5 (1%) 
I219 Acute myocardial infarction, unspecified 5 (1%) 
C793 
Secondary malignant neoplasm of brain and cerebral 
meninges 4 (1%) 
F059 Delirium due to known physiological condition 4 (1%) 
G403 Generalized idiopathic epilepsy and epileptic syndromes 4 (1%) 
I609 Nontraumatic subarachnoid hemorrhage, unspecified 4 (1%) 
I620 Nontraumatic subdural hemorrhage 4 (1%) 
I629 Nontraumatic intracranial hemorrhage, unspecified 4 (1%) 
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Table 3.1.2 Most frequent ICD-10 diagnoses recorded for CDDFT SM patients cont. 
ICD-10 
Code 
ICD-10 description 
Number (%) of 
patients 
J22X Unspecified acute lower respiratory infection 4 (1%) 
R296 Repeated falls 4 (1%) 
Other Other conditions with less than 1% (n=4) prevalence 151 (36%) 
 
The ICD-10 codes were summarised using CCS codes as used in earlier chapters. The most 
frequent SM diagnoses represented using level 2 CCS codes are shown in table 3.1.3.  
Table 3.1.3 CDDFT SM diagnoses displayed using level 2 CCS codes 
CCS level 2 
code 
CCS description 
Number 
(%) of 
patients 
6.9 Other nervous system disorders 55 (13%) 
6.4 Epilepsy; convulsions 52 (13%) 
6.5 Headache; including migraine 34 (8%) 
13.8 Other connective tissue disease 30 (7%) 
17.1 Symptoms; signs; and ill-defined conditions 29 (7%) 
6.3 Paralysis 28 (7%) 
10.1 Diseases of the urinary system 20 (5%) 
7.3 Cerebrovascular disease 17 (4%) 
7.2 Diseases of the heart 15 (4%) 
8.1 Respiratory infections 13 (3%) 
Unknown Unknown 9 (2%) 
5.4 Delirium dementia and amnestic and other cognitive disorders 7 (2%) 
6.8 Ear conditions 6 (1%) 
7.4 Diseases of arteries; arterioles; and capillaries 6 (1%) 
16.2 Fractures 6 (1%) 
5.5 Developmental disorders [654] 5 (1%) 
6.2 Hereditary and degenerative nervous system conditions 5 (1%) 
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Table 3.1.3 CDDFT SM diagnoses displayed using level 2 CCS codes cont. 
CCS level 2 
code 
CCS description 
Number 
(%) of 
patients 
2.12 Secondary malignancies [42.] 4 (1%) 
2.3 Cancer of bronchus; lung 4 (1%) 
6.1 Central nervous system infection 4 (1%) 
8.8 Other lower respiratory disease 4 (1%) 
16.4 Intracranial injury 4 (1%) 
Other Other conditions with less than 1% (n=4) prevalence 57 (14%) 
 
The CCS codes were combined into level 1 CCS codes to show broader clinical groupings as 
shown in table 3.1.4.   
Table 3.1.4 CDDFT SM diagnoses displayed using level 1 CCS codes 
CCS1 
code 
CCS code description 
Number (%) of 
patients 
1 Infectious and parasitic diseases 4 (1%) 
2 Neoplasms 15 (4%) 
3 
Endocrine; nutritional; and metabolic diseases and 
immunity disorders 9 (2%) 
5 Mental Illness 21 (5%) 
6 Diseases of the nervous system and sense organs 187 (45%) 
7 Diseases of the circulatory system 39 (9%) 
8 Diseases of the respiratory system 23 (6%) 
9 Diseases of the digestive system 3 (1%) 
10 Diseases of the genitourinary system 22 (5%) 
12 Diseases of the skin and subcutaneous tissue 1 (<1%) 
13 
Diseases of the musculoskeletal system and connective 
tissue 35 (8%) 
16 Injury and poisoning 17 (4%) 
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Table 3.1.4 CDDFT SM diagnoses displayed using level 1 CCS codes cont. 
CCS1 
code 
CCS code description 
Number (%) of 
patients 
17 
Symptoms; signs; and ill-defined conditions and factors 
influencing health status 29 (7%) 
18 Residual codes; unclassified; all E codes [259. and 260.] 9 (2%) 
 
The CDDFT SM diagnoses are graphically displayed in figure 3.1.3 with figure 1.2.3 from the 
literature review repeated below for comparison. 
 
Figure 3.1.3 CDDFT SM diagnoses summarised using CCS codes 
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Figure 1.2.3 Taxonomy of SM using CCS codes (repeated from chapter 1.2) 
3.1.4.6 Patient characteristics 
The demographics of the CDDFT sample are displayed below. 100% of patients had a gender 
recorded. One patient had no age documented but was recorded as an adult so was 
included. 
Table 3.1.5 Demographics of NEAS suspected stroke patients transported to CDDFT 
reported by discharge diagnosis 
 Total 
sample 
Stroke SM P value 
Number patients 1,848 1,243 605 - 
Mean age (SD) 72.4 (14.5) 74.1 (12.9) 69.0 (16.8) <0.001 
Gender (% male) 48% 49% 46% 0.119 
 
The mean age for males in the CDDFT cohort was 70.5 (stroke 71.4, SM 68.3). The mean age 
for females in the CDDFT cohort was 74.2 (stroke 76.6, SM 69.6). 
3.1.4.7 Physiological observations 
The physiological observations recorded on suspected stroke patients transported to CDDFT 
hospitals are displayed in table 3.1.6 below.  
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Table 3.1.6 Physiological observations in NEAS data on suspected stroke patients 
transported to CDDFT reported by discharge diagnosis 
Physiological 
observation 
% of patients 
with 
observation 
documented 
Stroke  
(mean, SD) 
SM (mean, SD) P value 
BM (mmol/l) 94% 7.7 (3.0) 7.3 (2.6) 0.008 
GCS 100% 14 (1.6) 14 (1.9) 0.054 
Heart rate 100% 82 (17.6) 84 (18.8) 0.010 
Irregular pulse 97% 26% 17% <0.001 
Pain (0-10) 65% 0.3 (1.3) 0.8 (2.0) <0.001 
SaO2 99% 96 (2.6) 96 (3.1) 0.273 
Respiratory rate 99% 17 (2.7) 18 (3.4) 0.008 
SBP (mmHg) 99% 158 (26.9) 151 (27.3) <0.001 
DBP (mmHg) 99% 88 (16.5) 85 (17.0) 0.005 
Temperature (Celsius) 89% 36.5 (0.7) 36.5 (0.9) 0.122 
 
3.1.4.8 Past medical history 
The PMH of suspected stroke patients transported to CDDFT are shown in table 3.1.7 below. 
Table 3.1.7 Past medical history of NEAS suspected stroke patients transported to 
CDDFT reported by discharge diagnosis 
 Patients with 
condition (% of 
total patients) 
Stroke (% of 
stroke 
patients with 
condition) 
SM (% of SM 
patients with 
condition) 
P value 
PMH Alcohol 
misuse 
33 (2%) 17 (1%) 16 (3%) 0.052 
PMH Angina 192 (10%) 133 (11%) 59 (10%) 0.531 
PMH Diabetes 334 (18%) 227 (18%) 107 (18%) 0.763 
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Table 3.1.7 Past medical history of NEAS suspected stroke patients transported to 
CDDFT reported by discharge diagnosis cont. 
 Patients with 
condition (% of 
total patients) 
Stroke (% of 
stroke 
patients with 
condition) 
SM (% of SM 
patients with 
condition) 
P value 
PMH Epilepsy 59 (3%) 17 (1%) 42 (7%) <0.001 
PMH Heart failure 68 (4%) 44 (4%) 24 (4%) 0.647 
PMH High 
cholesterol 
375 (20%) 270 (22%) 105 (17%) 0.029 
PMH Hypertension 674 (37%) 500 (40%) 174 (29%) <0.001 
PMH MI 158 (9%) 110 (9%) 48 (8%) 0.509 
PMH Migraine 28 (2%) 17 (1%) 11 (2%) 0.457 
PMH Smoking 55 (3%) 42 (3%) 13 (2%) 0.144 
PMH Stroke 425 (23%) 220 (18%) 205 (34%) <0.001 
PMH TIA 326 (18%) 199 (16%) 127 (21%) 0.008 
 
3.1.4.9 Clinical signs and symptoms 
The signs and symptoms recorded by the paramedics are displayed below. 
Table 3.1.8 NEAS observation on suspected stroke patients transported to CDDFT 
reported by discharge diagnosis 
 Patients with 
condition (% of 
total patients) 
Stroke (% of 
stroke 
patients with 
condition) 
SM (% of SM 
patients with 
condition) 
P value 
Abnormal gait 180 (10%) 129 (10%) 51 (8%) 0.185 
AF 259 (14%) 197 (16%) 62 (10%) 0.001 
Alcohol/Drug use 
reported 
60 (3%) 34 (3%) 26 (4%) 0.075 
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Table 3.1.8 NEAS observation on suspected stroke patients transported to CDDFT 
reported by discharge diagnosis cont. 
 Patients with 
condition (% of 
total patients) 
Stroke (% of 
stroke 
patients with 
condition) 
SM (% of SM 
patients with 
condition) 
P value 
Arm weakness* 1182 (64%) 851 (69%) 331 (55%) <0.001 
Chest pain 10 (1%) 4 (<1%) 6 (1%) 0.065 
Confusion 493 (27%) 322 (26%) 171 (28%) 0.282 
Dizziness 195 (11%) 129 (10%) 66 (11%) 0.727 
Eye issues (FT)* 77 (4%) 67 (5%) 10 (2%) <0.001 
Facial droop or 
weakness 
1016 (55%) 724 (58%) 292 (48%) <0.001 
FAST+ve* 919 (50%) 647 (52%) 272 (45%) 0.004 
Floppy 82 (4%) 55 (4%) 27 (5%) 0.97 
General weakness 381 (21%) 242 (20%) 139 (23%) 0.08 
Headache 400 (22%) 229 (18%) 171 (28%) <0.001 
Leg weakness* 893 (48%) 663 (53%) 230 (38%) <0.001 
Nausea or 
vomiting* 
224 (12%) 159 (13%) 65 (11%) 0.206 
Neck Stiffness 14 (1%) 5 (<1%) 9 (2%) 0.012 
Seizures 46 (3%) 4 (<1%) 42 (7%) <0.001 
Speech symptoms 1255 (68%) 885 (71%) 370 (61%) <0.001 
Syncope 32 (2%) 11 (1%) 21 (4%) <0.001 
Tremors 44 (2%) 17 (1%) 27 (5%) <0.001 
Unconscious 62 (3%) 27 (2%) 35 (6%) <0.001 
Visual 
disturbances* 
179 (10%) 107 (9%) 72 (12%) 0.025 
*The same criteria for these characteristics were used as documented in chapters 1.4 and 
2.2. 
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3.1.4.10 Paramedic documentation of impression 
Paramedic impression was examined to see if it related to discharge diagnoses. Impression 
was grouped into three distinct categories: 
1. Stroke only = stroke as only suspected diagnosis. 
2. Stroke and TIA = stroke and TIA documented as only diagnoses. 
3. Stroke plus other = stroke included amongst multiple differential diagnoses. 
These three categories of impression were then compared with hospital discharge 
diagnoses. 
Table 3.1.9 Paramedic impression and discharge diagnoses - CDDFT 
Impression Total patients Stroke SM 
Stroke only 1,413 1,023 (72%) 390 (28%) 
Stroke and TIA 140 88 (63%) 52 (37%) 
Stroke plus others 295 132 (45%) 163 (55%) 
 
The stroke plus other impression category included stroke plus a median of 2 additional 
impressions (range 1-8, IQR 1-2). Stroke patients with impression of ‘stroke plus other’ had 
30 different impressions documented in addition to stroke. SM patients with impression 
‘stroke plus other’ had 37 different impressions documented in addition to stroke.   
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3.1.4.11 STEAMv2 performance in the validation dataset 
Applying STEAMv2 to the validation dataset generated the following results. 
Table 3.1.10 STEAMv2 output when applied to the validation dataset 
STEAMv2 score Total patients Stroke SM 
0 1,606 1,143 463 
1 202 94 108 
2 39 6 33 
3 0 0 0 
4 1 0 1 
Note: STEAMv2 positive rows are shaded. 
STEAMv2 identified 34 SM patients and 6 stroke patients in the validation dataset using 2+ 
as the cut-off. The characteristics that triggered STEAMv2 (n=34, true SM patients) were: 
 SBP + FAST-ve = 1 patient 
 Temperature + HR + Age<40 = 1 patient 
 Seizures + PMH epilepsy = 8 patients 
 Seizures + PMH Epilepsy + Age<30 = 1 patient 
 Seizures + FAST-ve = 4 patients 
 Seizure + Age<40 = 1 patient 
 Age<30 = 12 patients 
 Age<40 + FAST-ve = 5 patients 
 Headache + PMH migraine + Age<40 = 1 patient 
The STEAMv2 false positives (n=6, true stroke patients) triggered the following combinations 
of characteristics: 
 Age<30 = 2 patients 
 Age<40 + FAST-ve = 2 patients 
 Seizures + FAST-ve = 1 patient 
 Headache + PMH Migraine + FAST-ve = 1 patient 
None of the STEAMv2 false positives (n=6) were recorded as thrombolysed. 
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Scoring ≥2 on STEAMv2 generated the following performance characteristics, with 95% CI, 
when applied to the CDDFT validation dataset: 
 Sensitivity 5.6% (3.9-7.8) 
 Specificity 99.5% (99.0-99.8) 
 Positive predictive value (PPV) 85.0% (71.0-93.1) 
 Negative predictive value (NPV) 68.4% (68.0-68.8) 
 Positive likelihood ratio (PLR) 11.6 (4.9-27.6) 
 Negative likelihood ratio (NLR) 1.0 (0.9-1.0) 
 Odds ratio (OR) 12.3 (5.1-29.4)  
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3.1.4.12 Comparing the development, refinement and validation datasets 
The development dataset (NHCT: 1,650 suspected stroke patients with a 40% SM rate) was 
described in chapter 1.5.  
The refinement dataset (NHCT, NUTH and NTEES: 3,797 suspected stroke patients with a 
41% SM rate) was described in chapter 2.2. 
The external validation dataset (CDDFT) included 1,848 suspected stroke patients with a 33% 
SM rate. 
3.1.4.13 Patient demographics 
The demographics of the suspected stroke cohorts are displayed in table 3.1.11.  
Table 3.1.11 Demographics of NEAS suspected stroke patients reported by discharge 
diagnosis 
Dataset  Suspected 
stroke 
Stroke SM P value 
Development Patients  1,650 989 (60%) 661 (40%) - 
Mean age (SD) 75.3 (13.4) 77.0 (11.7) 72.8 (15.3) <0.001 
Gender (% 
male) 
47% 50% 41% <0.001 
Refinement  Patients 3,797 2,240 (59%) 1,557 (41%) - 
Mean age (SD) 73.6 (14.3) 75.6 (12.4) 70.8 (16.2) <0.001 
Gender (% 
male) 
48% 52% 44% 0.001 
Validation Patients 1,848 1,243 (67%) 605 (33%) - 
Mean age (SD) 72.4 (14.5) 74.1 (12.9) 69.0 (16.8) <0.001 
Gender (% 
male) 
48% 49% 46% 0.119 
 
The mean age was statistically different (p<0.05) in all three diagnostic groups between the 
refinement and validation datasets. There was no statistical difference between the gender 
split in any of the diagnostic groups. 
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3.1.4.14 Source of diagnoses of suspected stroke patients 
The sources of the diagnoses for the NEAS suspected stroke patients in the development, 
refinement and validation datasets are reported in table 3.1.12. 
Table 3.1.12 Sources of diagnoses for suspected stroke patients 
 Development Refinement Validation 
Suspected stroke 
patients 
1,650 3,797 1,848 
Stroke based on SSNAP 839 (85%) 1,913 (85%) 915 (74%) 
Stroke based on HES 66 (7%) 163 (7%) 172 (14%) 
TIA based on HES 84 (8%) 164 (7%) 156 (13%) 
Total Stroke (inc TIA) 989 2,240 1,243 
SM based on HES 526 (80%) 990 (64%) 414 (68%) 
Assumed SM 135 (20%) 567 (36%) 191 (32%) 
Total SM 661 1,557 605 
Note. Percentages refer to the percentage of the relevant diagnostic group (stroke or SM) 
for each hospital i.e. 85% of 989 stroke diagnoses in the development cohort were based on 
SSNAP. 
3.1.4.15 Assumed SM patients 
SM patients were identified by either confirmed non-stroke diagnosis (any ICD-10 code 
other than I61, I63, I64 or TIA codes G458 and 459) in hospital HES systems or assumed 
based on inability to match with either SSNAP or HES. Patients with an assumed SM 
diagnosis are compared with patients with a confirmed SM diagnosis in table 3.1.13 below.  
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Table 3.1.13 Comparison of patients with confirmed SM diagnoses versus assumed SM 
diagnoses 
 Diagnoses Age  
(mean, SD) 
Gender  
(% Male) 
Development (n=661) Confirmed (n=526) 74.0 (14.7) 41 
Assumed (n=135) 67.5 (17.4) 41 
Refinement (n=1,557) Confirmed (n=990) 72.2 (15.6) 43 
Assumed (n=567) 68.3 (17.0) 46 
Validation (n=605) Confirmed (n=414) 67.8 (16.9) 45 
Assumed (n=191) 71.2 (17.1) 47 
 
Patients in the refinement dataset with a confirmed SM diagnosis were significantly older 
(independent samples t-test, p<0.001) than patients in the validation dataset. Patients with 
an assumed SM diagnosis were significantly younger (independent samples t-test, p=0.020) 
in the refinement dataset than patients in the validation dataset. There were no significant 
differences between the refinement and validation cohorts in terms of gender (chi squared 
test, confirmed diagnosis p=0.794, assumed diagnosis p=0.583). 
3.1.4.16 STEAMv2 results in datasets 
The results of applying STEAMv2 to the refinement and validation datasets are shown in 
table 3.1.14.  
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Table 3.1.14 Suspected stroke patients displayed by number of STEAM characteristics 
Dataset Number of 
positive STEAMv2 
characteristics 
Total patients Stroke  
(n, %) 
SM  
(n, %) 
Refinement 
(n=3,797) 
0 3,283 2,070 (63) 1,213 (37) 
1 421 162 (38) 259 (62) 
2 84 8 (10) 76 (90) 
3 8 0  8 (100) 
4 1 0 1 (100) 
Validation 
(n=1,848) 
0 1,606 1,143 (71) 463 (29) 
1 202 94 (47) 108 (53) 
2 39 6 (15) 33 (85) 
3 0 0 0 
4 1 0 1 (100) 
Note: STEAMv2 positive rows are shaded. 
3.1.4.17 STEAMv2 performance in datasets 
The performance of STEAMv2 in the validation dataset is described alongside the 
performance in the refinement dataset in table 3.1.15. STEAMv1 performance in the 
refinement and validation datasets is also displayed for comparison. 
Table 3.1.15 STEAM tool performance in the validation and refinement datasets 
  Validation dataset Refinement dataset Change 
STEAMv2 Sensitivity (95% CI) 5.6% (3.9-7.8) 5.5% (4.4-6.7) +0.1% 
Specificity (95% CI) 99.5% (99.0-99.8) 99.6% (99.3-99.9) -0.1% 
PPV (95% CI) 85.0% (70.5-93.1) 91.4% (83.8-95.6) -6.4% 
STEAMv1 Sensitivity (95% CI) 10.6% (8.2-13.3) 11.1% (9.5-12.7) -0.5% 
Specificity (95% CI) 98.0 (97.1-98.7) 98.3% (97.6-98.8) -0.3% 
PPV (95% CI) 71.9 (62.0-80.1) 81.5% (75.8-86.1) -9.6% 
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3.1.5 Discussion 
This chapter describes the validation of STEAMv2. A new dataset was created linking NEAS 
suspected stroke patients with hospital diagnoses from CDDFT in order to test the 
performance of STEAMv2 on patients who were not involved in the development or 
refinement process. STEAMv2 performed consistently in terms of sensitivity and specificity 
but the PPV dropped from 91.4% in the refinement dataset to 85.0% in the validation 
dataset.  
The validation dataset was the largest cohort from any individual trust and it differed from 
the refinement dataset in a number of ways. Patients in the validation dataset were younger 
than the patients used to develop STEAMv2. Stroke and SM patients were similar in terms of 
gender unlike the refinement dataset where there was a significant difference. The 
demographics of the assumed SM patients, which were examined separately, also showed a 
difference to the refinement dataset. Assumed SM patients were older than confirmed SM 
patients in the validation dataset compared to the refinement dataset where assumed SM 
patients were younger. The increased age of the assumed SM patients in the validation 
dataset could suggest that there were more stroke patients in this group as the overall 
populations were similar in terms of age. However, without true diagnoses for the assumed 
SM patients the cause of this difference is difficult to isolate.  
The validation dataset had a lower SM rate (33%) than the refinement dataset (41%) and 
CDDFT had the lowest SM rate of the four trusts who were involved. CDDFT had a slightly 
different process for admitting suspected stroke patients to the other three trusts. Due to 
the need to bypass one CDDFT hospital to access the stroke unit, NEAS paramedics can 
telephone the CDDFT stroke unit and discuss the suspected stroke patient before 
transporting them. This input may have influenced practice in crews local to CDDFT by 
making paramedics more cautious about labelling patients with less clear presentations as 
stroke. The younger age of CDDFT suspected stroke patients could also mean less very 
elderly patients with multiple comorbidities were considered as suspected stroke, or 
accepted by the stroke unit, due to the local redirection process.  
The stroke diagnoses in the validation dataset presented in a different pattern to the 
development and the refinement datasets with less patients being directly matched with 
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SSNAP and more stroke diagnoses being found via HES. The TIA rate in the validation dataset 
was also nearly double the rate of the development or refinement datasets.  
The differences in demographics, SM rate and pattern of diagnostic sources suggests that 
suspected stroke patients in the validation dataset were a slightly different population to the 
suspected stroke patients in the refinement dataset where the demographics, SM rates and 
diagnostic patterns were more consistent across the three trusts included. The discharge 
data collection processes varied between the four acute trusts depending on the level of 
technical support available so there may have been factors specific to the CDDFT data that 
influenced the SM rate. These differences could have influenced the performance of 
STEAMv2 in the validation dataset.   
STEAMv2 performed consistently in terms of sensitivity and specificity in the validation 
dataset but the PPV dropped from 91.4% in the refinement dataset to 85.0% in the 
validation dataset. This PPV value is still above the original STEAMv1 value from the 
development dataset (84%) which was considered acceptable by participants in the first 
round of focus groups (chapter 2.1). The lower PPV may also have been influenced by the 
lower rate of SM in the validation dataset. Another reason for this may have been the higher 
rate of FAST-ve stroke patients in the validation dataset (validation 54%, refinement 43%). 
This influenced the reduced PPV of STEAMv2 in the validation dataset as two-thirds of the 
false positives were FAST-ve strokes compared to only half in the refinement dataset. 
One of the issues with prognostic models like STEAMv2 that prevents them being adopted 
into clinical practice is lack of validation (Altman et al., 2009). The TeleStroke Mimic score 
(Ali et al., 2014), described in chapter 1.1, (which included age and seizures similar to 
STEAMv2) was the only SM tool with repeated validation studies. The TeleStroke Mimic 
score had internal and external validation in the original development paper and reported 
performance in terms of AUC of 0.75 for the development and 0.71 and 0.77 for the 
validation cohorts. It was then validated in an external telehealth cohort with an AUC of 0.70 
(Ali et al., 2016) and a mobile stroke unit study (Ali et al., 2018) which reported an AUC of 
0.74. These values compare to the AUC for STEAMv2 of 0.75 (refinement) and 0.77 
(validation). More recently the TeleStroke Mimic score has been evaluated in the pre-
hospital setting in Germany (Geisler et al., 2018). This study used data collected from a 
previous mobile stroke unit study to test the TeleStroke Mimic score. They found similar 
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demographic and PMH risk factors, a similar pattern of SM aetiologies and the same inverse 
relationship between sensitivity and specificity. 
3.1.5.1 Strengths and limitations 
The validation data were based on suspected stroke patients transported to CDDFT which 
provided a new dataset and was therefore classed as external validation. A future study 
could consider the performance of STEAMv2 in a different ambulance service to repeat the 
validation and increase the generalisability.  
Despite the large number (n=1,848) of patients in the CDDFT dataset, the differences in 
demographics, characteristics and patterns of diagnoses mean that this is a slightly different 
population to the refinement population. This could be considered fortuitous as it allowed 
STEAMv2 to be tested in a slightly different population, but also leads to cautious 
interpretation as there may be differences in the local processes, paramedic behaviour or 
other unknown factors, that influenced the composition of the stroke and SM populations. 
3.1.6 Conclusions 
Altman et al stated that ‘simplicity and reliability of measurements are important criteria in 
developing clinically useful prognostic models’ (Altman et al., 2009). STEAMv2 is a simple 
tool which was validated in this new dataset. Despite some differences between the 
validation dataset and the refinement dataset, STEAMv2 performed consistently apart from 
a small reduction in the PPV.  
3.1.7 Summary 
STEAMv2 has been developed, refined and validated using data from NEAS linked with 
discharge diagnoses from four acute trusts in the North East. The process of developing 
STEAMv2 was informed by focus groups with paramedics and clinicians, and usability testing 
by NEAS paramedics. The potential impact of STEAMv2 will be explored in the next chapter 
which will use simple modelling to consider potential outcomes. This is followed by chapter 
3.3 which reports the findings from a second phase of focus groups including the views of 
paramedics and clinicians from the North East and the North West. 
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Chapter 3.2 Modelling of potential impact of STEAMv2 
 
3.2.1 Introduction 
This chapter describes how the potential impact of introducing STEAMv2 into clinical 
practice was considered. Moons et al (Moons et al., 2009a) described three options for 
assessing the impact of a prognostic tool like STEAMv2: firstly, use conclusive evidence from 
development and validation studies to introduce the tool and observe its impact in practice; 
secondly, conduct further pragmatic research to expand the evidence base; thirdly, use 
modelling to explore the possible consequences of applying the tool. This chapter uses the 
third approach and describes a simple decision tree modelling approach. This modelling was 
then used to consider the impact that application of STEAMv2 could have across a range of 
care delivery outcomes. 
3.2.2 Chapter aims and objectives 
The aim of this chapter is to model and consider what impact STEAMv2 could have if it was 
applied in clinical practice.  
The objectives are: 
 Apply STEAMv2 to a simple model of pre-hospital stroke care.  
 Discuss how introducing STEAMv2 into pre-hospital stroke care could impact on 
stroke outcomes. 
3.2.3 Methods 
Simple models were developed to conceptualise and explore the impact of STEAMv2 on pre-
hospital stroke care. Pitt et al described three modelling approaches commonly used in 
healthcare research: qualitative modelling, mathematical modelling, and simulation (Pitt et 
al., 2016). As the purpose here was to understand the impact of an additional SM 
identification step upon the hyper acute stroke system, which includes pre-hospital and the 
acute hospital treatment, a simple mathematical modelling approach was chosen using 
discrete patient groups rather than using individual patient data in a simulation. This allowed 
the main components of the clinical care process to be represented and thereby generate 
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insight into patient pathways, the practical impact of key decisions and the resulting trade-
offs. 
The pre-hospital and hospital process was defined by a conceptual model to inform the 
creation of a mathematical decision tree representing the key decisions in pre-hospital 
stroke care. Adjusting the variables representing characteristics such as accuracy of stroke 
identification and application of the STEAMv2 tool allowed various system configurations to 
be considered. 
Four outcome categories are discussed related to the performance of a hyper-acute stroke 
system including: reperfusion treatment rates and speeds; disability impact; resource 
implications; and health economic outcomes (Monks et al., 2015).  
The overall process that will be discussed is summarised in figure 3.2.1 below. 
 
Figure 3.2.1 Stroke patient pathway from pre-hospital stroke care to system outcomes 
3.2.4 Conceptual model of pre-hospital stroke care 
Existing models describing acute stroke care were examined to help define the most 
relevant components of the proposed clinical pathway. Some models identified that the 
ambulance service was one of multiple routes by which stroke patients could arrive at 
hospital (Monks et al., 2012; Doggen et al., 2016), whereas others simply incorporated a 
time delay element in the pre-hospital phase without specifying a mode of admission (Bayer 
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et al., 2010; Lahr et al., 2013; Jacobson et al., 2015). For this purpose, modes of admission 
other than ambulance were not relevant as their care pathway would not be affected by the 
introduction of a paramedic SM tool. Churilov et al (Churilov et al., 2013) and Sheppard et al 
(Sheppard et al., 2015a) modelled the pre-hospital phase of acute stroke care and included 
pathways representing the potential for paramedics to recognise or not-recognise stroke.  
A simple conceptual model of the pre-hospital stroke pathway was created (figure 3.2.2) 
based upon the UK ambulance clinical practice guidelines (Association of Ambulance Chief 
Executives and Joint Royal Colleges Ambulance Liaison Committee, 2016). Pre-alerting was 
the only action included, as it is the only intervention other than stroke recognition in 
common paramedic practice that directly impacts on processes associated with stroke 
patient outcomes. Pre-alerting is discussed further below. As the focus of the model was the 
impact of paramedic identification of stroke versus SM it does not include the initial 999 call 
taker identification of stroke.  
 
Figure 3.2.2 Simple conceptual model of pre-hospital stroke pathway 1 
The model was then expanded to consider how suspected stroke patients would be directed 
towards hospital services, the actions that could be taken in the pre-hospital setting and the 
potential destinations (figure 3.2.3). Each box represents a possible choice or outcome so 
patients may or may not be pre-alerted. 
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Figure 3.2.3 Simple conceptual model of pre-hospital stroke pathway 2 
This simple conceptual model represents the key decisions and stages in the pre-hospital 
flow of suspected stroke patients and shows the potential outcomes in terms of the 
patient’s final destination. The SM tool was added to the pre-hospital stroke recognition 
stage (figure 3.2.4), where it can be used in combination with normal pre-hospital stroke 
recognition tools. This permits representation of the most relevant pathways which could 
occur including the additional pre-hospital identification process e.g. a stroke patient 
(population) could be identified as stroke and not SM (pre-hospital recognition) who is then 
pre-alerted (pre-hospital action) to the local HASU (destination).  
 
Figure 3.2.4 Simple conceptual model of pre-hospital stroke pathway 3 
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3.2.4.1 Population 
The population considered by this model could be simply stated as ‘suspected stroke 
population’ but this fails to consider that there are a population of stroke patients who will 
not be recognised (missed stroke or “stroke chameleons”). This group of patients need to be 
acknowledged when considering the number of patients who may be affected by any change 
to pre-hospital stroke pathways. 
3.2.4.2 Pre-hospital recognition 
Pre-hospital stroke recognition is based on the FAST in the UK, but this model could 
represent any stroke identification tool or process. The addition of the SM tool to this stage 
of the process shows how it is intended to work in conjunction with the initial stroke 
identification and how the combination would affect the actions which follow. 
3.2.4.3 Pre-hospital actions  
The only pre-hospital action in the current model is whether the patient is pre-alerted into 
hospital or not. It is impossible to say whether stroke chameleons, SM patients or non-
strokes would be pre-alerted to hospital as it depends on the overall condition of the 
patient, the attending paramedic and the local pathways and procedures. Pre-alerting is also 
influenced by the patient’s destination as some receiving units will require a pre-alert and 
others will not. The impact of pre-alerting is considered further under the treatment rates 
and speeds outcomes section.  
3.2.4.4 Destination 
Transportation to either ED or HASU are the two options available to paramedics who have 
identified a suspected stroke patient. The HASU may be at the local hospital or it may be at a 
distant hospital depending on the patients’ location and the organisation of services in that 
area. Therefore, there are three potential destinations included in the model: nearest ED; 
local HASU; or distant HASU. 
3.2.5 Decision tree model of pre-hospital stroke recognition 
Based on the conceptual model described above a mathematical model of pre-hospital 
stroke recognition was constructed to represent how a SM tool impacts on pre-hospital 
stroke recognition which is the first two components of the conceptual model i.e. definition 
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of the stroke and SM population. The focus is on these early stages as they determine the 
following course of action and the destination, in addition destination only becomes relevant 
when there are multiple possibilities. This model was structured as a decision tree (as shown 
in figure 3.2.5) with the underlying algorithm performed by Microsoft Excel. Decision tree 
modelling has previously been used to explore pre-hospital treatment of acute stroke 
(Lorenz et al., 2015), optimizing stroke care for thrombolysis (Penaloza-Ramos et al., 2014), 
and the impact of mechanical thrombectomy (McMeekin et al., 2017).  
The decision tree is a very simple representation of the pre-hospital recognition of stroke 
and the application of a SM tool. It does not account for any information which could 
influence that decision in clinical practice e.g. paramedic seniority or the patient’s 
combination of symptoms. This decision tree model was then used to consider the 
application of STEAMv2 in three scenarios: 
1. A theoretical population of 1,000 stroke patients. 
2. The North East region. 
3. The whole of the UK. 
 
 
Figure 3.2.5 Decision tree representation of pre-hospital stroke recognition (FN, false 
negative; TP, true positive; FP false positive; TN, true negative) 
 
 233 
 
3.2.6 Scenario 1: Applying STEAMv2 to a theoretical population 
The stroke population was set at 1,000 patients as a population size that represents one year 
of HASU stroke admissions, and is a convenient unit for scaling up and down. In the scenario 
below the model is parameterised with variables reflecting the probabilities and 
consequences of key decisions within each stage. The data used to parameterise decisions 
are described below in table 3.2.1. 
Table 3.2.1 Values used in scenario 1  
Parameter Value(s) Source(s) 
Stroke population 1,000  
SM rate 40% Chapters 1.4, 2.2 
Sensitivity pre-hospital stroke 
recognition 
79% Based on FAST. (Harbison et al., 
2003; Rudd et al., 2016a) 
PPV pre-hospital stroke recognition 60% Chapters 1.4, 2.2 
Sensitivity pre-hospital SM recognition 5% Chapter 2.2 (STEAMv2) 
PPV pre-hospital SM recognition 91% Chapter 2.2 (STEAMv2) 
 
Application of STEAMv2 was modelled reflecting the following degrees of implementation 
within the ambulance service: 
 Scenario 1a. No SM tool (current standard practice). 
 Scenario 1b. 50% STEAMv2 tool use. 
 Scenario 1c. 100% STEAMv2 tool use. 
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Table 3.2.2 Outputs from scenario 1  
 Scenario 1a  
(0 SM tool use) 
Scenario 1b  
(50% STEAMv2 use) 
Scenario 1c  
(100% STEAMv2 use) 
True positive: stroke  790 789 787 
False negative: 
stroke 
210 210 210 
False positive: SM  316 303 290 
True positive: SM 0 13 26 
False positive: 
stroke 
0 1 3 
Overall sensitivity of 
stroke recognition 
79% 79% 79% 
Overall PPV of 
stroke recognition 
60% 61% 61% 
Combined PPV of 
stroke and SM 
recognition 
60% 61% 62% 
 
This simple scenario shows the small numbers of patients who would be identified by 
STEAMv2 (n=29 if 100% use) and the very small impact this has on the predictive value of 
pre-hospital stroke recognition overall. 
3.2.7 Scenario 2: Applying STEAMv2 in the North East 
Scenario 1 demonstrated that STEAMv2 had minimal impact on stroke recognition when a 
population of 1,000 stroke patients was considered but it does not account for pre-hospital 
actions, different destinations or a system with multiple admission routes to hospital. The 
context in which a SM identification tool such as STEAMv2 becomes potentially more useful 
is across a region with multiple hospitals and the potential to bypass local hospitals to access 
distant HASUs. In this situation SM identification becomes potentially more impactful. 
Whole-system simulation modelling of patient transportation to multiple hospitals requires 
consideration of a large number of variables including: 
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 Local admission criteria 
 Local pre-alert requirements 
 Travel times and distances 
 Time taken and delays at various stages 
 Secondary transfers for stroke patients transported to a hospital without stroke 
services  
 Repatriation criteria.  
 
Modelling these variables would be necessary to understand the impact of introducing an 
additional decision stage for SM identification into a more realistic system with multiple 
hospitals, but this would introduce far more complexity than could be factored into a simple 
analytical mathematical model. Multiple hospital systems would also be difficult to 
generalise as they would be heavily influenced by local geography and pathways. 
A simple decision tree like figure 3.2.5 cannot adequately represent a regional pathway due 
to the multiple destinations and the factors described above, however if the region is 
considered as a single entity then a simple model can be applied.  
3.2.7.1 The North East 
The North East region served by NEAS stretches from the borders of Scotland in the north to 
Teesside in the south and across to Cumbria in the west. This area covers 3,230 square miles 
and includes 2.71 million people. In 2018 the North East included eight acute hospital trusts, 
nine EDs and six acute stroke units (North East Ambulance Service NHS Foundation Trust, 
2018).  
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Figure 3.2.6 Map of the North East (Wikivoyage, 2006)  
Three out of nine North East EDs do not accept stroke patients, these are the Queen 
Elizabeth Hospital in Gateshead (QE), South Tyneside District General Hospital (STGH) and 
Darlington Memorial Hospital (DMH). These three hospitals serve approximately 490,000 
people (QE 200k, STGH 140k, DMH 150k) which is 18% of the North East population. The 
NEAS stroke pathway redirects suspected stroke patients in the catchment areas of these 
three hospitals to the nearest hospital with a HASU. 
The NEAS data on regional suspected stroke admissions (chapter 1.4) reported 24,764 
patients attended by NEAS over three years. Based on this, the mean number of suspected 
stroke patients attended each year was 8,254. 
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Data from the North East Stroke Improvement Network estimated 13 stroke admissions per 
day across the North East. This equates to 4,745 stroke admissions per year. If a 40% SM rate 
is assumed (based on chapters 1.4 and 2.2) then the total suspected stroke admissions 
would be 7,908 per year.  
Based on these data, a reasonable approximation for suspected stroke admissions in the 
North East region is 8,000 per year. 
3.2.7.2 STEAMv2 impact on the North East 
The impact of applying STEAMv2 to patients who currently bypass their local ED to access 
HASU care in the North East region can be modelled with the following assumptions based 
on the 2018 organisation of stroke services: 
 8,000 annual suspected stroke admissions 
 40% SM rate 
 18% bypass rate 
 Pre-hospital stroke identification (FAST) = 79% sensitive, 60% PPV 
 STEAMv2 = 5% sensitive, 91% PPV 
 100% implementation. 
 
If STEAMv2 was only applied to the 18% of suspected stroke patients that could potentially 
bypass a local ED (n=1,440) then 42 patients would be identified by STEAMv2 comprising 38 
SM and 4 true stroke patients. If more services moved towards centralisation and local 
bypass, STEAMv2 would affect an increasing number of patients. The results of calculating 
these figures, using the assumptions stated above, over a range of bypass activity from 5-
75% are displayed in chart 3.2.1. 
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3.2.8 Scenario 3: Applying STEAMv2 to the UK population 
The impact of STEAMv2 on stroke admissions across the UK can be considered by scaling up 
the simple regional model used above. If the following assumptions are made: 
 100,000 strokes per year 
 40% SM rate 
 18% bypass rate 
 Pre-hospital stroke identification = 79% sensitive, 60% PPV 
 STEAMv2 = 5% sensitive, 91% PPV 
 100% implementation 
 
If STEAMv2 was applied to all suspected stroke patients then it would identify 2,893 patients 
of which 2,633 would be SM and 260 would be stroke patients. If an 18% bypass rate was 
assumed to identify patients who may be transported to a different hospital based on 
STEAMv2 application, then the national patient population affected is 520 patients including 
474 SM and 46 stroke patients. 
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3.2.9 Discussion 
This chapter aimed to model what impact STEAMv2 would have on pre-hospital stroke 
recognition if it was applied in clinical practice. A conceptual model of pre-hospital stroke 
care was developed which informed a mathematical model which showed that applying 
STEAMv2 in clinical practice would affect the admission destination for a small number of 
patients. However to make a judgement about its value, the impact on patient and system 
outcomes needs to be considered relative to the simplicity and low cost of the additional 
assessment step. The potential impact of pre-hospital SM identification on the four hyper-
acute stroke system outcomes identified by Monks et al (Monks et al., 2015): treatment 
rates and speeds; population disability impact; resource implications; and health economics, 
are discussed with reference to the simple models developed above.  
3.2.9.1 Treatment rates and speeds 
The key treatment for acute ischaemic stroke patients is thrombolysis. Although 15-20% of 
ischaemic stroke patients are expected to be eligible for thrombolysis, only 11-12% were 
treated with thrombolysis in the UK (RCP, 2017a). Thrombolysis rates are linked to speed of 
access to the treatment due to the 4.5 hour treatment window and the clear association 
between time since onset and benefit (Emberson et al., 2014). The pre-hospital factors that 
impact on the time to treatment include identification of stroke, the time spent in the pre-
hospital phase and whether or not the paramedic pre-alerts the patient.  
3.2.9.2 Missed stroke  
The discussion so far has focussed on the impact on patients diagnosed as stroke by 
ambulance services but there are patients where the diagnosis is missed (stroke 
chameleons) in the pre-hospital setting.  
Richoz et al (Richoz et al., 2015) described the outcomes of stroke chameleons attending a 
university hospital in Switzerland. They discussed how missed stroke diagnoses impacted on 
patient outcomes by missed thrombolysis opportunities in 23% of patients, delayed access 
to specialist care and extended the time before secondary prevention was implemented. 
Stroke chameleons had a lower chance of a favourable outcome (modified Rankin Scale 
(mRS) <3) and increased mortality rates compared to recognised stroke patients. Arch et al 
(Arch et al., 2016) reported on patients whose stroke diagnosis was initially missed in the ED. 
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In this population they showed that patients with an initially missed stroke diagnosis had a 
longer stay in hospital (6.9 days vs 5.9 days) and a higher rate of readmission within 60 days 
(33% vs 17%). Therefore improving overall identification of genuine stroke remains a 
priority.    
Efforts to improve the pre-hospital detection of stroke by introducing tools like FAST-AVVV 
(ataxia, vomiting, vertigo, visual deficit) or other tools including symptoms aimed at 
identifying posterior stroke may reduce the rate of missed strokes. However, these would 
potentially increase the SM rate. An expanded initial identification tool, with higher 
sensitivity but lower specificity, could be used in sequence with a tool like STEAMv2 where 
the combination may provide an improvement in overall performance. 
3.2.9.3 Pre-hospital treatment times 
Internal data from NEAS showed that between March 2017 and February 2018 the mean call 
to ambulance arrival was 19 minutes, the mean on scene time was 29 minutes and the mean 
travel time to hospital was 15 minutes for stroke patients. Combining these figures gives a 
mean call to hospital time of 63 minutes. 
The NEAS figures are slightly higher than figures reported by other UK ambulance services. A 
report by London Ambulance Service (LAS) (Clinical Audit and Research Unit, 2017) described 
stroke patients attended and transported by LAS. The median response time for suspected 
stroke patients was 7 minutes. The median on scene time was 32 minutes. 99% of patients 
were transported directly to a HASU with a median transport journey time of 15 minutes. 
The median overall call to HASU time was 55 minutes with a slight improvement (median 51 
minutes) if stroke was identified on the initial 999 call or a slight delay (median 60 minutes) 
if stroke was not identified on the initial 999 call. Sheppard et al (Sheppard et al., 2015b) 
described a median dispatch to hospital time of 42 minutes which was not affected by FAST 
status or pre-alerting in a UK cohort from the West Midlands.  
Introduction of STEAMv2 should have a minimal impact on pre-hospital treatment times 
unless it changed the destination hospital. Where STEAMv2 introduction could make a 
difference is pre-alerting. 
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3.2.9.4 Pre-alerting by paramedics   
Pre-alerting has been recognised as a key pre-hospital intervention that impacts on stroke 
patient outcomes. Pre-alerting by paramedics was independently associated with shorter 
time to medical assessment for stroke patients in a small Australian study (Mosley et al., 
2007). The link between pre-alerting and stroke patient outcomes was expanded upon in a 
large American study by Lin et al (Lin et al., 2012). Lin et al reported that paramedic pre-
alerting of stroke patients was associated with shorter in-hospital times to interventions, 
such as scanning and thrombolysis, associated with improved patient outcomes.  
Abboud et al (Abboud et al., 2016) showed that pre-hospital identification of stroke plus an 
appropriate pre-alert resulted in a shorter door to CT time than for those patients not 
recognised as stroke who were not pre-alerted (19 minutes vs 48 minutes). McKinney et al 
(McKinney et al., 2013) also showed a reduction in in-hospital time to CT scan interpretation 
(38 vs 48 minutes) and lab results (45 vs 54 minutes) for pre-alerted patients. Oostema et al 
(Oostema et al., 2014) reported that pre-alerting and high priority transportation were 
associated with rapid door to CT times. Oostema et al also documented that missed strokes 
were pre-alerted and transported as a high priority less often. Mckinney et al and Oostema 
et al both reported a trend towards increased rates of thrombolysis in pre-alerted patients 
but both studies had small numbers of patients who received thrombolysis so didn’t draw 
firmer conclusions. Hsieh et al (Hsieh et al., 2016) showed that ambulance pre-alerting 
significantly reduced the door to CT time by 6 minutes and showed a trend towards earlier 
administration of thrombolysis in a Taiwanese stroke system using CPSS, which is very 
similar to FAST. 
3.2.9.5 Summary of treatment rates and speeds 
Pre-hospital stroke care is about rapid recognition of stroke, minimising the time spent in 
the pre-hospital phase and appropriately pre-alerting the receiving hospital. The 
introduction of a SM tool may mean that some SM patients would not be pre-alerted or 
treated with the same urgency as a suspected stroke patient. However, STEAMv2 
introduction would potentially reduce the number of SM pre-alerted as stroke which could 
lead to increased confidence when a stroke pre-alert was placed that it would be a stroke 
and require urgent attendance. For outcomes related to treatment rates and speeds 
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introduction of a SM tool has benefits that are difficult to quantify, but which are likely to be 
small if they exist, and clear risks in terms of delayed access to treatment for stroke patients 
mistakenly identified as SM. 
3.2.9.6 Population disability impact 
There are two mechanisms by which pre-hospital stroke care, and identification of SM, could 
impact on the level of disability in the population. The first is by impacting on time to 
reperfusion treatment in the form of thrombolysis which reduces disability, which was 
discussed in the previous section. The second area of impact would be on timely access to 
specialist stroke units. 
Although thrombolysis is a key part of hyper-acute stroke care another very important 
aspect is rapid access to specialist stroke services which is beneficial for all stroke patients, 
nor just the minority who are eligible for thrombolysis. A Cochrane review (Stroke Unit 
Trialists Collaboration, 2013) reported that “Stroke patients who receive organised inpatient 
care in a stroke unit are more likely to be alive, independent, and living at home one year 
after the stroke”. Silvestrelli et al (Silvestrelli et al., 2006) reported that early (<3 hours) 
admission to a stroke unit improved functional outcomes in a cohort that excluded 
thrombolysis. Turner et al (Turner et al., 2015) showed that early access to a stroke unit was 
associated with increased odds of survival over the first year.  
Monks et al (Monks et al., 2016) modelled stroke unit capacity and showed that the number 
of acute beds was linked to delays in accessing the stroke unit for patients. As SM patients 
account for between 1 in 6 and 1 in 13 HASU beds (Dawson et al., 2016) then reducing bed 
occupancy by SM should lead to more rapid access for stroke patients and potentially 
improved outcomes. In summary the introduction of a SM tool should reduce SM use of 
HASU beds which would allow true stroke patients to be admitted faster. This would be an 
incremental streamlining of the current process with a small impact on any measure of 
disability compared to other interventions.  
3.2.9.7 Resource implications 
The actions attached to a SM tool would define the resource implications for the ambulance 
service. If SM patients were admitted to a local ED rather than a distant HASU then there 
may be some savings in terms of distance and time travelled, but there may also be 
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emergency transfers for stroke patients incorrectly transported to hospitals without stroke 
units. There may be a reduction in secondary transfers or repatriation of suspected stroke 
patients who did initially bypass a local hospital to access a distant HASU if some SM were 
directed to the local hospital. Overall, the numbers of SM patients identified by STEAMv2 are 
very small, even when applied across a region like the North East as described earlier, and 
suspected stroke make up only a small proportion of the total calls to the ambulance service 
so there would be negligible impact on the pre-hospital workforce.  
Dawson et al (Dawson et al., 2016) reported the mean length of stay (LOS) in hospital was 
2.8 days for SM patients whereas the mean length of stay for a stroke patient was 16.3 days 
(RCP, 2015). Based on these figures, and the small number of patients identified by 
STEAMv2, there would be very little if any impact on the stroke services in hospital. Any 
benefits seen by stroke services in terms of reduced use of resources would be minimal and 
offset by use of resources elsewhere. 
3.2.9.8 Markers of health economic outcomes  
Diverting SM patients away from HASUs should be economically beneficial. Admission to 
HASU is expensive due to the level of care involved, the specialist diagnostics and the 
multidisciplinary nature of the team. As many SM patients could be appropriately cared for 
on a non-HASU or general ward there is an economic argument to reduce SM admissions to 
HASU.  
Based on figures from the National Audit Office (The Comptroller and Auditor General, 2010) 
a HASU bed day cost £583, a day on a stroke unit cost £231, whereas a bed day on a general 
ward cost £181. Using annual inflation figures up to 2017 these costs equate to £744 for a 
HASU bed day, £293 for a stroke unit bed day and £230 for a general ward bed day.  
When Dawson et al (Dawson et al., 2016) reported that the mean LOS on a HASU was 2.8 
days for SM patients this figure included two distinct populations. The first comprised 80% of 
SM patients who were discharged directly from HASU following a mean LOS of 1.7 days. The 
second population comprised the remaining SM patients who were admitted to hospital and 
had a mean LOS of 7.3 days. The figures for the patients discharged directly from HASU are 
similar to those reported by Gargalas et al (Gargalas et al., 2017) for functional SM who 
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showed that medical and functional SM had slightly different mean LOS on HASU of 2.1 and 
1.5 days respectively. 
The total cost of a SM patient staying on a HASU, stroke unit or general ward based on the 
2017 bed day costs and mean LOS figures from Dawson and Gargalas are shown in table 
3.2.3. 
Table 3.2.3 Costs for SM stay on HASU, stroke unit and general ward 
Location LOS = 1.5 days LOS = 2.8 days 
HASU £1,116 £2,083 
Stroke unit £440 £820 
General ward £345 £644 
 
The cost saving for admitting a SM to a general ward rather than a HASU ranges from £771 
to £1,439 per patient based on these figures. Admitting SM patients to a stroke unit rather 
than a HASU would save between £676 and £1,263 per patient. However, this assumes that 
the resources available for stroke care remain constant even though the overall demand for 
specialist care has fallen because of the avoidance of SM admissions.  
Due to the high PPV of STEAMv2 the number of stroke patients who would be incorrectly 
classified as a SM is very small, but for these stroke patients there would be health economic 
consequences due to potentially delayed or missed thrombolysis opportunities and ongoing 
care costs. The SSNAP Health Economics tool for thrombolysis (RCP, 2017c) estimates that 
missing a single thrombolysis opportunity costs the NHS £3,000 and social care £2,800 over 
the first year. 
Early identification of SM patients could lead to a reduction in the rate of inappropriate 
thrombolysis. Chapter 1.2 reported that 9% of suspected stroke patients who were 
thrombolysed were a SM so a simple, cheap intervention like STEAMv2 which could help 
reduce this rate would have economic benefits. Goyal et al (Goyal et al., 2015) reported on 
the costs associated with administering thrombolysis to SM patients in the American 
healthcare system. SM patients who received thrombolysis had an extended length of stay 
and required higher level monitoring due to the risks associated with thrombolysis. The 
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overall excess treatment costs for SM patients administered thrombolysis was $5,401 
(£3,865) per admission.  
Overall, there is a clear health economic argument for reducing SM admissions to HASUs. 
Reducing inappropriate thrombolysis to SM patients is also desirable from a health 
economic viewpoint. The potential negative health economic consequences of delayed or 
missed thrombolysis treatment opportunities are difficult to quantify and will depend on the 
patient, the severity of the stroke and the ongoing care needs of the patient but could be 
considerable for a small number of patients. 
3.2.9.9 The impact of pre-hospital SM identification on hyper-acute stroke outcomes 
When the four outcomes identified by Monks et al were considered there were three 
distinct groups who would be affected by the introduction of a pre-hospital SM tool: 
patients, ambulance services and stroke services. The benefits of introducing STEAMv2 were 
difficult to quantify for patients but there are risks of delayed treatment times or missed 
thrombolysis. These risks were recognised in the focus groups and interviews described in 
chapters 2.1 and 2.3. The benefits to the ambulance service are minimal in terms of 
outcomes related to stroke but may include more efficient use of resources, however any 
resource benefits would be dictated by local geography and pathways. The benefits to 
stroke services are clear in terms of economics relating to HASU bed usage but need to be 
balanced against the impact of missed reperfusion treatment opportunities and the 
redistribution of patients to other areas of the NHS 
3.2.9.10 Strengths and weaknesses 
The value of the models described above is limited by their simplicity and the broad 
assumptions, such as 100% use of STEAMv2, used in their construction and parameter 
values. The potential consequences were discussed but the outcomes were not linked to the 
models so variations in pre-hospital stroke and SM recognition could not be directly 
explored. Sophisticated models which could incorporate multi-site systems and account for 
the time taken for each decision or action, could be developed using techniques such as 
discrete event simulation (Monks et al., 2012; Churilov et al., 2013) to provide a more 
precise estimate of impact of SM identification, but are unlikely to change the overall value. 
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This work focussed on the suspected stroke population but acknowledges that stroke 
chameleons needed to be accounted for. Recognition that around 20% of stroke patients are 
not identified as stroke in pre-hospital care, provides context and information on potential 
consequences for the small number of stroke patients who may be wrongly classified as SM 
by a tool like STEAMv2.  
Future models which develop in this area could consider the impact of telemedicine and 
how this would affect the pre-hospital decision making process and whether this would 
increase the on scene times. Puolakka et al (Puolakka et al., 2016) looked at physician advice 
via telemedicine and showed that it increased the on scene time so any benefit would need 
to be carefully considered. The identification of patients suitable for thrombectomy is 
another issue where the impact of pre-hospital decision making is being considered and the 
impact of SM on the outcomes is being modelled (Holodinsky et al., 2018). 
3.2.10 Conclusions 
This exercise resulted in a basic decision tree model that gave a crude estimate of the impact 
of STEAMv2 in terms of pre-hospital recognition of stroke and SM patients. The simple 
models used were not able to represent the complexities inherent in multi-site systems of 
stroke care with varying pathways. The impact of STEAMv2 on the North East region and the 
UK were considered by simplifying suspected stroke admissions to a single system and 
making assumptions accounting for the rate of potential bypass. These scenarios were very 
simplistic and only reported total figures of patients who may be affected by the application 
of STEAMv2, however they do inform the understanding of potential impact on the stroke 
care system. The scenarios gave an indication of the small impact that SM identification 
using STEAMv2 might have, which is unlikely to be changed using more sophisticated 
modelling approaches such as discrete event simulation. The only outcome area where 
introduction of a SM tool showed a clear potential benefit was in health economics and this 
needed to be balanced against the impact of delayed or missed thrombolysis opportunities.   
3.2.11 Summary 
The impact of pre-hospital SM identification is difficult to quantify but likely to be small using 
STEAMv2. The complexities of hyper-acute stroke care and the large number of variables in 
multi-site systems where patients can bypass local hospitals are difficult to model, but this is 
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where there may a greater argument for a tool like STEAMv2. If stroke services continue to 
centralise, and more patients bypass local hospitals to access distant HASUs, the low cost 
associated with STEAMv2 implementation makes it worth considering, assuming that its 
performance in clinical practice mirrored that suggested by the development, refinement 
and validation datasets. The results of this chapter were used to inform focus groups with 
professional stakeholders discussing the development and applicability of STEAMv2 which 
are described in the next chapter.   
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Chapter 3.3 Professional stakeholder views on STEAMv2 
 
3.3.1 Introduction 
STEAMv1 was refined into STEAMv2 based on an expanded clinical dataset and qualitative 
data gathered through focus groups (reported in part 2). Chapter 2.2 described the 
refinements to the STEAMv1 criteria, the addition of FAST-ve and the performance of 
STEAMv2. This chapter describes the design, data collection and findings of the third phase 
of qualitative work. This final phase was conducted to explore the views of healthcare 
professionals about STEAMv2. In addition to paramedics and hospital clinicians from the 
North East where STEAM was developed, this phase also included paramedics and hospital 
clinicians from the North West who were not involved in the development process and who 
worked in a different stroke care system. 
3.3.2 Chapter aims 
This chapter aims to report the views of healthcare professionals, who have experience and 
interest in acute stroke care, regarding the structure, development and applicability of 
STEAMv2.  
3.3.3 Methods 
The methods used in this phase of the study are identical to those used in the first phase of 
qualitative research reported in chapter 2.1. The methods are repeated in a shortened form 
below. 
3.3.3.1 Design 
A generic qualitative approach (Cooper and Endacott, 2007; Griffiths and Mooney, 2011) 
was selected. Focus groups were chosen as a suitable method for data collection as they 
allowed a range of participants, selected for their experience in acute stroke care, to express 
and discuss their views on the STEAMv2 tool.  
3.3.3.2 Participants 
Paramedics and hospital clinicians were recruited from two regions, the North East where 
STEAMv1 and STEAMv2 were developed and the North West, in order to provide a different 
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viewpoint on the structure, development and applicability of STEAMv2. The North West was 
also chosen due to the centralisation of stroke services in this region which meant that 
ambulances bypassed local hospitals to access central HASUs and the use of exclusion 
criteria by the North West Ambulance Service NHS Trust (NWAS) similar to STEAMv2. 
Separate focus groups were organised for the paramedics and the hospital clinicians. This 
was done in order to focus on the views of each professional group, as opposed to the 
interaction between the groups, and to avoid any perceived dominance by one group over 
the other. There was no expectation of reaching data saturation with only two focus groups 
in each region. The aim was to collect views about STEAMv2, not to report a comprehensive 
thematic analysis of paramedics’ or hospital clinicians’ views across the participating 
organisations. 
The four participating organisations in this phase were NEAS and NHCT from the North East 
and NWAS and Salford Royal NHS Foundation Trust (SRFT) from the North West. 
Volunteer sampling was used to recruit participants to focus groups. Participants were 
recruited by advertising for volunteers within the respective organisations and attendance at 
existing meetings where relevant professionals were present. All participants were supplied 
with information sheets regarding the study prior to the focus groups and had a chance to 
ask questions. Informed written consent was gained at the start of each focus group.  
The aim was to recruit 4-6 participants per focus group. These numbers would ensure a 
variety of views would be represented, with enough participants to promote discussion 
within a group that would be manageable by a single facilitator. 
3.3.3.3 Data collection and analysis 
A topic guide was developed with input from the supervisory team for use within the focus 
groups (see appendix Q). It covered broad areas including the development of STEAMv2 and 
the results of the modelling work described in chapter 3.2. The guide was intended to help 
keep the groups focussed on the issue of interest whilst allowing unexpected areas of 
discussion to arise.  
Stimulus material (see appendix R) was used in the form of an overview of the whole 
project, STEAMv1, STEAMv2 and a summary of the modelling work. This was given to all 
 250 
 
participants to stimulate conversation and to act as reference material during the 
discussions. 
Brief field notes were taken during the focus group and used by the researcher to ensure key 
points were covered and interesting points that arose were investigated without 
interrupting the flow of conversation. 
Digital audio recordings were made of the focus groups. These were transcribed verbatim by 
the researcher and anonymised for the purpose of analysis. Thematic analysis was 
conducted using a five stage framework as documented in chapters 2.1 and 2.3. 
3.3.3.4 Approvals 
Ethical approval for the qualitative phases of the study was gained from Newcastle 
University Faculty of Medical Sciences Ethics Committee (ref 01203/2016). Health Research 
Authority (HRA) approval was gained as this project included staff selected due to their 
positions in the NHS across multiple trusts (ref 207285). This project was adopted onto the 
National Institute for Health Research (NIHR) Clinical Research Network (CRN) portfolio (ref 
CPMS 32323). All approvals related to the qualitative work can be found in appendix J.  
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3.3.4 Findings 
Four focus groups were conducted involving 25 participants (eight paramedics, ten doctors 
and seven stroke nurses). Participants are indicated by codes P1-8, FG3 for the paramedics 
and H1-17, FG3 for the hospital clinicians. The findings of all four focus groups are presented 
in one narrative account due to the common topics addressed across the focus groups. 
Analysis of the transcripts identified 350 concepts which were combined into 31 themes. 
These were then grouped into five interconnected, over-arching themes: decision making; 
pre-hospital stroke identification; implementing SM tools within care pathways; strengths 
and limitations of the STEAM tool; and the stroke mimic population. Decision making was 
considered to be the core theme which underpinned the other themes. The five over-
arching themes are summarised in figure 3.3.1 and described below with anonymised 
illustrative quotes. The themes reported here are not combined with the themes reported in 
chapters 2.1 and 2.3 due to the focus having moved from the development of STEAMv1 
(chapter 2.1), to usability in the pre-hospital setting (chapter 2.3), to the aim of this chapter 
which focusses on STEAMv2. There were some common themes which emerged such as 
decision making/thought processes, the actions that STEAM would lead to and how this type 
of tool would work across the ambulance to hospital interface.  
 252 
 
 
Figure 3.3.1 Themes from the four professional focus groups in phase 3 discussing 
STEAMv2 
3.3.4.1 Strengths and limitations of the STEAM tool 
There was general consensus in all four focus groups that STEAMv2 was a pragmatic tool for 
identifying SM patients and that the development process was methodical and 
comprehensive: 
“I think you’ve undertaken a sensible approach, there’s nothing obvious amiss” P4, 
FG3 
“It seems straightforward enough, it’s not like it’s complicated difficult information to 
get hold of” N7, FG3 
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One point that was raised in the NEAS focus group was that the STEAMv2 criteria should be 
recorded on any suspected stroke patient, and that STEAMv2 prompted paramedics to 
question their suspected stroke diagnosis if the observations were unusual: 
“Some of this should really be common sense shouldn’t it, you should be starting to 
doubt whether this is actually a stroke if you’re bringing up these blood pressures, 
temperatures and heart rates so this it supports really what you’re already thinking” 
P1, FG3 
Participants from NHCT questioned whether STEAMv2 was an improvement over STEAMv1 
based on the data from the validation cohort. They also raised concerns about the added 
complexity of STEAMv2 although the following point was also asserted: 
“Intuitively looking at the information in the second version it would seem to be 
better” H7, FG3 
Participants from SRFT preferred STEAMv1 as they did not perceive the increased PPV to be 
to be a worthwhile trade-off with the reduced sensitivity and increased complexity: 
“I think you are more likely to get STEAMv1 done in the back of an ambulance than 
STEAMv2” H15, FG3 
In contrast to the SRFT clinicians the NEAS and NWAS paramedics preferred STEAMv2 but 
did acknowledge that it was more complex and that some form of memory aide would be 
helpful: 
“The only thing about STEAM2 compared to STEAM1 is that you’d probably have to 
have it on a card just to remember what all of those values are because there’s so 
many parameters in there” P3, FG3 
Paramedic participants commented that the performance characteristics (sensitivity, 
specificity and PPV) of STEAMv2 were acceptable, and considered specificity to be the most 
important property: 
“The important one is that 99% of strokes are being excluded, I think that is the most 
important of the criteria there” P5, FG3 
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Paramedics from NEAS and NWAS asserted that STEAMv2 was preferable based on the 
increased PPV and were particularly focussed on how it could be applied in practice. 
Embedding STEAMv2 in electronic patient records was suggested by NEAS who already use 
electronic records. NWAS paramedics suggested that quick and reliable feedback would be 
important to increase paramedics’ confidence with use of the tool. 
However, there were concerns expressed by clinicians in both hospital focus groups about 
the tangible impact STEAMv2 would have if it was applied in practice: 
“It probably doesn’t make sufficient impact on time, bed numbers or staffing to really 
make any big, any significant difference” H11, FG3 
There were also concerns raised about who would be responsible if an opportunity to treat a 
patient was missed due to use of a tool such as STEAMv2: 
“Is it NWAS that get sued for that, is it the people who made the protocol, is it the 
DGH (District General Hospital), you know, if this is potentially diverting people away 
from correct treatment who carries the can?” H15, FG3 
The inclusion of age as a criterion, one of the issues raised in the first phase of focus groups 
reported in chapter 2.1, was once again raised: 
“I do worry that hidden amongst the 1% who this doesn’t pick up are some 30 year 
olds who have had strokes who if anything need a rather faster response” H11, FG3  
Participants understood why age was included in STEAMv2, but examples of young patients 
who had strokes were given in two of the focus groups, which emphasised how these 
unusual cases are prominent in people’s minds. 
When discussing the linked patient data used to create STEAMv2 it was suggested that 
future work could consider whether discharge diagnoses were the most appropriate 
diagnoses to use as the basis for deriving a pre-hospital SM tool. It was suggested that 
looking for patients who received an early SM diagnosis, or who were not admitted to a 
stroke unit, might be a more appropriate population to target: 
“If you took the gold standard to be that the stroke physician was confident enough 
that they just turned them away then that’s what you are interested in, not so much 
whether the final diagnosis was stroke or not.” H14, FG3  
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3.3.4.2 The stroke mimic population 
Participants in all four focus groups commented on how SM are not a homogenous 
population:  
“All mimics are not equal, within them are things that are quite serious and need to 
be treated quickly and things that don’t matter and like you are not going to come 
from harm coming to a HASU with migraine” H14, Fg3  
One SM condition identified as needing rapid treatment was seizures. The fact that some 
stroke patients have seizures was explicitly mentioned in three focus groups: 
 “Strokes can cause seizures can’t they?” P6, FG3 
Seizures are currently an exclusion criterion in the NEAS and NWAS stroke pathways. All 
participants seemed comfortable with the idea of these patients being taken to the nearest 
ED rather than bypassing to a HASU: 
“The fact that you are trying to pick out sepsis and seizures is good because they 
could come to harm being carted for many miles past their local ED when they should 
have been there getting their antibiotics or lorazepam or whatever” H14, FG3  
This highlights that different SM conditions may require different treatments. For some SM 
conditions such as sepsis the nearest ED is the most appropriate destination as rapidity of 
treatment is important; whereas for other SM conditions such as brain tumours or 
functional disorders there are minimal negative consequences for the patient from 
bypassing their local hospital to get to a distant HASU. 
The appropriate pre-hospital treatment for differing SM conditions was discussed and 
particularly whether SM patients identified by STEAMv2 should be pre-alerted to the 
receiving hospital. There were differing views on this with North West participants 
suggesting a different type of pre-alert for SM patients, but the consensus of opinion was 
that it would be driven by the individual presentation (as some SM patients would need pre-
alerting due to their underlying condition): 
 “Some of the stroke mimics can be pretty time critical as well” P2, Fg3  
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One participant asked whether STEAMv2 had been considered for use as part of a telephone 
triage process. This area of application had not been previously considered, but the 
consensus within the NEAS focus group was that telephone triage should focus on high 
sensitivity and more refined decision making was only possible when a clinician was 
physically present with a potential stroke patient. 
The potential to use STEAMv2 to trigger a call from a paramedic on scene to a stroke unit for 
advice was discussed in both North West focus groups. At the time of the focus group NWAS 
did not have the ability to directly talk to the stroke units, and the feeling from the 
paramedics was that there was little benefit from being able to do so: 
“I think if we start having conversations on scene it could be like war and peace and 
delay our on scene time significantly rather than us just saying we’ve got this we are 
coming” P6, FG3  
This view was supported by the hospital clinicians who considered the type of patient where 
a paramedic might call for advice and what their response might be: 
“They’re going to say well they’re not quite moving their left arm but it kind of seems 
ok, then what are you going to do with that and then it will be stuff like that and 
you’ll just go I kind of have to see them” H14, FG3 
The question of who was responsible for the patient factored into discussions around the 
risks and benefits of paramedics being able to phone the stroke unit for advice: 
“The paramedics transferring the risk to the staff here aren’t they, and I don’t think 
they would accept that, particularly because they haven’t got the patient in front of 
them” H14, FG3 
Participants from the North West were not surprised by the high SM rate found in the 
literature or the NEAS data used to develop STEAMv2. Clinicians from SRFT reported their 
SM rate was still relatively high despite their efforts to reduce the SM rate: 
“So we are excluding all FAST negatives and we’re still getting a 25% mimic rate” 
H15, FG3 
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3.3.4.3 Pre-hospital stroke identification 
How stroke is identified in the pre-hospital setting was a theme that emerged primarily from 
the two focus groups with ambulance services. 
The FAST test is the main stroke identification criteria, used by both NEAS and NWAS, in 
their stroke pathways: 
“It’s very black and white, they’re either FAST positive or FAST negative, FAST positive 
stroke going to HASU, FAST negative they’re not” P3, FG3 
“We are very blunt at the minute as I say it’s FAST positive or negative and nothing in 
between” P8, FG3  
FAST negative patients were particularly problematic for the paramedics. They perceived 
that hospitals were reluctant to accept referrals for FAST negative suspected stroke patients. 
In the North West the volume of patients admitted to the HASUs was considered to be a 
factor by the paramedics: 
“In terms of resources they can’t just take everything suspected, its got to be quite 
clear cut for them and in terms of numbers they get through the door I just think it’s 
why they can be quite sort of it’s not FAST positive we can’t take it” P8, FG3 
The clinicians in the North West commented on the volume of patients they received due to 
the centralisation of services, and also mentioned that the exclusion of FAST negative 
patients by NWAS was not in agreement with national guidelines: 
“They (the Royal College of Physicians Stroke Guideline) do say that if they suspect a 
stroke they should bring them, which I think is what they do in practice” H14, FG3 
Several paramedics were confident in their ability to identify stroke patients despite the 
evidence around the SM rate, and knowledge about the limitations of the FAST test: 
 “Sometimes you turn up and it’s blatantly obvious that it’s a stroke” P1, FG3 
Other paramedics were aware of how their impression formed the initial part of the stroke 
identification chain: 
“We are not saying they have had a stroke, we are saying they are FAST positive, 
that’s why we brought them here so you can scan them and find out more” P6, FG3 
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There was recognition in all four focus groups that SM were an inevitable part of the existing 
model of stroke care, and that a balance between sensitivity and specificity of pre-hospital 
stroke identification was necessary: 
“I don’t know if there is an answer, I don’t think there is, I think it’s just one of those 
things that perhaps has to happen, that we get the mimics so what we make sure we 
do get all the patients and for paramedics not to feel like they’ve missed a patient” 
H17, FG3 
3.3.4.4 Implementing SM tools within care pathways 
The stroke care pathways which connected the ambulance services with the receiving 
hospitals in both regions were a prominent theme in the focus groups. The paramedics 
described how their stroke pathways were very prescriptive and largely dictated by FAST: 
“You sort of think these things to yourself when you’ve got a FAST positive patient but 
you think we’ve got this tool to follow, we can’t deviate from it” P6, FG3 
“We’ve bred people, everybody to go they’re FAST positive they’re having a stroke” 
P4, FG3 
Once the paramedics had identified a suspected stroke patient the pathway then became 
more variable due to local hospital practices: 
 “It changes so much between hospitals and areas” P8, FG3 
The organisation of stroke services within the hospital influenced the extent that 
participants thought a pre-hospital SM identification tool would beneficial: 
“Another consideration would be say if you were going to the same hospital anyway, 
so if your local ED happened to be where your HASU was you wouldn’t be concerned 
but if you were going somewhere, a hospital, like a district general that doesn’t have 
a HASU then people would be a bit more nervous” P6, FG3 
“If I were a stroke consultant working at (a local district general hospital) then it 
would seem reasonable for people who were scoring on this type of thing to go to ED 
rather than coming direct to the stroke unit cause the chances are very very high that 
they don’t need stroke unit input” H11, FG2 
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Clinicians in the North West were of the view that paramedic perceptions of the best 
hospital for the patient, along with a culture of treating for the worst possible outcome, 
would make implementation of a SM tool difficult. They considered that paramedics would 
take suspected stroke patients to a HASU regardless of what a SM tool indicated: 
“Because we’ve got this centralised service we’re also the neuro centre so I think they 
think so what if it’s a mimic, this is the neuro centre so it’s the best place for them 
anyway” H14, FG3 
Paramedics and hospital clinicians recognised that there were consequences of bypassing all 
suspected stroke patients into a HASU: 
“If you take somebody who is FAST positive to a HASU, and you’ve bypassed the 
nearest ED, they go to HASU, they have a scan, it’s not a stroke, they’ve then got to 
be repatriated back to the local ED so it’s more money for the ambulance service, the 
hospital, it’s bad for the patients, its poor experience for them” P6, FG3 
“We’re seeing loads of mimics when these people really don’t need to be here and its 
an ongoing problem, it’s not fair on the patients that they and their family then have 
an hours journey the next day to come for visiting time because the other problem 
with the mimics is we don’t have a repatriation policy” H15, FG3 
Issues with repatriation are influenced by local geography and pathways. This was 
highlighted when the North West HASU model was compared with London: 
“In London where everyone is within 20 minutes of a HASU it’s not such a big issue 
cause you’ll only be 20 minutes from your home wherever you go” H15, FG3 
The North West differs from the North East, and most other regions in the UK, in that NWAS 
has extensive pre-hospital exclusions that direct paramedics to take patients to local 
hospitals rather than HASUs. Most UK ambulance services identify suspected stroke patients 
based on FAST, exclude hypoglycaemia and seizures, and patients who aren’t excluded 
based on these two factors are taken to a HASU or stroke unit. The NWAS exclusion criteria 
are similar in nature to STEAMv2 and are listed below: 
 Age<16 years 
 Airway compromised following basic manoeuvres 
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 Respiratory rate<10 or >30 
 SaO2<90% post high flow O2 
 SBP<90mmHg 
 Heart rate<40 or >150 
 GCS<8 
 Any seizure activity reported during or causing this incident or 999 call 
 BM<4.0mmol/l post treatment 
The impression from the North West clinicians was that their exclusion criteria already 
filtered out a significant proportion of SM: 
“I don’t think this would add anything to our current setup, I know we’ve got quite, a 
fairly robust system in place already” H15, FG3 
This view was tempered by questions over how the existing North West exclusion criteria 
had been developed and how they were perceived compared with how the possible 
application of STEAMv2 was being perceived: 
“It’s interesting isn’t it that our criteria were just introduced, well I don’t know if 
we’ve ever been able to work out where they came from or who made them up but 
they’ve just been introduced, whereas you know you’ve very carefully tested these 
criteria and thinking about it and there’s a huge kind of disconnect where we’ve just 
gone ahead and done that and that’s fine whereas you’ve now got data and 
everybody’s going oh I don’t know about this” H14, FG3 
The performance of the North West exclusion criteria is compared with STEAMv2 in the 
discussion section. 
3.3.4.5 Decision making 
Decision making was the core theme as it featured strongly within the other themes. 
Decisions about how STEAMv2 should be applied, decisions about which SM could be 
appropriately treated at a local ED and who should make that decision, including the impact 
of how paramedics decide a patient is having a stroke and what subsequent decisions are 
available within existing pathways emerged within all the focus groups 
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One point which encapsulated the themes discussed so far was the idea of railroading or 
diagnostic momentum (Satya-Murti and Lockhart, 2015). This is where a decision sets a 
chain of events in motion that are difficult to deviate from. For stroke care, a tool like 
STEAMv2 could alter the normal chain of events: 
“The crew get there and go oh they’re having a stroke and it’s way down the line 
before someone goes, actually after they’ve been and come back from scan, they 
haven’t, whilst if you use this you might go yeah they’re probably not having a stroke 
just take them to ED” P3, FG2 
This idea of railroading overlaps with who takes responsibility for making the decision that a 
patient with stroke-like symptoms is actually a SM and how this fits into local pathways. The 
paramedics viewed STEAMv2 as a tool which would support their decision making and allow 
them to make informed decisions rather than following simple protocols based on the 
patient being FAST positive or negative: 
“You are making these judgments all the time, you are talking to people and then 
trying to say do I think this is a stroke, do I not think this is a stroke” P3, FG3 
Paramedics recognised that it is very difficult to design a tool that covers all the possibilities 
encountered in medicine, but they recognised the potential for STEAMv2 to improve their 
decision making: 
“It will be a tool to support your decision making, it won’t be the be all and end all” 
P2, FG3 
The need to justify decisions and defend how those decisions were made underpinned 
concerns about being challenged for adopting something like STEAMv2 that represented a 
change from the current protocol: 
“A lot of our job comes down to justification doesn’t it, so long as you’ve got 
something to back up why you’ve done or not done something then people are more 
likely to embrace it and feel confident doing it” P6, FG3 
One of the paramedics gave an example of a decision support tool (Newton et al., 2014) that 
had been implemented to help them to identify patients suitable for treatment in the 
community or at locations other than ED: 
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“Pathfinder is a good example of how you support staff who aren’t necessarily 
confident in their decision making, Pathfinder works because people then have a very 
clear process to follow and that they can fall back on and say that I followed that and 
that’s what happens” P4, FG3  
This demonstrated that when paramedics were supported in their decision making and had 
clear pathways to follow, then decision support tools were both feasible and acceptable to 
use in practice. 
3.3.5 Discussion 
This final phase of qualitative work reports the views of paramedics and hospital clinicians 
regarding the structure, development and applicability of STEAMv2. This generated five 
prominent themes: strengths and limitations of the STEAMv2 tool which recognised the 
simplicity and specificity of STEAMv2 but also the potential for false positive stroke patients; 
the SM population which included the heterogeneity within the population and considered 
what constituted appropriate treatment; pre-hospital stroke identification which highlighted 
the importance of FAST and the inevitability of SM; implementing SM tools within care 
pathways recognised local and regional differences; and decision making included who 
should make the decision and what support they might need. 
Decision making factors were key themes that featured strongly in this chapter as well as 
chapters 2.1 and 2.3. For a paramedic to decide that a patient with stroke-like symptoms 
was a SM and to then treat that patient as a SM would be an important decision and 
represent a substantial change from current practice. Paramedics and hospital clinicians 
were acutely aware of the potential risks (delayed or missed thrombolysis) and benefits 
(reducing SM bypass of local ED to access distant HASU) of making this decision. 
The views expressed by the paramedics were similar across the two regions with a high 
degree of acceptance of STEAMv2, the need for justification and support for appropriate 
decision making along with recognition of the influence of local pathways. The hospital 
clinicians also shared similar views across the two regions with regards to concerns about 
age as a criterion and missed opportunities to treat stroke patients. Hospital clinicians in 
both regions stated that STEAMv2 had potential benefits, particularly with future 
implementation of thrombectomy services and potential large-scale bypass to neurosurgical 
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units. However, neither group considered that STEAMv2 would improve their current 
system; despite there being marked differences between the pre-hospital pathways in each 
region.  
Participants saw potential value in a tool like STEAMv2 in a system with more bypass of local 
EDs and longer transfer times. If STEAMv2 were to be implemented in this type of system 
there was a lack of agreement between SRFT and NHCT as to whether STEAMv1 or STEAMv2 
was the optimal structure. Regional differences would make implementing STEAMv2 on a 
large scale and studying any impact challenging. Overall participants thought that pre-
hospital SM identification was logical and that STEAMv2 had been developed in a robust 
way, but due to the lack of tangible benefits and concerns around young stroke patients it 
did not represent an improvement over current systems.  
The perception of SM as a heterogeneous group was a topic that featured prominently in 
this phase. STEAMv2 was developed on the hypothesis that SM do not need to be treated at 
a HASU. The key messages from participants were that some SM patients would benefit 
from earlier treatment at a local ED and may be harmed by extended bypass; whereas for 
some patients it probably makes a negligible difference.  
The criteria used by NWAS to exclude suspected stroke patients from their stroke pathway 
were a topic of discussion in both North West focus groups. STEAMv2 and the NWAS 
exclusions share some common elements: hypotension, heart rate and seizures. The NWAS 
pathway was perceived as more acceptable than STEAMv2 despite lacking a robust 
development process and evidence of benefit. The performance of the NWAS exclusions are 
explored further below. 
The potential use of telemedicine and the ability for paramedics to directly contact stroke 
units was highlighted in this phase of the research. Three focus groups concluded that a SM 
decision would be optimally made in the pre-hospital setting, and that telemedicine offered 
little benefit and could potentially delay the decision-making process. NHCT explored the 
potential to use telemedicine to inform the pre-hospital decision making and considered 
how STEAMv2 could be applied in other settings such as ED triage.  
Participants’ views about the results of the modelling have not been presented as a separate 
theme but are included within the other themes. The small numbers of patients who would 
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be impacted, based on the modelling outputs, influenced participants’ perceptions of the 
lack of tangible benefit that introducing STEAMv2 would have. The four impact areas 
(treatment rates and speeds, population disability impact, resource implications, health 
economics) considered in the modelling were all discussed and contributed to the findings 
presented. The risk of delayed thrombolysis and missed opportunities to potentially reduce 
disability was of concern to participants, the workforce impact would mostly be seen in the 
ambulance service, and the economic benefits of reducing SM admissions to HASU needs to 
be balanced against the potential missed thrombolysis patients.    
3.3.5.1 Comparing STEAMv2 with the NWAS exclusions 
During the focus groups the NWAS stroke pathway were repeatedly referred to. NWAS 
participants remarked on the similarity between the STEAMv2 criteria and the NWAS stroke 
pathway exclusions. One SRFT participant commented on how they didn’t believe STEAMv2 
added anything to their existing pathway, but another participant identified that their 
current criteria had not been developed or tested in a robust fashion.  
In order to address these comments, the NWAS exclusions were tested on the complete 
North East dataset (refinement and validation cohorts combined). This complete dataset 
included 5,645 patients with 3,483 (62%) stroke patients and 2,162 (38%) SM patients. The 
results of testing the North West exclusions in this dataset are shown in table 3.3.1. 
Table 3.3.1 NWAS exclusion criteria tested in complete North East dataset 
Criteria Patients Stroke (%) SM (%) 
FAST-ve* 421 196 (47) 225 (53) 
RR<10 0 0 0 
RR>30 37 18 (49) 19 (51) 
SpO2<90 121 69 (57) 52 (43) 
SBP<90mmHg 13 7 (54) 6 (46) 
HR<40 4 0 (0) 4 (100) 
HR>150 25 16 (64) 9 (36) 
Seizures 148 30 (20) 118 (80) 
BM<4.0 26 10 (38) 16 (62) 
Total**  763 333*** (44) 430 (56) 
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* FAST-ve patients were removed initially, other criteria are reported on FAST+ve patients 
** Total values represent patients with any exclusion criterion so columns will not add up 
***333 stroke patients included 36 TIA patients 
There are a number of limitations to this testing: 
 NWAS excludes under 16, NEAS data based on 18+. 
 Unable to report on compromised airway patients. 
 NEAS physiological data represents mean values across the patient encounter. 
 Unable to comment on administration of high flow O2 for the SpO2 value. 
 GCS<8 patients were excluded from the NEAS data. 
With these acknowledged limitations, the results of applying the NWAS criteria and 
STEAMv2 to the complete North East dataset are reported in table 3.3.2. 
Table 3.3.2 Comparison of NWAS exclusion criteria and STEAMv2 in complete North East 
dataset 
Patients identified NWAS exclusions STEAMv2 
Suspected stroke  763 (14%) 133 (2%) 
Stroke 333 (10%) 14 (0.4%) 
SM 430 (20%) 119 (6%) 
 
NWAS is the only UK ambulance trust with extensive stroke pathway exclusions similar to 
STEAMv2 (see appendix S which is discussed more in chapter 4.0). Comparing these in the 
same dataset revealed that the NWAS exclusions identified nearly as many strokes as SM 
patients whereas STEAMv2 identified far fewer stroke patients. Replacing the NWAS criteria 
with STEAMv2 would result in a substantial increase in the total number of patients taken to 
the North West HASUs.  
3.3.5.2 Strengths and limitations 
The inclusion of views from paramedics and clinicians across two regions is a clear strength 
and highlights how local pathways and the interactions between paramedics and local 
hospitals need to be considered when developing pre-hospital interventions.  
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The themes presented here compliment and expand upon those presented in chapters 2.1 
and 2.3. Chapter 2.1 described the initial views of paramedics and clinicians about STEAMv1 
and the development process and identified areas such as age and BM that were addressed 
in the refinement process. The importance of decision making was also recognised at this 
early stage and it emerged as a central theme in the subsequent qualitative phases. Chapter 
2.3 explored the applicability and usability from the paramedics’ perspective and expanded 
on how STEAM could be applied in the pre-hospital setting and how it could influence 
decision making. This topic was further explored in this chapter with some similar opinions 
expressed by the NWAS paramedics. 
It could be inferred that the small number of sites involved, and participants’ experiences 
based on local and regional pathways are not representative of the wider professional 
groups. However, representing the views of all paramedics or stroke clinicians was not the 
aim of this phase.  
3.3.5.3 Future research  
The focus groups supplied useful suggestions for areas of future research such as targeting 
patients who were identified as SM early on rather than using discharge diagnoses, 
considering activity over a larger geographical area and how thrombectomy services would 
interact with a tool like STEAMv2.  
Future qualitative work in this area would benefit from the inclusion of the patients’ 
viewpoint which is not represented here. This would be important to consider as patients 
may have preferences as to where they are treated which would need to be taken into 
account. Also, decisions about what performance characteristics are acceptable, with the 
inevitable trade-off between sensitivity and specificity, would also benefit from patient 
input. The impact of thrombectomy services and how many SM patients potentially travel 
even longer distances would be another area to seek views on. 
NWAS have different types of pre-alerts depending on how the patient presents and future 
work in this area could consider whether a more nuanced version of STEAMv2 could be used 
to identify different types of SM that require different responses. 
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3.3.6 Conclusions 
Paramedics’ and hospital clinicians’ views about STEAMv2 were that it had been developed 
in a methodically acceptable way and had strong face validity. Concerns about the age 
criterion echoed concerns raised in earlier phases of qualitative work, despite the changes to 
the STEAM scoring criteria. Participants’ views were mixed on whether introducing STEAMv2 
would produce a tangible benefit for patients or local services. If a SM tool were to be 
introduced, then using telemedicine to inform the pre-hospital decision making was 
perceived to add little benefit. Factors such as existing local and regional pathways, 
paramedics perceptions of appropriate treatment and destinations, whether a SM tool 
would produce any tangible benefits and the impact of current practices on SM patients 
would all need to be considered further if STEAMv2 were to be implemented.  
3.3.7 Summary 
The findings reported in this chapter build upon the findings of chapters 2.1 and 2.3 and 
represent the views of paramedics and hospital clinicians on the structure, development and 
applicability of STEAMv2. These focus groups generated information on facilitators and 
barriers to implementing STEAMv2 into clinical practice. The barriers identified emphasise 
the importance of consultation work to explore how to optimally integrate a tool like 
STEAMv2 within pre-hospital to hospital pathways. Participants thought SM identification 
had potential benefits but that these would be dependent on the local systems and 
pathways. 
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Chapter 4.0 Discussion and conclusions 
 
4.0.1 The development of STEAMv2 
This thesis includes a series of interconnected projects that build upon each other in order to 
develop and evaluate a pre-hospital SM identification tool. The overall study is aligned with 
the ‘development’ and ‘Feasibility and piloting’ stages of the MRC framework for the 
development of complex interventions with the qualitative sections informing how STEAMv2 
could move into the ‘Evaluation’ and ‘Implementation’ stages (Craig et al., 2008). The need 
to explore this issue was evident as the systematic review (chapter 1.2) reported that 26% of 
pre-hospital suspected stroke patients were SM. The findings of chapter 1.4 revealed a 
higher SM rate (41%) in the NEAS population which highlighted the scale of the problem in 
the North East. The systematic review illustrated the frequency and variety of SM conditions 
and pointed towards how difficult it would be to identify SM conditions in pre-hospital care. 
The SM tool development (chapter 1.5), refinement (chapter 2.2) and validation (chapter 
3.1) stages constitute the core of the thesis and followed the methods laid out in a series of 
papers published in the BMJ in 2009 (Altman et al., 2009; Moons et al., 2009a; Moons et al., 
2009b; Royston et al., 2009). The development process was underpinned by the data 
analysis but was also clinically driven to create a simple and specific tool for pre-hospital SM 
identification. 
Linkage of the NEAS data to the patient diagnoses supplied by the hospitals was a key factor 
in the success of this project. Linkage with individual hospital trust data was time consuming 
and resource intensive, but provided richer data than would have been achieved if aggregate 
regional or national data had been used.  
Existing SM tools have not reported qualitative input in their development. In this thesis 
qualitative work with professional stakeholders, reported in chapters 1.3, 2.1, 2.3 and 3.3, 
guided the development of STEAM and STEAMv2. This work revealed contrasting views from 
paramedics and hospital clinicians in terms of whether STEAMv2 was acceptable or which 
version of STEAM was preferable. Participants thought that STEAMv2 would not be a 
significant improvement to existing systems, despite agreeing that the number of SM 
admitted to stroke services was an issue. The different views expressed by the paramedics 
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and the hospital clinicians may reflect the differing frames of reference of the two groups i.e. 
short term emergency versus longer term complete pathway. The stakeholder input 
informed the understanding of the problems with SM identification and the increasing 
realisation throughout the project that the tool that was developed may not be clinically 
acceptable. 
The multiple methods described in this thesis have created a SM identification tool based on 
a large sample of retrospective data with a development process that incorporated 
stakeholder views at multiple points. This multi-methods approach has produced STEAMv2, 
a robustly developed and validated tool with credible qualitative data providing insights into 
potential facilitators and barriers to future implementation.  
4.0.2 Other SM tools 
Ten previous SM tools were described in chapter 1.1. None were developed on pre-hospital 
data or intended for pre-hospital use. STEAMv2 includes elements that appear in many of 
these existing tools (age, seizures, migraine, SBP). The existing tools have been reported 
using a variety of measures but the ones that report sensitivity and specificity appear to 
favour specificity. Two of the best performing tools included elements that are not routinely 
available in current pre-hospital practice (NIHSS, (Ali et al., 2014); CTA, (Chang et al., 2012)).  
None of the existing SM tools included BM as a predictive characteristic, although ROSIER 
(Nor et al., 2005) had BM<3.5mmol/l as an exclusion criteria which influenced its inclusion in 
STEAMv2. There were very small numbers of SM patients with hypoglycaemia in the data so 
improving pre-hospital identification of diabetic SM may be more about reinforcing existing 
training and practices.  
The tool developed by Tobin et al (Tobin et al., 2009) had similar performance characteristics 
to STEAMv2 (sensitivity 7%, specificity 99%). Tobin et al concluded that most of the SM 
patients in their cohort required or benefitted from neurologist input and judged that their 
tool was not clinically useful. STEAMv2 was developed in a setting with a higher SM rate 
(40% vs 22%), identified patients who potentially would not require immediate neurological 
input (sepsis, syncope) and for a more clearly defined purpose in terms of reducing 
unnecessary bypass of local EDs, so despite the similarities in performance may still have 
some clinical value. 
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STEAMv2 was developed using similar methods to existing tools but for application in a 
different setting. Common predictors of SM diagnosis were identified in the pre-hospital 
data that were identified by other tools and datasets. The qualitative data presented in this 
thesis adds information about the applicability and barriers and facilitators to use of a SM 
tool. 
4.0.3 Strengths and weaknesses 
The work in this thesis followed a clear development process to iteratively develop a SM 
identification tool with a clearly defined purpose guided by the principles of simplicity and 
specificity. This process produced a tool with high content validity due to the professional 
stakeholder input. 
The large sample size and detailed pre-hospital data, including narrative data, gives 
confidence in the validity of the tool created. The only paper describing a larger sample of 
SM patients is the work by Merino et al (Merino et al., 2013) which described 8,187 patients 
from North America. They described a higher than average SM rate (30%) and found that 
younger age, female gender and characteristics such as absence of hypertension were all 
associated with SM diagnosis, which is consistent with the findings in this thesis. 
One limitation of the methods used was the use of deterministic and probabilistic methods 
for data linkage which resulted in assumptions being made about the diagnoses of a small 
number of patients. A further limitation is the incompleteness of the retrospective data 
which reflected the uncontrolled clinical recording of variables of interest. Prospective data 
collection would have been optimal and potentially may have produced different results. 
One area where data wasn’t gathered from the pre-hospital records was time since onset. 
The absence of this data is a weakness of this study as this data would have allowed patients 
within the thrombolysis time window to be identified and explored as a subgroup of 
interest. 
The professional stakeholder input at multiple points during the development process was a 
strength of the project and enhanced the applicability of the tool. The qualitative data 
informed the development of STEAMv2, generated insights and ideas for other projects 
(such as the exploration of the North West pathway exclusions in chapter 3.3) but also raised 
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the issue of whether it was acceptable for paramedics to identify a patient as a SM, even 
with the high levels of specificity that were aimed for.  
The lack of patient input into the development of STEAMv2 is a further limitation. Now 
STEAMv2 has been developed and validated, future work could involve presenting it to 
patients and carer groups in order to gain their perspective on its potential impact. Their 
insights would be invaluable when considering the acceptability of potential changes to 
existing regional or multi-system pathways. 
4.0.4 UK Pre-hospital stroke care 
This project was based on suspected stroke patient data collected in the North East and it 
was assumed that the North East was representative of the UK. Geographical variability in 
pre-hospital stroke care was identified as a factor to consider from the survey of paramedics 
(chapter 1.3). Discussions with paramedics and clinicians in the North East and the North 
West (chapter 3.3) revealed differences in their respective stroke pathways. As the pre-
hospital stroke pathways provide the context for any discussion of STEAMv2 application, a 
survey of UK pre-hospital stroke care pathways was conducted so that STEAMv2 could be 
considered with an up to date view of national pre-hospital practice. The results are in 
appendix S. 
This survey of UK ambulance services showed that pre-hospital stroke pathways generally 
reflected national recommendations. FAST was the standard stroke identification tool and 
seizures and reduced GCS were the most common exclusions. Pathways that included 
elements beyond FAST appear to be focussed on increasing the sensitivity of pre-hospital 
stroke identification by adding additional symptoms such as loss of balance or vertigo rather 
than increasing the specificity and PPV. This increases the relevance of a SM identification 
tool. Only one service had exclusion criteria similar to STEAMv2, therefore a SM 
identification tool would be novel for the majority of UK ambulance services.  
4.0.5 Implementation of STEAMv2 
The training necessary for implementing STEAMv2 appears to be minimal based on the 
usability testing in chapter 2.3. Implementation of any SM tool would need to involve 
multiple parties including the ambulance service, ED and hospital stroke services. 
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Implementation of STEAMv2 would need to consider interactions with the current stroke 
pathways and the sharing of responsibility for patients with negative consequences.  
STEAMv2 could be implemented as it is cheap, easy to train paramedics to use and should 
reduce the use of stroke services resources by SM. However, the lack of tangible impact and 
the potential for a small number of patients to have delayed access to treatment means that 
STEAMv2 was not seen as beneficial in the context of current pre-hospital and hyper acute 
stroke systems. The potential risks to individuals were perceived as outweighing the 
potential service level benefits.   
STEAMv2 could be implemented as part of a pre-hospital stroke care pathway using an 
algorithm type decision support tool. Clinical algorithms are commonly used in pre-hospital 
care to describe actions that should be taken in particular circumstances. The UK national 
ambulance guidelines use algorithms to represent the appropriate actions in situations 
including cardiac arrest, termination of resuscitation and foreign body airway obstruction 
(Association of Ambulance Chief Executives and Joint Royal Colleges Ambulance Liaison 
Committee, 2016). An example of what this might look like for STEAMv2, based on current 
thrombolysis timeframes and algorithms used in NEAS and other UK ambulance services, is 
shown in figure 4.0.1. Criteria such as the 4.5 hours since onset which is based on current 
ambulance practice could change due to thrombectomy service introduction. The final 
actions based on SM identification were key issues that were consistently identified during 
the qualitative phases of this study with participants debating what actions were 
appropriate. The exact criteria would be determined by the local ambulance and stroke 
services based on their geography and existing regional pathways. 
A potential method of supporting implementation of STEAMv2 into pre-hospital practice 
would be through an electronic platform or an app for use on a smart phone. An electronic 
tool was supported in the survey (chapter 1.3) and the qualitative work (chapters 2.1 and 
2.3). Stroke related pre-hospital electronic decision tools have been developed in recent 
years (Connected Health Cities, 2018). The algorithms underpinning these electronic tools 
are fairly simple once the tool itself is developed, they can be used to collect large amounts 
of data and can be updated remotely. However, there are information governance, IT 
integration, data security and technological support issues which would need to be 
addressed if they were to be used on patients. Porter et al described some of the issues with 
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introducing a computerised decision support tool into pre-hospital care and highlighted the 
need for organisational support (Porter et al., 2018). Support from multiple organisations 
including ambulance and receiving trusts, would be needed if a tool such as STEAMv2 were 
to be introduced in order to give staff the confidence to apply it in practice. 
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Figure 4.0.1 Potential pre-hospital stroke algorithm integrating STEAMv2 
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If STEAMv2 were to be implemented then further research would be needed to evaluate its 
impact in practice. The research designs suitable for evaluating the impact of this type of 
decision tool include a randomised controlled trial (RCT), a stepped-wedge design or an 
interrupted time series (Moons et al., 2009a)(Moons et al., 2009a)(Moons et al., 
2009a)(Moons et al., 2009a)(Moons et al., 2009a)(Moons et al., 2009a). An RCT could 
involve cluster randomisation, which is frequently used in pre-hospital research (Mason et 
al., 2007; Perkins et al., 2015), of ambulance stations where intervention paramedics use 
STEAMv2 and the control paramedics continue with standard care. Information would need 
to be collected and recorded in a standard fashion and ideally all patients admitted to 
hospital would need similar assessments. Outcomes would focus on the rate of correct 
diagnoses, process measures such as rate and time to thrombolysis and ultimately an 
evaluation of impact on patient health outcomes. There would be ethical issues with how 
and when patients would be consented to be included in the study and potential issues 
around STEAMv2 false positives having delayed access to treatment which would need to be 
addressed. 
This thesis focussed on decision making by paramedics in the pre-hospital setting but the 
idea of a SM identification tool has potential applications beyond this setting. During the 
study there were discussions about use of STEAM for telephone triage or in primary care. 
Telephone triage is not a good target for attempting to identify a patient as a SM using 
STEAMv2 as any decision about potential stroke symptoms ideally requires face to face 
contact and a clinical assessment of the patient. STEAM and STEAMv2, and the information 
used to develop the tools, were also of interest to clinicians working in primary care as they 
see suspected stroke patients in the community similar to paramedics.  
Authors of other SM identification tools such as the FABS (Goyal et al., 2016b) have 
discussed how they could be used to select patients for advanced imaging in hospital to aid 
in identifying patients who are less likely to have had a stroke. Dawson et al (Dawson et al., 
2016) also discussed the use of risk stratification to identify patients that would benefit from 
early advanced imaging who could then be discharged from the HASU. STEAMv2 could also 
be used for a similar purpose, although when the patient is in hospital with access to a wider 
range of tests and specialist input, factors such as appearances of initial CT brain imaging 
could be considered for making the SM decision. 
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4.0.6 Future implications of SM identification 
Since this project was first envisaged, stroke and pre-hospital care has advanced. Stroke 
services continue to evolve in order to deliver the highest standard of care to stroke 
patients. Developments in hospital based stroke care will drive changes in pre-hospital 
stroke care, e.g. thrombectomy services may require new bypass models, but pre-hospital 
developments may also influence hospital stroke care, e.g. portable ultrasound and 
telemedicine allowing paramedics to assess patients and transmit images to remote 
neurologists. In all of these developments, and any research around improving stroke care, 
identifying and targeting the correct patients will be vital to showing the benefit, so 
detection and exclusion of SM will continue to be of interest. 
Thrombectomy services are being commissioned and regional pathways to access these 
services are being planned (Evans et al., 2017). The implementation of thrombectomy 
services will focus attention on improving the identification of stroke patients, in order to 
avoid transferring SM patients long distances to regional providers. Purrucker et al 
(Purrucker et al., 2017) designed a combined scale to identify stroke, grade severity and 
detect LVO which is unusual in that it is a single tool rather than sequential use of multiple 
tools. Although various models of implementation are being discussed, primarily mothership 
versus drip-and-ship (Evans et al., 2017; Milne et al., 2017), all thrombectomy services will 
be more efficient if SM patients are correctly identified. The rate and impact of SM patients 
“incorrectly” taken to thrombectomy centres will need to be considered to optimise the 
efficiency and cost effectiveness of these specialist regional neuroscience centres. 
Stroke services continue to centralise at fewer, larger HASUs (Allen et al., 2017). This will 
increase the burden of SM on these large HASUs and may lead to more interest in reducing 
the SM rate by improving pre-hospital stroke identification. There is no new investment 
anticipated for pre-hospital stroke care specifically, and a simple, cheap assessment may be 
attractive even if the impact is small at a local level.   
Mobile stroke units continue to gain traction, particularly in the USA. The first unit in the UK 
was being trialled in Southend in April 2018 (Southend University Hospital, 2018). Mobile 
stroke units may be able to identify some SM in the pre-hospital setting and avoid HASU 
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admission, but this would be a very expensive way of addressing this issue. There is also a 
growing interest in novel diagnostic technologies for improving pre-hospital stroke 
identification which are discussed below.  
4.0.7 Diagnostics 
STEAMv2 is an attempt to improve the diagnostic performance of paramedics using data 
that is currently available in the pre-hospital setting. However, there are a number of studies 
looking into new methods of identifying and more accurately diagnosing stroke which may 
impact on pre-hospital pathways. 
Blood based biomarkers have the potential to improve acute stroke diagnosis (Whiteley et 
al., 2012; Restrepo et al., 2016; Bustamante et al., 2017). Taking blood in the prehospital 
setting is possible and could aid stroke and SM diagnosis (Mattila et al., 2016). Biomarkers 
have not been introduced due to a lack of evidence of performance in real world settings, 
but they do have the potential to help with identifying stroke, differentiating types of stroke 
and excluding SM. They could be used in conjunction, or in sequence, with currently used 
tools such as FAST to improve the sensitivity and specificity of stroke diagnosis or STEAMv2 
to improve the accuracy of SM diagnosis. One study that is currently under development is 
the PRISM study (UK Research and Innovation, 2018) which is investigating purines as a 
potential biomarker of stroke in the pre-hospital setting.  
Other stroke diagnostic devices are currently being investigated including electromagnetic 
measurement performed by the Cerebrotech visor (Cerebrotech Medical Systems, 2018), the 
evoked potential prototype developed by Alpha Stroke (Forest Devices, 2018) and the 
microwave based Strokefinder device (Medfield Diagnostics, 2018). Ultrasound is also being 
investigated for its potential to improve pre-hospital stroke diagnosis (Holscher et al., 2008) 
and treatment (Hitchcock and Holland, 2010). All of these devices may lead to 
improvements in stroke diagnoses, but how they interact with existing stroke identification 
tools, the cost-effectiveness and their impact on patient outcomes will need to be 
considered and evaluated.  
4.0.8 Future research 
Pre-hospital research has come a long way since Callaham described the “scanty science of 
prehospital emergency care” (Callaham, 1997). Paramedic involvement in pre-hospital 
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research is a growing area (NIHR Dissemination Centre, 2016), and research is an emerging 
career choice for paramedics (McClelland, 2013). There are a number of areas which could 
have been explored, but were beyond the scope and resources of this thesis.  
The linkage of pre-hospital data with final patient diagnoses underpinned this work and 
provided original data on the accuracy of paramedic stroke identification. Expansion and 
continuation of this data linkage could be used to refine and improve pre-hospital stroke 
identification and provide feedback to ambulance and stroke services about rates and types 
of SM patients. This type of data could be added to national audits like SSNAP or the 
ambulance quality indicators which currently do not include a measure of pre-hospital 
diagnostic accuracy. In the context of the service and technology developments described 
above, this would enable observation of the care delivery impact following the introduction 
of interventions such as: SM identification assessment; pre-hospital training; enhanced 
imaging; or novel diagnostics. Looking further ahead, linked pre-hospital and hospital data 
could be analysed using machine learning, which is already being considered in some areas 
of stroke care (Kamal et al., 2018), in order to develop, and improve upon, tools for purposes 
such as SM identification. 
One of the exclusion criteria in STEAMv2 development was a reduced level of consciousness 
represented by a GCS<8. This was a small population of patients (n=362 (6%) across the four 
hospital trusts) who would traditionally be pre-alerted to the nearest ED based on their 
reduced GCS. How patients with a significantly reduced level of consciousness due to a 
stroke could be more accurately identified would be an interesting question to explore, 
because if the underlying condition is a stroke the nearest ED may not be the most suitable 
location for their ongoing care.  
If STEAMv2 were to be developed further, access to new data for further refinement and 
validation would be necessary and additional data, such as time since onset or variables 
related to functional diagnoses, could be sought. STEAMv2 could also be tested in 
combination with a biomarker or novel diagnostic tech to explore their combined 
performance. STEAMv2 could also be compared with other SM tools if all the necessary 
variables were available. If a pre-hospital thrombectomy screening tool was introduced then 
this type of project could be repeated but focussed on SM identified by the new screening 
tool. 
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4.0.9 Conclusions  
Pre-hospital stroke care focusses on the identification of suspected stroke patients and rapid 
transport to specialist care due to the time dependent nature of acute stroke treatment. The 
FAST remains the standard tool used by UK pre-hospital services to identify stroke patients. 
All pre-hospital stroke identification tools seek to identify the maximum number of stroke 
patients using basic observations and symptoms, i.e. they prioritise sensitivity over 
specificity. Due to the non-specific nature of stroke symptoms, and the many other 
conditions producing similar symptoms, a significant percentage of suspected stroke 
patients have a final SM diagnosis. Although difficult to quantify, it is likely that this has a 
negative effect on outcomes and resources through unnecessary thrombolysis and “bed 
blocking” on HASU.   
A small number of SM presentations can be accurately identified in the pre-hospital setting 
based on currently available data using the STEAMv2 tool. STEAMv2 was robustly developed 
based on pre-hospital data with paramedic and hospital clinician input throughout the 
process. Whilst both groups were supportive of the idea of identifying SM patients, the risks 
of a very small proportion of stroke patients missing, or having delayed, treatment were 
perceived to outweigh the potential benefits in their current systems.  
SM will remain an inevitable part of the current system of acute stroke care, especially in the 
absence of objective diagnostic tests. Increased centralisation of stroke services and the 
need to accurately identify patients suitable for thrombectomy means that incremental 
improvements in pre-hospital stroke identification are desirable. Although STEAMv2 may 
not have sufficient impact by itself for wide-spread implementation, it is simple and would 
not require new resources. A tool like STEAMv2, possibly with the inclusion of more 
physiological parameters or in combination with novel diagnostic technology, may provide 
an acceptable and affordable approach to identification of SM. SM identification would 
allow better use of finite specialist resources in a system where patients faced longer 
transfers and there were fewer stroke units. In the current system, the lack of quantifiable 
benefits and the perceived risks due to delayed identification of some stroke patients mean 
that STEAMv2 is probably not applicable in practice. 
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Appendices 
Appendix A. Literature search strategy from systematic review of stroke mimics 
Database: Embase 
 
1     differential diagnosis/  
2     diagnostic error/  
3     false positive result/  
4     mimic.mp.  
5     1 or 2 or 3 or 4  
6     exp cerebrovascular accident/di [Diagnosis]  
7     exp transient ischemic attack/di [Diagnosis]  
8     stroke.mp.   
9     6 or 7 or 8  
10     5 and 9  
 
Database: Ovid MEDLINE(R)  
 
1     exp Stroke/di [Diagnosis]  
2     cerebrovascular accident.mp.  
3     exp Ischemic Attack, Transient/di [Diagnosis]  
4     1 or 2 or 3  
5     mimic.mp.  
6     diagnosis, differential/ or false positive reactions/  
7     5 or 6  
8     4 and 7  
  
Database: CINAHL  
  
S1 (MH "Stroke+/DI") OR cerebrovascular accident OR transient ischemic attack  
S2 (MH "Cerebral Ischemia, Transient/DI")   
S3 "mimic"  
S4 (MH "Diagnosis, Differential")  
S5 (MH "False Positive Results")  
S6 S3 OR S4 OR S5  
S7 (S3 OR S4 OR S5) AND (S1)    
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Appendix B. QATSDD Scoring 
QATSDD Criteria 
Paper A B C D E F G H I J K L M N Total % 
Aiyesimoju 
et al 0 2 3 0 3 1 1 3 0 3 1 1 0 0 18 43% 
Ali et al 0 2 3 0 3 3 0 3 0 3 3 0 0 3 23 55% 
Alves et al 0 3 3 0 2 0 0 2 0 3 2 0 0 0 15 36% 
An et al 0 1 3 0 1 3 2 3 3 3 3 3 0 2 27 64% 
Artto et al 0 3 3 0 3 3 3 3 0 3 3 2 0 3 29 69% 
Asaithambi 
et al 0 3 3 0 2 1 0 2 0 3 3 1 0 1 19 45% 
Ay et al 0 2 3 0 3 3 0 3 0 3 3 0 0 0 20 48% 
Barker et al 0 3 3 0 3 3 0 3 0 3 3 0 0 2 23 55% 
Brandler et 
al 0 3 3 3 3 2 2 3 0 3 3 3 0 3 31 74% 
Bray et al 0 3 3 0 2 3 3 2 3 3 3 3 0 1 29 69% 
Brunser et al 0 3 3 0 3 3 0 3 0 3 3 0 0 3 24 57% 
Chang et al 0 3 2 0 3 1 1 3 0 3 3 0 0 2 21 50% 
Chen et al 0 3 3 0 2 1 1 3 0 3 3 0 0 2 21 50% 
Chernyshev 
et al 0 2 3 0 3 1 1 3 0 3 3 0 0 3 22 52% 
Clarey et al 0 3 3 3 3 3 3 3 3 3 3 0 0 2 32 76% 
Dassan et al 0 2 1 0 1 3 2 2 1 3 3 2 0 2 22 52% 
Dawson et al 0 3 3 0 3 2 2 2 0 3 3 3 0 2 26 62% 
Eichel et al 0 3 3 0 2 3 3 3 0 3 2 3 0 3 28 67% 
El Husseini & 
Goldstein 0 2 2 0 3 1 0 3 0 3 3 0 0 2 19 45% 
Ferro et al 0 3 3 0 2 3 2 3 0 1 3 0 0 1 21 50% 
Foerch et al 0 3 2 0 2 3 3 2 0 3 3 0 0 3 24 57% 
Forster et al 0 3 2 0 3 3 3 3 0 3 3 3 0 3 29 69% 
Gargalas et 
al 0 3 3 0 2 3 3 3 3 3 3 3 0 3 32 76% 
Gioia et al 0 3 3 0 3 3 1 3 0 0 3 3 0 3 25 60% 
Gonzalez-
Garcia et al 0 3 3 0 2 3 1 2 0 1 1 0 0 2 18 43% 
Goyal et al  0 3 3 2 3 1 3 2 0 3 3 3 0 2 28 67% 
 282 
 
QATSDD Criteria cont. 
Paper A B C D E F G H I J K L M N Total % 
Goyal et al  0 3 3 0 3 3 3 3 0 3 3 3 0 2 29 69% 
Guillan et al 0 1 3 0 3 3 2 3 0 3 3 0 0 2 23 55% 
Hand et al 0 3 2 3 3 3 2 3 3 3 3 3 0 2 33 79% 
Hatzitolios et 
al 0 1 3 0 2 3 1 2 0 2 2 0 0 0 16 38% 
Hemmen et 
al 0 3 3 0 3 3 3 2 0 3 3 0 0 2 25 60% 
Jiang et al 0 3 3 0 3 3 3 3 3 3 3 3 0 3 33 79% 
Karlinski et al 0 3 3 0 3 3 0 3 0 3 3 2 0 1 24 57% 
Knauer et al 0 3 2 0 1 3 3 3 3 3 3 3 0 2 29 69% 
Kose et al 0 3 3 0 2 3 0 2 0 3 3 0 0 3 22 52% 
Kothari et al 0 3 3 0 3 3 1 3 0 3 3 1 0 3 26 62% 
Laskowitz et 
al 0 3 3 0 3 3 3 3 3 3 3 3 0 3 33 79% 
Lewandowski 
et al 0 3 2 0 3 3 0 3 0 3 3 0 0 2 22 52% 
Liberman et 
al 0 3 2 0 2 3 3 3 0 3 3 0 0 1 23 55% 
Libman et al 0 2 2 0 1 3 0 1 0 3 3 2 0 0 17 40% 
Luger et al 0 3 3 0 2 3 3 1 3 3 3 3 0 3 30 71% 
Mao et al 0 3 3 0 1 1 1 1 0 3 3 2 0 2 20 48% 
Martin et al 0 3 3 0 3 3 3 3 0 3 3 2 0 1 27 64% 
Mehta et al 0 2 3 0 2 1 1 3 0 3 3 2 0 2 22 52% 
Merino et al 0 3 3 0 3 3 1 3 0 3 3 3 0 3 28 67% 
Montaner et 
al 0 3 2 0 3 3 3 3 3 3 3 3 0 3 32 76% 
Natteru et al 0 3 3 0 3 1 1 1 2 3 3 1 0 2 23 55% 
Nor et al 0 3 3 0 3 3 3 3 0 3 3 3 0 2 29 69% 
Norris & 
Hachinski 0 2 3 0 3 0 1 3 0 1 1 0 0 0 14 33% 
O'Brien et al 0 3 3 0 2 3 3 3 0 3 3 0 0 1 24 57% 
O'Connell et 
al 0 3 2 0 1 3 3 1 3 3 3 3 0 2 27 64% 
Quenardelle 
et al  0 3 3 0 3 3 3 3 0 3 3 3 0 2 29 69% 
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QATSDD Criteria cont. 
Paper A B C D E F G H I J K L M N Total % 
Reid et al 0 3 3 0 3 3 1 3 0 2 2 0 0 0 20 48% 
Rostanski et 
al 0 3 3 0 3 2 0 2 0 3 3 2 0 2 23 55% 
Sarikaya et al 0 3 3 0 2 3 1 3 0 3 3 1 0 3 25 60% 
Scott & 
Silbergleit 0 3 3 0 2 3 3 2 0 3 3 1 0 3 26 62% 
Sequeira et 
al 0 3 3 0 3 2 1 3 0 3 3 1 0 2 24 57% 
Sharma et al 0 3 3 0 2 3 3 3 3 3 3 3 0 3 32 76% 
Sivakumaran 
et al 0 3 3 0 3 1 0 2 0 3 3 1 0 2 21 50% 
Taguchi et al 0 3 2 0 2 1 0 2 0 3 3 1 0 2 19 45% 
Tobin et al 0 3 3 0 3 3 3 1 0 3 3 3 0 0 25 60% 
Tsivgoulis et 
al 0 3 3 2 3 3 3 3 3 3 3 3 0 3 35 83% 
Tsivgoulis et 
al 0 3 3 0 3 3 1 3 0 3 3 3 0 2 27 64% 
Tuntiyatorn 
et al 0 3 3 0 3 3 1 3 0 3 3 2 0 2 26 62% 
Wendt et al 0 3 3 0 3 3 3 3 0 3 3 3 0 2 29 69% 
Whiteley et 
al 0 3 3 0 2 3 3 3 3 3 3 3 0 2 31 74% 
Winkler et al 0 3 3 0 2 3 3 3 0 3 3 0 0 2 25 60% 
Wolf et al 0 3 2 0 3 0 0 2 0 3 3 1 0 2 19 45% 
Zinkstok et al 0 3 3 0 3 3 3 3 0 3 3 0 0 2 26 62% 
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QATSDD 
Criteria 
 
A Explicit theoretical framework 
B Statement of aims/objectives in main body 
C Clear description of research setting 
D Evidence of sample size consideration in terms of analysis 
E Representative sample of target group of a reasonable size 
F Description of procedure for data collection 
G Rationale for choice of data collection tools 
H Detailed recruitment data 
I 
Statistical assessment of reliability and validity of measurement 
tools 
J 
Fit between stated research question and method of data 
collection 
K Fit between research question and method of analysis 
L Good justification for analytical method selected 
M Evidence of user involvement in design 
N Strengths and limitations critically discussed 
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Appendix C. Survey questions 
1. Do you agree to continue with the survey? Yes, No 
2. What is your age? <18, 18-20, 21-29, 30-39, 40-49, 50-59, 60+ 
3. Are you male of female? Male, Female 
4. How long have you worked in pre-hospital care? 0-2 years, 3-5 years, 6-10 years, 11-
20 years, more than 20 years 
5. What is your current job role? Paramedic, Specialist paramedic, Advanced 
Paramedic, Consultant Paramedic, Other paramedic, Non-paramedic 
6. Is your main job working for an NHS ambulance trust? Yes, No 
7. Which service do you work for? East of England Ambulance Service NHS Trust, East 
Midlands Ambulance Service NHS Trust, Isle of Wight Ambulance Service, London 
Ambulance Service NHS Trust, National Ambulance Service (Ireland), North East 
Ambulance Service NHS Foundation Trust,  North West Ambulance Service NHS Trust, 
Northern Ireland Ambulance Service Health and Social Care Trust, South West 
Ambulance Service NHS Foundation Trust, South Central Ambulance Service NHS 
Foundation Trust, South East Coast Ambulance Service NHS Foundation Trust, Scottish 
Ambulance Service, Welsh Ambulance Services NHS Trust, West Midlands Ambulance 
Service NHS Foundation Trust, Yorkshire Ambulance Service NHS Trust 
8. Where do you mainly work? HEMS, Hospital, Military, Primary care, Private 
ambulance service, Remote/offshore, SAR, University, Other (please specify) 
9. In which area do you mainly work? East of England, East Midlands, Isle of Wight, 
London, North East, North West, Northern Ireland, South West, South Central, South 
East Coast, Scotland, Wales,  West Midlands, Yorkshire, Other (please specify) 
10. What is your highest level of education relevant to your paramedic role? IHCD 
Paramedic, FdSc, BSc, PGCert, PGDip, Masters, Doctorate 
11. How did you qualify as a paramedic? IHCD, University, Other (please specify)  
12. Did your initial training about stroke consider it as a condition in isolation or was 
stroke covered as part of a wider neurological topic? Stroke covered in isolation, 
Stroke covered as part of wider neurology 
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13. Based on your current knowledge of stroke care how would you classify your initial 
training? Inadequate, Adequate, Excessive, Any comments on your initial stroke 
training? 
14. Would you like more training on prehospital stroke care? Yes, No, Unsure 
15. Do you think paramedics as a group need more training on prehospital stroke care? 
Yes, No, Unsure 
16. What type of training would you like regarding stroke going forward? 
17. Have you completed any Continuing Professional Development (CPD) activities 
focussed on stroke since qualifying as a paramedic? Yes, No 
18. What type of stroke CPD have you completed? Ambulance service based training 
University based training, Conference with stroke related content, Stroke specific 
lecture, seminar or workshop, Self directed learning (offline), Self directed learning 
(online), Other (please specify) 
19. How many hours CPD relevant to stroke have you done in the past 12 months? 
(approximately) 
20. What stroke assessment tools do you use to assess suspected stroke patients in your 
prehospital practice? Cincinnati Prehospital Stroke Scale (CPSS), Face Arms Speech 
Time (FAST),  
Los Angeles Prehospital Stroke Screen (LAPSS), Melbourne Ambulance Stroke Screen 
(MASS), Miami Emergency Neurologic Deficit (MEND), National Institutes of Health 
Stroke Scale (NIHSS), Recognition of Stroke in the Emergency Room (ROSIER), Los 
Angeles Motor Scale (LAMS), Rapid Arterial oCclusion Evaluation (RACE), Other 
(please specify) 
21. What stroke assessment tools have you been trained to use? CPSS, FAST, LAPSS, 
MASS, MEND, NIHSS, ROSIER, LAMS, RACE, Other (please specify) 
22. How would you rate your confidence when dealing with the following time critical 
conditions: Sepsis, STEMI, Stroke, Major trauma? Very little confidence, Little 
confidence, Neutral, Confident, Very confident 
23. To what extent do you think that prehospital actions influence a patient's outcome in 
the following time critical conditions: Sepsis, STEMI, Stroke, Major trauma? Very little 
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influence, Little influence, Neutral, Some influence, Very high influence 
24. How do you think prehospital care has changed over the course of your career for 
the following time critical conditions: Sepsis, STEMI, Stroke, Major trauma? Much 
worse, Slightly worse, No change, Slightly better, Much better 
25. Where do you take most stroke patients in your region? Direct to scan, Emergency 
Department (ED), Hyper Acute Stroke Unit (HASU), Stroke ward, Other (please specify) 
26. Does where you take stroke patients change depending on the time of day or day of 
the week? No, Yes - by time of day, Yes - by day of the week, Yes - by time and day 
27. Do you have access to any form of telemedicine for stroke patients? Yes, No, If yes, 
please describe what form this takes 
28. Do you get any feedback on stroke patients you treat and transport? Yes (formal),Yes 
(informal),  No 
29. Do you think that feedback on stroke patients you treat would be useful to you as a 
paramedic? Yes, No, If yes how would you like the feedback and to what level of 
detail? 
30. Would you routinely perform an ECG on a stroke patient? Yes - all stroke patients, 
Yes - only if they had chest pain, Not routinely, Any comments on ECGs on stroke 
patients 
31. Are you currently involved in any prehospital stroke research (apart from this 
survey)? Yes, No 
32. What prehospital stroke research are you involved in? PASTA, RIGHT2, TIER, Other 
(please specify) 
33. Had you heard of the term 'stroke mimic' before today? Yes, No 
34. What do you understand by the term 'stroke mimic'? Where a patient appears to be 
suffering from a different condition but their symptoms are due to a stroke., Where a 
patient appears to be having a stroke but their symptoms are due to a different 
condition., Where a patient describes stroke-like symptoms but is symptom free when 
you arrive. 
35. What proportion of suspected strokes admitted by ambulance do you think are 
stroke mimics? 
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36. What do you think are the three most common stroke mimics seen in prehospital 
care? Brain tumours, Headache, Mental illness, Metabolic disorders, Migraine, Sepsis, 
Seizures, Syncope, Toxins (including alcohol), Vertigo 
37. Do you think a tool that calculates the chance of a suspected stroke patient having a 
stroke mimic condition would be useful in prehospital care? Yes, No, Unsure 
38. In what format would a stroke mimic tool be most useful for the prehospital setting? 
Paper based, Electronic (stand alone app or program), Electronic (built into electronic 
patient record device), Other (please specify) 
39. How acceptable would it be for paramedics to treat a suspected stroke (FAS+ve) 
patient differently (i.e. take to ED instead of HASU) based on a test that indicates a 
high probability that the patient is a stroke mimic? Totally unacceptable, Mostly 
unacceptable, Neutral, Mostly acceptable, Totally acceptable 
40. How certain that a patient was a stroke mimic would you need to be to decide not to 
follow your normal stroke care protocol? 
41. Any thoughts or comments about prehospital identification and treatment of stroke 
mimics? 
42. Do you have access to referral pathways for TIAs in your region? Yes, No, Unsure 
43. Do you have access to TIA clinics in your region? Yes, No, Unsure 
44. Do you treat TIA with antiplatelets in your practice? Yes (aspirin), Yes (other 
antiplatelet), No 
45. Do you use a risk stratification tool for TIA patients? Yes, No 
46. Which risk stratification tool do you use on TIA patients? ABCD2, Other (please 
specify) 
47. What is the current timeframe for thrombolysis in stroke patients? Up to 2.5 hours, 
Up to 3.5 hours, Up to 4.5 hours, Up to 5.5 hours 
48. Have you heard of intra arterial thrombectomy for stroke? Yes, No 
49. What percentage of your workload do you think stroke makes up? 
50. If you have any comments you want to make on the current state of prehospital 
stroke care please record them below.  
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Appendix D. Example EPRF 
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Appendix E. Free-text data collection protocol 
Title: PaStraMi Free-text data extraction  
Objective 
Extraction of relevant stroke data from the free-text section of the North East Ambulance Service 
(NEAS) electronic patient record form (EPRF). 
Dataset 
NEAS stroke data from PaStraMi service evaluation project. 
Method 
Data are to be indicated as present with a ‘1’ and left blank if not present. 
Data are to be considered present if the EPRF indicates that the NEAS crew attending the patient 
directly report the sign or symptom at the time of their attendance. Signs and symptoms that 
resolved prior to NEAS attendance are not to be included.  
Data extraction check 
A sample of PaStraMi cases with data recorded in the comments section in the form of narrative text 
will be checked by a second researcher to report on extraction of relevant data. A sample of 60 cases 
will be checked. The sample will be randomly identified from cases with any freetext data. 
A level of interpretation is necessary for this type of narrative text so the cross checking will be done 
by a clinician with a similar background and level of training to the original data extractor. 
Guidance 
FAST+ve Documented means where some form of positive FAS test is indicated, not the signs, 
symptoms or observations that comprise the test. 
Eye Issues means signs recorded by the crew of gaze deviation, fixed stare or the like. 
Vision issues means patient reported symptoms of some form of visual disturbance. 
Output 
This process will allow level of agreement to be described using Cohen’s kappa as a measure of inter-
rater agreement in terms of number of freetext data points and agreement in the specific data points 
extracted. 
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Appendix F. NEAS and NHCT data linking protocol 
Title: PaStraMi Dataset Development Protocol (NEAS and Northumbria) 
Glossary 
CAD – Computer Aided Dispatch, unique identifying number for ambulance cases 
EPRF – Electronic Patient Report Form, documentation of patient contact with ambulance service 
HES – Hospital Episode Statistics, details of admitted NHS patients 
NEAS – North East Ambulance Service NHS Foundation Trust 
Northumbria – Northumbria Healthcare NHS Foundation Trust 
SSNAP – Sentinel Stroke National Audit Programme, national database of stroke patients 
TIA – Transient Ischaemic Attack, stroke like symptoms lasting less than 24 hours 
 
Objective 
Confirmation of hospital diagnosis of stroke, TIA and stroke mimic amongst a cohort of NEAS 
admissions who were given a paramedic diagnosis of suspected stroke.  
Initial main dataset: NEAS 
Data will be initially sourced from NEAS through a request placed with NEAS informatics. 
Timeframe: all cases between 01/06/2013 00:00 and 31/05/2016 23:59  
Identified by clinical impression includes stroke. 
The data fields requested include: Case Identifiers, Name, Age, Date & Times, Chief Complaint, 
Impression, Primary Survey Information, Vitals and History, Receiving Hospital and freetext 
comments  
Matching outcome dataset: Northumbria 
The NEAS suspected stroke cohort will be cross-referenced with:  
1. Northumbria SSNAP data for the same time interval 
2. HES if not found in SSNAP  
Matching 
Data will be matched using a 5 stage process: 
Step 1. Where Northumbria SSNAP data reports a CAD number that matches with a NEAS case of 
suspected stroke this will be classified as a true stroke.  
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Step 2. Where no CAD number is reported, cases will be matched in SSNAP on a combination of 
hospital, age, gender and time of arrival at the hospital. Due to variation in when and how 
ambulance arrival time is reported time +/- 20 minutes will be accepted. If time plus all other criteria 
match then this will be classified as a true stroke. If cases match on hospital + 2/3 factors then 
continue to step 3.  
Step 3. If unable to make a definite match based on the criteria in step 2 then further attempts to 
match can be made using patient postcode, onset time (if documented), date of birth plus any other 
data in the free text that is available. Individual NEAS EPRFs may need to be accessed to check data 
or gather additional data. Positive match as a true stroke requires consistent matching across the 
majority of criteria or clear explanation of differences. 
Step 4. If no match for NEAS suspected stroke (i.e. potential stroke mimic or TIA) then case details to 
be passed to Northumbria Healthcare NHS Foundation Trust including name; gender; age; hospital; 
date and time of admission; CAD number to identify final diagnosis (primary code) using HES. 
Step 5. If final diagnosis is available from Northumbria remaining NEAS cases to be classified as true 
stroke, stroke mimic or TIA. If unable to match on available data record case as unmatched. 
Data matching check 
A 10% sample of 30 cases (based on 1,800 total cases, 50% (n=900) match in total, 2/3rd (600) match 
at steps 1 and 2 leaving 300 match at step 3) matched at step 3 will be passed to a second researcher 
to check for agreement on the matching process. Level of agreement will be reported on using 
Cohen’s kappa as a measure of inter-rater agreement. 
Missing and unmatched data 
If data is missing from the dataset supplied by NEAS informatics then access to the source material 
(in the form of the EPRF) can allow data fields to be completed or indicated as missing data. 
Cases in the NEAS cohort which cannot be identified in SSNAP or HES will be reported by number and 
clinical characteristics. A sample of unmatched cases will be compared with the matched cases to 
identify the presence of any systematic bias.  
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Data flow diagram 
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Appendix G. Frequency distribution plots 
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Appendix H. Focus group 1 topic guide 
Paramedic Stroke Mimic (PaStraMi) Focus Groups 
Topic guide: Objective 1 
(These are not prescriptive, but points to be used to guide focus groups. Any topics that arise 
naturally during the course of the discussion should be explored.) 
Introduction and housekeeping 
 Researcher introduction and overview of study 
 Reiterate right to withdraw/stop anytime, confidentiality, anonymity, data 
storage/destruction 
 Any questions? 
 Permission to record interview – audio and video? 
 Consent 
PaStraMi development (Presentation) 
 Description of project 
 Description of findings of systematic literature review 
 Version 1 of Mimic Probability Score (MPS) based on analysis of data 
The Mimic Probability Score (MPS) 
 Initial thoughts on the MPS 
Stroke mimics 
 Stroke mimics as a general topic 
Characteristics of stroke mimics 
 Characteristics (demographic and clinical identified in literature review and data) 
Potential application of a stroke mimic tool 
 How would this type of tool work in the participants setting 
Barriers/facilitators to implementing a stroke mimic tool 
 What would help/hinder implementing this type of tool in prehospital care 
Particular populations/conditions who may be identified or at risk 
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 Are there particular groups (young women) or conditions (seizures, migraines) that are of 
concern to participants 
Any further questions 
 Explain what will happen next (further focus groups, data analysis, other project activities) 
 Thank all participants 
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Appendix I. Focus group 1 stimulus material 
Paramedic Stroke Mimic (PaStraMi) Focus Groups 
PaStraMi project 
 Stroke Mimics (SM) present stroke-like symptoms but have a different aetiology. 
Approximately 30% of suspected stroke admissions are SM 
 SM may bypass local hospitals to access distant hyper acute stroke units. This may be 
inconvenient for patients and families, inappropriate use of ambulance resources and place 
additional demands on stroke services   
 A range of stroke identification instruments are used in pre-hospital care. These instruments 
are intended to identify suspected strokes in an undifferentiated population so favour 
sensitivity over specificity  
 
 A systematic review of the literature indicates that 
o 29% of suspected strokes from pre-hospital care are SM 
o 27% of suspected strokes from hospital, ED and mixed settings are SM 
o 10% of suspected strokes who get thrombolysed are SM 
o Seizures/epilepsy and migraines/headaches are the most common SM 
 
 The aim of this project is to develop a tool which identifies SM using data available in the 
pre-hospital setting 
 The tool is intended to be applied to suspected stroke patients to inform decision making 
about patient destination   
 Early identification of SM patients may allow transport to appropriate non-stroke care and 
improve healthcare resource utilisation 
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STEAM tool 
The STEAM tool includes 5 criteria. 
 Systolic blood pressure <95mmHg 
 Temperature >38.0oC AND heart rate >90 
 Epilepsy (history of) AND seizures at presentation 
 Age <40 years 
 Migraine (history of) AND headache at presentation 
The presence of any of these characteristics in a suspected stroke patient indicates there is a high 
probability of that patient being a stroke mimic. 
The presence of ≥1 STEAM characteristic identifies SM with 11% (95% CI, 9-13) sensitivity, 99% (95% 
CI, 98-99) specificity, positive predictive value of 87% (95% CI, 78-92), negative predictive value of 
62% (95% CI, 61-63) 
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Appendix J. Approvals for qualitative work 
 
 
Mr Graham McClelland 
Research Paramedic, Stroke Association Research Fellow North East Ambulance Service 
NHS Foundation Trust Bernicia House, Goldcrest Way 
Newburn Riverside Newcastle upon Tyne NE15 8NY 
 
Email: hra.approval@nhs.net 
 
26 January 2017 
 
 
Dear Mr McClelland 
 
Letter of HRA Approval 
 
 
Study title: 
 
Input from professional stakeholder groups into the 
development and evaluation of a prehospital stroke mimic 
probability score IRAS project ID: 207285 
REC reference: 16/HRA/6225 
Sponsor North East Ambulance Service NHS Foundation Trust 
 
 
I am pleased to confirm that HRA Approval has been given for the above 
referenced study, on the basis described in the application form, protocol, 
supporting documentation and any clarifications noted in this letter. 
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Participation of NHS Organisations in England 
The sponsor should now provide a copy of this letter to all participating NHS 
organisations in England. 
 
 
Appendix B provides important information for sponsors and participating NHS 
organisations in England for arranging and confirming capacity and capability. Please 
read Appendix B carefully, in particular the following sections: 
 Participating NHS organisations in England – this clarifies the types of 
participating organisations in the study and whether or not all organisations will 
be undertaking the same activities 
 Confirmation of capacity and capability - this confirms whether or not each type 
of participating NHS organisation in England is expected to give formal confirmation 
of capacity and capability. Where formal confirmation is not expected, the section 
also provides details on the time limit given to participating organisations to opt out 
of the study, or request additional time, before their participation is assumed. 
 Allocation of responsibilities and rights are agreed and documented (4.1 of HRA 
assessment criteria) - this provides detail on the form of agreement to be used in 
the study to confirm capacity and capability, where applicable. 
Further information on funding, HR processes, and compliance with HRA criteria and 
standards is also provided. 
 
It is critical that you involve both the research management function (e.g. R&D office) 
supporting each organisation and the local research team (where there is one) in setting 
up your study. Contact details and further information about working with the research 
management function for each organisation can be accessed from www.hra.nhs.uk/hra-
approval. 
 
Appendices 
The HRA Approval letter contains the following appendices: 
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 A – List of documents reviewed during HRA assessment 
 B – Summary of HRA assessment 
 
After HRA Approval 
The attached document “After HRA Approval – guidance for sponsors and 
investigators” gives detailed guidance on reporting expectations for studies with 
HRA Approval, including: 
 Working with organisations hosting the research 
 Registration of Research 
 Notifying amendments 
 Notifying the end of the study 
 
The HRA website also provides guidance on these topics and is updated in the light of 
changes in reporting expectations or procedures. 
 
Scope 
HRA Approval provides an approval for research involving patients or staff in NHS 
organisations in England. 
 
If your study involves NHS organisations in other countries in the UK, please contact 
the relevant national coordinating functions for support and advice. Further 
information can be found at http://www.hra.nhs.uk/resources/applying-for-
reviews/nhs-hsc-rd-review/. 
 
 
If there are participating non-NHS organisations, local agreement should be obtained in 
accordance with the procedures of the local participating non-NHS organisation. 
 
User Feedback 
The Health Research Authority is continually striving to provide a high quality service to 
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all applicants and sponsors. You are invited to give your view of the service you have 
received and the application procedure. If you wish to make your views known please 
email the HRA at hra.approval@nhs.net. Additionally, one of our staff would be happy to 
call and discuss your experience of HRA Approval. 
 
HRA Training 
 
We are pleased to welcome researchers and research management staff at our training days 
– see details at http://www.hra.nhs.uk/hra-training/ 
 
Your IRAS project ID is 207285. Please quote this on all 
correspondence. Yours sincerely 
Beverley 
Mashege
de 
Assessor 
 
 
Email: hra.approval@nhs.net 
 
 
Copy to: Ms Sonia Byers (North East Ambulance Service NHS Foundation 
Trust), Sponsor Contact 
 
 
NIHR CRN Portfolio Applications Team 
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Newcastle 
University 
Graham McClelland 
Institute of Neuroscience (IoN) 
Faculty of Medical Sciences 
Newcastle University The Medical School Framlington Place Newcastle upon Tyne 
NE2 4HH United Kingdom 
 
FACULTY OF MEDICAL SCIENCES: ETHICS COMMITIEE 
Dear Graham, 
Title: Input from professional stakeholder groups into the development, evaluation 
and feasibility of a prehospital stroke mimic probability score 
Application No: 01203/2016 
Start date to end date:01/09/2016 to 31/08/2018 
 
On behalf of the Faculty of Medical Sciences Ethics Committee,Iam wr iting to 
confirm that the ethical aspects of your proposal have been considered and your 
study has been given ethical approval. 
The approval is limited to this project: 01203/2016 . If you wish for a further approval to 
extend this project, please submit a re-application to the FMS Ethics Committee and this 
will be considered. 
During the course of your research project you may find it necessary to revise 
your protocol. Substantial changes in methodology,or changes that impact on 
the interface between the researcher and the participants must be considered 
by the FMS Ethics Committee ,prior to implementation. * 
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At the close of your research project please report any adverse events that have 
occurred and the actions that were taken to the FMS Ethics Comm ittee .* 
Best wishes, 
Yo urs sincerely 
 
Kimberley Sutherland 
On behalf of Faculty Ethics Committee 
 
cc. 
Professor Daniel Nettle,Chair of FMS 
Ethics Committee Ms Lois Neal, Assistant 
Registrar (Research Strategy) 
*Please refer to the latest guidance available on the internal Newcastle we b-site. 
tel: +44 (0) 191 208 6000
 
* 
fax: +44 (0) 191 208 6621 THE    
QUEEN'S 
ANNIVERSARY PRIZES 
www.ncl.ac.uk 
lhe i.Klrverst- ,oi Ne' casde uponTnetr..ctng ( N,.,..,.tle l.Jrlr\«Sty
 2
013 
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Appendix K. Suspected stroke patients transported to Newcastle Hospitals 
Suspected stroke patients transported to Newcastle Hospitals 
There were 1,000 suspected stroke patients, including 38% SM, transported by NEAS to 
NUTH within the study timeframe. 
Patient Selection 
The process of identifying the suspected stroke patients transported by NEAS to NUTH is 
shown in figure AP11.1. 
 
Figure AP11.1. Identification of NEAS suspected stroke patients transported to NUTH 
Patient discharge diagnoses 
From the total cohort of 1,000 suspected stroke patients 527 (53%) were identified as stroke 
patients using SSNAP. The remaining 473 suspected stroke patients who were not positively 
matched in the SSNAP data were searched for using the NUTH electronic record system 
(HES).  
 39 patients were identified as TIA (ICD-10 codes G458 and G459) based on NUTH HES 
records. 
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 52 patients were identified as stroke based on NUTH HES records including diagnostic 
codes I61, I63 and I64.  
 306 patients had a SM ICD-10 diagnosis. 
 76 patients were unable to be linked with either SSNAP or HES. These patients were 
all assumed to be SM.  
Combining these figures results in 618 (62%) stroke patients and 382 (38%) SM patients. 
Assumed SM patients 
SM patients were identified (n=382) by either confirmed non-stroke diagnosis (n=306 
including any ICD-10 code other than I61, I63, I64 or TIA codes G458 and 459) in NUTH HES 
system or assumed (n=76) based on inability to match with either SSNAP or HES.  
The patients assumed to be SM (n=76) were compared with the patients with a confirmed 
SM diagnosis. 
Table AP11.1. Comparison of NUTH patients with confirmed SM diagnosis versus 
assumed SM diagnosis 
Diagnosis Age (mean, SD) Gender (% Male) 
Confirmed (n=306) 71.1 (16.2) 44 
Assumed (n=76) 68.5 (21.1) 41 
 
The two groups of SM patients were not significantly different in age (independent samples 
t-test, p=0.323) or gender (chi square test, p=0.565). 
Stroke mimic diagnoses 
One hundred and thirty-eight different ICD-10 diagnostic codes were recorded for the 306 
patients with a confirmed SM diagnosis. 
The ICD-10 based SM diagnoses are displayed in table AP11.2. 
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Table AP11.2 Most frequent ICD-10 diagnoses recorded for NUTH SM patients 
ICD-10 
Code 
ICD-10 description 
Number (%) of 
patients 
R298 
Other symptoms and signs involving the nervous and 
musculoskeletal systems 20 (7%) 
N390 Urinary tract infection, site not specified 17 (6%) 
R55X Syncope and collapse 15 (5%) 
R568 Convulsions, not elsewhere classified 14 (5%) 
R51X Headache 10 (3%) 
G439 Migraine, unspecified 8 (3%) 
R410 Disorientation, unspecified 8 (3%) 
J181 Lobar pneumonia, unspecified organism 7 (2%) 
C793 
Secondary malignant neoplasm of brain and cerebral 
meninges 5 (2%) 
F059 Delerium, unspecified 5 (2%) 
G409 Epilepsy, unspecified 5 (2%) 
J22X Unspecified acute lower respiratory infection 5 (2%) 
R202 Paresthesia of skin 5 (2%) 
G819 Hemiplegia, unspecified affecting unspecified side 4 (1%) 
I620 Nontraumatic subdural hemorrhage 4 (1%) 
J690 Pneumonitis due to inhalation of food and vomit 4 (1%) 
R208 Other disturbances of skin sensation 4 (1%) 
R478 Other speech disturbances 4 (1%) 
S0650 Traumatic subdural hemorrhage 4 (1%) 
C349 
Malignant neoplasm of unspecified part of unspecified 
bronchus or lung 3 (1%) 
C711 Malignant neoplasm of frontal lobe 3 (1%) 
E86X Volume depletion 3 (1%) 
F419 Anxiety disorder, unspecified 3 (1%) 
G510 Bell's palsy 3 (1%) 
I629 Nontraumatic intracranial hemorrhage, unspecified 3 (1%) 
I951 Orthostatic hypotension 3 (1%) 
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Table AP11.2 Most frequent ICD-10 diagnoses recorded for NUTH SM patients cont. 
ICD-10 
Code 
ICD-10 description 
Number (%) of 
patients 
R296 Repeated falls 3 (1%) 
Other Other conditions with less than 1% (n=3) prevalence 134 (44%) 
 
The ICD-10 codes were summarised using Clinical Classification Software (CCS) codes as used 
earlier in chapters 1.2 and 1.4. The most frequent SM diagnoses represented using level 2 
CCS codes are shown in table AP11.3.  
Table AP11.3 NUTH SM diagnoses displayed using level 2 CCS codes 
CCS level 2 
code 
CCS description 
Number 
(%) of 
patients 
6.9 Other nervous system disorders 28 (9%) 
6.4 Epilepsy; convulsions 27 (9%) 
13.8 Other connective tissue disease 25 (8%) 
6.5 Headache; including migraine 19 (6%) 
10.1 Diseases of the urinary system 19 (6%) 
7.3 Cerebrovascular disease 18 (6%) 
17.1 Symptoms; signs; and ill-defined conditions 16 (5%) 
8.1 Respiratory infections 10 (3%) 
2.11 Cancer; other primary 8 (3%) 
7.2 Diseases of the heart 8 (3%) 
7.4 Diseases of arteries; arterioles; and capillaries 8 (3%) 
Unknown Unknown 8 (3%) 
8.8 Other lower respiratory disease 7 (2%) 
2.12 Secondary malignancies 6 (2%) 
2.3 Cancer of bronchus; lung 6 (2%) 
5.11 Alcohol-related disorders 6 (2%) 
5.4 
Delirium dementia and amnestic and other cognitive 
disorders 6 (2%) 
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Table AP11.3 NUTH SM diagnoses displayed using level 2 CCS codes cont. 
CCS level 2 
code 
CCS description 
Number 
(%) of 
patients 
2.14 Neoplasms of unspecified nature or uncertain behavior 5 (2%) 
3.8 Fluid and electrolyte disorders 5 (2%) 
6.3 Paralysis 5 (2%) 
16.4 Intracranial injury 5 (2%) 
2.16 Benign neoplasms 4 (1%) 
8.4 Aspiration pneumonitis; food/vomitus 4 (1%) 
5.2 Anxiety disorders 3 (1%) 
6.6 Coma; stupor; and brain damage 3 (1%) 
6.7 Eye disorders 3 (1%) 
16.11 Poisoning 3 (1%) 
Other Other conditions with less than 1% (n=3) prevalence 41 (13%) 
 
The CCS codes were combined into level 1 CCS codes to show broader clinical groupings as 
shown in table AP11.4.   
Table AP11.4 NUTH SM diagnoses displayed using level 1 CCS codes 
CCS1 
code 
CCS code description Number 
(%) of 
patients 
1 Infectious and parasitic diseases 2 (1%) 
2 Neoplasms 30 (10%) 
3 Endocrine; nutritional; and metabolic diseases and immunity 
disorders 
9 (3%) 
4 Diseases of the blood and blood-forming organs 1 (<1%) 
5 Mental Illness 18 (6%) 
6 Diseases of the nervous system and sense organs 90 (29%) 
7 Diseases of the circulatory system 34 (11%) 
8 Diseases of the respiratory system 23 (8%) 
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Table AP11.4 NUTH SM diagnoses displayed using level 1 CCS codes cont. 
CCS1 
code 
CCS code description Number 
(%) of 
patients 
9 Diseases of the digestive system 9 (3%) 
10 Diseases of the genitourinary system 19 (6%) 
12 Diseases of the skin and subcutaneous tissue 1 (<1%) 
13 Diseases of the musculoskeletal system and connective tissue 28 (9%) 
16 Injury and poisoning 17 (6%) 
17 Symptoms; signs; and ill-defined conditions and factors 
influencing health status 
17 (6%) 
18 Residual codes; unclassified 8 (3%) 
 
The NUTH SM diagnoses are graphically displayed in figure AP11.2 with figure 1.2.3 from the 
literature review repeated below for comparison. 
 
Figure AP11.2 NUTH SM diagnoses summarised using CCS codes 
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Figure 1.2.3 Taxonomy of SM using CCS codes (repeated from chapter 1.2) 
Patient characteristics 
The demographics of the NUTH suspected stroke cohort are displayed in table AP11.5. 100% 
of patients had a gender recorded. One patient had no age documented but was recorded as 
an adult so was included. 
Table AP11.5 Demographics of NEAS suspected stroke patients transported to NUTH 
reported by discharge diagnosis 
 Total 
sample 
Stroke SM P value 
Number patients 1,000 618 382 - 
Mean age (SD) 73.5 (14.6) 75.3 (12.8) 70.8 (16.9) <0.001 
Gender (% male) 48% 50% 46% 0.060 
 
The mean age for males in the NUTH cohort was 70.9 (stroke 71.9, SM 69.1). The mean age 
for females in the NUTH cohort was 75.9 (stroke 78.6, SM 72.1). 
Physiological observations 
The physiological observations recorded on suspected stroke patients transported to NUTH 
hospitals are displayed in table AP11.6 below.  
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Table AP11.6. Physiological observations in NEAS data on suspected stroke patients 
transported to NUTH split by final diagnosis 
Physiological  
observations 
% of patients 
with 
observation 
documented 
Stroke  
(mean, SD) 
SM (mean, SD) P value 
BM (mmol/l) 96% 7.4 (2.9) 7.4 (3.1) 0.992 
GCS 100% 14 (1.8) 14 (2.0) 0.176 
Heart rate 99% 83 (18.9) 85 (19.5) 0.085 
Irregular pulse 96% 25% 15% <0.001 
Pain (0-10) 63% 0.3 (1.0) 0.7 (1.8) 0.002 
SaO2 99% 96 (2.2) 96 (4.4) 0.048 
Respiratory rate 100% 17 (3.1) 17 (3.1) 0.560 
SBP (mmHg) 99% 163 (29.1) 155 (29.6) <0.001 
DBP (mmHg) 99% 90 (17.4) 88 (18.1) 0.045 
Temperature (Celsius) 86% 36.5 (0.6) 36.5 (0.8) 0.804 
 
Past medical history 
The characteristics of suspected stroke patients transported by NEAS to NUTH hospitals are 
shown in table AP11.7 below. 
Table AP11.7 Past medical history of NEAS suspected stroke patients transported to 
NUTH reported by final diagnosis 
 Patients with 
condition (% of 
total patients) 
Stroke (% of 
stroke 
patients with 
condition) 
SM (% of SM 
patients with 
condition) 
P value 
PMH Alcohol 
misuse 
18 (2%) 6 (1%) 12 (3%) 0.012 
PMH Angina 79 (8%) 48 (8%) 31 (8%) 0.843 
PMH Diabetes 171 (17%) 121 (20%) 50 (13%) 0.008 
PMH Epilepsy 50 (5%) 19 (3%) 31 (8%) <0.001 
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Table AP11.7 Past medical history of NEAS suspected stroke patients transported to 
NUTH reported by final diagnosis cont. 
 Patients with 
condition (% of 
total patients) 
Stroke (% of 
stroke 
patients with 
condition) 
SM (% of SM 
patients with 
condition) 
P value 
PMH Heart failure 25 (3%) 18 (3%) 7 (2%) 0.288 
PMH High 
cholesterol 
144 (14%) 95 (15%) 49 (13%) 0.265 
PMH Hypertension 305 (30%) 215 (35%) 90 (24%) <0.001 
PMH MI 100 (10%) 64 (10%) 36 (9%) 0.633 
PMH Migraine 13 (1%) 5 (1%) 8 (2%) 0.081 
PMH Smoking 19 (2%) 13 (2%) 6 (2%) 0.549 
PMH Stroke 257 (26%) 142 (23%) 115 (30%) 0.012 
PMH TIA 161 (16%) 101 (16%) 60 (16%) 0.790 
 
Clinical signs and symptoms 
The signs and symptoms recorded by the paramedics are displayed below. 
Table AP11.8 NEAS observations on suspected stroke patients transported to NUTH 
reported by discharge diagnosis 
  
Patients with 
condition (% of 
total patients) 
Stroke (% of 
stroke 
patients with 
condition) 
SM (% of SM 
patients with 
condition) 
P value 
Abnormal gait 72 (7%) 53 (9%) 19 (5%) 0.032 
AF* 102 (10%) 75 (12%) 27 (7%) 0.01 
Alcohol/Drug use 
reported 
35 (4%) 12 (2%) 23 (6%) 0.001 
Altered Sensation 
(FT)* 
96 (10%) 47 (8%) 49 (13%) 0.006 
Arm weakness* 642 (64%) 440 (71%) 202 (53%) <0.001 
 320 
 
Table AP11.8 NEAS observations on suspected stroke patients transported to NUTH 
reported by discharge diagnosis cont. 
 
Patients with 
condition (% of 
total patients) 
Stroke (% of 
stroke 
patients with 
condition) 
SM (% of SM 
patients with 
condition) 
P value 
Chest pain 5 (1%) 2 (<1%) 3 (1%) 0.315 
Confusion 290 (29%) 163 (26%) 127 (33%) 0.02 
Dizziness 68 (7%) 35 (6%) 33 (9%) 0.069 
Eye issues (FT)* 69 (7%) 46 (7%) 23 (6%) 0.389 
Facial droop or 
weakness 
544 (54%) 372 (60%) 172 (45%) <0.001 
FAST +ve* 535 (54%) 360 (58%) 175 (46%) <0.001 
Floppy 44 (4%) 29 (5%) 15 (4%) 0.566 
General weakness 178 (18%) 95 (15%) 83 (22%) 0.011 
Headache 203 (20%) 112 (18%) 91 (24%) 0.029 
Leg weakness* 458 (46%) 327 (53%) 131 (34%) <0.001 
Nausea or 
vomiting* 
113 (11%) 63 (10%) 50 (13%) 0.16 
Neck Stiffness 13 (1%) 7 (1%) 6 (2%) 0.552 
Seizures 31 (3%) 3 (1%) 28 (7%) <0.001 
Speech symptoms 679 (68%) 453 (73%) 226 (59%) <0.001 
Syncope 11 (1%) 3 (1%) 8 (2%) 0.018 
Tremors 22 (2%) 11 (2%) 11 (3%) 0.249 
Unconscious 38 (4%) 14 (2%) 24 (6%) 0.001 
Visual 
disturbances* 
75 (8%) 39 (6%) 36 (9%) 0.069 
*The same criteria for these characteristics was used as documented in chapter 1.4 
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Paramedic documentation of impression 
Paramedic impression was examined to see if it related to discharge diagnosis. Impression 
was grouped into three distinct categories: 
1. Impression = stroke as only suspected diagnosis. 
2. Impression = stroke and TIA documented as only diagnoses. 
3. Impression = stroke included amongst multiple differential diagnoses. 
These three categories of impression were then compared with hospital discharge 
diagnoses. 
Table AP11.9 Paramedic impression and discharge diagnoses - NUTH 
Impression Total patients Stroke  SM 
Stroke only 758 515 (68%) 243 (32%) 
Stroke and TIA 80 45 (56%) 35 (44%) 
Stroke plus others 162 58 (36%) 104 (64%) 
 
The stroke plus other impression category included stroke plus a median of 1 additional 
impressions (range 1-6, IQR 1-2). Stroke patients with impression of ‘stroke plus other’ had 
25 different impressions documented in addition to stroke. SM patients with impression 
‘stroke plus other’ had 31 different impressions documented in addition to stroke.  
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Appendix L. Suspected stroke patients transported to North Tees Hospitals 
Suspected stroke patients transported to North Tees Hospitals 
There were 1,147 suspected stroke patients, including 45% SM, transported by NEAS to 
NTEES within the study timeframe. 
Patient Selection 
The process of identifying suspected stroke patients (n=1,147) transported by NEAS to NTEES 
is shown in figure AP12.1. 
 
Figure AP12.1. Identification of NEAS suspected stroke patients transported to NTEES 
Final patient diagnoses 
From the total cohort of 1,147 suspected stroke patients 547 (48%) were identified as stroke 
patients using SSNAP. The remaining 600 suspected stroke patients who were not positively 
matched in the SSNAP data were searched for using the NTEES electronic record system 
(HES).  
 41 patients were identified as TIA (ICD-10 codes G458 and G459) based on NTEES HES 
records. 
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 45 patients were identified as stroke based on NTEES HES records including 
diagnostic codes I61, I63 and I64.  
 158 patients had a SM ICD-10 diagnosis. 
 356 patients were unable to be linked with either SSNAP or HES. These patients were 
all assumed to be SM.  
Combining these figures results in 633 (55%) stroke patients and 514 (45%) SM patients. 
Assumed SM patients 
SM patients were identified (n=514) by either confirmed non-stroke diagnosis (n=158 
including any ICD-10 code other than I61, I63, I64 or TIA codes G458 and 459) in NTEES HES 
system or assumed (n=356) based on inability to match with either SSNAP or HES.  
The patients assumed to be SM (n=356) were compared with the patients with a confirmed 
SM diagnosis. 
Table AP12.1. Comparison of NTEES patients with confirmed SM diagnosis versus 
assumed SM diagnosis 
Diagnosis Age (mean, SD) Gender (% Male) 
Confirmed (n=158) 68.0 (16.4) 49 
Assumed (n=356) 68.2 (16.6) 49 
 
The two groups of SM patients were not significantly different in age (independent samples 
t-test, p=0.917) or gender (chi square test, p=0.965). 
Stroke mimic diagnoses 
Seventy different ICD-10 diagnostic codes were recorded for the 158 patients with a 
confirmed SM diagnosis. 
The ICD-10 based SM diagnoses are displayed in table AP12.2. 
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Table AP12.2. Most frequent ICD-10 diagnoses recorded for NTEES SM patients 
ICD-10 
Code 
ICD-10 description Number (%) of 
patients 
N390 Urinary tract infection, site not specified 12 (8%) 
R55X Syncope and collapse 12 (8%) 
M628 Other specified disorders of muscle 10 (6%) 
R568 Convulsions, not elsewhere classified 10 (6%) 
G510 Bell's palsy 8 (5%) 
G409 Epilepsy, unspecified 6 (4%) 
G431 Migraine with aura 6 (4%) 
G819 Hemiplegia, unspecified affecting unspecified side 5 (3%) 
R51X Headache 5 (3%) 
J189 Pneumonia, unspecified organism 4 (3%) 
R208 Other disturbances of skin sensation 4 (3%) 
J181 Lobar pneumonia, unspecified organism 3 (2%) 
J22X Unspecified acute lower respiratory infection 3 (2%) 
A084 Viral intestinal infection, unspecified 2 (1%) 
A099 Gastroenteritis and colitis of unspecified origin 2 (1%) 
C793 Secondary malignant neoplasm of brain and cerebral 
meninges 
2 (1%) 
F059 Delerium, unspecified 2 (1%) 
F100 Mental and behavioural disorders due to use of alcohol: 
Acute intoxication 
2 (1%) 
G439 Migraine, unspecified 2 (1%) 
I629 Nontraumatic intracranial hemorrhage, unspecified 2 (1%) 
I951 Orthostatic hypotension 2 (1%) 
I959 Hypotension, unspecified 2 (1%) 
M4782 Other spondylosis cervical region 2 (1%) 
R073 Other chest pain 2 (1%) 
R296 Repeated falls 2 (1%) 
R470 Aphasia 2 (1%) 
R478 Other speech disturbances 2 (1%) 
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Table AP12.2. Most frequent ICD-10 diagnoses recorded for NTEES SM patients cont. 
ICD-10 
Code 
ICD-10 description Number (%) of 
patients 
Other Other conditions with less than 1% (n=2) prevalence 42 (27%) 
 
The ICD-10 codes were summarised using CCS codes. The most frequent SM diagnoses 
represented using level 2 CCS codes are shown in table AP12.3.  
Table AP12.3 NTEES SM diagnoses displayed using level 2 CCS codes 
CCS level 2 
code 
CCS description Number (%) 
of patients 
6.9 Other nervous system disorders 23 (15%) 
6.4 Epilepsy; convulsions 18 (11%) 
13.8 Other connective tissue disease 15 (9%) 
6.5 Headache; including migraine 14 (9%) 
10.1 Diseases of the urinary system 13 (8%) 
17.1 Symptoms; signs; and ill-defined conditions 12 (8%) 
8.1 Respiratory infections 7 (4%) 
7.4 Diseases of arteries; arterioles; and capillaries 6 (4%) 
6.3 Paralysis 5 (3%) 
7.2 Diseases of the heart 4 (3%) 
9.1 Intestinal infection 4 (3%) 
5.11 Alcohol-related disorders 3 (2%) 
5.4 Delirium dementia and amnestic and other cognitive 
disorders 
3 (2%) 
7.3 Cerebrovascular disease 3 (2%) 
8.8 Other lower respiratory disease 3 (2%) 
1.3 Viral infection 2 (1%) 
2.12 Secondary malignancies 2 (1%) 
3.8 Fluid and electrolyte disorders 2 (1%) 
6.2 Hereditary and degenerative nervous system conditions 2 (1%) 
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Table AP12.3 NTEES SM diagnoses displayed using level 2 CCS codes cont. 
CCS level 2 
code 
CCS description Number (%) 
of patients 
13.3 Spondylosis; intervertebral disc disorders; other back 
problems 
2 (1%) 
16.2 Fractures 2 (1%) 
Other Other conditions with less than 1% (n=2) prevalence 13 (8%) 
 
The CCS codes were combined into level 1 CCS codes to show broader clinical groupings as 
shown in table AP12.4.   
Table AP12.4. NTEES SM diagnoses displayed using level 1 CCS codes 
CCS1 
code 
CCS code description Number (%) of 
patients 
1 Infectious and parasitic diseases 3 (2%) 
2 Neoplasms 4 (3%) 
3 Endocrine; nutritional; and metabolic diseases and 
immunity disorders 
2 (1%) 
4 Diseases of the blood and blood-forming organs 1 (1%) 
5 Mental Illness 7 (4%) 
6 Diseases of the nervous system and sense organs 65 (41%) 
7 Diseases of the circulatory system 13 (8%) 
8 Diseases of the respiratory system 12 (8%) 
9 Diseases of the digestive system 4 (3%) 
10 Diseases of the genitourinary system 13 (8%) 
12 Diseases of the skin and subcutaneous tissue 2 (1%) 
13 Diseases of the musculoskeletal system and connective 
tissue 
17 (11%) 
16 Injury and poisoning 3 (2%) 
17 Symptoms; signs; and ill-defined conditions and factors 
influencing health status 
12 (8%) 
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The NTEES SM diagnoses are graphically displayed in figure AP12.2 with figure 1.2.3 from the 
systematic review repeated below for comparison. 
 
Figure AP12.2. NTEES SM diagnoses summarised using CCS codes 
 
Figure 1.2.3 Taxonomy of SM using CCS codes (repeated from chapter 1.2) 
Patient characteristics 
The demographics of the NTEES sample are displayed below. 100% of patients had a gender 
recorded. Seventeen patient had no age documented but were recorded as adults so were 
included. 
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Table AP12.5. Demographics of NEAS suspected stroke patients transported to NTEES 
split by final diagnosis 
 Total 
sample 
Stroke SM P value 
Number patients 1,147 633 514 - 
Mean age (SD) 71.3 (14.9) 73.8 (13.0) 68.1 (16.5) <0.001 
Gender (% male) 49% 49% 49% 0.982 
 
The mean age for males in the NTEES cohort was 69.2 (stroke 70.6, SM 67.5). The mean age 
for females in the NTEES cohort was 73.3 (stroke 77.1, SM 68.7). 
Physiological observations 
The physiological observations recorded on suspected stroke patients transported to NTEES 
hospitals are displayed in table AP12.6 below.  
Table AP12.6. Physiological observations in NEAS data on suspected stroke patients 
transported to NTEES split by final diagnosis 
Physiological  
observations 
% of patients 
with 
observation 
documented 
Stroke  
(mean, SD) 
SM (mean, SD) P value 
BM (mmol/l) 96% 7.7(2.9) 7.6 (2.9) 0.489 
GCS 100% 14 (1.7) 14 (1.7) 0.047 
Heart rate 99% 83 (18.5) 83 (18.3) 0.753 
Irregular pulse 99% 24% 16% <0.001 
Pain (0-10) 66% 0.3 (1.2) 0.7 (1.8) <0.001 
SaO2 99% 96 (3.1) 96 (2.5) 0.352 
Respiratory rate 99% 17 (3.0) 17 (2.8) 0.636 
SBP (mmHg) 99% 160 (28.7) 154 (27.4) <0.001 
DBP (mmHg) 99% 88 (17.4) 88 (18.2) 0.777 
Temperature (Celsius) 88% 36.4 (0.7) 36.6 (0.8) 0.003 
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Past medical history 
The past medical history of suspected stroke patients transported by NEAS to NTEES 
hospitals are shown in table AP12.7 below. 
Table AP12.7. Characteristics of NEAS suspected stroke patients transported to NTEES 
split by discharge diagnosis 
 Patients with 
condition (% of 
total patients) 
Stroke (% of 
stroke 
patients with 
condition) 
SM (% of SM 
patients with 
condition) 
P value 
PMH Alcohol 
misuse 
24 (2%) 12 (2%) 12 (2%) 0.606 
PMH Angina 110 (10%) 63 (10%) 47 (9%) 0.644 
PMH Diabetes 184 (16%) 100 (16%) 84 (16%) 0.803 
PMH Epilepsy 50 (4%) 21 (3%) 29 (6%) 0.055 
PMH Heart failure 33 (3%) 23 (4%) 10 (2%) 0.089 
PMH High 
cholesterol 
243 (21%) 137 (22%) 106 (21%) 0.674 
PMH Hypertension 391 (34%) 225 (36%) 166 (32%) 0.248 
PMH MI 113 (10%) 63 (10%) 50 (10%) 0.899 
PMH Migraine 13 (1%) 4 (1%) 9 (2%) 0.075 
PMH Smoking 30 (3%) 17 (3%)  13 (3%) 0.869 
PMH Stroke 290 (25%) 125 (20%) 165 (32%) <0.001 
PMH TIA 192 (17%) 81 (13%) 111 (22%) <0.001 
 
Clinical signs and symptoms 
The signs and symptoms recorded by the paramedics are displayed below. 
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Table AP12.8. NEAS observation on suspected stroke patients transported to NTEES split 
by discharge diagnosis 
  Patients with 
condition (% of 
total patients) 
Stroke (% of 
stroke patients 
with 
condition) 
SM (% of SM 
patients with 
condition) 
P value 
Abnormal gait 119 (10%) 76 (12%) 43 (8%) 0.044 
AF* 96 (8%) 65 (10%) 31 (6%) 0.01 
Alcohol/Drug use 
reported 
30 (3%) 11 (2%) 19 (4%) 0.039 
Altered Sensation 
(FT)* 
105 (9%) 40 (6%) 65 (13%) <0.001 
Arm weakness* 758 (66%) 460 (73%) 298 (58%) <0.001 
Chest pain 27 (2%) 12 (2%) 15 (3%) 0.256 
Confusion 330 (29%) 170 (27%) 160 (31%) 0.112 
Dizziness 118 (10%) 51 (8%) 67 (13%) 0.006 
Eye issues (FT)* 46 (4%) 32 (5%) 14 (3%) 0.045 
Facial droop or 
weakness 
654 (57%) 385 (61%) 269 (52%) 0.004 
FAST+ve* 542 (47%) 313 (49%) 229 (45%) 0.099 
Floppy 60 (5%) 31 (5%) 29 (6%) 0.573 
General weakness 280 (24%) 137 (22%) 143 (28%) 0.015 
Headache 274 (24%) 121 (19%) 153 (30%) <0.001 
Leg weakness* 563 (49%) 349 (55%) 214 (42%) <0.001 
Nausea or 
vomiting* 
143 (13%) 62 (10%) 81 (16%) 0.002 
Neck Stiffness 26 (2%) 11 (2%) 15 (3%) 0.182 
Seizures 34 (3%) 10 (2%) 24 (5%) 0.002 
Speech symptoms 774 (68%) 460 (73%) 314 (61%) <0.001 
Syncope 7 (1%) 3 (1%) 4 (1%) 0.511 
Tremors 34 (3%) 17 (3%) 17 (3%) 0.537 
Unconscious 49 (4%) 23 (4%) 26 (5%) 0.235 
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Table AP12.8. NEAS observation on suspected stroke patients transported to NTEES split 
by discharge diagnosis cont. 
 Patients with 
condition (% of 
total patients) 
Stroke (% of 
stroke patients 
with 
condition) 
SM (% of SM 
patients with 
condition) 
P value 
Visual 
disturbances* 
110 (10%) 51 (8%) 59 (12%) 0.05 
*The same criteria for these characteristics was used as documented in chapter 1.4 
Paramedic documentation of impression 
Paramedic impression was examined to see if it related to final diagnosis. Impression was 
grouped into three distinct categories: 
1. Impression = stroke as only suspected diagnosis. 
2. Impression = stroke and TIA documented as only diagnoses. 
3. Impression = stroke included amongst multiple differential diagnoses. 
These three categories of impression were then compared with final hospital diagnoses. 
Table AP12.9. Paramedic impression and discharge diagnoses - NTEES 
Impression Total patients Stroke  SM 
Stroke only 872 514 (59%) 358 (41%) 
Stroke and TIA 87 47 (54%) 40 (46%) 
Stroke plus others 188 72 (38%) 116 (62%) 
 
The stroke plus other impression category included stroke plus a median of 2 additional 
impressions (range 1-8, IQR 1-2). Stroke patients with impression of ‘stroke plus other’ had 
25 different impressions documented in addition to stroke. SM patients with impression 
‘stroke plus other’ had 31 different impressions documented in addition to stroke.   
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Appendix M. Usability testing feedback form 
Paramedic Stroke Mimic (PaStraMi) Study 
Feedback on mimic assessment tool 
1. What are your general thoughts on the mimic assessment 
tool? 
 
2. How easy or difficult was it to include the mimic tool 
characteristics in your assessment? 
Very difficult Difficult Neutral  Easy     Very Easy 
3. Did the mimic tool agree with your clinical decision making? 
Never  Rarely Sometimes Mostly Always 
4. What did you think about using the mimic tool in practice? 
 
5. Are there any criteria within the tool that you think need 
changing? 
 
6. What format do you think the tool would be most useful in? 
 
7. What would be the best way to train paramedics to use this 
tool if it became part of normal practice? 
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8. When the tool indicated a patient may be a stroke mimic how 
would you have felt about not following your standard stroke 
protocol? 
 
9. How could you see the mimic tool fitting in with your local 
protocols? 
 
10. Is there anything else you think might be useful to the 
project going forward that we haven’t asked about? 
 
Name…………………………………………………………………………………………….. 
Signed……………………………………………………………………………………………. 
Date………………………………………………………………………......................... 
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Appendix N. Usability testing training material 
Paramedic Stroke Mimic (PaStraMi) Study 
Stroke mimic assessment tool training 
Background 
Between 25 and 50% of suspected stroke patients admitted 
to hospital by ambulance turn out to be non-stroke 
conditions. We call these conditions stroke mimics as they 
present with stroke like symptoms but have a different 
underlying cause. This project is looking into whether 
paramedics can accurately identify some of these stroke 
mimics using the tool described below. 
The tool 
We have developed a simple tool that identifies some stroke 
mimics. The STEAM tool involves 5 characteristics that 
indicate a suspected stroke patient may be a stroke mimic. 
1. Systolic blood pressure < 95mmHg 
2. Temperature > 38oC AND heart rate >90 bpm 
3. History of Epilepsy AND seizures at presentation 
4. Age < 40 years 
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5. History of Migraine AND headache at presentation 
The presence of 1 or more of these characteristics identifies 
around 10% of stroke mimics with around 90% accuracy. 
What you need to do 
We want you to document the presence or absence of these 
characteristics when you are attending a suspected stroke 
patient and consider if the patient could be a stroke mimic.  
IMPORTANT - We are NOT asking you to change your 
treatment in any way so follow your normal stroke protocol. 
We will contact you at the end of the study for some 
feedback on the tool and how you used it in practice. 
What happens next? 
If you are happy with the tool please email Graham 
McClelland to confirm you are happy to participate in this 
evaluation and start using the STEAM tool on all suspected 
strokes. If you are not happy with the tool please contact 
Graham McClelland and we will arrange face to face training 
or answer any questions you may have. 
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Contacts 
Graham or Sonia can be contacted any time during the study 
if you have any questions or concerns. 
Graham McClelland graham.mcclelland@neas.nhs.uk or on 
0191 430 2244 or 0191 208 6232 
If you would like to speak to someone else about the study 
please contact Sonia Byers (R&D Manager) 
Sonia.byers@neas.nhs.uk or on 0191 430 2192 
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Appendix O. Usability testing interview topic guide 
Paramedic Stroke Mimic (PaStraMi) Study 
Interview schedule: mimic evaluation 
(These are not prescriptive, but points to be used to guide interviews. Any topics that arise naturally 
during the course of the discussion should be explored.) 
Introduction and housekeeping 
 Researcher introduction and overview of study 
 Reiterate right to withdraw/stop anytime, confidentiality, anonymity, data 
storage/destruction 
 Any questions? 
 Permission to record interview – audio? 
 Consent 
PaStraMi development (Presentation) 
 Description of project 
 Description of findings of systematic literature review 
 Development of the mimic tool 
Stroke mimics 
 Stroke mimics as a general topic (refer back to literature and survey data) 
The Mimic Tool 
 Initial thoughts on the mimic tool 
 How did people find using the tool? Any tweaks or suggestions? 
 Did the tool fit into participant’s normal assessment and practice? Were there any issues? 
 Format of the tool – would memory aids be useful? 
 Particular patients where the tool was used? 
Any feedback on/from hospitals? 
Barriers/facilitators to implementing the stroke mimic tool 
 What would help/hinder implementing this type of tool in prehospital care 
 How could we roll this out across a large area? 
 Any particular training needs? 
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Particular populations/conditions who may be identified or at risk 
 Are there particular groups (young) or conditions (seizures, migraines) that are of concern to 
participants 
Any further questions 
 Explain what will happen next (further interviews, data analysis, other project activities) 
 Thank participant 
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Appendix P. Usability testing interview stimulus material 
STEAMv1 
Application to GCS8+  
 1 point for SBP<95mmHg 
 1 point for Temp>38.0oC AND HR>90 BPM 
 1 point for Seizures AND PMH epilepsy 
 1 point for Age < 40 years 
 1 point for Migraine AND headache 
Score 1+ = 11% sens, 99% spec, 86% PPV 
 
STEAMv2 
Application to GCS8+ and BM3+ 
 1 point for SBP<90mmHg 
 1 point for Temp>38.5oC AND HR>90 BPM 
 1 point for Seizures OR 2 points for Seizures AND PMH epilepsy 
 1 point for Age < 40 years OR 2 points for Age < 30 years 
 1 point for Migraine AND headache 
 1 point for FAST-ve 
Score 2+ = 5% sens, 100% spec, 92% PPV 
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Usability testing 
SBP, Temp, HR, Age all consistently recorded 
Seizures commonly recorded 
Headache recorded about half the time 
PMH epilepsy or migraine rarely recorded 
STEAM rarely recorded 
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Appendix Q. Focus group 3 topic guide 
Paramedic Stroke Mimic (PaStraMi) Focus Groups 
Topic guide: Focus group 3  
Introduction and housekeeping 
 Researcher introduction and overview of study 
 Reiterate right to withdraw/stop anytime, confidentiality, anonymity, data 
storage/destruction, no right or wrong answers 
 Any questions? 
 Permission to record interview – audio? 
 Consent 
Background 
Development process, lit – survey – STEAMv1 – FG – usability – refinement – STEAMv2 – modelling 
(handout1 – process, STEAMv1 and v2) 
Topics 
 STEAMv2 
o STEAMv2 criteria 
o STEAMv2 performance 
o Compare and contrast STEAMv1 and v2  
 how does STEAM1 (more SM but more stroke) compare with STEAMv2 (less 
of both but more accuracy) 
 
 Pre-alerting stroke and SM patients  
 Existing prehospital exclusion criteria in local practice 
 Time since onset 
 Telemedicine 
 
 Modelling 
o 4 domains (handout 2 – domains, outputs) 
o Chameleon rate – context 
o FP rate 
o 3 relevant groups – patients, ambulance service, stroke services 
 Could this work in practice?  
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 What would you like to see next? 
Any further questions 
 Explain what will happen next  
 Thank all participants 
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Appendix R. Focus group 3 stimulus material  
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Appendix S. UK pre-hospital stroke pathways 
In May 2018 stroke pathways were sourced from all ten of the UK regional ambulance 
services and the Northern Irish, Scottish and Welsh ambulance services to explore how 
representative the NEAS and NWAS pathways were and to determine if other services were 
already using criteria to rule out SM. Pathways were sourced from each services website or 
via direct contact with paramedics in each service. The results are shown in table AP19.1. 
 
The results showed that FAST was included in all 13 pathways, which supported the results 
of the survey in chapter 1.2, but revealed that three services had additional screening 
criteria including leg weakness and posterior circulation stroke symptoms. Since this survey 
was conducted one service introduced BEFAST so four services now have additional 
screening criteria. It is unknown how these additional screening criteria impact on the SM 
rate and how a tool like STEAMv2 would perform in these services both of which would be 
valuable areas for future research. 
The upper time limit for transporting a suspected stroke patient directly to specialist stroke 
services as a medical emergency varied between 3 and 6 hours from onset, with two services 
extending the time threshold to 12 and 48 hours for specific presentations. 
Seizures (6 pathways) and reduced consciousness level (4 pathways) were criteria for 
transportation to the nearest ED instead of specialist stroke services. The blood glucose 
Ambulance Service 
Number Stroke identification tool Summary of pathway
Minimum 
age Time (hours)
GCS 
exclusion
BM (mmol/l) 
exclusion
Seizures 
excluded Other exclusions
1a FAST
ASU if FAST+ within 4 hours, local ED 
if not NA 4 <8 <4.0 Yes
Airway, RR<10 or >30, 
SPO2<90, BP<90, HR<40 or 
1b FAST
<4 hours HASU, 4-48 hours HASU +/- 
pre-alert anticoags, >48 hours 
nearest ED 16+ Variable <8 <4.0 Yes
Airway, RR<10 or >30, 
SPO2<90, BP<90, HR<40 or 
>150
2 FAST
<4.5 hours pre-alert to HASU, >4.5 
hours normal driving to HASU 18+ 4.5 Yes ABC concern = local ED
3 FAST + AVVV mnemonic
Within 5 hours, conscious, pre-alert 
ED NA 5 Conscious <3.0 Yes
4 FAST
Symptom onset <4.5 hours = 
thrombolysing hospital NA 4.5
5 FAST
Arrive at thrombolysing hospital 
within 5.5 hours from onset NA 5.5 <4.0 Yes
6 FAST
4.5-6 hours pre-alert to stroke team 
at hospital, otherwise normal clinical 
practice 18+ Variable <4.0 Yes
7 FAST
Symptoms<3 hours = HASU, 
symptoms>3 hours nearest ASU, both 
with pre-alert NA 3
8 FAST & MEND
4.5-6 hours to arrival dependent on 
hospital NA Variable <3.5
9 FAST
Thrombolysing hospital within 4.5 
hours otherwise nearest ED NA 4.5 Hypoglycaemia Major ABC problem
10 FAST Onset within 5 hours 18+ 5 <11 <3.5
11 FAST
<4.5 hours pre-alert most 
approrpriate ED, >4.5 hours normal 
drive to ED NA 4.5 <4.0
12
FAST inc leg weakness or 
vision loss <12 hours
Pre-alert to local shortest travel time 
HASU otherwise nearest ED with pre-
alert 18+ <8 Yes
Airway, LOC, head injury, 
clinically unstable
13 FAST
Time critical = nearest ED, FAST+ pre-
alert to recognised stroke unit NA
Table AP19.1. Summary of pre-hospital stroke pathways
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threshold for considering hypoglycaemia varied from 3 to 4 mmol/l (8 pathways). One 
service (service 1) used physiological parameters e.g. respiratory rate, heart rate and blood 
pressure, to direct potential stroke patients to ED. 
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